SAR 10-Q Quarterly Report Nov. 30, 2024 | Alphaminr
SARATOGA INVESTMENT CORP.

SAR 10-Q Quarter ended Nov. 30, 2024

SARATOGA INVESTMENT CORP.
10-Ks and 10-Qs
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
PROXIES
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-Q

Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the Quarterly Period Ended November 30, 2024

Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Commission File No. 814-00732

SARATOGA INVESTMENT CORP.

(Exact name of registrant as specified in its charter)

Maryland 20-8700615
(State or other jurisdiction of
incorporation or organization)
(I.R.S. Employer
Identification Number)

535 Madison Avenue

New York, New York 10022

(Address of principal executive offices)

(212) 906-7800

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, par value $0.001 per share SAR The New York Stock Exchange
6.00% Notes due 2027 SAT The New York Stock Exchange
8.00% Notes due 2027 SAJ The New York Stock Exchange
8.125% Notes due 2027 SAY The New York Stock Exchange
8.50% Notes due 2027 SAZ The New York Stock Exchange

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days: Yes ☒   No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒   No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer Accelerated filer
Non-accelerated filer Smaller reporting company
Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐   No

The number of outstanding common shares of the registrant as of January 7, 2025 was 14,346,373 .

TABLE OF CONTENTS

Page
PART I. FINANCIAL INFORMATION 1
Item 1. Consolidated Financial Statements 1
Consolidated Statements of Assets and Liabilities as of November 30, 2024 (unaudited) and February 29, 2024 1
Consolidated Statements of Operations for the three and nine months ended November 30, 2024 (unaudited) and November 30, 2023 (unaudited) 2
Consolidated Statements of Changes in Net Assets for three and nine months ended November 30, 2024 (unaudited) and November 30, 2023 (unaudited) 3
Consolidated Statements of Cash Flows for the nine months ended November 30, 2024 (unaudited) and November 30, 2023 (unaudited) 4
Consolidated Schedules of Investments as of November 30, 2024 (unaudited) and February 29, 2024 5
Notes to Consolidated Financial Statements as of November 30, 2024 (unaudited) 28
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 108
Item 3. Quantitative and Qualitative Disclosures About Market Risk 149
Item 4. Controls and Procedures 150
PART II. OTHER INFORMATION 151
Item 1. Legal Proceedings 151
Item 1A. Risk Factors 151
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 152
Item 3. Defaults Upon Senior Securities 152
Item 4. Mine Safety Disclosures 152
Item 5. Other Information 152
Item 6. Exhibits 153
Signatures 155

i

PART I. FINANCIAL INFORMATION

Item 1. Consolidated Financial Statements

Saratoga Investment Corp.

Consolidated Statements of Assets and Liabilities

November 30,
2024
February 29,
2024
(unaudited)
ASSETS
Investments at fair value
Non-control/Non-affiliate investments (amortized cost of $ 852,158,089 and $ 1,035,879,751 , respectively) $ 875,707,680 $ 1,019,774,616
Affiliate investments (amortized cost of $ 37,627,241 and $ 26,707,415 , respectively) 39,803,456 27,749,137
Control investments (amortized cost of $ 77,556,847 and $ 117,196,571 , respectively) 44,582,096 91,270,036
Total investments at fair value (amortized cost of $ 967,342,177 and $ 1,179,783,737 , respectively) 960,093,232 1,138,793,789
Cash and cash equivalents 147,614,810 8,692,846
Cash and cash equivalents, reserve accounts 102,549,213 31,814,278
Interest receivable (net of reserve of $ 68,735 and $ 9,490,340 , respectively) 7,462,134 10,298,998
Management fee receivable 327,368 343,023
Other assets 1,871,192 1,163,225
Current income tax receivable 1,931 99,676
Total assets $ 1,219,919,880 $ 1,191,205,835
LIABILITIES
Revolving credit facilities $ 52,500,000 $ 35,000,000
Deferred debt financing costs, revolving credit facilities ( 1,467,001 ) ( 882,122 )
SBA debentures payable 214,000,000 214,000,000
Deferred debt financing costs, SBA debentures payable ( 5,072,871 ) ( 5,779,892 )
8.75% Notes Payable 2025 20,000,000 20,000,000
Discount on 8.75% notes payable 2025 ( 35,045 ) ( 112,894 )
Deferred debt financing costs, 8.75% notes payable 2025 ( 1,460 ) ( 4,777 )
7.00% Notes Payable 2025 12,000,000 12,000,000
Discount on 7.00 % notes payable 2025 ( 100,675 ) ( 193,175 )
Deferred debt financing costs, 7.00 % notes payable 2025 ( 12,257 ) ( 24,210 )
7.75% Notes Payable 2025 5,000,000 5,000,000
Deferred debt financing costs, 7.75 % notes payable 2025 ( 33,209 ) ( 74,531 )
4.375% Notes Payable 2026 175,000,000 175,000,000
Premium on 4.375 % notes payable 2026 363,367 564,260
Deferred debt financing costs, 4.375 % notes payable 2026 ( 1,073,336 ) ( 1,708,104 )
4.35% Notes Payable 2027 75,000,000 75,000,000
Discount on 4.35 % notes payable 2027 ( 233,940 ) ( 313,010 )
Deferred debt financing costs, 4.35 % notes payable 2027 ( 773,704 ) ( 1,033,178 )
6.25% Notes Payable 2027 15,000,000 15,000,000
Deferred debt financing costs, 6.25 % notes payable 2027 ( 219,726 ) ( 273,449 )
6.00% Notes Payable 2027 105,500,000 105,500,000
Discount on 6.00 % notes payable 2027 ( 96,638 ) ( 123,782 )
Deferred debt financing costs, 6.00 % notes payable 2027 ( 1,696,769 ) ( 2,224,403 )
8.00% Notes Payable 2027 46,000,000 46,000,000
Deferred debt financing costs, 8.00 % notes payable 2027 ( 1,013,039 ) ( 1,274,455 )
8.125% Notes Payable 2027 60,375,000 60,375,000
Deferred debt financing costs, 8.125 % notes payable 2027 ( 1,256,679 ) ( 1,563,594 )
8.50 % Notes Payable 2028 57,500,000 57,500,000
Deferred debt financing costs, 8.50% notes payable 2028 ( 1,373,467 ) ( 1,680,039 )
Base management and incentive fees payable 7,521,835 8,147,217
Deferred tax liability 4,581,381 3,791,150
Accounts payable and accrued expenses 2,500,210 1,337,542
Interest and debt fees payable 5,875,852 3,582,173
Due to Manager 796,396 450,000
Total liabilities 845,054,225 820,981,727
Commitments and contingencies (See Note 9)
NET ASSETS
Common stock, par value $ 0.001 , 100,000,000 common shares authorized, 13,909,206 and 13,653,476 common shares issued and outstanding, respectively 13,909 13,654
Capital in excess of par value 377,235,609 371,081,199
Total distributable deficit ( 2,383,863 ) ( 870,745 )
Total net assets 374,865,655 370,224,108
Total liabilities and net assets $ 1,219,919,880 $ 1,191,205,835
NET ASSET VALUE PER SHARE $ 26.95 $ 27.12

See accompanying notes to consolidated financial statements.

1

Saratoga Investment Corp.

Consolidated Statements of Operations

(unaudited)

For the three months ended For the nine months ended
November 30,
2024
November 30,
2023
November 30,
2024
November 30,
2023
INVESTMENT INCOME
Interest from investments
Interest income:
Non-control/Non-affiliate investments $ 28,301,622 $ 28,741,745 $ 95,247,113 $ 83,542,257
Affiliate investments 458,765 1,165,585 1,446,620 2,799,735
Control investments 1,220,769 2,183,242 4,465,137 6,314,550
Payment in kind interest income:
Non-control/Non-affiliate investments 355,161 88,106 2,073,035 706,339
Affiliate investments 424,357 221,348 915,807 644,484
Control investments
-
258,729 284,590 542,581
Total interest from investments 30,760,674 32,658,755 104,432,302 94,549,946
Interest from cash and cash equivalents 1,627,718 521,574 3,923,380 1,864,956
Management fee income 775,398 819,929 2,372,177 2,453,967
Dividend income(*):
Non-control/Non-affiliate investments 172,557 509,365 584,827 621,398
Control investments 948,102 1,319,219 3,160,742 4,679,699
Total dividend from investments 1,120,659 1,828,584 3,745,569 5,301,097
Structuring and advisory fee income 740,705 312,135 1,186,548 1,786,357
Other income 853,481 199,368 1,900,184 530,210
Total investment income 35,878,635 36,340,345 117,560,160 106,486,533
OPERATING EXPENSES
Interest and debt financing expenses 13,044,000 12,522,357 39,135,022 36,628,641
Base management fees 4,412,000 4,857,059 14,161,025 14,262,147
Incentive management fees expense (benefit) 3,109,834 2,243,621 11,244,838 4,828,442
Professional fees 670,376 434,552 1,795,572 1,407,275
Administrator expenses 1,250,000 1,075,000 3,458,333 2,797,917
Insurance 76,743 81,002 231,936 244,804
Directors fees and expenses 83,500 80,729 276,500 280,797
General and administrative 759,902 660,062 2,190,613 1,957,906
Income tax expense (benefit) 36,625 219,900 98,263 ( 11,193 )
Total operating expenses 23,442,980 22,174,282 72,592,102 62,396,736
NET INVESTMENT INCOME 12,435,655 14,166,063 44,968,058 44,089,797
REALIZED AND UNREALIZED GAIN (LOSS) ON INVESTMENTS
Net realized gain (loss) from investments:
Non-control/Non-affiliate investments 4,806,390 60,565 5,365,091 151,256
Control investments 638,355
-
( 54,564,070 )
-
Net realized gain (loss) from investments 5,444,745 60,565 ( 49,198,979 ) 151,256
Net change in unrealized appreciation (depreciation) on investments:
Non-control/Non-affiliate investments ( 7,026,951 ) ( 1,948,502 ) 39,654,726 ( 15,334,087 )
Affiliate investments 179,825 ( 1,084,259 ) 1,134,493 ( 1,289,895 )
Control investments ( 2,071,457 ) ( 14,833,592 ) ( 7,048,216 ) ( 23,302,249 )
Net change in unrealized appreciation (depreciation) on investments ( 8,918,583 ) ( 17,866,353 ) 33,741,003 ( 39,926,231 )
Net change in provision for deferred taxes on unrealized (appreciation) depreciation on investments ( 126,875 ) ( 415,894 ) ( 747,063 ) ( 577,693 )
Net realized and unrealized gain (loss) on investments ( 3,600,713 ) ( 18,221,682 ) ( 16,205,039 ) ( 40,352,668 )
Realized losses on extinguishment of debt
-
-
-
( 110,056 )
NET INCREASE (DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS $ 8,834,942 $ ( 4,055,619 ) $ 28,763,019 $ 3,627,073
WEIGHTED AVERAGE - BASIC AND DILUTED EARNINGS (LOSS) PER COMMON SHARE $ 0.64 $ ( 0.31 ) $ 2.09 $ 0.29
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING - BASIC AND DILUTED 13,789,951 13,052,896 13,733,008 12,355,815

* Certain prior period amounts have been reclassified to conform to current period presentation.

See accompanying notes to consolidated financial statements.

2

Saratoga Investment Corp.

Consolidated Statements of Changes in Net Assets

(unaudited)

For the nine months ended
November 30,
2024
November 30,
2023
INCREASE FROM OPERATIONS:
Net investment income $ 44,968,058 $ 44,089,797
Net realized gain (loss) from investments ( 49,198,979 ) 151,256
Realized losses on extinguishment of debt
-
( 110,056 )
Net change in unrealized appreciation (depreciation) on investments 33,741,003 ( 39,926,231 )
Net change in provision for deferred taxes on unrealized (appreciation) depreciation on investments ( 747,063 ) ( 577,693 )
Net increase in net assets resulting from operations 28,763,019 3,627,073
DECREASE FROM SHAREHOLDER DISTRIBUTIONS:
Total distributions to shareholders ( 30,276,137 ) ( 25,832,379 )
Net decrease in net assets from shareholder distributions ( 30,276,137 ) ( 25,832,379 )
CAPITAL SHARE TRANSACTIONS:
Proceeds from issuance of common stock (1) 2,777,426 31,510,617
Capital contribution from Manager 199,652 3,093,288
Stock dividend distribution 3,220,162 2,667,152
Repurchases of common stock
-
( 2,157,605 )
Repurchase fees
-
( 1,772 )
Offering costs ( 42,575 ) ( 305,667 )
Net increase in net assets from capital share transactions 6,154,665 34,806,013
Total increase in net assets 4,641,547 12,600,707
Net assets at beginning of period 370,224,108 346,958,042
Net assets at end of period $ 374,865,655 $ 359,558,749

(1) See Note 11 to the Consolidated Financial Statements contained herein for more information on share issuance.

See accompanying notes to consolidated financial statements.

3

Saratoga Investment Corp.

Consolidated Statements of Cash Flows

(unaudited)

For the nine months ended
November 30,
2024
November 30,
2023
Operating activities
NET INCREASE (DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS $ 28,763,019 $ 3,627,073
ADJUSTMENTS TO RECONCILE NET INCREASE (DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS TO NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES:
Distributions from CLO, payment-in-kind and other adjustments to cost ( 4,546,611 ) 4,054,128
Net accretion of discount on investments ( 2,181,920 ) ( 1,641,652 )
Amortization of deferred debt financing costs 3,781,712 3,909,127
Realized losses on extinguishment of debt
-
110,056
Income tax expense (benefit) 43,168 ( 11,193 )
Net realized (gain) loss from investments 49,198,979 ( 151,256 )
Net change in unrealized (appreciation) depreciation on investments ( 33,741,003 ) 39,926,231
Net change in provision for deferred taxes on unrealized (appreciation) depreciation on investments 747,063 577,693
Proceeds from sales and repayments of investments 296,246,215 19,247,834
Purchases of investments ( 126,275,103 ) ( 202,883,641 )
(Increase) decrease in operating assets:
Interest receivable 2,836,864 ( 1,075,968 )
Management fee receivable 15,655 ( 223 )
Other assets ( 707,967 ) ( 401,046 )
Current income tax receivable 97,745 336,875
Increase (decrease) in operating liabilities:
Base management and incentive fees payable ( 625,382 ) ( 3,975,165 )
Accounts payable and accrued expenses 1,162,668 621,900
Interest and debt fees payable 2,293,679 956,499
Directors fees payable
-
( 14,932 )
Due to Manager 346,396 239,065
NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES 217,455,177 ( 136,548,595 )
Financing activities
Borrowings on debt 30,000,000 62,500,000
Paydowns on debt ( 12,500,000 ) ( 57,000,000 )
Issuance of notes
-
77,500,000
Payments of deferred debt financing costs ( 1,176,806 ) ( 4,474,813 )
Proceeds from issuance of common stock 2,777,426 31,510,617
Capital contribution from Manager 199,652 3,093,288
Payments of cash dividends ( 27,055,975 ) ( 23,165,227 )
Repurchases of common stock
-
( 2,157,605 )
Repurchases fees
-
( 1,772 )
Payments of offering costs ( 42,575 ) ( 305,667 )
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES ( 7,798,278 ) 87,498,821
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS AND CASH AND CASH EQUIVALENTS, RESERVE ACCOUNTS 209,656,899 ( 49,049,774 )
CASH AND CASH EQUIVALENTS AND CASH AND CASH EQUIVALENTS, RESERVE ACCOUNTS, BEGINNING OF PERIOD 40,507,124 96,076,273
CASH AND CASH EQUIVALENTS AND CASH AND CASH EQUIVALENTS, RESERVE ACCOUNTS, END OF PERIOD (See note 2) $ 250,164,023 $ 47,026,499
Supplemental information:
Interest paid during the period $ 33,059,630 $ 31,763,015
Cash paid for taxes 617,665 654,930
Supplemental non-cash information:
Payment-in-kind interest income and other adjustments to cost 9,920,201 ( 4,054,128 )
Net accretion of discount on investments 2,181,920 1,641,652
Amortization of deferred debt financing costs 3,781,712 3,909,127
Stock dividend distribution 3,220,162 2,667,152

See accompanying notes to consolidated financial statements.

4

Saratoga Investment Corp.

Consolidated Schedule of Investments

November 30, 2024

(unaudited)

Company(1) Industry Investment
Interest Rate/
Maturity
Original
Acquisition
Date
Principal/
Number of
Shares
Cost Fair
Value (c)
% of
Net Assets
Non-control/Non-affiliate investments - 234.0% (b)
Altvia MidCo, LLC. Alternative Investment Management Software First Lien Term Loan
(3M USD TERM SOFR+ 8.50 %), 12.97 % Cash, 7/18/2027
7/18/2022 $ 8,857,800 $ 8,790,649 $ 8,867,544 2.4 %
Altvia MidCo, LLC. (h) Alternative Investment Management Software Series A-1 Preferred Shares 7/18/2022 2,000,000 2,000,000 2,718,029 0.7 %
Total Alternative Investment Management Software 10,790,649 11,585,573 3.1 %
BQE Software, Inc. (d) Architecture & Engineering Software First Lien Term Loan
(3M USD TERM SOFR+ 6.75 %), 11.22 % Cash, 4/13/2028
4/13/2023 $ 24,500,000 24,307,518 24,990,000 6.7 %
BQE Software, Inc. (j) Architecture & Engineering Software Delayed Draw Term Loan
(3M USD TERM SOFR+ 6.75 %), 11.22 % Cash, 4/13/2028
4/13/2023 $ 750,000 745,836 765,000 0.2 %
Total Architecture & Engineering Software 25,053,354 25,755,000 6.9 %
GrowthZone, LLC Association Management Software First Lien Term Loan
(3M USD TERM SOFR+ 8.25 %), 12.72 % Cash, 5/10/2028
5/10/2023 $ 23,395,388 23,085,098 23,984,952 6.4 %
Golden TopCo LP (h) Association Management Software Class A-2 Common Units 5/10/2023 1,072,394 1,072,394 1,380,841 0.4 %
Total Association Management Software 24,157,492 25,365,793 6.8 %
Artemis Wax Corp. (d)(j) Consumer Services Delayed Draw Term Loan
(1M USD TERM SOFR+ 7.50 %), 12.03 % Cash, 5/20/2026
5/20/2021 $ 57,500,000 57,301,213 56,850,250 15.2 %
Artemis Wax Corp. (h) Consumer Services Series B-1 Preferred Stock 5/20/2021 934,463 1,500,000 615,929 0.2 %
Artemis Wax Corp. (h) Consumer Services Series D Preferred Stock 12/22/2022 331,640 1,711,866 2,087,850 0.6 %
Total Consumer Services 60,513,079 59,554,029 16.0 %
Schoox, Inc. (h), (i) Corporate Education Software Series 1 Membership Interest 12/8/2020 1,050 475,698 4,624,002 1.2 %
Total Corporate Education Software 475,698 4,624,002 1.2 %
GreyHeller LLC (h) Cyber Security Common Stock 11/10/2021 7,857,689 1,906,275 3,437,554 0.9 %
Total Cyber Security 1,906,275 3,437,554 0.9 %

5

Saratoga Investment Corp.

Consolidated Schedule of Investments

November 30, 2024

(unaudited)

Company(1) Industry Investment
Interest Rate/
Maturity
Original
Acquisition
Date
Principal/
Number of
Shares
Cost Fair
Value (c)
% of
Net Assets
Gen4 Dental Partners Holdings, LLC Dental Practice Management First Lien Term Loan
(6M USD TERM SOFR+ 5.50 %), 9.88 % Cash, 5/13/2030
5/13/2024 $ 7,125,000 7,056,826 7,073,700 1.9 %
Gen4 Dental Partners Holdings, LLC (j) Dental Practice Management Delayed Draw Term Loan
(6M USD TERM SOFR+ 5.50 %), 9.88 % Cash, 5/13/2030
5/13/2024 $ - - - 0.0 %
Gen4 Dental Partners Holdings, LLC (j) Dental Practice Management Revolving Credit Facility
(6M USD TERM SOFR+ 5.50 %), 9.88 % Cash, 5/13/2030
5/13/2024 $ - - - 0.0 %
Gen4 Dental Partners Holdings, LLC (h)(i) Dental Practice Management Series A Preferred Units 2/8/2023 493,999 1,027,519 1,002,818 0.3 %
Modis Dental Partners OpCo, LLC Dental Practice Management First Lien Term Loan
(1M USD TERM SOFR+ 9.43 %), 13.96 % Cash, 4/18/2028
4/18/2023 $ 7,000,000 6,918,971 7,140,000 1.9 %
Modis Dental Partners OpCo, LLC (j) Dental Practice Management Delayed Draw Term Loan
(1M USD TERM SOFR+ 9.43 %), 13.96 % Cash, 4/18/2028
4/18/2023 $ 8,600,000 8,490,633 8,772,000 2.3 %
Modis Dental Partners OpCo, LLC (h) Dental Practice Management Class A Preferred Units 4/18/2023 2,950,000 2,950,000 2,639,985 0.7 %
New England Dental Partners Dental Practice Management First Lien Term Loan
(3M USD TERM SOFR+ 8.00 %), 12.62 % Cash, 11/25/2025
11/25/2020 $ 6,555,000 6,538,499 6,625,794 1.8 %
New England Dental Partners Dental Practice Management Delayed Draw Term Loan
(3M USD TERM SOFR+ 8.00 %), 12.62 % Cash, 11/25/2025
11/25/2020 $ 2,150,000 2,147,430 2,173,220 0.6 %
Total Dental Practice Management 35,129,878 35,427,517 9.5 %
Exigo, LLC (d) Direct Selling Software First Lien Term Loan
(1M USD TERM SOFR+ 6.25 %), 10.88 % Cash, 3/16/2027
3/16/2022 $ 24,127,538 24,010,777 23,343,393 6.2 %
Exigo, LLC (j) Direct Selling Software Revolving Credit Facility
(1M USD TERM SOFR+ 6.25 %), 10.88 % Cash, 3/16/2027
3/16/2022 $ - - ( 20,313 ) 0.0 %
Exigo, LLC (h), (i) Direct Selling Software Common Units 3/16/2022 1,041,667 1,041,667 747,131 0.2 %
Total Direct Selling Software 25,052,444 24,070,211 6.4 %
C2 Educational Systems, Inc. (d) Education Services First Lien Term Loan
(3M USD TERM SOFR+ 8.50 %), 12.97 % Cash, 5/31/2025
5/31/2017 $ 23,000,000 22,984,603 22,981,600 6.1 %
C2 Educational Systems, Inc. (j) Education Services Delayed Draw Term Loan
(3M USD TERM SOFR+ 8.50 %), 12.97 % Cash, 5/31/2025
4/28/2023 $ - - - 0.0 %
C2 Education Systems, Inc. (h) Education Services Series A-1 Preferred Stock 5/18/2021 3,127 499,904 598,074 0.2 %
Total Education Services 23,484,507 23,579,674 6.3 %

6

Saratoga Investment Corp.

Consolidated Schedule of Investments

November 30, 2024

(unaudited)

Company(1) Industry Investment
Interest Rate/
Maturity
Original
Acquisition
Date
Principal/
Number of
Shares
Cost Fair
Value (c)
% of
Net Assets
Modern Campus (fka Destiny Solutions Inc.) (h)(i) Education Software Limited Partner Interests 5/16/2018 3,068 3,969,291 11,292,087 3.0 %
GoReact Education Software First Lien Term Loan
(3M USD TERM SOFR+ 7.50 %), 12.17 % Cash/ 1.00 % PIK, 1/17/2025
1/17/2020 $ 8,142,981 8,139,422 8,142,981 2.2 %
GoReact (j) Education Software Delayed Draw Term Loan
(3M USD TERM SOFR+ 7.50 %), 12.17 % Cash/ 1.00 % PIK, 1/17/2025
1/18/2022 $ - - - 0.0 %
Identity Automation Systems (h) Education Software Common Stock Class A-2 Units 8/25/2014 232,616 232,616 1,178,242 0.3 %
Identity Automation Systems (h) Education Software Common Stock Class A-1 Units 3/6/2020 43,715 171,571 322,576 0.1 %
Ready Education (d) Education Software First Lien Term Loan
(3M USD TERM SOFR+ 7.00 %), 11.47 % Cash, 8/5/2027
8/5/2022 $ 27,000,000 26,827,805 26,878,500 7.2 %
Total Education Software 39,340,705 47,814,386 12.8 %
TG Pressure Washing Holdings, LLC (h) Facilities Maintenance Preferred Equity 8/12/2019 488,148 488,148 - 0.0 %
Total Facilities Maintenance 488,148 - 0.0 %
Davisware, LLC Field Service Management First Lien Term Loan
(3M USD TERM SOFR+ 6.50 %), 10.97 % Cash, 11/30/2025
9/6/2019 $ 6,000,000 6,000,000 6,001,800 1.6 %
Davisware, LLC (j) Field Service Management Delayed Draw Term Loan
(3M USD TERM SOFR+ 6.50 %), 10.97 % Cash, 11/30/2025
9/6/2019 $ 5,477,790 5,477,790 5,479,433 1.5 %
Total Field Service Management 11,477,790 11,481,233 3.1 %
GDS Software Holdings, LLC Financial Services First Lien Term Loan
(3M USD TERM SOFR+ 7.00 %), 11.47 % Cash, 12/30/2026
12/30/2021 $ 22,713,926 22,640,119 22,691,212 6.1 %
GDS Software Holdings, LLC (d) Financial Services Delayed Draw Term Loan
(3M USD TERM SOFR+ 7.00 %), 11.47 % Cash, 12/30/2026
12/30/2021 $ 3,286,074 3,265,729 3,282,788 0.9 %
GDS Software Holdings, LLC (h) Financial Services Common Stock Class A Units 8/23/2018 250,000 250,000 440,785 0.1 %
Total Financial Services 26,155,848 26,414,785 7.1 %
Ascend Software, LLC Financial Services Software First Lien Term Loan
(3M USD TERM SOFR+ 7.50 %), 12.23 % Cash, 12/15/2026
12/15/2021 $ 6,000,000 5,970,627 5,977,200 1.6 %
Ascend Software, LLC (j) Financial Services Software Delayed Draw Term Loan
(3M USD TERM SOFR+ 7.50 %), 12.23 % Cash, 12/15/2026
12/15/2021 $ 4,050,000 4,035,166 4,034,610 1.1 %
Total Financial Services Software 10,005,793 10,011,810 2.7 %

7

Saratoga Investment Corp.

Consolidated Schedule of Investments

November 30, 2024

(unaudited)

Company(1) Industry Investment
Interest Rate/
Maturity
Original
Acquisition
Date
Principal/
Number of
Shares
Cost Fair
Value (c)
% of
Net Assets
Inspect Point Holdings, LLC Fire Inspection Business Software First Lien Term Loan
(1M USD TERM SOFR+ 6.50 %), 11.03 % Cash, 07/19/2028
7/19/2023 $ 10,000,000 9,918,672 10,150,000 2.7 %
Inspect Point Holdings, LLC (j) Fire Inspection Business Software Delayed Draw Term Loan
(1M USD TERM SOFR+ 6.50 %), 11.03 % Cash, 07/19/2028
7/19/2023 $ - - - 0.0 %
Total Fire Inspection Business Software 9,918,672 10,150,000 2.7 %
Stretch Zone Franchising, LLC (d) Health/Fitness Franchisor First Lien Term Loan
(3M USD TERM SOFR+ 7.00 %), 11.47 % Cash, 3/31/2028
3/31/2023 $ 28,717,271 28,496,472 28,430,099 7.6 %
Stretch Zone Franchising, LLC (j) Health/Fitness Franchisor Delayed Draw Term Loan
(3M USD TERM SOFR+ 7.00 %), 11.47 % Cash, 3/31/2028
3/31/2023 $ - - - 0.0 %
Stretch Zone Franchising, LLC (h) Health/Fitness Franchisor Class A Units 3/31/2023 20,000 2,000,000 1,579,066 0.4 %
Total Health/Fitness Franchisor 30,496,472 30,009,165 8.0 %
Alpha Aesthetics Partners OpCo, LLC Healthcare Services First Lien Term Loan
(1M USD TERM SOFR+ 9.93 %), 14.46 % Cash, 3/20/2028
3/20/2023 $ 3,900,000 3,854,880 3,978,000 1.2 %
Alpha Aesthetics Partners OpCo, LLC (j) Healthcare Services Delayed Draw Term Loan
(1M USD TERM SOFR+ 9.93 %), 14.46 % Cash, 3/20/2028
3/20/2023 $ 11,447,385 11,305,102 11,676,333 3.1 %
Alpha Aesthetics Partners OpCo, LLC (h) Healthcare Services Class A Preferred Units 3/20/2023 3,675,000 3,675,000 3,624,323 1.0 %
Axiom Medical Consulting, LLC Healthcare Services First Lien Term Loan
(3M USD TERM SOFR+ 6.00 %), 10.47 % Cash, 9/11/2028
9/11/2023 $ 10,000,000 9,928,579 10,082,000 2.7 %
Axiom Medical Consulting, LLC (j) Healthcare Services Delayed Draw Term Loan
(3M USD TERM SOFR+ 6.00 %), 10.47 % Cash, 9/11/2028
9/11/2023 $ - - - 0.0 %
Axiom Parent Holdings, LLC (h) Healthcare Services Class A Preferred Units 6/19/2018 400,000 258,389 628,910 0.2 %
ComForCare Health Care (d) Healthcare Services First Lien Term Loan
(3M USD TERM SOFR+ 6.25 %), 10.72 % Cash, 12/31/2027
1/31/2017 $ 55,000,000 54,735,947 55,220,000 14.7 %
Total Healthcare Services 83,757,897 85,209,566 22.9 %

8

Saratoga Investment Corp.

Consolidated Schedule of Investments

November 30, 2024

(unaudited)

Company(1) Industry Investment
Interest Rate/
Maturity
Original
Acquisition
Date
Principal/
Number of
Shares
Cost Fair
Value (c)
% of
Net Assets
Procurement Partners, LLC Healthcare Software First Lien Term Loan
(3M USD TERM SOFR+ 6.50 %), 10.97 % Cash, 5/12/2026
11/12/2020 $ 35,125,000 35,010,241 35,125,000 9.4 %
Procurement Partners, LLC Healthcare Software Delayed Draw Term Loan
(3M USD TERM SOFR+ 6.50 %), 10.97 % Cash, 5/12/2026
11/12/2020 $ 10,300,000 10,277,796 10,300,000 2.7 %
Procurement Partners Holdings LLC (h) Healthcare Software Class A Units 11/12/2020 571,219 571,219 409,679 0.1 %
Procurement Partners Holdings LLC (h) Healthcare Software Class AA Units 11/12/2020 220,385 30,994 108,206 0.0 %
Total Healthcare Software 45,890,250 45,942,885 12.2 %
Roscoe Medical, Inc. (h) Healthcare Supply Common Stock 3/26/2014 5,081 508,077 - 0.0 %
Total Healthcare Supply 508,077 - 0.0 %
Granite Comfort, LP (d) HVAC Services and Sales First Lien Term Loan
(3M USD TERM SOFR+ 7.41 %), 11.88 % Cash, 5/16/2027
11/16/2020 $ 43,000,000 42,821,673 42,389,400 11.3 %
Granite Comfort, LP (j)(d) HVAC Services and Sales Delayed Draw Term Loan
(3M USD TERM SOFR+ 7.41 %), 11.88 % Cash, 5/16/2027
11/16/2020 $ 16,207,805 16,086,197 15,977,654 4.3 %
Total HVAC Services and Sales 58,907,870 58,367,054 15.6 %
Vector Controls Holding Co., LLC (h) Industrial Products Warrants to Purchase Limited Liability Company Interests, Expires 3/6/2025 5/31/2015 343 - 8,726,466 2.3 %
Total Industrial Products - 8,726,466 2.3 %
AgencyBloc, LLC Insurance Software First Lien Term Loan
(1M USD TERM SOFR+ 7.76 %), 12.29 % Cash, 10/1/2026
10/1/2021 $ 15,675,341 15,600,419 15,692,584 4.2 %
Panther ParentCo LLC (h) Insurance Software Class A Units 10/1/2021 2,500,000 2,500,000 4,692,238 1.3 %
Total Insurance Software 18,100,419 20,384,822 5.5 %

9

Saratoga Investment Corp.

Consolidated Schedule of Investments

November 30, 2024

(unaudited)

Company(1) Industry Investment
Interest Rate/
Maturity
Original
Acquisition
Date
Principal/
Number of
Shares
Cost Fair
Value (c)
% of
Net Assets
Avantra (Maple Holdings Midco Limited) IT Services First Lien Term Loan
(3M USD TERM SOFR+ 7.97 %), 12.44 % Cash, 9/20/2029
9/19/2024 $ 17,000,000 16,816,077 16,809,600 4.5 %
Maple Holdings Midco Limited (h) IT Services Class A Common Units 9/19/2024 2,000,000 2,000,000 2,000,000 0.5 %
Total IT Services 18,816,077 18,809,600 5.0 %
ActiveProspect, Inc. (d) Lead Management Software First Lien Term Loan
(3M USD TERM SOFR+ 6.00 %), 10.67 % Cash, 8/8/2027
8/8/2022 $ 11,525,624 11,462,397 11,640,880 3.1 %
ActiveProspect, Inc. (j) Lead Management Software Delayed Draw Term Loan
(3M USD TERM SOFR+ 6.00 %), 10.67 % Cash, 8/8/2027
8/8/2022 $ - - - 0.0 %
Total Lead Management Software 11,462,397 11,640,880 3.1 %
Madison Logic, Inc. (d)(m) Marketing Orchestration Software First Lien Term Loan
(1M USD TERM SOFR+ 7.50 %), 12.03 % Cash, 12/30/2028
12/30/2022 $ 18,775,160 18,565,083 18,433,452 4.9 %
Total Marketing Orchestration Software 18,565,083 18,433,452 4.9 %
ARC Health OpCo LLC (d) Mental Healthcare Services First Lien Term Loan
(3M USD TERM SOFR+ 8.40 %), 12.86 % Cash, 8/5/2027
8/5/2022 $ 6,500,000 6,448,840 6,193,200 1.7 %
ARC Health OpCo LLC (d) Mental Healthcare Services Delayed Draw Term Loan
(3M USD TERM SOFR+ 8.40 %), 12.86 % Cash, 8/5/2027
8/5/2022 $ 26,914,577 26,905,399 25,644,209 6.8 %
ARC Health OpCo LLC (h) Mental Healthcare Services Class A Preferred Units 8/5/2022 3,818,400 4,169,599 610,944 0.2 %
Total Mental Healthcare Services 37,523,838 32,448,353 8.7 %
Chronus LLC Mentoring Software First Lien Term Loan
(3M USD TERM SOFR+ 5.25 %), 9.87 % Cash, 8/26/2026
8/26/2021 $ 15,000,000 14,934,015 14,869,500 4.0 %
Chronus LLC (d) Mentoring Software First Lien Term Loan
(3M USD TERM SOFR+ 6.00 %), 10.62 % Cash, 8/26/2026
8/26/2021 $ 5,000,000 4,970,378 4,956,500 1.3 %
Chronus LLC (h) Mentoring Software Series A Preferred Stock 8/26/2021 3,000 3,000,000 2,070,892 0.6 %
Total Mentoring Software 22,904,393 21,896,892 5.9 %

10

Saratoga Investment Corp.

Consolidated Schedule of Investments

November 30, 2024

(unaudited)

Company(1) Industry Investment
Interest Rate/
Maturity
Original
Acquisition
Date
Principal/
Number of
Shares
Cost Fair
Value (c)
% of
Net Assets
Cloudpermit Intermediate Holding Company Municipal Government Software First Lien Term Loan
(3M USD TERM SOFR+ 5.75 %), 10.22 % Cash, 9/5/2029
9/5/2024 $ 28,000,000 27,730,175 27,720,000 7.4 %
Cloudpermit Intermediate Holding Company (j) Municipal Government Software Delayed Draw Term Loan
(3M USD TERM SOFR+ 5.75 %), 10.22 % Cash, 9/5/2029
9/5/2024 $ - - - 0.0 %
Cloudpermit Intermediate Holding Company (h) Municipal Government Software Limited Partner Interests 9/5/2024 2,000 2,000,000 2,000,000 0.5 %
Total Municipal Government Software 29,730,175 29,720,000 7.9 %
Omatic Software, LLC (d) Non-profit Services First Lien Term Loan
(3M USD TERM SOFR+ 8.00 %), 12.73 % Cash/ 1.00 % PIK, 6/30/2025
5/29/2018 $ 16,381,249 16,366,585 16,428,755 4.4 %
Total Non-profit Services 16,366,585 16,428,755 4.4 %
Emily Street Enterprises, L.L.C. (d) Office Supplies Senior Secured Note
(3M USD TERM SOFR+ 6.25 %), 11.00 % Cash, 12/31/2027
12/28/2012 $ 4,000,000 3,995,859 4,018,000 1.1 %
Emily Street Enterprises, L.L.C. (h) Office Supplies Warrant Membership Interests,
Expires 12/31/2027
12/28/2012 49,318 400,000 1,428,364 0.4 %
Total Office Supplies 4,395,859 5,446,364 1.5 %
Buildout, Inc. (d) Real Estate Services First Lien Term Loan
(3M USD TERM SOFR+ 7.00 %), 11.57 % Cash, 7/9/2025
7/9/2020 $ 14,000,000 13,973,317 13,588,400 3.6 %
Buildout, Inc. Real Estate Services Delayed Draw Term Loan
(3M USD TERM SOFR+ 7.00 %), 11.57 % Cash, 7/9/2025
2/12/2021 $ 38,500,000 38,417,815 37,368,100 10.0 %
Buildout, Inc. (h)(i) Real Estate Services Limited Partner Interests 7/9/2020 1,250 1,372,557 846,303 0.2 %
Total Real Estate Services 53,763,689 51,802,803 13.8 %
Wellspring Worldwide Inc. Research Software First Lien Term Loan
(3M USD TERM SOFR+ 8.42 %), 12.89 % Cash, 12/22/2028
6/27/2022 $ 9,552,000 9,481,207 9,552,000 2.5 %
Wellspring Worldwide Inc. Research Software Delayed DrawTerm Loan
(3M USD TERM SOFR+ 8.42 %), 12.89 % Cash, 12/22/2028
6/27/2022 $ 14,400,000 14,246,419 14,400,000 3.8 %
Archimedes Parent LLC (h) Research Software Class A Common Units 6/27/2022 2,475,160 2,475,160 2,421,510 0.6 %
Total Research Software 26,202,786 26,373,510 6.9 %

11

Saratoga Investment Corp.

Consolidated Schedule of Investments

November 30, 2024

(unaudited)

Company(1) Industry Investment
Interest Rate/
Maturity
Original
Acquisition
Date
Principal/
Number of
Shares
Cost Fair
Value (c)
% of
Net Assets
LFR Chicken LLC Restaurant First Lien Term Loan
(1M USD TERM SOFR+ 7.00 %), 11.53 % Cash, 11/19/2026
11/19/2021 $ 12,000,000 11,945,149 12,000,000 3.2 %
LFR Chicken LLC (j) Restaurant Delayed Draw Term Loan
(1M USD TERM SOFR+ 7.00 %), 11.53 % Cash, 11/19/2026
11/19/2021 $ 18,000,000 17,855,726 18,000,000 4.8 %
LFR Chicken LLC (h) Restaurant Series B Preferred Units 11/19/2021 497,183 1,000,000 1,534,323 0.4 %
Total Restaurant 30,800,875 31,534,323 8.4 %
Avionte Holdings, LLC (h) Staffing Services Class A Units 1/8/2014 100,000 100,000 3,136,598 0.8 %
Total Staffing Services 100,000 3,136,598 0.8 %
JDXpert Talent Acquisition Software First Lien Term Loan
(3M USD TERM SOFR+ 8.50 %), 13.23 % Cash, 5/2/2027
5/2/2022 $ 6,000,000 5,963,746 6,060,000 1.6 %
JDXpert Talent Acquisition Software Delayed Draw Term Loan
(3M USD TERM SOFR+ 8.50 %), 13.23 % Cash, 5/2/2027
5/2/2022 $ 1,000,000 992,919 1,010,000 0.3 %
JDXpert (j) Talent Acquisition Software Delayed Draw Term Loan
(3M USD TERM SOFR+ 8.50 %), 13.23 % Cash, 5/2/2027
3/31/2023 $ 500,000 495,614 505,000 0.1 %
Jobvite, Inc. (d) Talent Acquisition Software First Lien Term Loan
(3M USD TERM SOFR+ 7.50 %), 11.97 % Cash, 8/5/2028
8/5/2022 $ 20,000,000 19,893,434 19,878,000 5.3 %
Total Talent Acquisition Software 27,345,713 27,453,000 7.3 %
VetnCare MSO, LLC (j) Veterinary Services Delayed Draw Term Loan
(3M USD TERM SOFR+ 5.75 %), 10.22 % Cash, 5/12/2028
5/12/2023 $ 12,680,505 12,569,302 12,671,625 3.4 %
Total Veterinary Services 12,569,302 12,671,625 3.4 %
Sub Total Non-control/Non-affiliate investments 852,158,089 875,707,680 234.0 %

12

Saratoga Investment Corp.

Consolidated Schedule of Investments

November 30, 2024

(unaudited)

Company(1) Industry Investment
Interest Rate/
Maturity
Original
Acquisition
Date
Principal/
Number of
Shares
Cost Fair
Value (c)
% of
Net Assets
Affiliate investments - 10.5% (b)
ETU Holdings, Inc. (f) Corporate Education Software First Lien Term Loan
(3M USD TERM SOFR+ 9.00 %), 13.62 % Cash, 8/18/2027
8/18/2022 $ 7,000,000 6,954,826 6,977,600 1.9 %
ETU Holdings, Inc. (f) Corporate Education Software Second Lien Term Loan
15.00 % PIK, 2/18/2028
8/18/2022 $ 6,862,855 6,826,569 6,140,197 1.6 %
ETU Holdings, Inc. (f)(h) Corporate Education Software Series A Preferred Units 8/18/2022 3,000,000 3,000,000 - 0.0 %
Total Corporate Education Software 16,781,395 13,117,797 3.5 %
Axero Holdings, LLC (f) Employee Collaboration Software First Lien Term Loan
4.50 % Cash, (3M USD TERM SOFR + 2.50 %) PIK, 12/31/2027
6/30/2021 $ 15,653,168 15,629,225 15,653,168 4.2 %
Axero Holdings, LLC (f) Employee Collaboration Software Delayed Draw Term Loan
4.50 % Cash, (3M USD TERM SOFR + 2.50 %) PIK, 12/31/2027
6/30/2021 $ 1,110,870 1,105,403 1,110,870 0.3 %
Axero Holdings, LLC (f)(j) Employee Collaboration Software Revolving Credit Facility
4.50 % Cash, (3M USD TERM SOFR + 2.50 %) PIK, 12/31/2027
2/3/2022 $ - - - 0.0 %
Axero Holdings, LLC (f)(h) Employee Collaboration Software Series A Preferred Units 6/30/2021 2,055,609 2,055,609 3,403,000 0.9 %
Axero Holdings, LLC (f)(h) Employee Collaboration Software Series B Preferred Units 6/30/2021 2,055,609 2,055,609 6,518,621 1.6 %
Total Employee Collaboration Software 20,845,846 26,685,659 7.0 %
Sub Total Affiliate investments 37,627,241 39,803,456 10.5 %

13

Saratoga Investment Corp.

Consolidated Schedule of Investments

November 30, 2024

(unaudited)

Company(1) Industry Investment
Interest Rate/
Maturity
Original
Acquisition
Date
Principal/
Number of
Shares
Cost Fair
Value (c)
% of
Net Assets
Control investments - 12.0% (b)
Zollege PBC (k)(g) Education Services First Lien Term Loan
4.84 % PIK, 8/9/2027
5/11/2021 $ 1,461,250 1,461,250 1,103,390 0.3 %
Zollege PBC (h)(g) Education Services Common Stock 5/11/2021 7,731,294 558,799 3,101,000 0.8 %
Total Education Services 2,020,049 4,204,390 1.1 %
Pepper Palace, Inc. (k)(g) Specialty Food Retailer First Lien Term Loan
4.42 % PIK, 12/31/2028
6/30/2021 $ 2,400,000 2,400,000 1,349,520 0.4 %
Pepper Palace, Inc. (j)(k)(g) Specialty Food Retailer Delayed Draw Term Loan
4.42 % PIK, 12/31/2028
6/30/2021 $ - - - 0.0 %
Pepper Palace, Inc. (j)(k)(g) Specialty Food Retailer Revolving Credit Facility
4.42 % PIK, 12/31/2028
6/30/2021 $ 400,000 400,000 224,920 0.1 %
Pepper Palace, Inc. (h)(g) Specialty Food Retailer Class A Units 6/30/2021 100,000 138,561 - 0.0 %
Total Specialty Food Retailer 2,938,561 1,574,440 0.5 %
Saratoga Investment Corp. CLO 2013-1, Ltd. (a)(e)(g) Structured Finance Securities Other/Structured Finance Securities
0.00 %, 4/20/2033
1/22/2008 $ 111,000,000 16,628,297 1,269,512 0.3 %
Saratoga Investment Corp. CLO 2013-1, Ltd. Class F-2-R-3 Note (a)(g) Structured Finance Securities Other/Structured Finance Securities
(3M USD TERM SOFR+ 10.00 %), 14.73 %, 4/20/2033
8/9/2021 $ 9,375,000 9,375,000 4,332,188 1.2 %
Saratoga Investment Corp. Senior Loan Fund 2022-1, Ltd. Class E Note (a)(g) Structured Finance Securities Other/Structured Finance Securities
(3M USD TERM SOFR+ 8.55 %), 13.02 %, 10/20/2033
10/28/2022 $ 12,250,000 11,392,500 12,250,000 3.3 %
Total Structured Finance Securities 37,395,797 17,851,700 4.8 %
Saratoga Senior Loan Fund I JV, LLC (a)(g)(j) Investment Fund Unsecured Loan
10.00 %, 10/20/2033
12/17/2021 $ 17,618,954 17,618,954 16,198,866 4.3 %
Saratoga Senior Loan Fund I JV, LLC (a)(g) Investment Fund Membership Interest 12/17/2021 17,583,486 17,583,486 4,752,700 1.3 %
Total Investment Fund 35,202,440 20,951,566 5.6 %
Sub Total Control investments 77,556,847 44,582,096 12.0 %
TOTAL INVESTMENTS - 256.5% (b) $ 967,342,177 $ 960,093,232 256.5 %

Number of Shares Cost Fair Value % of
Net Assets
Cash and cash equivalents and cash and cash equivalents, reserve accounts - 66.7% (b)
U.S. Bank Money Market (l) 250,164,023 $ 250,164,023 $ 250,164,023 66.7 %
Total cash and cash equivalents and cash and cash equivalents, reserve accounts 250,164,023 $ 250,164,023 $ 250,164,023 66.7 %

(1) Securities are exempt from registration under Rule 144A of the Securities Act of 1933, as amended, and are restricted securities. Money market funds are valued at net asset value and are considered level 1 investments within the fair value hierarchy.
(a) Represents an investment that is not a “qualifying asset” under Section 55(a) of the Investment Company Act of 1940, as amended (the 1940 Act”). As of November 30, 2024, non-qualifying assets represent 4.0% of the Company’s portfolio at fair value. As a BDC, the Company generally has to invest at least 70% of its total assets in qualifying assets.
(b) Percentages are based on net assets of $374,865,655 as of November 30, 2024.

14

Saratoga Investment Corp.

Consolidated Schedule of Investments

November 30, 2024

(unaudited)

(c) Because there is no “readily available market quotations” (as defined in the 1940 Act) for these investments, the fair values of these investments were determined using significant unobservable inputs and approved in good faith by our board of directors. These investments have been included as Level 3 in the Fair Value Hierarchy (see Note 3 to the consolidated financial statements).
(d) These securities are either fully or partially pledged as collateral under the Company’s senior secured revolving credit facility (see Note 8 to the consolidated financial statements).
(e) This investment does not have a stated interest rate that is payable thereon. As a result, the 0.00% interest rate in the table above represents the effective interest rate currently earned on the investment cost and is based on the current cash interest and other income generated by the investment.
(f) As defined in the 1940 Act, this portfolio company is an “affiliate” as we own between 5.0% and 25.0% of the outstanding voting securities. Transactions during the nine months ended November 30, 2024 in which the issuer was an affiliate are as follows:

Company Purchases Sales Total
Interest from
Investments
Management
Fee Income
Net Realized
Gain (Loss)
from
Investments
Net Change
in Unrealized
Appreciation
(Depreciation)
Axero Holdings, LLC $ 10,000 $
-
$ 835,832 $
-
$
-
$ 2,363,153
ETU Holdings, Inc.
-
-
1,526,595
-
-
( 1,228,660 )
Total $ 10,000 $
-
$ 2,362,427 $
-
$
-
$ 1,134,493

(g) As defined in the 1940 Act, we “control” this portfolio company because we own more than 25% of the portfolio company’s outstanding voting securities. Transactions during the nine months ended November 30, 2024 in which the issuer was both an affiliate and a portfolio company that we control are as follows:

Company Purchases Sales Total
Interest from
Investments
Total
Dividends
from
Investments
Management
Fee Income
Net Realized
Gain (Loss)
from
Investments
Net Change
in Unrealized
Appreciation
(Depreciation)
Netreo Holdings, LLC $
-
$ 2,260,337 $ 921,530 $
-
$
-
$ ( 5,445,808 ) $ 3,802,854
Pepper Palace, Inc. 1,050,000
-
1,338
-
-
( 34,007,427 ) ( 1,364,121 )
Zollege PBC 200,000 209,460 110,862
-
-
( 15,110,835 ) 2,184,341
Saratoga Investment Corp. CLO 2013-1, Ltd.
-
-
-
-
2,372,177
-
( 2,857,525 )
Saratoga Investment Corp. Senior Loan Fund 2022-1, Ltd. Class E Note
-
-
1,287,028
-
-
-
-
Saratoga Investment Corp. CLO 2013-1, Ltd. Class F-2-R-3 Note
-
-
1,107,547
-
-
-
( 4,543,039 )
Saratoga Senior Loan Fund I JV, LLC - - 1,321,422
-
- - 380,569
Saratoga Senior Loan Fund I JV, LLC - - - 3,160,742 - - ( 4,651,295 )
Total $ 1,250,000 $ 2,469,797 $ 4,749,727 $ 3,160,742 $ 2,372,177 $ ( 54,564,070 ) $ ( 7,048,216 )

(h) Non-income producing at November 30, 2024.
(i) Includes securities issued by an affiliate of the company.
(j) All or a portion of this investment has an unfunded commitment as of November 30, 2024. (See Note 9 to the consolidated financial statements).
(k) As of November 30, 2024, the investment was on non-accrual status. The fair value of these investments was approximately $2.7 million, which represented 0.3% of the Company’s portfolio (see Note 2 to the consolidated financial statements).
(l) Included within cash and cash equivalents and cash and cash equivalents, reserve accounts in the Company’s consolidated statements of assets and liabilities as of November 30, 2024.

(m) This investment elected to PIK 20% of accrued interest, with 80% of accrued interest payable in cash.

SOFR - Secured Overnight Financing Rate

1M USD TERM SOFR - The 1 month USD TERM SOFR rate as of November 30, 2024 was 4.53%.

3M USD TERM SOFR - The 3 month USD TERM SOFR rate as of November 30, 2024 was 4.47%.

6M USD TERM SOFR - The 6 month USD TERM SOFR rate as of November 30, 2024 was 4.38%.

PIK - Payment-in-Kind (see Note 2 to the consolidated financial statements).

See accompanying notes to consolidated financial statements.

15

Saratoga Investment Corp.

Consolidated Schedule of Investments

February 29, 2024

Company(1) Industry Investment
Interest Rate/
Maturity
Original
Acquisition
Date
Principal/
Number of
Shares
Cost Fair
Value (c)
% of
Net Assets
Non-control/Non-affiliate investments - 276.5% (b)
Altvia MidCo, LLC. Alternative Investment Management Software First Lien Term Loan
(3M USD TERM SOFR+ 8.50 %), 13.83 % Cash, 7/18/2027
7/18/2022 $ 7,900,000 $ 7,840,328 $ 7,884,990 2.1 %
Altvia MidCo, LLC. (h) Alternative Investment Management Software Series A-1 Preferred Shares 7/18/2022 2,000,000 2,000,000 2,894,346 0.8 %
Total Alternative Investment Management Software 9,840,328 10,779,336 2.9 %
BQE Software, Inc. Architecture & Engineering Software First Lien Term Loan
(3M USD TERM SOFR+ 6.75 %), 12.08 % Cash, 4/13/2028
4/13/2023 $ 24,500,000 24,285,669 24,497,550 6.6 %
BQE Software, Inc. (j) Architecture & Engineering Software Delayed Draw Term Loan
(3M USD TERM SOFR+ 6.75 %), 12.08 % Cash, 4/13/2028
4/13/2023 $ 750,000 743,481 749,925 0.2 %
Total Architecture & Engineering Software 25,029,150 25,247,475 6.8 %
GrowthZone, LLC Association Management Software First Lien Term Loan
(3M USD TERM SOFR+ 8.25 %), 13.58 % Cash, 5/10/2028
5/10/2023 $ 22,649,425 22,292,083 22,934,808 6.2 %
Golden TopCo LP (h) Association Management Software Class A-2 Common Units 5/10/2023 1,072,394 1,072,394 1,154,132 0.3 %
Total Association Management Software 23,364,477 24,088,940 6.5 %
Artemis Wax Corp. (d)(j) Consumer Services Delayed Draw Term Loan
(1M USD TERM SOFR+ 6.75 %), 12.07 % Cash, 5/20/2026
5/20/2021 $ 57,500,000 57,208,255 58,149,750 15.7 %
Artemis Wax Corp. (h) Consumer Services Series B-1 Preferred Stock 5/20/2021 934,463 1,500,000 4,822,941 1.3 %
Artemis Wax Corp. (h) Consumer Services Series D Preferred Stock 12/22/2022 278,769 1,500,000 1,716,380 0.5 %
Total Consumer Services 60,208,255 64,689,071 17.5 %
Schoox, Inc. (h), (i) Corporate Education Software Series 1 Membership Interest 12/8/2020 1,050 475,698 4,426,630 1.2 %
Total Corporate Education Software 475,698 4,426,630 1.2 %
GreyHeller LLC (h) Cyber Security Common Stock 11/10/2021 7,857,689 1,906,275 2,826,009 0.8 %
Total Cyber Security 1,906,275 2,826,009 0.8 %

16

Saratoga Investment Corp.

Consolidated Schedule of Investments

February 29, 2024

Company(1) Industry Investment
Interest Rate/
Maturity
Original
Acquisition
Date
Principal/
Number of
Shares
Cost Fair
Value (c)
% of
Net Assets
Gen4 Dental Partners Holdings, LLC Dental Practice Management Delayed Draw Term Loan
(3M USD TERM SOFR+ 10.22 %), 15.55 % Cash, 4/29/2026
2/8/2023 $ 11,000,000 10,979,958 11,110,000 3.0 %
Gen4 Dental Partners Holdings, LLC (h)(i) Dental Practice Management Series A Preferred Units 2/8/2023 493,999 1,027,519 1,111,499 0.3 %
Modis Dental Partners OpCo, LLC Dental Practice Management First Lien Term Loan
(1M USD TERM SOFR+ 9.48 %), 14.80 % Cash, 4/18/2028
4/18/2023 $ 7,000,000 6,906,453 7,113,400 1.9 %
Modis Dental Partners OpCo, LLC Dental Practice Management Delayed Draw Term Loan
(1M USD TERM SOFR+ 9.48 %), 14.80 % Cash, 4/18/2028
4/18/2023 $ 7,500,000 7,392,367 7,621,500 2.1 %
Modis Dental Partners OpCo, LLC (h) Dental Practice Management Class A Preferred Units 4/18/2023 2,950,000 2,950,000 2,682,996 0.7 %
New England Dental Partners Dental Practice Management First Lien Term Loan
(3M USD TERM SOFR+ 8.00 %), 13.48 % Cash, 11/25/2025
11/25/2020 $ 6,555,000 6,526,643 6,198,408 1.7 %
New England Dental Partners Dental Practice Management Delayed Draw Term Loan
(3M USD TERM SOFR+ 8.00 %), 13.48 % Cash, 11/25/2025
11/25/2020 $ 4,650,000 4,635,903 4,397,040 1.2 %
Total Dental Practice Management 40,418,843 40,234,843 10.9 %
Exigo, LLC (d) Direct Selling Software First Lien Term Loan
(1M USD TERM SOFR+ 5.75 %), 11.17 % Cash, 3/16/2027
3/16/2022 $ 24,313,135 24,167,354 23,165,555 6.3 %
Exigo, LLC (j) Direct Selling Software Revolving Credit Facility
(1M USD TERM SOFR+ 5.75 %), 11.17 % Cash, 3/16/2027
3/16/2022 $ - - ( 49,167 ) 0.0 %
Exigo, LLC (h), (i) Direct Selling Software Common Units 3/16/2022 1,041,667 1,041,667 957,067 0.3 %
Total Direct Selling Software 25,209,021 24,073,455 6.6 %

17

Saratoga Investment Corp.

Consolidated Schedule of Investments

February 29, 2024

Company(1) Industry Investment
Interest Rate/
Maturity
Original
Acquisition
Date
Principal/
Number of
Shares
Cost Fair
Value (c)
% of
Net Assets
C2 Educational Systems, Inc. (d) Education Services First Lien Term Loan
(3M USD TERM SOFR+ 8.50 %), 13.83 % Cash, 5/31/2025
5/31/2017 $ 21,500,000 21,478,821 21,459,150 5.8 %
C2 Educational Systems, Inc. (j) Education Services Delayed Draw Term Loan
(3M USD TERM SOFR+ 8.50 %), 13.83 % Cash, 5/31/2025
4/28/2023 $ - - - 0.0 %
C2 Education Systems, Inc. (h) Education Services Series A-1 Preferred Stock 5/18/2021 3,127 499,904 576,118 0.2 %
Zollege PBC (k) Education Services First Lien Term Loan
(3M USD TERM SOFR+ 7.00 %), 12.33 % Cash/ 2.00 % PIK, 5/11/2026
5/11/2021 $ 16,409,153 16,340,466 3,493,509 0.9 %
Zollege PBC (j)(k) Education Services Delayed Draw Term Loan
(3M USD TERM SOFR+ 7.00 %), 12.33 % Cash/ 2.00 % PIK, 5/11/2026
5/11/2021 $ 1,364,109 1,358,200 290,419 0.1 %
Zollege PBC (h) Education Services Class A Units 5/11/2021 250,000 250,000 - 0.0 %
Total Education Services 39,927,391 25,819,196 7.0 %
Destiny Solutions Inc. (h)(i) Education Software Limited Partner Interests 5/16/2018 3,068 3,969,291 9,894,736 2.7 %
GoReact Education Software First Lien Term Loan
(3M USD TERM SOFR+ 7.50 %), 13.03 % Cash/ 1.00 % PIK, 1/17/2025
1/17/2020 $ 8,087,775 8,060,498 8,087,775 2.2 %
GoReact (j) Education Software Delayed Draw Term Loan
(3M USD TERM SOFR+ 7.50 %), 13.03 % Cash/ 1.00 % PIK, 1/17/2025
1/18/2022 $ - - - 0.0 %
Identity Automation Systems (h) Education Software Common Stock Class A-2 Units 8/25/2014 232,616 232,616 569,355 0.2 %
Identity Automation Systems (h) Education Software Common Stock Class A-1 Units 3/6/2020 43,715 171,571 235,296 0.1 %
Ready Education Education Software First Lien Term Loan
(3M USD TERM SOFR+ 7.00 %), 12.33 % Cash, 8/5/2027
8/5/2022 $ 27,000,000 26,797,063 26,792,100 7.2 %
Total Education Software 39,231,039 45,579,262 12.4 %
TG Pressure Washing Holdings, LLC (h) Facilities Maintenance Preferred Equity 8/12/2019 488,148 488,148 231,181 0.1 %
Total Facilities Maintenance 488,148 231,181 0.1 %
Davisware, LLC Field Service Management First Lien Term Loan
(3M USD TERM SOFR+ 7.00 %), 12.33 % Cash, 7/31/2024
9/6/2019 $ 6,000,000 5,991,382 5,989,200 1.6 %
Davisware, LLC (j) Field Service Management Delayed Draw Term Loan
(3M USD TERM SOFR+ 7.00 %), 12.33 % Cash, 7/31/2024
9/6/2019 $ 4,727,790 4,714,256 4,719,280 1.3 %
Total Field Service Management 10,705,638 10,708,480 2.9 %
GDS Software Holdings, LLC Financial Services First Lien Term Loan
(3M USD TERM SOFR+ 7.00 %), 12.33 % Cash, 12/30/2026
12/30/2021 $ 22,713,926 22,624,322 22,545,843 6.1 %
GDS Software Holdings, LLC Financial Services Delayed Draw Term Loan
(3M USD TERM SOFR+ 7.00 %), 12.33 % Cash, 12/30/2026
12/30/2021 $ 3,286,074 3,262,111 3,261,757 0.9 %
GDS Software Holdings, LLC (h) Financial Services Common Stock Class A Units 8/23/2018 250,000 250,000 468,204 0.1 %
Total Financial Services 26,136,433 26,275,804 7.1 %

18

Saratoga Investment Corp.

Consolidated Schedule of Investments

February 29, 2024

Company(1) Industry Investment
Interest Rate/
Maturity
Original
Acquisition
Date
Principal/
Number of
Shares
Cost Fair
Value (c)
% of
Net Assets
Ascend Software, LLC Financial Services Software First Lien Term Loan
(3M USD TERM SOFR+ 7.50 %), 13.10 % Cash, 12/15/2026
12/15/2021 $ 6,000,000 5,961,680 5,920,200 1.6 %
Ascend Software, LLC (j) Financial Services Software Delayed Draw Term Loan
(3M USD TERM SOFR+ 7.50 %), 13.10 % Cash, 12/15/2026
12/15/2021 $ 4,050,000 4,029,154 3,996,135 1.1 %
Total Financial Services Software 9,990,834 9,916,335 2.7 %
Inspect Point Holdings, LLC Fire Inspection Business Software First Lien Term Loan
(1M USD TERM SOFR+ 6.50 %), 11.82 % Cash, 07/19/2028
7/19/2023 $ 10,000,000 9,908,861 9,916,000 2.7 %
Inspect Point Holdings, LLC (j) Fire Inspection Business Software First Lien Term Loan
(1M USD TERM SOFR+ 6.50 %), 11.82 % Cash, 07/19/2028
7/19/2023 $ - - - 0.0 %
Total Fire Inspection Business Software 9,908,861 9,916,000 2.7 %
Stretch Zone Franchising, LLC Health/Fitness Franchisor First Lien Term Loan
(3M USD TERM SOFR+ 7.00 %), 12.33 % Cash, 3/31/2028
3/31/2023 $ 30,000,000 29,740,931 29,970,000 8.1 %
Stretch Zone Franchising, LLC (j) Health/Fitness Franchisor Delayed Draw Term Loan
(3M USD TERM SOFR+ 7.00 %), 12.33 % Cash, 3/31/2028
3/31/2023 $ - - - 0.0 %
Stretch Zone Franchising, LLC (h) Health/Fitness Franchisor Class A Units 3/31/2023 20,000 2,000,000 2,062,331 0.6 %
Total Health/Fitness Franchisor 31,740,931 32,032,331 8.7 %

19

Saratoga Investment Corp.

Consolidated Schedule of Investments

February 29, 2024

Company(1) Industry Investment
Interest Rate/
Maturity
Original
Acquisition
Date
Principal/
Number of
Shares
Cost Fair
Value (c)
% of
Net Assets
Alpha Aesthetics Partners OpCo, LLC Healthcare Services First Lien Term Loan
(1M USD TERM SOFR+ 9.98 %), 15.30 % Cash, 3/20/2028
3/20/2023 $ 3,900,000 3,847,845 3,959,670 1.2 %
Alpha Aesthetics Partners OpCo, LLC (j) Healthcare Services Delayed Draw Term Loan
(1M USD TERM SOFR+ 9.98 %), 15.30 % Cash, 3/20/2028
3/20/2023 $ 8,600,000 8,482,841 8,731,580 2.4 %
Alpha Aesthetics Partners OpCo, LLC (h) Healthcare Services Class A Preferred Units 3/20/2023 2,850,000 2,850,000 2,859,121 0.8 %
Axiom Medical Consulting, LLC Healthcare Services First Lien Term Loan
(3M USD TERM SOFR+ 6.00 %), 11.33 % Cash, 9/11/2028
9/11/2023 $ 10,000,000 9,917,367 9,913,000 2.7 %
Axiom Medical Consulting, LLC (j) Healthcare Services Delayed Draw Term Loan
(3M USD TERM SOFR+ 6.00 %), 11.33 % Cash, 9/11/2028
9/11/2023 $ - - - 0.0 %
Axiom Parent Holdings, LLC (h) Healthcare Services Class A Preferred Units 6/19/2018 400,000 258,389 630,740 0.2 %
ComForCare Health Care (d) Healthcare Services First Lien Term Loan
(3M USD TERM SOFR+ 6.25 %), 11.58 % Cash, 1/31/2025
1/31/2017 $ 25,000,000 24,973,000 25,000,000 6.8 %
Total Healthcare Services 50,329,442 51,094,111 14.1 %
HemaTerra Holding Company, LLC (d) Healthcare Software First Lien Term Loan
(1M USD TERM SOFR+ 8.25 %), 13.57 % Cash, 1/31/2027
4/15/2019 $ 54,927,713 54,624,303 55,087,003 14.9 %
HemaTerra Holding Company, LLC Healthcare Software Delayed Draw Term Loan
(1M USD TERM SOFR+ 8.25 %), 13.57 % Cash, 1/31/2027
4/15/2019 $ 13,755,875 13,710,513 13,795,767 3.7 %
TRC HemaTerra, LLC (h) Healthcare Software Class D Membership Interests 4/15/2019 2,487 2,816,693 5,362,439 1.4 %
Procurement Partners, LLC Healthcare Software First Lien Term Loan
(3M USD TERM SOFR+ 6.50 %), 11.83 % Cash, 5/12/2026
11/12/2020 $ 35,125,000 34,965,458 35,125,000 9.5 %
Procurement Partners, LLC (j) Healthcare Software Delayed Draw Term Loan
(3M USD TERM SOFR+ 6.50 %), 11.83 % Cash, 5/12/2026
11/12/2020 $ 10,300,000 10,230,001 10,300,000 2.8 %
Procurement Partners Holdings LLC (h) Healthcare Software Class A Units 11/12/2020 571,219 571,219 826,280 0.2 %
Total Healthcare Software 116,918,187 120,496,489 32.5 %
Roscoe Medical, Inc. (h) Healthcare Supply Common Stock 3/26/2014 5,081 508,077 - 0.0 %
Total Healthcare Supply 508,077 - 0.0 %

20

Saratoga Investment Corp.

Consolidated Schedule of Investments

February 29, 2024

Company(1) Industry Investment
Interest Rate/
Maturity
Original
Acquisition
Date
Principal/
Number of
Shares
Cost Fair
Value (c)
% of
Net Assets
Book4Time, Inc. (a)(d) Hospitality/Hotel First Lien Term Loan
(3M USD TERM SOFR+ 7.50 %), 12.83 %, 12/22/2025
12/22/2020 $ 3,136,517 3,122,542 3,136,517 0.8 %
Book4Time, Inc. (a) Hospitality/Hotel Delayed Draw Term Loan
(3M USD TERM SOFR+ 7.50 %), 12.83 %, 12/22/2025
12/22/2020 $ 2,000,000 1,989,839 2,000,000 0.5 %
Book4Time, Inc. (a)(h)(i) Hospitality/Hotel Class A Preferred Shares 12/22/2020 200,000 156,826 389,531 0.1 %
Knowland Group, LLC (k) Hospitality/Hotel Second Lien Term Loan
(3M USD TERM SOFR+ 8.00 %), 13.48 % Cash/ 3.00 % PIK, 12/31/2024
11/9/2018 $ 15,878,989 15,878,989 12,642,851 3.4 %
Sceptre Hospitality Resources, LLC Hospitality/Hotel First Lien Term Loan
(3M USD TERM SOFR+ 7.25 %), 12.58 % Cash, 11/15/2027
4/27/2020 $ 23,000,000 22,835,500 23,278,300 6.3 %
Sceptre Hospitality Resources, LLC (j) Hospitality/Hotel Delayed Draw Term Loan
(3M USD TERM SOFR+ 7.25 %), 12.58 % Cash, 11/15/2027
9/2/2021 $ - - - 0.0 %
Total Hospitality/Hotel 43,983,696 41,447,199 11.1 %
Granite Comfort, LP (d) HVAC Services and Sales First Lien Term Loan
(3M USD TERM SOFR+ 7.46 %), 12.79 % Cash, 5/16/2027
11/16/2020 $ 43,000,000 42,781,757 43,000,000 11.6 %
Granite Comfort, LP (j) HVAC Services and Sales Delayed Draw Term Loan
(3M USD TERM SOFR+ 7.46 %), 12.79 % Cash, 5/16/2027
11/16/2020 $ 16,207,805 16,059,588 16,207,805 4.4 %
Total HVAC Services and Sales 58,841,345 59,207,805 16.0 %
Vector Controls Holding Co., LLC (d) Industrial Products First Lien Term Loan
(3M USD TERM SOFR+ 6.50 %), 11.75 % Cash, 3/6/2025
3/6/2013 $ 923,886 923,886 923,886 0.2 %
Vector Controls Holding Co., LLC (h) Industrial Products Warrants to Purchase Limited Liability Company Interests, Expires 11/30/2027 5/31/2015 343 - 8,171,235 2.2 %
Total Industrial Products 923,886 9,095,121 2.4 %
AgencyBloc, LLC Insurance Software First Lien Term Loan
(1M USD TERM SOFR+ 7.76 %), 13.09 % Cash, 10/1/2026
10/1/2021 $ 15,788,864 15,686,250 15,806,231 4.3 %
Panther ParentCo LLC (h) Insurance Software Class A Units 10/1/2021 2,500,000 2,500,000 4,014,869 1.1 %
Total Insurance Software 18,186,250 19,821,100 5.4 %
LogicMonitor, Inc. (d) IT Services First Lien Term Loan
(3M USD TERM SOFR+ 6.50 %), 11.83 % Cash, 5/17/2026
3/20/2020 $ 43,000,000 42,967,165 43,000,000 11.6 %
Total IT Services 42,967,165 43,000,000 11.6 %
ActiveProspect, Inc. (d) Lead Management Software First Lien Term Loan
(3M USD TERM SOFR+ 6.00 %), 11.53 % Cash, 8/8/2027
8/8/2022 $ 12,000,000 11,920,834 12,120,000 3.3 %
ActiveProspect, Inc. (j) Lead Management Software Delayed Draw Term Loan
(3M USD TERM SOFR+ 6.00 %), 11.53 % Cash, 8/8/2027
8/8/2022 $ - - - 0.0 %
Total Lead Management Software 11,920,834 12,120,000 3.3 %
Centerbase, LLC Legal Software First Lien Term Loan
(3M USD TERM SOFR+ 7.75 %), 13.08 % Cash, 1/18/2027
1/18/2022 $ 21,033,360 20,882,496 20,709,446 5.6 %
Total Legal Software 20,882,496 20,709,446 5.6 %
Madison Logic, Inc. (d) Marketing Orchestration Software First Lien Term Loan
(3M USD TERM SOFR+ 7.00 %), 12.33 % Cash, 12/30/2028
12/30/2022 $ 18,857,500 18,544,720 18,420,006 5.0 %
Total Marketing Orchestration Software 18,544,720 18,420,006 5.0 %

21

Saratoga Investment Corp.

Consolidated Schedule of Investments

February 29, 2024

Company(1) Industry Investment
Interest Rate/
Maturity
Original
Acquisition
Date
Principal/
Number of
Shares
Cost Fair
Value (c)
% of
Net Assets
ARC Health OpCo LLC (d) Mental Healthcare Services First Lien Term Loan
(3M USD TERM SOFR+ 8.47 %), 13.81 % Cash, 8/5/2027
8/5/2022 $ 6,500,000 6,438,832 6,490,900 1.8 %
ARC Health OpCo LLC (d)(j) Mental Healthcare Services Delayed Draw Term Loan
(3M USD TERM SOFR+ 8.47 %), 13.81 % Cash, 8/5/2027
8/5/2022 $ 26,914,577 26,903,916 26,876,897 7.3 %
ARC Health OpCo LLC (h) Mental Healthcare Services Class A Preferred Units 8/5/2022 3,818,400 4,169,599 4,009,323 1.1 %
Total Mental Healthcare Services 37,512,347 37,377,120 10.2 %
Chronus LLC Mentoring Software First Lien Term Loan
(3M USD TERM SOFR+ 5.25 %), 10.73 % Cash, 8/26/2026
8/26/2021 $ 15,000,000 14,911,921 14,841,000 4.0 %
Chronus LLC Mentoring Software First Lien Term Loan
(3M USD TERM SOFR+ 6.00 %), 11.48 % Cash, 8/26/2026
8/26/2021 $ 5,000,000 4,962,938 4,947,000 1.3 %
Chronus LLC (h) Mentoring Software Series A Preferred Stock 8/26/2021 3,000 3,000,000 2,280,881 0.6 %
Total Mentoring Software 22,874,859 22,068,881 5.9 %
Omatic Software, LLC Non-profit Services First Lien Term Loan
(3M USD TERM SOFR+ 8.00 %), 13.59 % Cash/ 1.00 % PIK, 6/30/2025
5/29/2018 $ 16,270,192 16,239,922 16,266,938 4.4 %
Total Non-profit Services 16,239,922 16,266,938 4.4 %
Emily Street Enterprises, L.L.C. Office Supplies Senior Secured Note
(3M USD TERM SOFR+ 7.50 %), 12.83 % Cash, 12/31/2025
12/28/2012 $ 6,000,000 5,992,437 6,027,000 1.6 %
Emily Street Enterprises, L.L.C. (h) Office Supplies Warrant Membership Interests,
Expires 12/31/2025
12/28/2012 49,318 400,000 1,153,874 0.3 %
Total Office Supplies 6,392,437 7,180,874 1.9 %
Buildout, Inc. (d) Real Estate Services First Lien Term Loan
(3M USD TERM SOFR+ 7.00 %), 12.43 % Cash, 7/9/2025
7/9/2020 $ 14,000,000 13,950,236 13,631,800 3.7 %
Buildout, Inc. Real Estate Services Delayed Draw Term Loan
(3M USD TERM SOFR+ 7.00 %), 12.47 % Cash, 7/9/2025
2/12/2021 $ 38,500,000 38,342,798 37,487,450 10.1 %
Buildout, Inc. (h)(i) Real Estate Services Limited Partner Interests 7/9/2020 1,250 1,372,557 1,231,195 0.3 %
Total Real Estate Services 53,665,591 52,350,445 14.1 %

22

Saratoga Investment Corp.

Consolidated Schedule of Investments

February 29, 2024

Company(1) Industry Investment
Interest Rate/
Maturity
Original
Acquisition
Date
Principal/
Number of
Shares
Cost Fair
Value (c)
% of
Net Assets
Wellspring Worldwide Inc. Research Software First Lien Term Loan
(1M USD TERM SOFR+ 6.00 %), 11.32 % Cash, 12/22/2028
6/27/2022 $ 9,552,000 9,474,084 9,483,226 2.6 %
Wellspring Worldwide Inc. Research Software Delayed DrawTerm Loan
(1M USD TERM SOFR+ 6.00 %), 11.32 % Cash, 12/22/2028
6/27/2022 $ 14,400,000 14,227,504 14,296,320 3.9 %
Archimedes Parent LLC (h) Research Software Class A Common Units 6/27/2022 2,475,160 2,475,160 2,475,160 0.7 %
Total Research Software 26,176,748 26,254,706 7.2 %
LFR Chicken LLC Restaurant First Lien Term Loan
(1M USD TERM SOFR+ 7.00 %), 12.32 % Cash, 11/19/2026
11/19/2021 $ 12,000,000 11,926,272 12,104,400 3.3 %
LFR Chicken LLC Restaurant Delayed Draw Term Loan
(1M USD TERM SOFR+ 7.00 %), 12.32 % Cash, 11/19/2026
11/19/2021 $ 9,000,000 8,935,545 9,078,300 2.5 %
LFR Chicken LLC (h) Restaurant Series B Preferred Units 11/19/2021 497,183 1,000,000 1,397,572 0.4 %
Total Restaurant 21,861,817 22,580,272 6.2 %
JobNimbus LLC Roofing Contractor Software First Lien Term Loan
(1M USD TERM SOFR+ 8.75 %), 14.17 % Cash, 9/20/2026
3/28/2023 $ 18,777,459 18,624,294 19,014,055 5.1 %
Total Roofing Contractor Software 18,624,294 19,014,055 5.1 %
Pepper Palace, Inc. (d)(k) Specialty Food Retailer First Lien Term Loan
(3M USD TERM SOFR+ 6.25 %), 11.73 % Cash, 6/30/2026
6/30/2021 $ 33,320,000 33,148,332 2,409,036 0.7 %
Pepper Palace, Inc. (j)(k) Specialty Food Retailer Delayed Draw Term Loan
(3M USD TERM SOFR+ 6.25 %), 11.73 % Cash, 6/30/2026
6/30/2021 $ 1,101,600 1,092,422 79,646 0.0 %
Pepper Palace, Inc. (j)(k) Specialty Food Retailer Revolving Credit Facility
(3M USD TERM SOFR+ 6.25 %), 11.73 % Cash, 6/30/2026
6/30/2021 $ - - - 0.0 %
Pepper Palace, Inc. (h) Specialty Food Retailer Membership Interest (Series A) 6/30/2021 1,000,000 1,000,000 - 0.0 %
Pepper Palace, Inc. (h) Specialty Food Retailer Membership Interest (Series B) 6/30/2021 197,035 197,035 - 0.0 %
Total Specialty Food Retailer 35,437,789 2,488,682 0.7 %

23

Saratoga Investment Corp.

Consolidated Schedule of Investments

February 29, 2024

Company(1) Industry Investment
Interest Rate/
Maturity
Original
Acquisition
Date
Principal/
Number of
Shares
Cost Fair
Value (c)
% of
Net Assets
ArbiterSports, LLC (d) Sports Management First Lien Term Loan
(3M USD TERM SOFR+ 6.00 %), 11.33 % Cash, 2/21/2025
2/21/2020 $ 26,000,000 25,945,071 26,000,000 7.0 %
ArbiterSports, LLC Sports Management Delayed Draw Term Loan
(3M USD TERM SOFR+ 6.00 %), 11.33 % Cash, 2/21/2025
2/21/2020 $ 1,000,000 1,000,000 1,000,000 0.3 %
Total Sports Management 26,945,071 27,000,000 7.3 %
Avionte Holdings, LLC (h) Staffing Services Class A Units 1/8/2014 100,000 100,000 3,287,970 0.9 %
Total Staffing Services 100,000 3,287,970 0.9 %
JDXpert Talent Acquisition Software First Lien Term Loan
(3M USD TERM SOFR+ 8.50 %), 14.10 % Cash, 5/2/2027
5/2/2022 $ 6,000,000 5,955,935 6,060,000 1.6 %
JDXpert (j) Talent Acquisition Software Delayed Draw Term Loan
(3M USD TERM SOFR+ 8.50 %), 14.10 % Cash, 5/2/2027
5/2/2022 $ 1,000,000 991,649 1,010,000 0.3 %
Jobvite, Inc. (d) Talent Acquisition Software First Lien Term Loan
(6M USD TERM SOFR+ 8.00 %), 13.27 % Cash, 8/5/2028
8/5/2022 $ 20,000,000 19,875,273 19,826,000 5.6 %
Total Talent Acquisition Software 26,822,857 26,896,000 7.5 %
VetnCare MSO, LLC (j) Veterinary Services Delayed Draw Term Loan
(3M USD TERM SOFR+ 5.75 %), 11.08 % Cash, 5/12/2028
5/12/2023 $ 4,680,505 4,638,599 4,753,048 1.3 %
Total Veterinary Services 4,638,599 4,753,048 1.3 %
Sub Total Non-control/Non-affiliate investments 1,035,879,751 1,019,774,616 276.5 %

24

Saratoga Investment Corp.

Consolidated Schedule of Investments

February 29, 2024

Company(1) Industry Investment
Interest Rate/
Maturity
Original
Acquisition
Date
Principal/
Number of
Shares
Cost Fair
Value (c)
% of
Net Assets
Affiliate investments - 7.5% (b)
ETU Holdings, Inc. (f) Corporate Education Software First Lien Term Loan
(3M USD TERM SOFR+ 9.00 %), 14.48 % Cash, 8/18/2027
8/18/2022 $ 7,000,000 6,945,060 6,983,200 1.9 %
ETU Holdings, Inc. (f) Corporate Education Software Second Lien Term Loan
15.00 % PIK, 2/18/2028
8/18/2022 $ 6,130,483 6,089,408 5,454,290 1.5 %
ETU Holdings, Inc. (f)(h) Corporate Education Software Series A Preferred Units 8/18/2022 3,000,000 3,000,000 1,162,040 0.3 %
Total Corporate Education Software 16,034,468 13,599,530 3.7 %
Axero Holdings, LLC (f) Employee Collaboration Software First Lien Term Loan
(3M USD TERM SOFR+ 8.00 %), 13.48 % Cash, 6/30/2026
6/30/2021 $ 5,500,000 5,468,859 5,555,000 1.5 %
Axero Holdings, LLC (f) Employee Collaboration Software Delayed Draw Term Loan
(3M USD TERM SOFR+ 8.00 %), 13.48 % Cash, 6/30/2026
6/30/2021 $ 1,100,000 1,092,870 1,111,000 0.3 %
Axero Holdings, LLC (f)(j) Employee Collaboration Software Revolving Credit Facility
(3M USD TERM SOFR+ 8.00 %), 13.48 % Cash, 6/30/2026
2/3/2022 $ - - - 0.0 %
Axero Holdings, LLC (f)(h) Employee Collaboration Software Series A Preferred Units 6/30/2021 2,055,609 2,055,609 2,877,000 0.8 %
Axero Holdings, LLC (f)(h) Employee Collaboration Software Series B Preferred Units 6/30/2021 2,055,609 2,055,609 4,606,607 1.2 %
Total Employee Collaboration Software 10,672,947 14,149,607 3.8 %
Sub Total Affiliate investments 26,707,415 27,749,137 7.5 %

25

Saratoga Investment Corp.

Consolidated Schedule of Investments

February 29, 2024

Company(1) Industry Investment
Interest Rate/
Maturity
Original
Acquisition
Date
Principal/
Number of
Shares
Cost Fair
Value (c)
% of
Net Assets
Control investments - 24.7% (b)
Netreo Holdings, LLC (g) IT Services First Lien Term Loan
(3M USD TERM SOFR + 6.50 %), 11.98 % Cash/ 3.50 % PIK
12/31/2025
7/3/2018 $ 5,693,748 5,686,791 5,582,719 1.5 %
Netreo Holdings, LLC (d)(g) IT Services Delayed Draw Term Loan
(3M USD TERM SOFR + 6.50 %), 11.98 % Cash/ 3.50 % PIK,
12/31/2025
5/26/2020 $ 25,271,214 25,193,452 24,778,425 6.7 %
Netreo Holdings, LLC (g)(h) IT Services Common Stock Class A Units 7/3/2018 4,600,677 8,344,500 5,060,745 1.4 %
Total IT Services 39,224,743 35,421,889 9.6 %
Saratoga Investment Corp. CLO 2013-1, Ltd. (a)(e)(g) Structured Finance Securities Other/Structured Finance Securities
0.00 %, 4/20/2033
1/22/2008 $ 111,000,000 22,001,887 9,500,627 2.6 %
Saratoga Investment Corp. CLO 2013-1, Ltd. Class F-2-R-3 Note (a)(g) Structured Finance Securities Other/Structured Finance Securities
(3M USD TERM SOFR+ 10.00 %), 15.60 %, 4/20/2033
8/9/2021 $ 9,375,000 9,375,000 8,875,227 2.4 %
Saratoga Investment Corp. Senior Loan Fund 2022-1, Ltd. Class E Note (a)(g) Structured Finance Securities Other/Structured Finance Securities
(3M USD TERM SOFR+ 8.55 %), 13.88 %, 10/20/2033
10/28/2022 $ 12,250,000 11,392,500 12,250,000 3.3 %
Total Structured Finance Securities 42,769,387 30,625,854 8.3 %
Saratoga Senior Loan Fund I JV, LLC (a)(g)(j) Investment Fund Unsecured Loan
10.00 %, 10/20/2033
12/17/2021 $ 17,618,954 17,618,954 15,818,297 4.3 %
Saratoga Senior Loan Fund I JV, LLC (a)(g) Investment Fund Membership Interest 12/17/2021 17,583,486 17,583,487 9,403,996 2.5 %
Total Investment Fund 35,202,441 25,222,293 6.8 %
Sub Total Control investments 117,196,571 91,270,036 24.7 %
TOTAL INVESTMENTS - 308.7% (b) $ 1,179,783,737 $ 1,138,793,789 308.7 %

Number of Shares Cost Fair Value % of
Net Assets
Cash and cash equivalents and cash and cash equivalents, reserve accounts - 10.9% (b)
U.S. Bank Money Market (l) 40,507,124 $ 40,507,124 $ 40,507,124 10.9 %
Total cash and cash equivalents and cash and cash equivalents, reserve accounts 40,507,124 $ 40,507,124 $ 40,507,124 10.9 %

(1) Securities are exempt from registration under Rule 144A of the Securities Act of 1933, as amended, and are restricted securities. Money market funds are valued at net asset value and are considered level 1 investments within the fair value hierarchy.
(a) Represents an investment that is not a “qualifying asset” under Section 55(a) of the Investment Company Act of 1940, as amended (the 1940 Act”). As of February 29, 2024, non-qualifying assets represent 6.2% of the Company’s portfolio at fair value. As a BDC, the Company generally has to invest at least 70% of its total assets in qualifying assets.
(b) Percentages are based on net assets of $370,224,108 as of February 29, 2024.
(c) Because there is no “readily available market quotations” (as defined in the 1940 Act) for these investments, the fair values of these investments were determined using significant unobservable inputs and approved in good faith by our board of directors. These investments have been included as Level 3 in the Fair Value Hierarchy (see Note 3 to the consolidated financial statements).

26

Saratoga Investment Corp.

Consolidated Schedule of Investments

February 29, 2024

(d) These securities are either fully or partially pledged as collateral under the Company’s senior secured revolving credit facility (see Note 8 to the consolidated financial statements).
(e) This investment does not have a stated interest rate that is payable thereon. As a result, the 0.00% interest rate in the table above represents the effective interest rate currently earned on the investment cost and is based on the current cash interest and other income generated by the investment.
(f) As defined in the 1940 Act, this portfolio company is an “affiliate” as we own between 5.0% and 25.0% of the outstanding voting securities. Modis Dental Partners OpCo, LLC and Alpha Aesthetics Partners OpCo, LLC are no longer affiliates as of February 29, 2024. Transactions during the year ended February 29, 2024 in which the issuer was an affiliate are as follows:

Company Purchases Sales Total
Interest from
Investments
Management
Fee Income
Net Realized
Gain (Loss)
from
Investments
Net Change
in Unrealized
Appreciation
(Depreciation)
Axero Holdings, LLC $
-
$
-
$ 931,008 $
-
$
-
$ 976,251
ETU Holdings, Inc.
-
-
1,915,718
-
-
( 2,518,080 )
Modis Dental Partners OpCo, LLC 8,845,000
-
656,579
-
-
-
Alpha Aesthetics Partners OpCo, LLC 10,498,789
-
670,737
-
-
-
Total $ 19,343,789 $
-
$ 4,174,042 $
-
$
-
$ ( 1,541,829 )

(g) As defined in the 1940 Act, we “control” this portfolio company because we own more than 25% of the portfolio company’s outstanding voting securities. Transactions during the year ended February 29, 2024 in which the issuer was both an affiliate and a portfolio company that we control are as follows:

Company Purchases Sales Total
Interest from
Investments
Total
Dividends
from
Investments
Management
Fee Income
Net Realized
Gain (Loss)
from
Investments
Net Change
in Unrealized
Appreciation
(Depreciation)
Netreo Holdings, LLC $ 2,475,000 $
-
$ 4,374,804 $
-
$
-
$
-
$ ( 12,083,067 )
Saratoga Investment Corp. CLO 2013-1, Ltd.
-
-
-
-
3,270,232
-
( 4,733,934 )
Saratoga Investment Corp. Senior Loan Fund 2022-1, Ltd. Class E Note
-
-
1,696,890
-
-
-
895,505
Saratoga Investment Corp. CLO 2013-1, Ltd. Class F-2-R-3 Note
-
-
1,469,668
-
-
-
43,821
Saratoga Senior Loan Fund I JV, LLC
-
-
1,781,472
-
-
-
( 1,800,657 )
Saratoga Senior Loan Fund I JV, LLC
-
-
-
5,911,564
-
-
( 3,702,956 )
Total $ 2,475,000 $
-
$ 9,322,834 $ 5,911,564 $ 3,270,232 $
-
$ ( 21,381,288 )

(h) Non-income producing at February 29, 2024.
(i) Includes securities issued by an affiliate of the company.
(j) All or a portion of this investment has an unfunded commitment as of February 29, 2024. (See Note 9 to the consolidated financial statements).
(k) As of February 29, 2024, the investment was on non-accrual status. The fair value of these investments was approximately $18.9 million, which represented 1.7% of the Company’s portfolio (see Note 2 to the consolidated financial statements).
(l) Included within cash and cash equivalents and cash and cash equivalents, reserve accounts in the Company’s consolidated statements of assets and liabilities as of February 29, 2024.

SOFR - Secured Overnight Financing Rate

1M USD TERM SOFR - The 1 month USD TERM SOFR rate as of February 29, 2024 was 5.32%.

3M USD TERM SOFR - The 3 month USD TERM SOFR rate as of February 29, 2024 was 5.33%.

6M USD TERM SOFR - The 6 month USD TERM SOFR rate as of February 29, 2024 was 5.27%.

PIK - Payment-in-Kind (see Note 2 to the consolidated financial statements).

See accompanying notes to consolidated financial statements.

27

SARATOGA INVESTMENT CORP.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

November 30, 2024

(unaudited)

Note 1. Organization

Saratoga Investment Corp. (the “Company”, “we”, “our” and “us”) is a non-diversified closed end management investment company incorporated in Maryland that has elected to be regulated as a business development company (“BDC”) under the Investment Company Act of 1940, as amended (the “1940 Act”). The Company commenced operations on March 23, 2007 as GSC Investment Corp. and completed the initial public offering (“IPO”) on March 28, 2007. The Company has elected, and intends to qualify annually, to be treated for U.S. federal income tax purposes as a regulated investment company (“RIC”) under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”). The Company’s investment objective is to generate current income and, to a lesser extent, capital appreciation from its investments.

GSC Investment, LLC (the “LLC”) was organized in May 2006 as a Maryland limited liability company. On March 21, 2007, the Company was incorporated and concurrently therewith the LLC was merged with and into the Company, with the Company as the surviving entity, in accordance with the procedure for such merger in the LLC’s limited liability company agreement and Maryland law. In connection with such merger, each outstanding limited liability company interest of the LLC was converted into a share of common stock of the Company.

On July 30, 2010, the Company changed its name from “GSC Investment Corp.” to “Saratoga Investment Corp.” in connection with the consummation of a recapitalization transaction.

The Company is externally managed and advised by the investment adviser, Saratoga Investment Advisors, LLC (the “Manager” or “Saratoga Investment Advisors”), pursuant to an investment advisory and management agreement (the “Management Agreement”).

The Company has established wholly owned subsidiaries, SIA-AAP, Inc., SIA-ARC, Inc., SIA-Avionte, Inc., SIA-AX, Inc., SIA-G4, Inc., SIA-GH, Inc., SIA-MDP, Inc., SIA-PP Inc., SIA-SZ, Inc., SIA-TG, Inc., SIA-TT, Inc. and SIA-Vector, Inc., which are structured as Delaware entities that are treated as corporations for U.S. federal income tax purposes and are intended to facilitate its compliance with the requirements to be treated as a RIC under the Code by holding equity or equity-like investments in portfolio companies organized as limited liability companies, or LLCs (or other forms of pass through entities). These entities are consolidated for accounting purposes, but are not consolidated for U.S. federal income tax purposes and may incur U.S. federal income tax expenses as a result of their ownership of portfolio companies. In February 2022, SIA-GH, Inc., SIA-TT Inc. and SIA-VR, Inc. received an approved plan of liquidation following the sale of equity held by each of the portfolio companies.  In June 2024, SIA-MAC, Inc. and SIA-VR, Inc. were dissolved.

Our wholly owned subsidiaries, Saratoga Investment Corp. SBIC II LP (“SBIC II LP”) and Saratoga Investment Corp. SBIC III LP (“SBIC III LP”, and together with SBIC II LP, the “SBIC Subsidiaries”), received licenses to operate as small business investment companies from the SBA on August 14, 2019 and September 29, 2022, respectively. Each of the SBIC Subsidiaries provides up to $ 175.0 million in long-term capital in the form of debentures guaranteed by the SBA. Our wholly owned subsidiary Saratoga Investment Corp. SBIC LP (“SBIC LP”) repaid its outstanding debentures and subsequently surrendered its license to the SBA on January 3, 2024, providing the Company access to all undistributed capital of SBIC LP, and SBIC LP subsequently merged with and into the Company. Under current SBIC regulations, for two or more SBICs under common control, the maximum amount of outstanding SBA debentures cannot exceed $ 350.0 million with at least $ 175.0 million in combined regulatory capital.

The Company has formed wholly owned special purpose entities organized as Delaware limited liability companies, Saratoga Investment Funding II LLC (“SIF II”) and Saratoga Investment Funding III LLC (“SIF III”) for the purpose of the Encina Credit Facility and the Live Oak Credit Facility (each as defined below), respectively. The senior secured revolving credit facility (the “Encina Credit Facility) with Encina Lender Finance, LLC (“Encina”) is supported by loans held by SIF II and pledged to Encina, and the senior secured revolving credit facility (the “Live Oak Credit Facility”) with Live Oak Banking Company (“Live Oak”) is supported by loans held by SIF III and pledged to Live Oak.

On October 26, 2021, the Company and TJHA JV I LLC (“TJHA”) entered into a Limited Liability Company Agreement to co-manage Saratoga Senior Loan Fund I JV LLC (“SLF JV”). SLF JV is under joint control and is not consolidated. SLF JV is invested in Saratoga Investment Corp Senior Loan Fund 2022-1 Ltd. (“SLF 2022”), which is a wholly owned subsidiary of SLF JV. SLF 2022 was formed for the purpose of making investments in a diversified portfolio of broadly syndicated first lien and second lien term loans or bonds in the primary and secondary markets. On October 28, 2022, SLF 2022 issued $ 402.1 million of debt (the “2022 JV CLO Notes”) through a collateralized loan obligation trust (the “JV CLO trust”). The 2022 JV CLO Notes were issued pursuant to an indenture, dated October 28, 2022 (the “JV Indenture”), with U.S. Bank Trust Company, National Association (as successor in interest to U.S. Bank National Association) (the “Trustee”) servicing as the trustee.

28

Note 2. Summary of Significant Accounting Policies

Basis of Presentation

The accompanying consolidated financial statements have been prepared on the accrual basis of accounting in conformity with U.S. generally accepted accounting principles (“U.S. GAAP”), are stated in U.S. Dollars and include the accounts of the Company and its wholly owned special purpose financing subsidiaries, SIF II, SIF III, SBIC II LP, SBIC III LP, SIA-AAP, Inc., SIA-ARC, Inc., SIA-Avionte, Inc., SIA-AX, Inc., SIA-G4, Inc., SIA-GH, Inc., SIA-MDP, Inc.,, SIA-PP, Inc., SIA-SZ, Inc., SIA-TG, Inc., SIA-TT Inc., and SIA-Vector, Inc. All intercompany accounts and transactions have been eliminated in consolidation. All references made to the “Company,” “we,” and “us” herein include Saratoga Investment Corp. and its consolidated subsidiaries, except as stated otherwise.

The Company, SBIC II LP, and SBIC III LP are all considered to be investment companies for financial reporting purposes and have applied the guidance in the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 946, Financial Services — Investment Companies (“ASC 946”). There have been no changes to the Company, SBIC II LP, or SBIC III LP’s status as investment companies during the three months ended November 30, 2024.

Principles of Consolidation

Under the investment company rules and regulations pursuant to ASC 946, the Company is precluded from consolidating any entity other than another investment company or controlled operating company whose business consists of providing services to the Company.  As a result, the consolidated financial statements of the Company include only the accounts of the Company and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.

The Company has determined that SLF JV is an investment company under ASC 946; however, in accordance with such guidance the Company will generally not consolidate its investment in a company other than a wholly owned investment company subsidiary. SLF JV is not a wholly owned investment company subsidiary as the Company and TJHA each have an equal 50 % voting interest in SLF JV and thus neither party has a controlling financial interest. Furthermore, FASB ASC Topic 810, Consolidation , concludes that in a joint venture where both members have equal decision-making authority, it is not appropriate for one member to consolidate the joint venture since neither has control. Accordingly, the Company does not consolidate its investment in SLF JV.

Use of Estimates in the Preparation of Financial Statements

The preparation of the accompanying consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosure of contingent assets and liabilities at the date of the financial statements, and income, gains (losses) and expenses during the period reported. Actual results could differ materially from those estimates.

Operating Segment

The Company invests in various industries and separately evaluates the performance of each of its investment relationships. However, because each of these investment relationships have similar business and economic characteristics, they have been aggregated into a single investment segment. All applicable segment disclosures are included in or can be derived from the Company’s consolidated financial statements (See Note 3. Investments ).

Cash and Cash Equivalents

Cash and cash equivalents include short-term, liquid investments in a money market fund. The Company places its cash in financial institutions and, at times, such balances may be in excess of the Federal Deposit Insurance Corporation insurance limits. Cash and cash equivalents are carried at cost which approximates fair value. Pursuant to Section 12(d)(1)(A) of the 1940 Act, the Company may not invest in another investment company, such as a money market fund, if such investment would cause the Company to:

own more than 3.0 % of the investment company’s total outstanding voting stock;

hold securities in the investment company having an aggregate value in excess of 5.0 % of the value of the Company’s total assets; or

hold securities in investment companies having an aggregate value in excess of 10.0 % of the value of the Company’s total assets.

As of November 30, 2024, the Company did not exceed any of these limitations.

29

Cash and Cash Equivalents, Reserve Accounts

Cash and cash equivalents, reserve accounts include amounts held in designated bank accounts in the form of cash and short-term liquid investments in money market funds, and, at times, such balances may be in excess of the Federal Deposit Insurance Corporation insurance limits, representing payments received on secured investments or other reserved amounts associated with the Encina Credit Facility or the Live Oak Credit Facility held by the Company’s wholly owned subsidiaries, SIF II and SIF III, respectively. The Company is required to use these amounts to pay interest expense, reduce borrowings, or pay other amounts in accordance with the terms of the Encina Credit Facility and the Live Oak Credit Facility.

In addition, cash and cash equivalents, reserve accounts also include amounts held in designated bank accounts, in the form of cash and short-term liquid investments in money market funds, within the Company’s wholly owned subsidiaries, SBIC II LP and SBIC III LP.

The statements of cash flows explain the change during the period in the total of cash, cash equivalents and amounts generally described as restricted cash and restricted cash equivalents when reconciling the beginning-of-period and end-of-period total amounts.

The following table provides a reconciliation of cash and cash equivalents and cash and cash equivalents, reserve accounts reported within the consolidated statements of assets and liabilities that sum to the total of the same such amounts shown in the consolidated statements of cash flows:

November 30,
2024
February 29,
2024
Cash and cash equivalents $ 147,614,810 $ 8,692,846
Cash and cash equivalents, reserve accounts 102,549,213 31,814,278
Total cash and cash equivalents and cash and cash equivalents, reserve accounts $ 250,164,023 $ 40,507,124

Investment Classification

The Company classifies its investments in accordance with the requirements of the 1940 Act. Under the 1940 Act, “control investments” are defined as investments in companies in which the Company owns more than 25.0 % of the voting securities or maintains greater than 50.0 % of the board representation. Under the 1940 Act, “affiliated investments” are defined as those non-control investments in companies in which the Company owns between 5.0 % and 25.0 % of the voting securities. Under the 1940 Act, “non-affiliated investments” are defined as investments that are neither control investments nor affiliated investments.

Investment Valuation

The Company accounts for its investments at fair value in accordance with the FASB ASC Topic 820, Fair Value Measurement (“ASC 820”). ASC 820 defines fair value, establishes a framework for measuring fair value, establishes a fair value hierarchy based on the quality of inputs used to measure fair value and enhances disclosure requirements for fair value measurements. ASC 820 requires the Company to assume that its investments are to be sold or its liabilities are to be transferred at the measurement date in the principal market to independent market participants, or in the absence of a principal market, in the most advantageous market, which may be a hypothetical market. Market participants are defined as buyers and sellers in the principal or most advantageous market that are independent, knowledgeable, and willing and able to transact.

Investments for which market quotations are readily available are fair valued at such market quotations obtained from independent third-party pricing services and market makers subject to any decision by the Company’s board of directors to approve a fair value determination to reflect significant events affecting the value of these investments. The Company values investments for which market quotations are not readily available at fair value as approved, in good faith, by the Company’s board of directors based on input from the Manager, the audit committee of the board of directors and a third-party independent valuation firm.

30

The Company undertakes a multi-step valuation process each quarter when valuing investments for which market quotations are not readily available, as described below:

each investment is initially valued by the responsible investment professionals of the Manager and preliminary valuation conclusions are documented, reviewed and discussed with our senior management; and

an independent valuation firm engaged by the Company’s board of directors independently reviews a selection of these preliminary valuations each quarter so that the valuation of each investment for which market quotes are not readily available is reviewed by the independent valuation firm at least once each fiscal year. The Company uses a third-party independent valuation firm to value its investment in the subordinated notes of Saratoga Investment Corp. CLO 2013-1, Ltd. (“Saratoga CLO”), the Class F-2-R-3 Notes of the Saratoga CLO, and the Class E Notes of the SLF 2022 every quarter.

In addition, all investments are subject to the following valuation process:

the audit committee of the Company’s board of directors reviews and approves each preliminary valuation and the Manager and independent valuation firm (if applicable) will supplement the preliminary valuation to reflect any comments provided by the audit committee; and

the Company’s board of directors discusses the valuations and approves the fair value of each investment, in good faith, based on the input of the Manager, independent valuation firm (to the extent applicable) and the audit committee of the board of directors.

The Company uses multiple techniques for determining fair value based on the nature of the investment and experience with those types of investments and specific portfolio companies. The selections of the valuation techniques and the inputs and assumptions used within those techniques often require subjective judgements and estimates. These techniques include market comparables, discounted cash flows and enterprise value waterfalls. Fair value is best expressed as a range of values from which the Company determines a single best estimate. The types of inputs and assumptions that may be considered in determining the range of values of the Company’s investments include the nature and realizable value of any collateral, the portfolio company’s ability to make payments, market yield trend analysis and volatility in future interest rates, call and put features, the markets in which the portfolio company does business, comparison to publicly traded companies, discounted cash flows and other relevant factors.

The Company’s investments in the subordinated notes of Saratoga CLO, Class F-2-R-3 Notes of the Saratoga CLO and the Class E Notes of SLF 2022 are carried at fair value, which is based on a discounted cash flow valuation technique that utilizes prepayment, re-investment and loss inputs based on historical experience and projected performance, economic factors, the characteristics of the underlying cash flow, and comparable yields for equity interests in collateralized loan obligation funds, when available, as determined by the Manager and recommended to the Company’s board of directors. Specifically, the Company uses Intex cash flows, or an appropriate substitute, to form the basis for the valuation of its investment in the subordinated notes of Saratoga CLO, Class F-2-R-3 Notes of the Saratoga CLO and the Class E Notes of SLF 2022. The inputs are based on available market data and projections provided by third parties as well as management estimates. The Company uses the output from the Intex models (i.e., the estimated cash flows) to perform a discounted cash flow analysis on expected future cash flows to determine the valuation for our investment in Saratoga CLO.

The Company’s equity investment in SLF JV is measured using the proportionate share of the net asset value (“NAV”), or equivalent, of SLF JV as a practical expedient for fair value, provided by ASC 820. The Company’s unsecured loan investment in SLF JV is based on a discounted cash flow valuation technique.

Because such valuations, and particularly valuations of private investments and private companies, are inherently uncertain, they may fluctuate over short periods of time and may be based on estimates. The determination of fair value may differ materially from the values that would have been used if a ready market for these investments existed. The Company’s NAV could be materially affected if the determinations regarding the fair value of its investments were materially higher or lower than the values that the Company ultimately realizes upon the disposal of such investments.

31

Rule 2a-5 under the 1940 Act (“Rule 2a-5”) establishes a regulatory framework for determining fair value in good faith for purposes of the 1940 Act. Rule 2a-5 permits boards of directors, subject to board oversight and certain other conditions, to designate the investment adviser to perform fair value determinations. Rule 2a-5 also defines when market quotations are “readily available” for purposes of the 1940 Act and the threshold for determining whether a fund must determine the fair value of a security. Rule 31a-4 under the 1940 Act (“Rule 31a-4”) provides for certain recordkeeping requirements associated with fair value determinations. While the Company’s board of directors has not elected to designate Saratoga Investment Advisors as the valuation designee, the Company has established policies and procedures in compliance with the applicable requirements of Rule 2a-5 and Rule 31a-4.

Derivative Financial Instruments

The Company accounts for derivative financial instruments in accordance with FASB ASC Topic 815, Derivatives and Hedging (“ASC 815”). ASC 815 requires recognizing all derivative instruments as either assets or liabilities on the consolidated statements of assets and liabilities at fair value. The Company values derivative contracts at the closing fair value provided by the counterparty. Changes in the values of derivative contracts are included in the consolidated statements of operations.

Investment Transactions and Income Recognition

Purchases and sales of investments and the related realized gains or losses are recorded on a trade-date basis. Interest income, adjusted for amortization of premium and accretion of discount, is recorded on an accrual basis to the extent that such amounts are expected to be collected. The Company stops accruing interest on its investments when it is determined that interest is no longer collectible. Discounts and premiums on investments purchased are accreted/amortized using the effective yield method. The amortized cost of investments represents the original cost adjusted for the accretion of discounts over the life of the investment and amortization of premiums on investments up to the earliest call date.

Loans are generally placed on non-accrual status when there is reasonable doubt that principal or interest will be collected. Accrued interest is generally reserved when a loan is placed on non-accrual status. Interest payments received on non-accrual loans may be recognized as a reduction in principal depending upon management’s judgment regarding collectability. Non-accrual loans are restored to accrual status when past due principal and interest is paid and, in management’s judgment, are likely to remain current, although management may make exceptions to this general rule if the loan has sufficient collateral value and is in the process of collection. At November 30, 2024, our investment in two controlled portfolio companies were on non-accrual status with a fair value of approximately $ 2.7 million, or 0.3 % of the fair value of our portfolio. At February 29, 2024, our investment in three non-controlled portfolio companies were on non-accrual status with a fair value of approximately $ 18.9 million, or 1.7 % of the fair value of our portfolio.

Interest income on our investment in the subordinated note of Saratoga CLO is recorded using the effective interest method in accordance with the provisions of ASC Topic 325-40, Investments-Other, Beneficial Interests in Securitized Financial Assets , based on the anticipated yield and the estimated cash flows over the projected life of the investment. Yields are revised when there are changes in actual or estimated cash flows due to changes in prepayments and/or re-investments, credit losses or asset pricing. Changes in estimated yield are recognized as an adjustment to the estimated yield over the remaining life of the investment from the date the estimated yield was changed.

Payment-in-Kind Interest

The Company may hold debt and preferred equity investments in its portfolio that contain a payment-in-kind (“PIK”) interest provision. The PIK interest, which represents contractually deferred interest added to the investment balance that is generally due at maturity, is generally recorded on an accrual basis to the extent such amounts are expected to be collected. The Company stops accruing PIK interest if it is expected that the issuer will not be able to pay all principal and interest when due. The Company restores to accrual status when past due principal and interest is paid and, in management’s judgment, are likely to remain current, although management may make exceptions to this general rule if the loan has sufficient collateral value and is in the process of collection.

32

Dividend Income

Dividend income is recorded in the consolidated statements of operations when earned.

Structuring and Advisory Fee Income

Structuring and advisory fee income represents various fee income earned and received for performing certain investment structuring and advisory activities during the closing of new investments.

Other Income

Other income includes prepayment income fees, and monitoring, administration, redemption and amendment fees and is recorded in the consolidated statements of operations when earned.

Deferred Debt Financing Costs

Financing costs incurred in connection with our credit facility and notes are deferred and amortized using the straight-line method over the life of the respective facility and debt securities. Financing costs incurred in connection with the SBA debentures of SBIC II LP and SBIC III LP are deferred and amortized using the straight-line method over the life of the debentures. Any discount or premium on the issuance of any debt is accreted and amortized using the effective interest method over the life of the respective debt security.

The Company presents deferred debt financing costs on the balance sheet as a contra-liability, which is a direct deduction from the carrying amount of that debt liability, consistent with debt discounts.

Realized Loss on Extinguishment of Debt

Upon the repayment of debt obligations that are deemed to be extinguishments, the difference between the principal amount due at maturity adjusted for any unamortized debt issuance costs is recognized as a loss (i.e., the unamortized debt issuance costs are recognized as a loss upon extinguishment of the underlying debt obligation).

Contingencies

In the ordinary course of business, the Company may enter into contracts or agreements that contain indemnifications or warranties. Future events could occur that lead to the execution of these provisions against the Company. Based on its history and experience, management reasonably believes that the likelihood of such an event is remote. Therefore, the Company has not accrued any liabilities in connection with such indemnifications.

In the ordinary course of business, the Company may directly or indirectly be a defendant or plaintiff in legal actions with respect to bankruptcy, insolvency or other types of proceedings. Such lawsuits may involve claims that could adversely affect the value of certain financial instruments owned by the Company.

Income Taxes

The Company has elected, and intends to qualify annually, to be treated for U.S. federal income tax purposes as a RIC under Subchapter M of the Code. By meeting these requirements, the Company generally will not be subject to U.S. federal income tax on ordinary income or capital gains timely distributed to stockholders. Therefore, no provision has been recorded for federal income taxes, except as related to the Corporate Blockers (as defined below) and long-term capital gains, when applicable.

In order to qualify as a RIC, among other requirements, the Company generally is required to timely distribute to its stockholders at least 90 % of its “investment company taxable income”, as defined by the Code, for each fiscal tax year. The Company will be subject to U.S. federal income tax imposed at corporate rates on its investment company taxable income and net capital gains that it does not timely distribute to shareholders. The Company will be subject to a non-deductible U.S. federal excise tax of 4 % on undistributed income if it does not distribute at least (1) 98 % of its net ordinary income in any calendar year, (2) 98.2 % of its capital gain net income for each one-year period ending on October 31and (3) any net ordinary income and capital gain net income that it recognized for preceding years, but were not distributed during such year, and on which the Company paid no U.S federal income tax.

33

Depending on the level of investment company taxable income earned in a tax year and the amount of net capital gains recognized in such tax year, the Company may choose to carry forward investment company taxable income and net capital gains in excess of current year dividend distributions into the next tax year and pay U.S. federal income tax, and possibly the 4 % U.S. federal excise tax on such income, as required. To the extent that the Company determines that its estimated current year annual investment company taxable income will be in excess of estimated current year dividend distributions for U.S. federal excise tax purposes, the Company accrues the U.S. federal excise tax, if any, on estimated excess taxable income as taxable income is earned. For the years ended February 29, 2024, 2023 and 2022, the excise tax accrual on estimated excess taxable income was $ 1.8 million, $ 1.1 million and $ 0.6 million, respectively.

In accordance with U.S. Treasury regulations and published guidance issued by the Internal Revenue Service (“IRS”), a publicly offered RIC may treat a distribution of its own stock as counting toward its RIC distribution requirements if each stockholder may elect to receive his, her, or its entire distribution in either cash or stock of the RIC. This published guidance indicates that the rule will apply where the aggregate amount of cash to be distributed to all stockholders is not at least 20 % of the aggregate declared distribution. Under the published guidance, if too many stockholders elect to receive cash, the cash available for distribution must be allocated among the stockholders electing to receive cash (with the balance of the distribution paid in stock). In no event will any stockholder, electing to receive cash, receive less than 20 % of his or her entire distribution in cash. If these and certain other requirements are met, for U.S. federal income tax purposes, the amount of the dividend paid in stock will be equal to the amount of cash that could have been received instead of stock.

The Company may utilize wholly owned holding companies that are treated as corporations for U.S. federal income tax purposes when making equity investments in portfolio companies taxed as pass-through entities to meet its source-of-income requirements as a RIC (“Corporate Blockers”). Corporate Blockers are consolidated in the Company’s U.S. GAAP financial statements and may result in current and deferred U.S. federal and state income tax expense with respect to income derived from those investments. Such income, net of applicable income taxes, is not included in the Company’s tax-basis net investment income until distributed by the Corporate Blocker, which may result in timing and character differences between the Company’s U.S. GAAP and tax-basis net investment income and realized gains and losses. Income tax expense or benefit from Corporate Blockers related to net investment income are included in total operating expenses, while any expense or benefit related to federal or state income tax originated for capital gains and losses are included together with the applicable net realized or unrealized gain or loss line item. Deferred tax assets of the Corporate Blockers are reduced by a valuation allowance when, in the opinion of management, it is more-likely than-not that some portion or all of the deferred tax assets will not be realized.

FASB ASC Topic 740, Income Taxes , (“ASC 740”), provides guidance for how uncertain tax positions should be recognized, measured, presented and disclosed in the financial statements. ASC 740 requires the evaluation of tax positions taken or expected to be taken in the course of preparing the Company’s tax returns to determine whether the tax positions are “more-likely-than-not” of being sustained by the applicable tax authority. Tax positions deemed to meet a “more-likely-than-not” threshold would be recorded as a tax benefit or expense in the current period. The Company recognizes interest and penalties, if any, related to unrecognized tax benefits as income tax expense on the consolidated statements of operations. During the fiscal year ended February 29, 2024, the Company did not incur any interest or penalties. Although we file federal and state tax returns, our major tax jurisdiction is federal. The 2021, 2022, 2023 and 2024 federal tax years for the Company remain subject to examination by the IRS. At November 30, 2024 and February 29, 2024, there were no uncertain tax positions. The Company is not aware of any tax positions for which it is reasonably possible that the total amounts of unrecognized tax benefits will change significantly in the next 12 months.

Dividends

Dividends to common stockholders are recorded on the ex-dividend date. The amount to be paid out as a dividend is determined by the board of directors. Net realized capital gains, if any, are generally distributed at least annually, although we may decide to retain some or all of our net capital gains for reinvestment.

We have adopted a dividend reinvestment plan (“DRIP”) that provides for reinvestment of our dividend distributions on behalf of our stockholders unless a stockholder elects to receive cash. As a result, if our board of directors authorizes, and we declare, a cash dividend, then our stockholders who have not “opted out” of the DRIP by the dividend record date will have their cash dividends automatically reinvested into additional shares of our common stock, rather than receiving the cash dividends. We have the option to satisfy the share requirements of the DRIP through the issuance of new shares of common stock or through open market purchases of common stock by the DRIP plan administrator.

34

Capital Gains Incentive Fee

The Company records an expense accrual on the consolidated statements of operations relating to the capital gains incentive fee payable to the Manager, as recorded on the consolidated statements of assets and liabilities when the net realized and unrealized gain on its investments exceed all net realized and unrealized capital losses on its investments, as a capital gains incentive fee would be owed to the Manager if the Company were to liquidate its investment portfolio at such time.

The actual incentive fee payable to the Manager related to capital gains will be determined and payable in arrears at the end of each fiscal year and only reflect those realized capital gains net of realized and unrealized losses for the period.

Recent Accounting Pronouncements

In November 2023, the FASB issued ASU 2023-07, Improvements to Reportable Segment Disclosures . ASU 2023-07 enhances the disclosures required for reportable segments on an annual and interim basis. ASU 2023-07 is effective on a retrospective basis for annual periods beginning after December 15, 2023, and for interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted; however, the Company has not elected to adopt this provision as of the date of the financial statements contained in this quarterly report. The Company is still assessing the impact of the new guidance.

In December 2023, the FASB issued ASU 2023-09, Improvements to Income Tax Disclosures . The amendments in this update require more disaggregated information on income taxes paid. ASU 2023-09 is effective for years beginning after December 15, 2024. Early adoption is permitted, however the Company has not elected to early adopt this provision as of the date of the financial statements contained in this report. The Company is still assessing the impact of the new guidance.

Risk Management

In the ordinary course of its business, the Company manages a variety of risks, including market and credit risk. Market risk is the risk of potential adverse changes to the value of investments because of changes in market conditions such as interest rate movements and volatility in investment prices.

Credit risk is the risk of default or non-performance by portfolio companies, equivalent to the investment’s carrying amount. The Company is also exposed to credit risk related to maintaining all of its cash and cash equivalents, including those in reserve accounts, at a major financial institution and credit risk related to any of its derivative counterparties.

The Company has investments in lower rated and comparable quality unrated high yield bonds and bank loans. Investments in high yield investments are accompanied by a greater degree of credit risk. The risk of loss due to default by the issuer is significantly greater for holders of high yield securities, because such investments are generally unsecured and are often subordinated to other creditors of the issuer.

Note 3. Investments

As noted above, the Company values all investments in accordance with ASC 820. As defined in ASC 820, fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between independent market participants at the measurement date.

35

ASC 820 establishes a hierarchal disclosure framework which prioritizes and ranks the level of market price observability of inputs used in measuring investments at fair value. Market price observability is affected by a number of factors, including the type of investment and the characteristics specific to the investment. Investments with readily available active quoted prices or for which fair value can be measured from actively quoted prices generally will have a higher degree of market price observability and a lesser degree of judgment used in measuring fair value.

Based on the observability of the inputs used in the valuation techniques, the Company is required to provide disclosures on fair value measurements according to the fair value hierarchy. The fair value hierarchy ranks the observability of the inputs used to determine fair values. Investments carried at fair value are classified and disclosed in one of the following three categories:

Level 1—Valuations based on quoted prices in active markets for identical assets or liabilities that the Company has the ability to access.

Level 2— Pricing inputs are other than quoted prices in active markets, which are either directly or indirectly observable as of the reporting date. Such inputs may be quoted prices for similar assets or liabilities, quoted markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full character of the financial instrument, or inputs that are derived principally from, or corroborated by, observable market information. Investments that are generally included in this category include illiquid debt securities and less liquid, privately held or restricted equity securities, for which some level of recent trading activity has been observed.

Level 3—Pricing inputs are unobservable for the investment and includes situations where there is little, if any, market activity for the investment. The inputs may be based on the Company’s own assumptions about how market participants would price the asset or liability or may use Level 2 inputs, as adjusted, to reflect specific investment attributes relative to a broader market assumption. Even if observable market data for comparable performance or valuation measures (earnings multiples, discount rates, other financial/valuation ratios, etc.) are available, such investments are grouped as Level 3 if any significant data point that is not also market observable (private company earnings, cash flows, etc.) is used in the valuation technique. We use multiple techniques for determining fair value based on the nature of the investment and experience with those types of investments and specific portfolio companies. The selections of the valuation techniques and the inputs and assumptions used within those techniques often require subjective judgements and estimates. These techniques include market comparables, discounted cash flows and enterprise value waterfalls. Fair value is best expressed as a range of values from which the Company determines a single best estimate. The types of inputs and assumptions that may be considered in determining the range of values of our investments include the nature and realizable value of any collateral, the portfolio company’s ability to make payments, market yield trend analysis and volatility in future interest rates, call and put features, the markets in which the portfolio company does business, comparison to publicly traded companies, discounted cash flows and other relevant factors.

36

In addition to using the above inputs in investment valuations, the Company continues to employ the valuation policy approved by the board of directors that is consistent with ASC 820 and the 1940 Act (see Note 2. Summary of Significant Accounting Policies ). Consistent with our valuation policy, the Company evaluates the source of inputs, including any markets in which its investments are trading, in determining fair value.

The following table presents fair value measurements of investments, by major class, as of November 30, 2024 (dollars in thousands), according to the fair value hierarchy:

Fair Value Measurements Valued Using Net Asset
Level 1 Level 2 Level 3 Value* Total
First lien term loans $
-
$
-
$ 833,223 $
-
$ 833,223
Second lien term loans
-
-
6,140
-
6,140
Unsecured term loans
-
-
16,199
-
16,199
Structured finance securities
-
-
17,852
-
17,852
Equity interests
-
-
81,927 4,752 86,679
Total $
-
$
-
$ 955,341 $ 4,752 $ 960,093

* The Company’s equity investment in SLF JV is measured using the proportionate share of the NAV, or equivalent, as a practical expedient and thus has not been classified in the fair value hierarchy. The Company’s unsecured loan investment in SLF JV is based on a discounted cash flow valuation technique.

The following table presents fair value measurements of investments, by major class, as of February 29, 2024 (dollars in thousands), according to the fair value hierarchy:

Fair Value Measurements Valued Using Net Asset
Level 1 Level 2 Level 3 Value* Total
First lien term loans $
-
$
-
$ 976,423 $
-
$ 976,423
Second lien term loans
-
-
18,097
-
18,097
Unsecured term loans
-
-
15,818
-
15,818
Structured finance securities
-
-
30,626
-
30,626
Equity interests
-
-
88,426 9,404 97,830
Total $
-
$
-
$ 1,129,390 $ 9,404 $ 1,138,794

* The Company’s equity investment in SLF JV is measured using the proportionate share of the NAV, or equivalent, as a practical expedient and thus has not been classified in the fair value hierarchy. The Company’s unsecured loan investment in SLF JV is based on a discounted cash flow valuation technique.

The following table provides a reconciliation of the beginning and ending balances for investments that use Level 3 inputs for the nine months ended November 30, 2024 (dollars in thousands):

First lien term loans Second lien term loans Unsecured term loans Structured finance securities Equity interests Total
Balance as of February 29, 2024 $ 976,423 $ 18,097 $ 15,818 $ 30,626 $ 88,426 $ 1,129,390
Payment-in-kind and other adjustments to cost 1,912 8,003
-
( 5,373 ) 4 4,546
Net accretion of discount on investments 2,177 5
-
-
-
2,182
Net change in unrealized appreciation (depreciation) on investments 41,727 3,185 381 ( 7,401 ) 500 38,392
Purchases 121,207
-
-
-
5,069 126,276
Sales and repayments ( 262,551 ) ( 23,150 )
-
-
( 10,545 ) ( 296,246 )
Net realized gain (loss) from investments ( 47,672 )
-
-
-
( 1,527 ) ( 49,199 )
Balance as of November 30, 2024 $ 833,223 $ 6,140 $ 16,199 $ 17,852 $ 81,927 $ 955,341
Net change in unrealized appreciation (depreciation) for the period relating to those Level 3 assets that were still held by the Company at the end of the period $ ( 3,649 ) $ 3,185 $ 381 $ ( 7,401 ) $ ( 3,998 ) $ ( 11,482 )

37

Purchases, PIK and other adjustments to cost include purchases of new investments at cost, effects of refinancing/restructuring, accretion/amortization of income from discount/premium on debt securities, and PIK interests. For the nine months ended November 30, 2024, non-cash restructurings related to two controlled investments resulting in realized losses of $ 49.1 m were included in net realized (gain) loss from investments on the consolidated statements of cash flows.

Sales and repayments represent net proceeds received from investments sold and principal paydowns received during the period.

Transfers and restructurings, if any, are recognized at the beginning of the period in which they occur. There were no transfers or restructurings in or out of Levels 1, 2 or 3 during the nine months ended November 30, 2024.

The following table provides a reconciliation of the beginning and ending balances for investments that use Level 3 inputs for the nine months ended November 30, 2023 (dollars in thousands):

First lien term loans Second lien term loans Unsecured term loans Structured finance securities Equity interests Total
Balance as of February 28, 2023 $ 798,534 $ 14,936 $ 20,661 $ 41,362 $ 83,990 $ 959,483
Payment-in-kind and other adjustments to cost 1,147 624
-
( 5,531 ) ( 293 ) ( 4,053 )
Net accretion of discount on investments 1,637 4
-
-
-
1,641
Net change in unrealized appreciation (depreciation) on investments ( 20,102 ) ( 691 ) 341 ( 6,444 ) ( 7,715 ) ( 34,611 )
Purchases 194,541
-
-
-
8,343 202,884
Sales and repayments ( 15,865 )
-
( 3,383 )
-
-
( 19,248 )
Net realized gain (loss) from investments
-
-
-
-
151 151
Balance as of November 30, 2023 $ 959,892 $ 14,873 $ 17,619 $ 29,387 $ 84,476 $ 1,106,247
Net change in unrealized appreciation (depreciation) for the year relating to those Level 3 assets that were still held by the Company at the end of the period $ ( 20,033 ) $ ( 691 ) $ ( 5 ) $ ( 6,444 ) $ ( 7,792 ) $ ( 34,965 )

Transfers and restructurings, if any, are recognized at the beginning of the period in which they occur. There were no transfers or restructurings in or out of Levels 1, 2 or 3 during the nine months ended November 30, 2023.

The valuation techniques and significant unobservable inputs used in recurring Level 3 fair value measurements of assets as of November 30, 2024 were as follows (dollars in thousands):

Fair Value Valuation Technique Unobservable Input Range Weighted Average*
First lien term loans $ 833,223 Market Comparables Market Yield (%) 10.1 % - 20.5 % 12.3 %
Revenue Multiples (x) 2.5 x
2.5x
Third-party Bid (x) 8.0 x
8.0x
Second lien term loans 6,140 Market Comparables Market Yield (%) 19.5 % 19.5 %
Unsecured term loans 16,199 Discounted Cash Flow Discount Rate (%) 10.5 % 10.5 %
Structured finance securities 17,852 Discounted Cash Flow Discount Rate (%) 8.5 % - 40.0 % 14.9 %
Recovery Rate (%) 35.0 % - 70.0 % 61.5 %
Prepayment Rate (%) 20.0 % 20.0 %
Equity interests 81,927 Enterprise Value Waterfall Revenue Multiples (x) 0.1 x - 9.4 x
6.7x
EBITDA Multiples (x) 1.0 x - 21.9 x
8.6x
Total $ 955,341

* The weighted average in the table above is calculated based on each investment’s fair value weighting, using the applicable unobservable input.

38

The valuation techniques and significant unobservable inputs used in recurring Level 3 fair value measurements of assets as of February 29, 2024 were as follows (dollars in thousands):

Fair Value Valuation Technique Unobservable Input Range Weighted Average*
First lien term loans $ 976,423 Market Comparables Market Yield (%) 10.6 % - 17.2 % 13.0 %
Revenue Multiples (x) 4.6 x - 9.4 x
6.6x
EBITDA Multiples (x) 5.0 x - 6.0 x
5.6x
Third-party bid (x) 3.9 x - 4.2 x
4.0x
Second lien term loans 18,097 Market Comparables Market Yield (%) 19.0 % - 28.3 % 25.5 %
EBITDA Multiples (x) 7.0 x
7.0x
Third-party bid (x) 29.7 x
29.7x
Unsecured term loans 15,818 Discounted Cash Flow Discount Rate (%) 10.5 % 10.5 %
Structured finance securities 30,626 Discounted Cash Flow Discount Rate (%) 8.5 % - 22.0 % 15.1 %
Recovery Rate (%) 35.0 % - 70.0 % 70.0 %
Prepayment Rate (%) 20.0 % 20.0 %
Equity interests 88,426 Enterprise Value Waterfall EBITDA Multiples (x) 4.7 x - 20.4 x
10.4x
Revenue Multiples (x) 1.3 x - 10.4 x
6.3x
Third-party bid (x) 3.9 x
3.9x
Total $ 1,129,390

* The weighted average in the table above is calculated based on each investment’s fair value weighting, using the applicable unobservable input.

For investments utilizing a market comparables valuation technique, a significant increase (decrease) in the market yield, in isolation, would result in a significantly lower (higher) fair value measurement, and a significant increase (decrease) in any of the earnings before interest, tax, depreciation and amortization (“EBITDA”) or revenue valuation multiples, in isolation, would result in a significantly higher (lower) fair value measurement. For investments utilizing a discounted cash flow valuation technique, a significant increase (decrease) in the discount rate, and prepayment rate, in isolation, would result in a significantly lower (higher) fair value measurement while a significant increase (decrease) in recovery rate, in isolation, would result in a significantly higher (lower) fair value measurement. For investments utilizing a market quote, third party bid or net asset value in deriving a value, a significant increase (decrease) in the market quote, bid or net asset value in isolation, would result in a significantly higher (lower) fair value measurement.

The composition of our investments as of November 30, 2024 at amortized cost and fair value was as follows (dollars in thousands):

Investments at Amortized Cost Amortized Cost
Percentage of Total Portfolio
Investments at Fair Value Fair Value Percentage of Total Portfolio
First lien term loans $ 834,750 86.3 % $ 833,223 86.8 %
Second lien term loans 6,827 0.7 6,140 0.6
Unsecured term loans 17,619 3.9 16,199 1.7
Structured finance securities 37,396 1.8 17,852 1.9
Equity interests 70,750 7.3 86,679 9.0
Total $ 967,342 100.0 % $ 960,093 100.0 %

The composition of our investments as of February 29, 2024 at amortized cost and fair value was as follows (dollars in thousands):

Investments at Amortized Cost Amortized Cost Percentage of Total Portfolio Investments at Fair Value Fair Value Percentage of Total Portfolio
First lien term loans $ 1,019,678 86.4 % $ 976,423 85.7 %
Second lien term loans 21,968 1.9 18,097 1.6
Unsecured term loans 17,619 1.5 15,818 1.4
Structured finance securities 42,769 3.6 30,626 2.7
Equity interests 77,750 6.6 97,830 8.6
Total $ 1,179,784 100.0 % $ 1,138,794 100.0 %

39

For loans and debt securities for which market quotations are not readily available, the Company determines their fair value based on third party indicative broker quotes, where available, or the inputs that a hypothetical market participant would use to value the security in a current hypothetical sale using a market comparables valuation technique. In applying the market comparables valuation technique, the Company determines the fair value based on such factors as market participant inputs including synthetic credit ratings, estimated remaining life, current market yield and interest rate spreads of similar securities as of the measurement date. If, in the Company’s judgment, the market comparables technique is not sufficient or appropriate, the Company may use additional techniques such as an asset liquidation or expected recovery model.

For equity securities of portfolio companies and partnership interests, the Company determines the fair value using an enterprise value waterfall valuation technique. Under the enterprise value waterfall valuation technique, the Company determines the enterprise fair value of the portfolio company and then waterfalls the enterprise value over the portfolio company’s securities in order of their preference relative to one another. To estimate the enterprise value of the portfolio company, the Company weighs some or all of the traditional market valuation techniques and factors based on the individual circumstances of the portfolio company in order to estimate the enterprise value. The techniques for performing investments may be based on, among other things: valuations of comparable public companies, recent sales of private and public comparable companies, discounting the forecasted cash flows of the portfolio company, third party valuations of the portfolio company, considering offers from third parties to buy the company, estimating the value to potential strategic buyers and considering the value of recent investments in the equity securities of the portfolio company. For non-performing investments, the Company may estimate the liquidation or collateral value of the portfolio company’s assets and liabilities. The Company also takes into account historical and anticipated financial results.

The Company’s investments in Saratoga CLO and SLF 2022 are carried at fair value, which is based on a discounted cash flow valuation technique that utilizes prepayment, re-investment and loss inputs based on historical experience and projected performance, economic factors, the characteristics of the underlying cash flow, and comparable yields for equity interests in collateralized loan obligation funds similar to Saratoga CLO and SLF 2022, when available, as determined by the Manager and recommended to the Company’s board of directors. Specifically, the Company uses Intex cash flows, or an appropriate substitute, to form the basis for the valuation of the investment in Saratoga CLO and SLF 2022. The cash flows use a set of inputs including projected default rates, recovery rates, reinvestment rates and prepayment rates in order to arrive at estimated valuations. The inputs are based on available market data and projections provided by third parties as well as management estimates. The Company ran Intex models based on inputs about the refinanced Saratoga CLO’s structure and the SLF 2022 structure, including capital structure, cost of liabilities and reinvestment period. The Company uses the output from the Intex models (i.e., the estimated cash flows) to perform a discounted cash flow analysis on expected future cash flows to determine a valuation for our investments in Saratoga CLO and SLF 2022 at November 30, 2024. The inputs at November 30, 2024 for the valuation model include:

Default rate: 2.0%

Recovery rate: 35%-70%

Discount rate: 8.5%-40.0%

Prepayment rate: 20.0%

Reinvestment rate / price: S+365bps / $99.00

The Company’s equity investment in SLF JV is measured using the proportionate share of the NAV of SLF JV, or equivalent, as practical expedient.

40

Investment Concentration

Set forth is a brief description of each portfolio company in which the fair value of the Company’s investment represents greater than 5 % of the Company’s total assets as of November 30, 2024, excluding Saratoga CLO, SLF JV and SLF 2022 (see Note 4. Investment in Saratoga CLO and Note 5. Investment in SLF JV for more information on Saratoga CLO, SLF JV and SLF 2022, respectively).

Artemis Wax Corp.

Artemis Wax Corporation is a U.S. based retail aggregator of European Wax Center (“EWC”) franchise locations with a concentration in the northeast. Founded in 2004, EWC is the largest U.S. body waxing national chain with more than 800 locations across the country.

Granite Comfort, LP

Granite Comfort, LP is a U.S. based heating, ventilation and air conditioning (“HVAC”) company. The company provides traditional service and replacement of HVAC / plumbing systems, as well as a rental model that is in the early stages of implementation.

Note 4. Investment in Saratoga CLO

On January 22, 2008, the Company entered into a collateral management agreement with Saratoga CLO, pursuant to which the Company acts as its collateral manager. The Saratoga CLO was initially refinanced in October 2013 with its reinvestment period extended to October 2016. On November 15, 2016, the Company completed a second refinancing of the Saratoga CLO with its reinvestment period extended to October 2018.

On December 14, 2018, the Company completed a third refinancing and upsize of the Saratoga CLO (the “2013-1 Reset CLO Notes”). The third Saratoga CLO refinancing, among other things, extended its reinvestment period to January 2021, and extended its legal maturity date to January 2030 . Following this refinancing, the Saratoga CLO portfolio increased its aggregate principal amount from approximately $ 300.0 million to approximately $ 500.0 million of predominantly senior secured first lien term loans.

On February 11, 2020, the Company entered into an unsecured loan agreement (“CLO 2013-1 Warehouse 2 Loan”) with Saratoga Investment Corp. CLO 2013-1 Warehouse 2, Ltd. (“CLO 2013-1 Warehouse 2”), a wholly owned subsidiary of Saratoga CLO. During the fourth quarter ended February 28, 2021, the CLO 2013-1 Warehouse 2 Ltd. was repaid in full.

On February 26, 2021, the Company completed the fourth refinancing of the Saratoga CLO. This refinancing, among other things, extended the Saratoga CLO reinvestment period to April 2024, extended its legal maturity to April 2033, and added a non-call period of February 2022. In addition, and as part of the refinancing, the Saratoga CLO was upsized from $ 500 million in assets to approximately $ 650 million. As part of this refinancing and upsizing, the Company invested an additional $ 14.0 million in all of the newly issued subordinated notes of the Saratoga CLO, and purchased $ 17.9 million in aggregate principal amount of the Class F-R-3 Notes tranche at par. Concurrently, the existing $ 2.5 million of Class F-R-2 Notes, $ 7.5 million of Class G-R-2 Notes and $ 25.0 million of the CLO 2013-1 Warehouse 2 Loan were repaid. The Company also paid $ 2.6 million of transaction costs related to the refinancing and upsizing on behalf of the Saratoga CLO, to be reimbursed from future equity distributions. At August 31, 2021, the outstanding receivable of $ 2.6 million was repaid in full.

On August 9, 2021, the Company exchanged its existing $ 17.9 million Class F-R-3 Note for $ 8.5 million Class F-1-R-3 Notes and $ 9.4 million Class F-2-R-3 Notes at par. On August 11, 2021, the Company sold its Class F-1-R-3 Notes to third parties, resulting in a realized loss of $ 0.1 million.

41

On June 10, 2024, the Company completed its fifth refinancing of the Saratoga CLO. This refinancing, among other things, did not extend the Saratoga CLO reinvestment period nor extend its legal maturity, while adjusting the interest rate of two of the existing Notes. The Issuer issued $ 422.5 million of notes (the “2013-1 2024 Reset CLO Notes”), consisting of Class A-1-R-4 and Class A-2-R-4. The 2013-1 2024 Reset CLO Notes were issued pursuant to the Indenture with the same Trustee. Proceeds of the issuance of the 2013-1 2024 Reset CLO Notes were used along with existing assets of the Saratoga CLO to redeem the existing Class A-1-R-3 and Class A-2-R-3 Notes. No other Notes were refinanced as part of this refinancing. The Saratoga CLO paid $ 0.5 million of transaction costs related to the refinancing.

The Saratoga CLO remains effectively 100.0 % owned and managed by the Company. The Company receives a base management fee of 0.10 % per annum and a subordinated management fee of 0.40 % per annum of the outstanding principal amount of Saratoga CLO’s assets, paid quarterly to the extent of available proceeds. Following the third refinancing and the issuance of the 2013-1 Reset CLO Notes on December 14, 2018, the Company is no longer entitled to an incentive management fee equal to 20.0 % of excess cash flow to the extent the Saratoga CLO subordinated notes receive an internal rate of return paid in cash equal to or greater than 12.0 %.

For the three months ended November 30, 2024 and November 30, 2023, the Company accrued management fee income of $ 0.8 million and $ 0.8 million, respectively, and interest income of $ 0.0 million and $ 0.0 million, respectively, from the subordinated notes of Saratoga CLO.

For the nine months ended November 30, 2024 and November 30, 2023, the Company accrued management fee income of $ 2.4 million and $ 2.5 million, respectively, and interest income of $ 0.0 million and $ 0.0 million, respectively, from the subordinated notes of Saratoga CLO.

As of November 30, 2024, the aggregate principal amounts of the Company’s investments in the subordinated notes and Class F-2-R-3 Notes of the Saratoga CLO was $ 111.0 million and $ 9.4 million, respectively, which had a corresponding fair value of $ 1.3 million and $ 4.3 million, respectively. The Company determines the fair value of its investment in the subordinated notes of Saratoga CLO based on the present value of the projected future cash flows of the subordinated notes over the life of Saratoga CLO. As of November 30, 2024, Saratoga CLO had investments with a principal balance of $ 558.8 million and a weighted average spread over TERM SOFR of 3.7 % and had debt with a principal balance of $ 559.2 million with a weighted average spread over TERM SOFR of 2.3 %. As a result, Saratoga CLO earns a “spread” between the interest income it receives on its investments and the interest expense it pays on its debt and other operating expenses, which is distributed quarterly to the Company as the holder of its subordinated notes. As of November 30, 2024, the present value of the projected future cash flows of the subordinated notes was approximately $ 1.3 million, using a 40 % discount rate. The Company’s total investment in the subordinate notes of Saratoga CLO is $ 57.8 million, which consists of additional investments of $ 30 million in January 2008, $ 13.8 million in December 2018 and $ 14.0 million in February 2021; to date, the Company has received distributions of $ 90.0 million, management fees of $ 37.5 million and incentive fees of $ 1.2 million.

As of February 29, 2024, the Company determined that the fair value of its investment in the subordinated notes of Saratoga CLO was $ 9.5 million. As of February 29, 2024, the fair value of its investment in the Class F-R-3 Notes of Saratoga CLO was $ 8.9 million. As of February 29, 2024, Saratoga CLO had investments with a principal balance of $ 640.8 million and a weighted average spread over TERM SOFR of 3.8 % and had debt with a principal balance of $ 611.0 million with a weighted average spread over TERM SOFR of 2.2 %. As of February 29, 2024, the present value of the projected future cash flows of the subordinated notes, was approximately $ 9.5 million, using a 22.0 % discount rate. The Company’s total investment in the subordinate notes of Saratoga CLO is $ 57.8 which consists of additional investments of $ 30 million in January 2008, $ 13.8 million in December 2018 and $ 14.0 million in February 2021. To date the Company has since received distributions of $ 84.6 million, management fees of $ 35.1 million and incentive fees of $ 1.2 million.

Below is certain financial information from the separate financial statements of Saratoga CLO as of November 30, 2024 (unaudited) and February 29, 2024 and for the three and nine months ended November 30, 2024 (unaudited) and November 30, 2023 (unaudited).

42

Saratoga Investment Corp. CLO 2013-1, Ltd.

Statements of Assets and Liabilities

November 30,
2024
February 29,
2024
(unaudited)
ASSETS
Investments at fair value
Loans at fair value (amortized cost of $ 548,610,503 and $ 629,345,724 , respectively) $ 523,822,494 $ 606,531,189
Equities at fair value (amortized cost of $ 2,911,603 and $ 1,649,986 , respectively) 1,909,443 1,020,585
Total investments at fair value (amortized cost of $ 551,522,106 and $ 630,995,710 , respectively) 525,731,937 607,551,774
Cash and cash equivalents 26,917,052 12,104,832
Receivable from open trades 1,684,753 2,865,174
Interest receivable (net of reserve of $ 605,564 and $ 615,604 , respectively) 3,038,940 3,402,471
Due from affiliate 57,001 3,953
Prepaid expenses and other assets 119,457 205,400
Total assets $ 557,549,140 $ 626,133,604
LIABILITIES
Interest payable $ 4,351,257 $ 5,043,712
Payable from open trades 1,685,480 10,519,573
Accrued base management fee 65,474 68,605
Accrued subordinated management fee 261,895 274,418
Accounts payable and accrued expenses 141,542 84,199
Saratoga Investment Corp. CLO 2013-1, Ltd. Notes:
Class A-1-R-3 Senior Secured Floating Rate Notes
-
357,500,000
Class A-2-R-3 Senior Secured Floating Rate Notes
-
65,000,000
Class A-1-R-4 Senior Secured Floating Rate Notes 305,727,301
-
Class A-2-R-4 Senior Secured Floating Rate Notes 65,000,000
-
Class B-FL-R-3 Senior Secured Floating Rate Notes 60,500,000 60,500,000
Class B-FXD-R-3 Senior Secured Fixed Rate Notes 11,000,000 11,000,000
Class C-FL-R-3 Deferrable Mezzanine Floating Rate Notes 26,000,000 26,000,000
Class C-FXD-R-3 Deferrable Mezzanine Fixed Rate Notes 6,500,000 6,500,000
Class D-R-3 Deferrable Mezzanine Floating Rate Notes 39,000,000 39,000,000
Discount on Class D-R-3 Notes ( 201,967 ) ( 220,100 )
Class E-R-3 Deferrable Mezzanine Floating Rate Notes 27,625,000 27,625,000
Discount on Class E-R-3 Notes ( 2,098,217 ) ( 2,286,598 )
Class F-1-R-3 Notes Deferrable Junior Floating Rate Notes 8,500,000 8,500,000
Class F-2-R-3 Notes Deferrable Junior Floating Rate Notes 9,375,000 9,375,000
Deferred debt financing costs ( 1,266,542 ) ( 1,707,224 )
Subordinated Notes 111,000,000 111,000,000
Discount on Subordinated Notes ( 33,185,548 ) ( 36,164,988 )
Total liabilities 639,980,675 697,611,597
Commitments and contingencies
NET ASSETS
Ordinary equity, par value $ 1.00 , 250 ordinary shares authorized, 250 and 250 common shares issued and outstanding, respectively 250 250
Total distributable earnings (loss) ( 82,431,785 ) ( 71,478,243 )
Total net deficit ( 82,431,535 ) ( 71,477,993 )
Total liabilities and net assets $ 557,549,140 $ 626,133,604

See accompanying notes to financial statements.

43

Saratoga Investment Corp. CLO 2013-1, Ltd.

Statements of Operations

(unaudited)

For the three months ended For the nine months ended
November 30,
2024
November 30,
2023
November 30,
2024
November 30,
2023
INVESTMENT INCOME
Total interest from investments $ 13,342,306 $ 15,599,943 $ 43,995,503 $ 46,240,246
Interest from cash and cash equivalents 289,869 139,759 853,765 480,995
Other income 124,901 286,607 1,225,297 756,831
Total investment income 13,757,076 16,026,309 46,074,565 47,478,072
EXPENSES
Interest and debt financing expenses 13,408,313 14,644,320 42,605,821 43,349,057
Base management fee 775,398 163,985 1,094,754 490,793
Subordinated management fee
-
655,943 1,277,423 1,963,174
Professional fees 79,709 87,540 222,005 260,431
Trustee expenses 64,157 64,554 187,635 193,588
Other expense 66,339 50,330 242,902 190,215
Total expenses 14,393,916 15,666,672 45,630,540 46,447,258
NET INVESTMENT INCOME (LOSS) ( 636,840 ) 359,637 444,025 1,030,814
REALIZED AND UNREALIZED LOSS ON INVESTMENTS
Net realized loss from investments ( 1,278,236 ) ( 6,298,909 ) ( 8,472,121 ) ( 9,048,743 )
Net change in unrealized depreciation on investments ( 1,626,867 ) ( 313,230 ) ( 2,346,233 ) 2,702,275
Net realized and unrealized gain (loss) on investments ( 2,905,103 ) ( 6,612,139 ) ( 10,818,354 ) ( 6,346,468 )
Realized losses on extinguishment of debt
-
-
( 579,213 )
-
NET INCREASE (DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS $ ( 3,541,943 ) $ ( 6,252,502 ) $ ( 10,953,542 ) $ ( 5,315,654 )

See accompanying notes to financial statements

44

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

November 30, 2024

(unaudited)

Issuer Name Industry Asset Name Asset
Type
Reference
Rate/Spread
SOFR/LIBOR Floor Current Rate (All In) Maturity
Date
Principal/
Number of Shares
Cost Fair
Value
Altisource Solutions S.a r.l. Banking, Finance, Insurance & Real Estate Common Stock Equity 15,981 $ - $ 14,223
Endo Finance Holdings, Inc. Healthcare & Pharmaceuticals Common Stock Equity 23,799 660,422 583,076
Endo Finance Holdings, Inc. Healthcare & Pharmaceuticals Warrants Equity 349 9,685 8,551
Envision Parent Inc Healthcare & Pharmaceuticals Common Stock Equity 4,410 175,000 50,715
Envision Parent Inc Healthcare & Pharmaceuticals Warrants Equity 92,837 - 4,642
Instant Brands Litigation Trust Consumer goods: Durable Equity Interest Equity 50,038 34,198 150,000
Isagenix International, LLC Beverage, Food & Tobacco Common Stock Equity 86,398 - -
Research Now Group, Inc Media: Advertising, Printing & Publishing Common Stock Equity 39,808 557,312 676,736
Resolute Investment Managers (American Beacon), Inc. Banking, Finance, Insurance & Real Estate Common Stock Equity 24,320 1,034,581 66,880
URS TOPCO, LLC Transportation: Cargo Common Stock Equity 25,330 440,405 354,620
1011778 B.C Unltd Liability Co Beverage, Food & Tobacco Term Loan B6 Loan 1M USD SOFR+ 1.75 % 0.00 % 6.32 % 9/20/2030 $ 1,440,272 1,422,144 1,437,391
19TH HOLDINGS GOLF, LLC Consumer goods: Durable Term Loan Loan 1M USD SOFR+ 3.25 % 0.50 % 7.99 % 2/7/2029 2,454,811 2,376,785 2,396,510
888 Acquisitions Limited Hotel, Gaming & Leisure Term Loan B Loan 6M USD SOFR+ 5.25 % 0.00 % 9.50 % 7/8/2028 3,052,566 2,796,616 2,930,463
Adtalem Global Education Inc. Services: Business Term Loan B (08/24) Loan 1M USD SOFR+ 2.75 % 0.75 % 7.32 % 8/12/2028 582,329 579,025 585,240
Aegis Sciences Corporation Healthcare & Pharmaceuticals Term Loan Loan 3M USD SOFR+ 5.50 % 1.00 % 10.28 % 5/9/2025 2,277,447 2,275,329 1,408,214

45

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

November 30, 2024

(unaudited)

Issuer Name Industry Asset Name Asset
Type
Reference
Rate/Spread
SOFR/LIBOR Floor Current Rate (All In) Maturity
Date
Principal/
Number of Shares
Cost Fair
Value
Agiliti Health Inc. Healthcare & Pharmaceuticals Term Loan B (03/23) Loan 6M USD SOFR+ 3.00 % 0.00 % 7.26 % 5/1/2030 2,159,600 2,145,396 2,123,167
AHEAD DB Holdings, LLC Services: Business Term Loan B3 (07/24) Loan 3M USD SOFR+ 3.50 % 0.75 % 8.10 % 2/1/2031 2,902,931 2,843,841 2,923,629
Air Canada Transportation: Consumer Term Loan B (03/24) Loan 3M USD SOFR+ 2.00 % 0.00 % 6.75 % 3/21/2031 995,000 992,585 996,423
AIT Worldwide Logistics Holdings, Inc. Transportation: Cargo Term Loan B (10/24) Loan 1M USD SOFR+ 4.75 % 0.75 % 9.48 % 4/5/2030 2,455,696 2,336,935 2,475,145
AlixPartners, LLP Banking, Finance, Insurance & Real Estate Term Loan B (01/21) Loan 1M USD SOFR+ 2.50 % 0.50 % 7.19 % 2/4/2028 241,249 241,115 242,557
Alkermes, Inc. Healthcare & Pharmaceuticals Term Loan B (3/21) Loan 1M USD SOFR+ 2.50 % 0.50 % 7.19 % 3/12/2026 2,088,347 2,082,135 2,090,957
Allen Media, LLC Media: Diversified & Production Term Loan (7/21) Loan 3M USD SOFR+ 5.50 % 0.00 % 10.25 % 2/10/2027 4,315,175 4,299,517 2,807,021
Alliant Holdings Intermediate, LLC Banking, Finance, Insurance & Real Estate Term Loan B6 (09/24) Loan 1M USD SOFR+ 2.75 % 0.00 % 7.35 % 9/19/2031 799,019 799,019 803,517
Allied Universal Holdco LLC Services: Business Term Loan 4/21 Loan 1M USD SOFR+ 3.75 % 0.50 % 8.42 % 5/12/2028 1,940,000 1,934,896 1,952,125
Alterra Mountain Company (Intrawest Resort Holdings) Hotel, Gaming & Leisure First Lien Term Loan Loan 1M USD SOFR+ 3.00 % 0.00 % 7.57 % 5/31/2030 249,375 249,375 251,245
Altisource Solutions S.a r.l. (c) Banking, Finance, Insurance & Real Estate Term Loan B (03/18) Loan 3M USD SOFR+ 5.00 % 1.00 % 9.70 % 4/30/2025 1,143,064 1,143,280 514,379
Altium Packaging LLC Containers, Packaging & Glass Term Loan B Loan 1M USD SOFR+ 2.50 % 0.00 % 7.07 % 6/11/2031 483,788 482,610 482,781
Amer Sports Oyj (MASCOT BIDCO OY) Consumer goods: Durable USD Term Loan B (01/24) Loan 3M USD SOFR+ 2.75 % 0.00 % 7.24 % 2/17/2031 349,125 347,589 352,180
American Axle & Manufacturing Inc. Automotive Term Loan (12/22) Loan 1M USD SOFR+ 3.00 % 0.50 % 7.62 % 12/13/2029 480,000 468,818 481,800
American Greetings Corporation Media: Advertising, Printing & Publishing Term Loan B (04/24) Loan 1M USD SOFR+ 5.75 % 0.00 % 10.32 % 10/30/2029 2,945,449 2,944,082 2,963,121
American Trailer World Corp Automotive Term Loan Loan 1M USD SOFR+ 3.75 % 0.75 % 8.42 % 3/3/2028 1,357,439 1,356,452 1,162,307
AmWINS Group, LLC Banking, Finance, Insurance & Real Estate Term Loan 2/21 Loan 1M USD SOFR+ 2.25 % 0.75 % 6.94 % 2/17/2028 1,925,038 1,911,926 1,932,257
Anastasia Parent LLC Consumer goods: Non-durable Term Loan Loan 3M USD SOFR+ 3.75 % 0.00 % 8.62 % 8/11/2025 940,000 939,214 605,125

46

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

November 30, 2024

(unaudited)

Issuer Name Industry Asset Name Asset
Type
Reference
Rate/Spread
SOFR/LIBOR Floor Current Rate (All In) Maturity
Date
Principal/ Number of Shares Cost

Fair
Value

Anchor Packaging, LLC Containers, Packaging & Glass Term Loan (4/24) Loan 1M USD SOFR+ 3.75 % 0.00 % 8.44 % 7/18/2029 1,949,282 1,932,103 1,959,730
AP Core Holdings II LLC High Tech Industries Term Loan B1 Loan 1M USD SOFR+ 5.50 % 0.75 % 10.19 % 9/1/2027 1,699,981 1,686,320 1,655,782
AP Core Holdings II LLC High Tech Industries Term Loan B2 Loan 1M USD SOFR+ 5.50 % 0.75 % 10.19 % 9/1/2027 500,000 495,988 485,730
APEX GROUP TREASURY LLC Banking, Finance, Insurance & Real Estate Term Loan B (07/24) Loan 6M USD SOFR+ 4.00 % 0.00 % 9.08 % 7/27/2028 491,269 468,492 495,774
Apollo Commercial Real Estate Finance, Inc. Banking, Finance, Insurance & Real Estate Term Loan B Loan 1M USD SOFR+ 2.75 % 0.00 % 7.44 % 5/15/2026 2,885,787 2,873,078 2,878,572
Apollo Commercial Real Estate Finance, Inc. Banking, Finance, Insurance & Real Estate Term Loan B1 (2/21) Loan 1M USD SOFR+ 3.50 % 0.50 % 8.19 % 3/6/2028 965,000 959,761 955,350
AppLovin Corporation High Tech Industries Term Loan B Loan 1M USD SOFR+ 2.50 % 0.50 % 7.19 % 8/19/2030 964,769 964,769 964,943
AppLovin Corporation High Tech Industries Term Loan B  (3/24) Loan Prime 1.50 % 0.50 % 9.25 % 10/25/2028 1,466,381 1,464,622 1,465,853
AqGen Ascensus, Inc. Banking, Finance, Insurance & Real Estate Term Loan Loan 1M USD SOFR+ 3.50 % 0.50 % 8.19 % 8/2/2028 496,075 492,900 499,176
Aramark Services, Inc. Services: Consumer Term Loan Loan 1M USD SOFR+ 1.75 % 0.00 % 6.44 % 1/15/2027 2,331,250 2,302,315 2,331,973
Aramark Services, Inc. Services: Consumer Term Loan B7 (03/24) Loan 1M USD SOFR+ 2.00 % 0.00 % 6.57 % 4/6/2028 1,753,715 1,749,408 1,758,380
ARC FALCON I INC. Chemicals, Plastics, & Rubber Term Loan Loan 1M USD SOFR+ 3.50 % 0.50 % 8.17 % 9/23/2028 973,774 971,828 980,902
ARCIS GOLF LLC Services: Consumer Term Loan B Loan 1M USD SOFR+ 3.75 % 0.50 % 8.44 % 11/24/2028 494,245 490,303 497,952
Aretec Group, Inc. Banking, Finance, Insurance & Real Estate Term Loan B 2 Loan 1M USD SOFR+ 4.00 % 0.00 % 8.57 % 8/9/2030 2,622,898 2,609,234 2,637,979
Aspire Bakeries Holdings, LLC Beverage, Food & Tobacco Term loan Loan 1M USD SOFR+ 4.25 % 0.00 % 8.82 % 12/23/2030 895,500 887,468 899,978
Assuredpartners Inc. Banking, Finance, Insurance & Real Estate Term Loan B5 (02/24) Loan 1M USD SOFR+ 3.50 % 0.50 % 8.07 % 2/14/2031 1,293,500 1,291,978 1,301,662
Asurion, LLC Banking, Finance, Insurance & Real Estate Term Loan B10 Loan 1M USD SOFR+ 4.00 % 0.00 % 8.67 % 8/19/2028 1,960,000 1,891,862 1,962,038

47

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

November 30, 2024

(unaudited)

Issuer Name Industry Asset Name Asset
Type
Reference
Rate/Spread
SOFR/LIBOR Floor Current Rate (All In) Maturity
Date
Principal/ Number of Shares Cost Fair
Value
Asurion, LLC Banking, Finance, Insurance & Real Estate Term Loan B12 Loan 1M USD SOFR+ 4.25 % 0.00 % 8.82 % 9/19/2030 2,919,478 2,915,698 2,915,215
ATHENAHEALTH GROUP INC. Healthcare & Pharmaceuticals Term Loan B (2/22) Loan 1M USD SOFR+ 3.25 % 0.50 % 7.82 % 2/15/2029 1,307,142 1,303,688 1,310,410
Avolon TLB Borrower 1 (US) LLC Capital Equipment Term Loan B6 Loan 1M USD SOFR+ 1.75 % 0.00 % 6.36 % 6/22/2030 1,472,622 1,427,186 1,472,210
Axalta Coating Systems US Holdings Chemicals, Plastics, & Rubber Term Loan B (11/24) Loan 1M USD SOFR+ 1.75 % 0.50 % 6.27 % 12/20/2029 851,048 844,586 853,712
AZURITY PHARMACEUTICALS, INC. Healthcare & Pharmaceuticals Term Loan B Loan 3M USD SOFR+ 6.62 % 0.75 % 11.49 % 9/20/2027 431,250 424,125 419,391
B&G Foods, Inc. Beverage, Food & Tobacco Term Loan B Loan 1M USD SOFR+ 3.50 % 0.00 % 8.07 % 10/10/2029 533,621 531,858 533,621
BAKELITE UK INTERMEDIATE LTD. Chemicals, Plastics, & Rubber Term Loan (5/24) Loan 3M USD SOFR+ 3.50 % 0.50 % 8.10 % 5/29/2029 1,477,528 1,471,911 1,487,220
Baldwin Insurance Group Holdings, LLC Banking, Finance, Insurance & Real Estate Term Loan B Loan 1M USD SOFR+ 3.25 % 0.00 % 7.82 % 5/26/2031 1,644,400 1,634,073 1,656,733
Belfor Holdings Inc. Services: Consumer Term Loan B-1 (11/23) Loan 1M USD SOFR+ 3.75 % 0.50 % 8.32 % 11/1/2030 1,494,834 1,481,878 1,505,118
Bengal Debt Merger Sub LLC Beverage, Food & Tobacco Term Loan Loan 3M USD SOFR+ 3.25 % 0.50 % 7.95 % 1/24/2029 1,955,000 1,954,381 1,354,893
Blackstone Mortgage Trust, Inc. Banking, Finance, Insurance & Real Estate Term Loan B Loan 1M USD SOFR+ 2.25 % 0.00 % 6.94 % 4/23/2026 962,019 959,704 960,816
Blackstone Mortgage Trust, Inc. Banking, Finance, Insurance & Real Estate Term Loan (6/21) Loan 1M USD SOFR+ 2.75 % 0.50 % 7.44 % 4/23/2026 1,439,044 1,435,048 1,435,447
Bombardier Recreational Products, Inc. Consumer goods: Durable Term Loan Loan 1M USD SOFR+ 2.75 % 0.00 % 7.44 % 1/22/2031 1,429,361 1,425,833 1,431,648
Bombardier Recreational Products, Inc. Consumer goods: Durable Term Loan B3 Loan 1M USD SOFR+ 2.75 % 0.50 % 7.44 % 12/13/2029 490,047 480,448 491,654
Boost Newco Borrower, LLC (Worldpay) Banking, Finance, Insurance & Real Estate Term Loan (06/24) Loan 3M USD SOFR+ 2.50 % 0.00 % 7.10 % 1/31/2031 500,000 497,765 504,105
Boxer Parent Company, Inc. High Tech Industries Term Loan B (06/24) Loan 3M USD SOFR+ 3.75 % 0.00 % 8.34 % 7/30/2031 1,007,194 1,002,871 1,013,599
BrightSpring Health Services (Phoenix Guarantor) Healthcare & Pharmaceuticals Term Loan (02/24) Loan 1M USD SOFR+ 3.25 % 0.00 % 7.82 % 2/21/2031 967,638 967,638 974,895

48

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

November 30, 2024

(unaudited)

Issuer Name Industry Asset Name Asset
Type
Reference
Rate/Spread
SOFR/LIBOR Floor Current Rate (All In) Maturity
Date
Principal/ Number of Shares Cost Fair
Value
BroadStreet Partners, Inc. Banking, Finance, Insurance & Real Estate Term Loan B-4 Loan 1M USD SOFR+ 3.25 % 0.00 % 7.82 % 6/14/2031 2,903,607 2,901,538 2,918,444
Brookfield WEC Holdings Inc. Energy: Electricity Term Loan B Loan 1M USD SOFR+ 2.25 % 0.00 % 6.92 % 1/27/2031 1,444,069 1,444,069 1,449,008
BROWN GROUP HOLDING, LLC Aerospace & Defense Term Loan B-2 Loan 1M USD SOFR+ 2.75 % 0.00 % 7.32 % 7/1/2031 492,516 482,581 494,771
Buckeye Partners, L.P. Utilities: Oil & Gas Term Loan B4 (05/24) Loan 1M USD SOFR+ 2.00 % 0.00 % 6.57 % 11/22/2030 665,004 662,876 666,321
Buckeye Partners, L.P. Utilities: Oil & Gas Term Loan B5 (09/24) Loan 1M USD SOFR+ 1.75 % 0.00 % 6.32 % 11/2/2026 567,280 565,840 567,672
BW Gas & Convenience Holdings LLC Beverage, Food & Tobacco Term Loan B Loan 1M USD SOFR+ 3.50 % 0.50 % 8.19 % 3/31/2028 2,418,750 2,405,594 2,431,860
Callaway Golf Company Retail Term Loan B Loan 1M USD SOFR+ 3.00 % 0.00 % 7.57 % 3/16/2030 472,500 468,551 469,939
Calpine Corporation Utilities: Electric Term Loan B10 (01/24) Loan 1M USD SOFR+ 2.00 % 0.00 % 6.57 % 1/31/2031 1,990,000 1,980,789 1,994,259
Camping World, Inc. Retail Term Loan B (5/21) Loan 1M USD SOFR+ 2.50 % 0.75 % 7.19 % 6/5/2028 2,443,038 2,286,576 2,391,392
CAPSTONE BORROWER INC Services: Business Term Loan B (05/24) Loan 3M USD SOFR+ 3.25 % 0.00 % 7.85 % 6/17/2030 874,867 863,792 878,148
CareerBuilder, LLC (c) Services: Business Term Loan B3 Loan 1M USD SOFR+ 2.50 % 0.00 % 7.19 % 7/31/2026 4,046,036 4,032,687 404,604
Castle US Holding Corporation Media: Advertising, Printing & Publishing Term Loan B (USD) Loan 1M USD SOFR+ 3.75 % 0.00 % 8.44 % 1/27/2027 1,934,080 1,929,004 1,075,832
CASTLELAKE AVIATION LLC Aerospace & Defense Term Loan B Loan 3M USD SOFR+ 2.75 % 0.50 % 7.70 % 10/21/2027 982,500 977,381 985,772
CBL & Associates Limited Partnership Retail Term Loan 11/21 Loan 1M USD SOFR+ 2.75 % 1.00 % 7.54 % 11/1/2025 2,246,084 2,087,998 2,097,281
CCC Intelligent Solutions Inc. Services: Business Term Loan B Loan 1M USD SOFR+ 2.25 % 0.50 % 6.94 % 9/16/2028 243,125 242,851 244,280
CCI Buyer, Inc Telecommunications Term Loan Loan 3M USD SOFR+ 4.00 % 0.75 % 8.60 % 12/17/2027 241,250 240,026 242,888
CCRR Parent, Inc. Healthcare & Pharmaceuticals Term Loan Loan 1M USD SOFR+ 4.25 % 0.50 % 8.92 % 3/5/2028 982,500 948,322 610,378

49

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

November 30, 2024

(unaudited)

Issuer Name Industry Asset Name Asset
Type
Reference
Rate/Spread
SOFR/LIBOR Floor Current Rate (All In) Maturity
Date
Principal/
Number of Shares
Cost Fair
Value
CCRR Parent, Inc. Healthcare & Pharmaceuticals Term Loan B Loan 3M USD SOFR+ 4.25 % 0.75 % 9.03 % 3/5/2028 965,000 962,597 594,160
CCS-CMGC Holdings, Inc. Healthcare & Pharmaceuticals Term Loan Loan 3M USD SOFR+ 5.50 % 0.00 % 10.82 % 9/25/2025 2,356,250 2,352,816 693,916
CDK GLOBAL, INC. High Tech Industries Term Loan  B (05/24) Loan 3M USD SOFR+ 3.25 % 0.00 % 7.85 % 7/6/2029 992,500 970,171 993,076
CENTURI GROUP, INC. Construction & Building Term Loan B Loan 1M USD SOFR+ 2.50 % 0.50 % 7.19 % 8/27/2028 616,921 613,354 617,723
Charlotte Buyer, Inc. Services: Business Term Loan B (07/24) Loan 1M USD SOFR+ 4.75 % 0.50 % 9.37 % 2/11/2028 1,477,500 1,409,649 1,488,168
Chemours Company, (The) Chemicals, Plastics, & Rubber Term Loan B2 Loan 1M USD SOFR+ 3.50 % 0.50 % 8.07 % 8/18/2028 2,375,719 2,343,004 2,386,600
Churchill Downs Incorporated Hotel, Gaming & Leisure Term Loan B1 (3/21) Loan 1M USD SOFR+ 2.00 % 0.00 % 6.67 % 3/17/2028 482,500 481,987 483,706
CIMPRESS PUBLIC LIMITED COMPANY Media: Advertising, Printing & Publishing Term Loan B1 (05/24) Loan 1M USD SOFR+ 3.00 % 0.50 % 7.57 % 5/17/2028 1,945,049 1,883,424 1,958,023
CITADEL SECURITIES LP Banking, Finance, Insurance & Real Estate Term Loan (10/24) Loan 1M USD SOFR+ 2.00 % 0.00 % 6.57 % 10/31/2031 4,826,890 4,826,890 4,845,280
Citco Funding LLC Banking, Finance, Insurance & Real Estate Term Loan B (06/24) Loan 6M USD SOFR+ 2.75 % 0.50 % 7.31 % 4/27/2028 990,025 986,322 997,450
Clarios Global LP Automotive Term Loan B  (07/24) Loan 1M USD SOFR+ 2.50 % 0.00 % 7.07 % 5/6/2030 1,197,000 1,192,203 1,203,739
Claros Mortgage Trust, Inc Banking, Finance, Insurance & Real Estate Term Loan B-1 (11/21) Loan 1M USD SOFR+ 4.50 % 0.50 % 9.17 % 8/9/2026 3,377,586 3,367,642 3,276,258
CLYDESDALE ACQUISITION HOLDINGS, INC. Containers, Packaging & Glass Term Loan B Loan 1M USD SOFR+ 3.18 % 0.50 % 7.75 % 4/13/2029 1,220,000 1,198,551 1,226,686
Columbus McKinnon Corporation Capital Equipment Term Loan (03/24) Loan 3M USD SOFR+ 2.50 % 0.50 % 7.10 % 5/14/2028 366,056 365,561 367,429
Connect Finco SARL Telecommunications Term Loan B (03/24) Loan 1M USD SOFR+ 4.50 % 0.50 % 9.07 % 9/27/2029 2,873,063 2,804,916 2,480,401
Consolidated Communications, Inc. Telecommunications Term Loan B Loan 1M USD SOFR+ 3.50 % 0.75 % 8.19 % 10/2/2027 2,714,005 2,581,960 2,688,900

50

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

November 30, 2024

(unaudited)

Issuer Name Industry Asset Name Asset
Type
Reference
Rate/Spread
SOFR/LIBOR Floor Current Rate (All In) Maturity
Date
Principal/
Number of Shares
Cost Fair
Value
CORAL-US CO-BORROWER LLC Telecommunications Term Loan B-5 Loan 3M USD SOFR+ 2.25 % 0.00 % 7.00 % 1/31/2028 4,000,000 3,992,430 3,985,840
Corelogic, Inc. Services: Business Term Loan (4/21) Loan 1M USD SOFR+ 3.50 % 0.50 % 8.19 % 6/2/2028 2,425,000 2,418,601 2,409,456
Cortes NP Acquisition Corp (Vertiv) Capital Equipment Term Loan B (05/24) Loan 1M USD SOFR+ 2.00 % 0.00 % 6.66 % 3/2/2027 1,925,599 1,925,599 1,935,496
Creative Artists Agency, LLC Media: Diversified & Production Term Loan B (09/24) Loan 1M USD SOFR+ 2.75 % 0.00 % 7.32 % 9/12/2031 1,576,094 1,567,369 1,584,857
CROCS INC Consumer goods: Durable Term Loan B (01/24) Loan 1M USD SOFR+ 2.25 % 0.50 % 6.82 % 2/19/2029 862,500 838,623 866,571
Cross Financial Corp Banking, Finance, Insurance & Real Estate Term Loan B2 (10/24) Loan 1M USD SOFR+ 3.25 % 0.00 % 7.82 % 10/24/2031 485,063 483,806 488,700
Crown Subsea Communications Holding, Inc. Construction & Building Term Loan B Loan 1M USD SOFR+ 4.00 % 0.75 % 8.57 % 1/30/2031 2,394,000 2,372,592 2,422,441
CTC Holdings, LP Banking, Finance, Insurance & Real Estate Term Loan (2/22) Loan 3M USD SOFR+ 5.00 % 0.50 % 9.66 % 2/15/2029 2,193,750 2,155,366 2,188,266
CTS Midco, LLC High Tech Industries Term Loan B Loan 3M USD SOFR+ 6.00 % 1.00 % 10.85 % 11/2/2027 1,923,807 1,896,277 1,914,188
Dave & Buster’s Inc. Hotel, Gaming & Leisure Term Loan B (1/24) Loan 1M USD SOFR+ 3.25 % 0.50 % 7.94 % 6/29/2029 762,038 734,081 763,806
DCert Buyer, Inc. High Tech Industries Term Loan Loan 1M USD SOFR+ 4.00 % 0.00 % 8.57 % 10/16/2026 1,443,325 1,443,325 1,411,933
Delek US Holdings, Inc. Utilities: Oil & Gas Term Loan B (11/22) Loan 1M USD SOFR+ 3.50 % 0.50 % 8.17 % 11/16/2029 5,305,500 5,215,591 5,306,985
Derby Buyer LLC Chemicals, Plastics, & Rubber Term Loan (5/24) Loan 1M USD SOFR+ 3.50 % 0.50 % 8.16 % 11/1/2030 621,875 613,650 623,622
DexKo Global, Inc. (Dragon Merger) Automotive Term Loan (9/21) Loan 3M USD SOFR+ 3.75 % 0.50 % 8.62 % 10/4/2028 975,000 972,491 915,018
Diamond Sports Group, LLC Media: Broadcasting & Subscription 1st Priority Term Loan Loan 1M USD SOFR+ 10.00 % 1.00 % 14.77 % 5/25/2026 35,166 34,709 30,038
DIRECTV FINANCING, LLC Media: Broadcasting & Subscription Term Loan (1/24) Loan 3M USD SOFR+ 5.25 % 0.75 % 10.10 % 8/2/2029 2,974,675 2,957,251 2,929,728
DISCOVERY PURCHASER CORPORATION Chemicals, Plastics, & Rubber Term Loan Loan 3M USD SOFR+ 4.38 % 0.50 % 8.95 % 10/4/2029 1,473,918 1,383,648 1,481,081

51

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

November 30, 2024

(unaudited)

Issuer Name Industry Asset Name Asset
Type
Reference
Rate/Spread
SOFR/LIBOR Floor Current Rate (All In) Maturity
Date
Principal/
Number of Shares
Cost Fair
Value
Dispatch Acquisition Holdings, LLC Environmental Industries Term Loan B (3/21) Loan 3M USD SOFR+ 4.25 % 0.75 % 9.00 % 3/25/2028 483,750 481,157 460,873
DOMTAR CORPORATION Forest Products & Paper Term Loan 9/21 Loan 1M USD SOFR+ 5.50 % 0.75 % 10.19 % 11/30/2028 3,114,554 3,067,307 3,000,344
DOTDASH MEREDITH, INC. Media: Advertising, Printing & Publishing Term Loan B Loan 1M USD SOFR+ 3.50 % 0.50 % 8.17 % 12/1/2028 1,911,111 1,770,962 1,923,056
DRI HOLDING INC. Media: Advertising, Printing & Publishing Term Loan (12/21) Loan 1M USD SOFR+ 5.25 % 0.50 % 10.04 % 12/15/2028 3,902,444 3,794,546 3,767,809
DRW Holdings, LLC Banking, Finance, Insurance & Real Estate Term Loan B (06/24) Loan 6M USD SOFR+ 3.50 % 0.00 % 8.59 % 6/17/2031 6,305,000 6,278,762 6,312,881
DTZ U.S. Borrower, LLC Construction & Building 2024-3 Term Loan (09/24) Loan 1M USD SOFR+ 3.25 % 0.50 % 7.82 % 1/31/2030 1,097,250 1,074,013 1,097,250
DTZ U.S. Borrower, LLC Construction & Building Term Loan B1 (06/24) Loan 1M USD SOFR+ 3.00 % 0.50 % 7.57 % 1/31/2030 2,014,107 2,012,682 2,026,695
Dye & Durham Corporation Services: Business Term Loan B (04/24) Loan 3M USD SOFR+ 4.25 % 1.00 % 8.95 % 4/11/2031 1,435,714 1,415,334 1,439,907
EAB Global, Inc. Services: Business Term Loan (08/21) Loan 1M USD SOFR+ 3.25 % 0.50 % 7.82 % 8/16/2028 972,613 970,107 975,530
Echo Global Logistics, Inc. Services: Business Term Loan Loan 1M USD SOFR+ 3.75 % 0.50 % 8.42 % 11/23/2028 1,950,000 1,947,987 1,923,188
Edelman Financial Group Inc., The Banking, Finance, Insurance & Real Estate Term Loan B (05/24) Loan 1M USD SOFR+ 3.25 % 0.00 % 7.82 % 4/7/2028 2,155,371 2,151,733 2,167,700
ELECTRON BIDCO INC. Healthcare & Pharmaceuticals Term Loan Loan 1M USD SOFR+ 3.00 % 0.50 % 7.69 % 11/1/2028 487,500 486,305 490,396
ELO Touch Solutions, Inc. Media: Diversified & Production Term Loan (12/18) Loan 1M USD SOFR+ 6.50 % 0.00 % 11.19 % 12/14/2025 2,137,656 2,120,001 2,130,089
Embecta Corp Healthcare & Pharmaceuticals Term Loan B Loan 1M USD SOFR+ 3.00 % 0.50 % 7.57 % 3/30/2029 2,993,180 2,946,385 2,962,919
Emrld Borrower LP Capital Equipment Term Loan B (04/23) Loan 6M USD SOFR+ 2.50 % 0.00 % 6.93 % 5/31/2030 992,500 988,384 994,048
Endo Finance Holdings, Inc. Healthcare & Pharmaceuticals Term Loan B Loan 1M USD SOFR+ 4.00 % 0.50 % 8.57 % 4/23/2031 2,000,000 1,981,375 2,002,500
Endure Digital, Inc. High Tech Industries Term Loan B Loan 1M USD SOFR+ 3.50 % 0.75 % 8.27 % 2/10/2028 2,418,750 2,413,091 1,615,386

52

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

November 30, 2024

(unaudited)

Issuer Name Industry Asset Name Asset
Type
Reference
Rate/Spread
SOFR/LIBOR Floor Current Rate (All In) Maturity
Date
Principal/
Number of Shares
Cost Fair
Value
Entain Holdings (Gibraltar) Limited Hotel, Gaming & Leisure Term Loan B3 (5/24) Loan 6M USD SOFR+ 2.75 % 0.50 % 8.01 % 10/31/2029 1,480,034 1,466,934 1,486,517
EOS U.S. FINCO LLC Transportation: Cargo Term Loan Loan 6M USD SOFR+ 6.00 % 0.50 % 11.26 % 10/6/2029 956,250 896,755 674,453
Equiniti Group PLC Services: Business Term Loan B Loan 6M USD SOFR+ 4.50 % 0.50 % 10.01 % 12/11/2028 972,500 966,227 983,441
Evertec Group LLC Banking, Finance, Insurance & Real Estate Term Loan B (09/23) Loan 1M USD SOFR+ 3.25 % 0.50 % 7.84 % 10/30/2030 1,125,000 1,110,023 1,130,625
Fiesta Purchaser, Inc. Beverage, Food & Tobacco First Lien TLB Loan 1M USD SOFR+ 4.00 % 0.00 % 8.57 % 2/12/2031 498,750 494,258 501,618
Finco I LLC Banking, Finance, Insurance & Real Estate Term Loan  B (9/24) Loan 1M USD SOFR+ 2.25 % 0.00 % 6.82 % 6/27/2029 2,795,563 2,793,146 2,808,842
First Brands Group, LLC Automotive 1st Lien Term Loan (3/21) Loan 3M USD SOFR+ 5.00 % 1.00 % 9.85 % 3/30/2027 4,825,000 4,789,935 4,656,125
First Eagle Investment Management Banking, Finance, Insurance & Real Estate Term Loan B (02/24) Loan 3M USD SOFR+ 3.00 % 0.00 % 7.60 % 3/5/2029 5,066,194 5,058,251 5,081,139
First Student Bidco Inc. Transportation: Consumer Term Loan B Loan 3M USD SOFR+ 3.00 % 0.50 % 7.87 % 7/21/2028 709,476 706,391 712,449
First Student Bidco Inc. Transportation: Consumer Term Loan C Loan 3M USD SOFR+ 3.00 % 0.50 % 7.87 % 7/21/2028 216,966 216,012 217,875
Fitness International, LLC (LA Fitness) Services: Consumer Term Loan  B (1/24) Loan 1M USD SOFR+ 5.25 % 1.00 % 9.92 % 2/5/2029 1,194,000 1,163,022 1,197,486
Flutter Financing B.V. Hotel, Gaming & Leisure Term Loan B3 (11/23) Loan 3M USD SOFR+ 2.00 % 0.50 % 6.60 % 11/25/2030 3,721,875 3,712,626 3,741,266
Franchise Group, Inc. Services: Consumer Term Loan B Loan 1M USD SOFR+ 9.00 % 1.00 % 13.74 % 5/6/2025 355,828 350,854 352,270
Franchise Group, Inc. (c) Services: Consumer First Out Term Loan Loan 6M USD SOFR+ 4.75 % 0.75 % 10.39 % 3/10/2026 827,674 825,253 460,543
Franchise Group, Inc. (c) Services: Consumer Term Loan B Loan 3M USD SOFR+ 4.75 % 0.75 % 9.57 % 3/10/2026 3,041,686 2,974,951 1,692,485
Franchise Group, Inc. (d) Services: Consumer Term Loan DIP New Money Loan 1M USD SOFR+ 9.00 % 1.00 % 0.00 % 5/6/2025 - ( 7,194 ) 2,572
Franklin Square Holdings, L.P. Banking, Finance, Insurance & Real Estate Term Loan B (04/24) Loan 1M USD SOFR+ 2.25 % 0.00 % 6.82 % 4/25/2031 4,241,841 4,235,807 4,257,748
Froneri International (R&R Ice Cream) Beverage, Food & Tobacco Term Loan B4 (10/24) Loan 1M USD SOFR+ 2.00 % 0.00 % 6.57 % 9/16/2031 1,915,000 1,914,548 1,912,855

53

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

November 30, 2024

(unaudited)

Issuer Name Industry Asset Name Asset
Type
Reference
Rate/Spread
SOFR/LIBOR Floor Current Rate (All In) Maturity
Date
Principal/
Number of Shares
Cost Fair
Value
Garrett LX III S.a r.l. Automotive Term Loan Loan 3M USD SOFR+ 2.75 % 0.50 % 7.34 % 4/30/2028 1,455,000 1,451,205 1,464,094
Gemini HDPE LLC Chemicals, Plastics, & Rubber Term Loan B (12/20) Loan 3M USD SOFR+ 3.00 % 0.50 % 7.85 % 12/31/2027 2,101,237 2,092,761 2,102,813
Genesee & Wyoming, Inc. Transportation: Cargo Term Loan B (03/24) Loan 3M USD SOFR+ 2.00 % 0.00 % 6.60 % 4/10/2031 1,500,000 1,492,864 1,503,900
GGP Inc. Banking, Finance, Insurance & Real Estate Term Loan B Loan 1M USD SOFR+ 2.50 % 0.00 % 7.17 % 8/27/2025 2,374,877 2,316,895 2,371,243
GIP Pilot Acquisition Partners, L.P. Energy: Oil & Gas Term Loan (05/24) Loan 3M USD SOFR+ 2.50 % 0.00 % 7.09 % 10/4/2030 453,688 451,738 456,524
Global Tel*Link Corporation Telecommunications Term Loan (6/24) Loan 1M USD SOFR+ 7.50 % 3.00 % 12.07 % 7/31/2029 4,821,101 4,750,449 4,681,289
Go Daddy Operating Company, LLC High Tech Industries Term Loan B7 Loan 1M USD SOFR+ 1.75 % 0.00 % 6.32 % 5/30/2031 942,594 942,594 943,499
GOLDEN WEST PACKAGING GROUP LLC Forest Products & Paper Term Loan (11/21) Loan 3M USD SOFR+ 5.25 % 0.75 % 10.10 % 12/1/2027 1,800,000 1,791,369 1,494,000
GOTO GROUP, INC. High Tech Industries First Lien Term Loan Loan 1M USD SOFR+ 4.75 % 0.00 % 9.47 % 4/30/2028 1,248,518 784,356 1,108,060
GOTO GROUP, INC. High Tech Industries Second-Out Term Loan (02/24) Loan 1M USD SOFR+ 4.75 % 0.00 % 9.47 % 4/30/2028 1,724,144 1,651,504 684,485
Graham Packaging Co Inc Containers, Packaging & Glass Term Loan B (07/24) Loan 1M USD SOFR+ 2.50 % 0.00 % 7.07 % 8/4/2027 830,576 827,963 833,766
Great Outdoors Group, LLC Retail Term Loan B2 Loan 1M USD SOFR+ 3.75 % 0.75 % 8.44 % 3/6/2028 962,725 960,449 966,133
Griffon Corporation Consumer goods: Durable Term Loan B Loan 1M USD SOFR+ 2.25 % 0.00 % 6.82 % 1/24/2029 142,813 142,636 143,438
Grosvenor Capital Management Holdings, LLLP Banking, Finance, Insurance & Real Estate Term Loan B (5/24) Loan 1M USD SOFR+ 2.25 % 0.00 % 6.82 % 2/25/2030 2,793,711 2,793,267 2,806,283
Groupe Solmax Inc. Environmental Industries Term Loan (6/21) Loan 1M USD SOFR+ 4.75 % 0.75 % 9.44 % 5/27/2028 2,418,409 2,123,407 2,220,197
GYP HOLDINGS III CORP. Construction & Building Term Loan  (1/24) Loan 1M USD SOFR+ 2.25 % 0.00 % 6.82 % 5/12/2030 247,505 246,479 247,299
Hertz Corporation (The) Transportation: Consumer Term Loan B Loan 1M USD SOFR+ 3.75 % 0.00 % 8.34 % 6/30/2028 2,088,230 2,037,051 1,851,028

54

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

November 30, 2024

(unaudited)

Issuer Name Industry Asset Name Asset
Type
Reference
Rate/Spread
SOFR/LIBOR Floor Current Rate (All In) Maturity
Date
Principal/
Number of Shares
Cost Fair
Value
Hillman Group Inc. (The) (New) Consumer goods: Durable Term Loan B-1 (2/21) Loan 1M USD SOFR+ 2.25 % 0.50 % 6.82 % 7/14/2028 2,723,502 2,721,899 2,730,665
Hilton Domestic Operating Company Inc. Hotel, Gaming & Leisure Term Loan B 4 Loan 1M USD SOFR+ 1.75 % 0.00 % 6.34 % 11/8/2030 1,500,000 1,496,904 1,508,820
Hilton Grand Vacations Borrower LLC Hotel, Gaming & Leisure Term Loan B Loan 1M USD SOFR+ 2.75 % 0.00 % 8.18 % 8/2/2028 500,000 500,000 502,500
HLF Financing SARL (Herbalife) Consumer goods: Non-durable Term Loan Loan 1M USD SOFR+ 6.75 % 0.50 % 11.32 % 4/12/2029 3,077,445 3,075,506 3,038,331
Holley Purchaser, Inc Automotive Term Loan (11/21) Loan 1M USD SOFR+ 3.75 % 0.75 % 8.44 % 11/17/2028 2,195,737 2,190,375 2,143,237
Hudson River Trading LLC Banking, Finance, Insurance & Real Estate Term Loan (10/24) Loan 1M USD SOFR+ 3.00 % 0.00 % 7.63 % 3/29/2030 5,790,000 5,702,726 5,799,669
Hunter Douglas Inc Consumer goods: Durable Term Loan B-1 Loan 3M USD SOFR+ 3.50 % 0.50 % 8.02 % 2/26/2029 2,456,093 2,247,201 2,462,233
Hyperion Refinance S.a.r.l. Banking, Finance, Insurance & Real Estate Term Loan B Loan 1M USD SOFR+ 3.50 % 0.50 % 8.07 % 2/15/2031 2,985,000 2,971,677 2,996,850
Idera, Inc. High Tech Industries Term Loan (06/24) Loan 3M USD SOFR+ 3.50 % 0.75 % 8.07 % 3/2/2028 4,738,026 4,734,054 4,682,733
IMA Financial Group, Inc. Banking, Finance, Insurance & Real Estate Term Loan (10/21) Loan Prime 2.25 % 0.50 % 10.00 % 11/1/2028 2,446,324 2,438,849 2,448,624
INDY US BIDCO, LLC Services: Business Term Loan (11/21) Loan 1M USD SOFR+ 3.75 % 0.00 % 8.44 % 3/6/2028 2,176,438 2,175,863 2,166,100
INEOS 226 Ltd. Chemicals, Plastics, & Rubber Term Loan 3/23 Loan 1M USD SOFR+ 3.75 % 0.00 % 8.42 % 3/13/2030 493,750 489,613 493,750
Ineos US Finance LLC Chemicals, Plastics, & Rubber Term Loan C Loan 1M USD SOFR+ 3.25 % 0.00 % 7.82 % 2/18/2030 992,500 984,319 996,847
INEOS US PETROCHEM LLC Chemicals, Plastics, & Rubber Term Loan B Loan 1M USD SOFR+ 4.25 % 0.00 % 8.92 % 4/2/2029 2,701,299 2,651,063 2,703,001
Informatica Inc. High Tech Industries Term Loan B (06/24) Loan 1M USD SOFR+ 2.25 % 0.00 % 6.82 % 10/27/2028 487,500 487,456 489,328
Ingram Micro Inc. Wholesale Term Loan B Loan 3M USD SOFR+ 2.75 % 0.00 % 7.56 % 9/17/2031 693,439 689,349 699,507
Inmar, Inc. Services: Business Term Loan (06/23) Loan 3M USD SOFR+ 5.00 % 1.00 % 9.60 % 10/30/2031 3,308,125 3,228,689 3,312,260

55

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

November 30, 2024

(unaudited)

Issuer Name Industry Asset Name Asset
Type
Reference
Rate/Spread
SOFR/LIBOR Floor Current Rate (All In) Maturity
Date
Principal/
Number of Shares
Cost Fair
Value
Innophos, Inc. Chemicals, Plastics, & Rubber Term Loan B Loan 1M USD SOFR+ 3.75 % 0.00 % 8.44 % 2/4/2027 477,500 476,860 474,516
IRB Holding Corporation Beverage, Food & Tobacco Term Loan B Loan 1M USD SOFR+ 2.75 % 0.75 % 7.42 % 12/15/2027 492,487 489,079 494,511
Isagenix International, LLC (c) Beverage, Food & Tobacco Term Loan Loan 6M USD SOFR+ 2.50 % 0.00 % 7.15 % 4/13/2028 1,348,264 977,195 235,946
Isolved Inc. Services: Business Term Loan B (11/24) Loan 1M USD SOFR+ 3.25 % 0.00 % 7.84 % 10/15/2030 621,879 616,218 626,356
Jane Street Group Banking, Finance, Insurance & Real Estate Term Loan B (10/24) Loan 3M USD SOFR+ 2.00 % 0.00 % 6.51 % 1/26/2028 3,850,000 3,849,305 3,864,823
Journey Personal Care Corp. Consumer goods: Non-durable Term Loan B Loan 1M USD SOFR+ 4.25 % 0.75 % 9.05 % 3/1/2028 2,902,500 2,862,195 2,905,228
JP Intermediate B, LLC (b) Consumer goods: Non-durable Term Loan 7/23 Loan Prime 6.50 % 1.00 % 14.25 % 11/20/2027 3,413,673 3,401,805 164,300
Kleopatra Finco S.a r.l. Containers, Packaging & Glass Term Loan (1/21) (USD) Loan 6M USD SOFR+ 4.73 % 0.50 % 9.72 % 2/12/2026 1,447,500 1,446,962 1,381,335
Kodiak BP, LLC Construction & Building Term Loan B2 Loan 1M USD SOFR+ 3.25 % 0.75 % 7.94 % 3/13/2028 482,347 481,620 482,467
Kodiak BP, LLC Construction & Building Term Loan B Loan 1M USD SOFR+ 3.75 % 0.00 % 8.32 % 3/13/2028 497,500 495,285 497,420
Koppers Inc Chemicals, Plastics, & Rubber Term Loan B (04/24) Loan 1M USD SOFR+ 3.00 % 0.50 % 7.62 % 4/10/2030 987,550 962,956 992,488
KREF Holdings X LLC Banking, Finance, Insurance & Real Estate Term Loan (11/21) Loan 3M USD SOFR+ 3.50 % 0.50 % 8.35 % 9/1/2027 482,603 477,180 482,603
Lakeland Tours, LLC (c) Hotel, Gaming & Leisure Holdco Fixed Term Loan Loan Fixed 0.00 % 0.00 % 8.00 % 9/27/2027 1,127,568 653,045 146,584
Latham Pool Products, Inc. Consumer goods: Durable Term Loan 2/22 Loan 3M USD SOFR+ 3.75 % 0.50 % 8.49 % 2/23/2029 994,406 980,719 976,388
Lealand Finance Company B.V. (c) Energy: Oil & Gas Exit Term Loan Loan 1M USD SOFR+ 1.00 % 0.00 % 5.69 % 12/31/2027 363,957 363,957 140,123
LHS BORROWER, LLC Construction & Building Term Loan (02/22) Loan 1M USD SOFR+ 4.75 % 0.50 % 9.42 % 2/16/2029 2,456,567 2,110,430 2,362,407

56

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

November 30, 2024

(unaudited)

Issuer Name Industry Asset Name Asset
Type
Reference
Rate/Spread
SOFR/LIBOR Floor Current Rate (All In) Maturity
Date
Principal/
Number of Shares
Cost Fair
Value
Lifetime Brands, Inc Consumer goods: Non-durable Term Loan Loan 1M USD SOFR+ 5.50 % 1.00 % 10.24 % 8/26/2027 1,597,089 1,592,497 1,547,180
Liquid Tech Solutions Holdings, LLC Services: Business Term Loan Loan 1M USD SOFR+ 4.75 % 0.75 % 9.55 % 3/17/2028 967,500 965,961 965,081
LOYALTY VENTURES INC. (b) Services: Business Loyalty Ventures Claims Term Loan B Prime 5.50 % 0.50 % 14.00 % 11/3/2027 2,913,525 2,904,521 211,231
LPL Holdings, Inc. Banking, Finance, Insurance & Real Estate Term Loan B1 Loan 1M USD SOFR+ 1.75 % 0.00 % 6.52 % 11/11/2026 1,186,065 1,185,668 1,185,816
LSF11 A5 HOLDCO LLC Chemicals, Plastics, & Rubber Term Loan B (06/24) Loan 1M USD SOFR+ 3.50 % 0.50 % 8.19 % 10/15/2028 1,724,904 1,708,336 1,735,254
LSF11 TRINITY BIDCO INC Aerospace & Defense Term Loan B (06/24) Loan 1M USD SOFR+ 3.50 % 0.00 % 8.09 % 6/14/2030 973,382 961,021 979,466
LSF9 Atlantis Holdings, LLC (A Wireless) Retail Term Loan  Extended Loan 3M USD SOFR+ 5.25 % 0.75 % 9.85 % 3/31/2029 2,706,059 2,641,182 2,732,280
Lumen Technologies Inc Telecommunications Term Loan B1 (3/24) Loan 1M USD SOFR+ 2.35 % 2.00 % 7.04 % 4/15/2029 1,612,346 1,611,691 1,506,544
Lumen Technologies Inc Telecommunications Term Loan B2 (3/24) Loan 1M USD SOFR+ 2.35 % 2.00 % 7.04 % 4/15/2030 1,612,346 1,611,682 1,493,435
MAGNITE, INC. Services: Business Term Loan B (09/24) Loan 1M USD SOFR+ 3.75 % 0.00 % 8.32 % 2/6/2031 3,241,875 3,212,215 3,274,294
Marriott Ownership Resorts, Inc. Hotel, Gaming & Leisure Term Loan  B (3/24) Loan 1M USD SOFR+ 2.25 % 0.00 % 6.82 % 4/1/2031 1,313,781 1,313,781 1,315,016
Match Group, Inc, The Services: Consumer Term Loan (1/20) Loan 3M USD SOFR+ 1.75 % 0.00 % 6.71 % 2/13/2027 250,000 249,794 249,688
Max US Bidco Inc. Beverage, Food & Tobacco Term Loan B Loan 1M USD SOFR+ 5.00 % 0.50 % 9.57 % 10/3/2030 1,990,000 1,870,928 1,898,460
Mayfield Agency Borrower Inc. (FeeCo) Banking, Finance, Insurance & Real Estate Term Loan B (06/24) Loan 1M USD SOFR+ 3.75 % 0.00 % 8.32 % 2/28/2028 3,415,608 3,345,894 3,435,521
McGraw-Hill Education, Inc. Media: Advertising, Printing & Publishing Term Loan B Loan 3M USD SOFR+ 4.00 % 0.50 % 8.60 % 8/1/2031 1,299,171 1,290,698 1,314,709
MedAssets Software Inter Hldg, Inc. High Tech Industries FINThrive Software Intermediate Holdings Inc. Loan 1M USD SOFR+ 4.00 % 0.50 % 9.36 % 12/18/2028 - 5,230 -
Michaels Companies Inc Retail Term Loan B (Magic Mergeco) Loan 3M USD SOFR+ 4.25 % 0.75 % 9.12 % 4/8/2028 2,423,612 2,412,391 1,785,475

57

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

November 30, 2024

(unaudited)

Issuer Name Industry Asset Name Asset
Type
Reference
Rate/Spread
SOFR/LIBOR Floor Current Rate (All In) Maturity
Date
Principal/
Number of Shares
Cost Fair
Value
MIWD Holdco II LLC Construction & Building Term Loan B2 (03/24) Loan 1M USD SOFR+ 3.00 % 0.00 % 7.57 % 3/21/2031 498,750 496,372 502,805
MKS Instruments, Inc. High Tech Industries Term Loan B (07/24) Loan 1M USD SOFR+ 2.25 % 0.50 % 6.84 % 8/17/2029 1,336,407 1,334,304 1,343,423
Momentive Performance Materials Inc. Chemicals, Plastics, & Rubber Term Loan (03/23) Loan 1M USD SOFR+ 4.00 % 0.00 % 8.57 % 3/28/2028 492,500 478,031 494,194
Moneygram International, Inc. Services: Business Term Loan B Loan 3M USD SOFR+ 4.75 % 0.50 % 9.68 % 6/1/2030 2,971,316 2,628,009 2,888,683
Mosel Bidco SE High Tech Industries Term Loan B Loan 3M USD SOFR+ 4.50 % 0.50 % 9.10 % 9/28/2030 500,000 495,581 505,625
MPH Acquisition Holdings LLC (Multiplan) Services: Business Term Loan B (08/21) Loan 3M USD SOFR+ 4.25 % 0.50 % 9.03 % 9/1/2028 2,939,394 2,744,556 2,146,081
NAB Holdings, LLC (North American Bancard) Banking, Finance, Insurance & Real Estate Term Loan B (06/24) Loan 3M USD SOFR+ 2.75 % 0.50 % 7.35 % 11/23/2028 2,917,838 2,913,688 2,915,766
Napa Management Services Corp Healthcare & Pharmaceuticals Term Loan B (02/22) Loan 1M USD SOFR+ 5.25 % 0.75 % 9.92 % 2/22/2029 2,947,103 2,483,465 2,733,438
Natgasoline LLC Chemicals, Plastics, & Rubber Term Loan Loan 6M USD SOFR+ 3.50 % 0.00 % 9.02 % 11/14/2025 3,278,801 3,272,511 3,237,816
National Mentor Holdings, Inc. Healthcare & Pharmaceuticals Term Loan C 2/21 Loan 3M USD SOFR+ 3.75 % 0.75 % 8.45 % 3/2/2028 87,464 87,236 86,443
National Mentor Holdings, Inc. Healthcare & Pharmaceuticals Term Loan 2/21 Loan 1M USD SOFR+ 3.75 % 0.75 % 8.42 % 3/2/2028 2,687,310 2,682,245 2,655,949
Nexstar Broadcasting, Inc. (Mission Broadcasting) Media: Broadcasting & Subscription Term Loan Loan 1M USD SOFR+ 2.50 % 0.00 % 7.19 % 9/18/2026 635,091 632,598 636,958
Next Level Apparel, Inc. Retail Term Loan Loan 3M USD SOFR+ 7.50 % 1.00 % 12.89 % 8/9/2026 2,404,573 2,390,217 1,890,595
NortonLifeLock Inc. High Tech Industries Term Loan B (05/24) Loan 1M USD SOFR+ 1.75 % 0.50 % 6.32 % 9/12/2029 973,750 970,732 974,363
Nouryon Finance B.V. Chemicals, Plastics, & Rubber Term Loan B (10/24) Loan 6M USD SOFR+ 3.25 % 0.00 % 7.66 % 4/3/2028 488,548 484,738 493,228
Novae LLC Automotive Term Loan B Loan 1M USD SOFR+ 5.00 % 0.75 % 9.69 % 12/22/2028 1,950,000 1,940,284 1,901,250
Olaplex, Inc. Consumer goods: Non-durable Term Loan (2/22) Loan 1M USD SOFR+ 3.50 % 0.50 % 8.17 % 2/23/2029 2,448,552 2,369,471 2,313,049

58

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

November 30, 2024

(unaudited)

Issuer Name Industry Asset Name Asset
Type
Reference
Rate/Spread
SOFR/LIBOR Floor Current Rate (All In) Maturity
Date
Principal/
Number of Shares
Cost Fair
Value
Open Text Corporation High Tech Industries Term Loan B (08/23) Loan 1M USD SOFR+ 1.75 % 0.50 % 6.44 % 1/31/2030 925,633 903,173 926,984
Oxbow Carbon, LLC Metals & Mining Term Loan B (04/23) Loan 1M USD SOFR+ 3.50 % 0.50 % 8.07 % 5/2/2030 493,750 485,406 491,592
PACIFIC DENTAL SERVICES, LLC Healthcare & Pharmaceuticals Term Loan B (02//24) Loan 1M USD SOFR+ 2.75 % 0.00 % 7.36 % 3/17/2031 1,194,000 1,192,946 1,201,833
PACTIV EVERGREEN GROUP HOLDINGS INC. Containers, Packaging & Glass Term Loan B4 (05/24) Loan 1M USD SOFR+ 2.50 % 0.00 % 7.07 % 9/24/2028 921,247 918,888 927,152
Padagis LLC Healthcare & Pharmaceuticals Term Loan Loan 3M USD SOFR+ 4.75 % 0.50 % 9.60 % 7/6/2028 941,176 935,433 865,882
PAR PETROLEUM LLC Energy: Oil & Gas Term Loan B Loan 3M USD SOFR+ 3.75 % 0.50 % 8.33 % 2/28/2030 2,464,969 2,443,742 2,445,964
PATAGONIA HOLDCO LLC Telecommunications Term Loan B Loan 3M USD SOFR+ 5.75 % 0.50 % 10.85 % 8/1/2029 2,954,924 2,624,512 2,778,870
Pathway Partners Vet Management Company LLC Services: Business Term Loan Loan 1M USD SOFR+ 3.75 % 0.00 % 8.44 % 3/31/2027 477,821 473,330 400,237
PCI Gaming Authority Hotel, Gaming & Leisure Term Loan Loan 1M USD SOFR+ 2.00 % 0.00 % 6.57 % 7/18/2031 792,504 791,446 790,895
PEARLS (Netherlands) Bidco B.V. Chemicals, Plastics, & Rubber USD Term Loan (02/22) Loan 3M USD SOFR+ 4.00 % 0.50 % 8.59 % 2/28/2029 976,067 974,938 984,003
PEDIATRIC ASSOCIATES HOLDING COMPANY, LLC Healthcare & Pharmaceuticals Term Loan (12/22) Loan 3M USD SOFR+ 3.25 % 0.50 % 8.10 % 12/29/2028 1,463,382 1,459,636 1,419,320
Penn National Gaming, Inc Hotel, Gaming & Leisure Term Loan B Loan 1M USD SOFR+ 2.75 % 0.50 % 7.42 % 5/3/2029 977,500 974,252 979,455
Peraton Corp. Aerospace & Defense Term Loan B Loan 1M USD SOFR+ 3.75 % 0.75 % 8.42 % 2/1/2028 5,195,081 5,186,501 4,869,557
PHYSICIAN PARTNERS, LLC Healthcare & Pharmaceuticals Term Loan Loan 3M USD SOFR+ 4.00 % 0.50 % 8.74 % 12/23/2028 2,936,095 2,885,602 1,178,108
Pitney Bowes Inc Services: Business Term Loan B Loan 1M USD SOFR+ 4.00 % 0.00 % 8.69 % 3/17/2028 3,869,748 3,851,488 3,908,445
Plastipak Holdings Inc. Containers, Packaging & Glass Term Loan B Loan 1M USD SOFR+ 2.25 % 0.50 % 6.82 % 12/1/2028 1,795,294 1,790,211 1,801,183
Playtika Holding Corp. High Tech Industries Term Loan B (3/21) Loan 1M USD SOFR+ 2.75 % 0.00 % 7.44 % 3/13/2028 4,342,500 4,337,712 4,358,350

59

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

November 30, 2024

(unaudited)

Issuer Name Industry Asset Name Asset
Type
Reference
Rate/Spread
SOFR/LIBOR Floor Current Rate (All In) Maturity
Date
Principal/
Number of Shares
Cost Fair
Value
PMHC II, INC. Chemicals, Plastics, & Rubber Term Loan (02/22) Loan 3M USD SOFR+ 4.25 % 0.50 % 9.06 % 4/21/2029 1,960,000 1,953,553 1,958,785
PointClickCare Technologies, Inc. High Tech Industries Term Loan B (10/24) Loan 1M USD SOFR+ 3.25 % 0.00 % 7.82 % 11/3/2031 482,575 481,320 485,591
Polymer Process Holdings, Inc. Containers, Packaging & Glass Term Loan Loan 1M USD SOFR+ 4.75 % 0.75 % 9.44 % 2/12/2028 4,020,266 3,999,162 4,002,697
Pre-Paid Legal Services, Inc. Services: Consumer Term Loan (12/21) Loan 1M USD SOFR+ 3.75 % 0.50 % 8.44 % 12/15/2028 2,925,000 2,909,258 2,934,331
Prime Security Services Borrower, LLC (ADT) Services: Consumer Term Loan B (04/24) Loan 1M USD SOFR+ 2.25 % 0.00 % 6.91 % 10/14/2030 1,990,013 1,972,697 1,994,052
PRIORITY HOLDINGS, LLC Services: Consumer Term Loan B (5/24) Loan 1M USD SOFR+ 4.75 % 0.50 % 9.32 % 5/16/2031 2,910,206 2,894,086 2,911,108
PriSo Acquisition Corporation Construction & Building Term Loan (01/21) Loan 3M USD SOFR+ 3.25 % 0.75 % 8.10 % 12/28/2027 482,490 481,373 476,623
Project Leopard Holdings, Inc. (NEW) High Tech Industries Term Loan B (06/22) Loan 3M USD SOFR+ 5.25 % 0.50 % 9.94 % 7/20/2029 982,500 931,073 876,724
Propulsion (BC) Finco Aerospace & Defense Term Loan B (10/24) Loan 3M USD SOFR+ 3.25 % 0.50 % 7.87 % 9/14/2029 744,318 737,577 750,369
PUG LLC Services: Consumer Term Loan B (03/24) Loan 1M USD SOFR+ 4.75 % 0.00 % 9.32 % 3/15/2030 466,953 466,078 466,855
Quartz AcquireCo, LLC High Tech Industries Term Loan B (05/24) Loan 3M USD SOFR+ 2.75 % 0.00 % 7.35 % 6/28/2030 1,238,120 1,229,494 1,242,763
Quikrete Holdings, Inc. Construction & Building Quikrete 3/24 (2031) Loan 1M USD SOFR+ 2.50 % 0.00 % 7.07 % 4/14/2031 995,000 992,642 993,508
R1 RCM INC. Healthcare & Pharmaceuticals Term Loan (12/23) Loan 1M USD SOFR+ 3.00 % 0.00 % 8.36 % 6/21/2029 1,200,000 1,185,480 1,204,200
Rackspace Technology Global, Inc. High Tech Industries Super-Priority Term Loan (03/24) Loan 1M USD SOFR+ 6.25 % 0.75 % 11.00 % 5/15/2028 548,287 543,428 563,069
Rackspace Technology Global, Inc. High Tech Industries Term Loan  (3/24) Loan 1M USD SOFR+ 2.75 % 0.75 % 7.50 % 5/15/2028 2,045,392 1,104,879 1,238,751
RAND PARENT LLC Transportation: Cargo Term Loan B Loan 3M USD SOFR+ 3.75 % 0.00 % 8.35 % 3/16/2030 2,462,578 2,389,704 2,473,980
RealPage, Inc. High Tech Industries Term Loan (04/21) Loan 1M USD SOFR+ 3.00 % 0.50 % 7.69 % 4/24/2028 970,000 969,177 963,210

60

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

November 30, 2024

(unaudited)

Issuer Name Industry Asset Name Asset
Type
Reference
Rate/Spread
SOFR/LIBOR Floor Current Rate (All In) Maturity
Date
Principal/
Number of Shares
Cost Fair
Value
Rent-A-Center, Inc. Retail Term Loan B2 (9/21) Loan 3M USD SOFR+ 2.75 % 0.50 % 7.34 % 2/17/2028 1,845,141 1,818,512 1,849,754
Research Now Group, Inc Media: Advertising, Printing & Publishing Second-Out Term Loan Loan 3M USD SOFR+ 5.50 % 1.00 % 10.29 % 7/15/2028 2,894,682 2,767,068 2,677,581
Research Now Group, Inc Media: Advertising, Printing & Publishing Term Loan (07/24) Loan 3M USD SOFR+ 5.00 % 1.00 % 10.38 % 7/15/2028 339,588 335,009 339,870
Resideo Funding Inc. Services: Consumer Term Loan B (05/24) Loan 1M USD SOFR+ 2.00 % 0.00 % 6.59 % 2/11/2028 674,488 674,193 674,772
Resolute Investment Managers (American Beacon), Inc. Banking, Finance, Insurance & Real Estate Term Loan (12/23) Loan 3M USD SOFR+ 6.50 % 1.00 % 11.37 % 4/30/2027 1,953,393 1,953,393 1,782,471
Restoration Hardware, Inc. Retail Term Loan (9/21) Loan 1M USD SOFR+ 2.50 % 0.50 % 7.19 % 10/20/2028 3,401,078 3,397,811 3,315,336
Reynolds Consumer Products LLC Containers, Packaging & Glass Term Loan Loan 1M USD SOFR+ 1.75 % 0.00 % 6.42 % 2/4/2027 1,027,008 1,027,008 1,031,865
Russell Investments US Inst’l Holdco, Inc. (c) Banking, Finance, Insurance & Real Estate Term Loan B PIK (3/24) Loan 3M USD SOFR+ 5.00 % 1.00 % 9.59 % 5/30/2027 5,756,457 5,744,770 5,416,481
RV Retailer LLC Automotive Term Loan Loan 3M USD SOFR+ 3.75 % 0.75 % 8.50 % 2/8/2028 2,905,350 2,874,547 2,706,333
Ryan Specialty Group LLC Banking, Finance, Insurance & Real Estate Term Loan B (09/24) Loan 1M USD SOFR+ 2.25 % 0.00 % 6.82 % 9/15/2031 1,455,934 1,448,107 1,461,029
S&S HOLDINGS LLC Services: Business Term Loan Loan 1M USD SOFR+ 5.00 % 0.50 % 9.70 % 3/10/2028 2,414,925 2,380,406 2,411,061
Sally Holdings LLC Retail Term Loan  B Loan 1M USD SOFR+ 1.75 % 0.00 % 6.32 % 2/28/2030 492,500 489,527 491,678
Schweitzer-Mauduit International, Inc. High Tech Industries Term Loan B Loan 1M USD SOFR+ 3.75 % 0.75 % 8.44 % 4/20/2028 949,942 947,430 949,942
Scientific Games Holdings LP Hotel, Gaming & Leisure Term Loan B Loan 3M USD SOFR+ 3.00 % 0.50 % 7.59 % 4/4/2029 492,500 491,808 493,978
Sedgwick Claims Management Services, Inc. Services: Business Term Loan B 2/23 Loan 3M USD SOFR+ 3.00 % 0.00 % 7.59 % 7/31/2031 987,500 980,541 994,087
SETANTA AIRCRAFT LEASING DAC Aerospace & Defense Term Loan B (05/24) Loan 3M USD SOFR+ 1.75 % 0.00 % 6.35 % 11/5/2028 500,000 499,272 502,145
Sitel Worldwide Corporation Services: Business USD Term Loan (7/21) Loan 1M USD SOFR+ 3.75 % 0.50 % 8.44 % 8/28/2028 1,940,000 1,935,152 1,244,219

61

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

November 30, 2024

(unaudited)

Issuer Name Industry Asset Name Asset
Type
Reference
Rate/Spread
SOFR/LIBOR Floor Current Rate (All In) Maturity
Date
Principal/
Number of Shares
Cost Fair
Value
SiteOne Landscape Supply, LLC Services: Business Term Loan B (06/24) Loan 1M USD SOFR+ 1.75 % 0.50 % 6.41 % 3/23/2030 1,260,861 1,256,216 1,264,014
Smyrna Ready Mix Concrete, LLC Construction & Building Term Loan B Loan 1M USD SOFR+ 3.50 % 0.00 % 8.07 % 4/1/2029 510,361 507,388 513,551
Sparta U.S. HoldCo LLC Chemicals, Plastics, & Rubber Term Loan (04/21) Loan 1M USD SOFR+ 3.25 % 0.75 % 7.91 % 8/2/2030 1,945,000 1,939,725 1,955,036
Specialty Pharma III Inc. Services: Business Term Loan Loan 1M USD SOFR+ 4.25 % 0.75 % 8.92 % 3/31/2028 1,940,000 1,929,743 1,920,600
Spin Holdco, Inc. Services: Consumer Term Loan 3/21 Loan 3M USD SOFR+ 4.00 % 0.75 % 9.26 % 3/4/2028 2,895,000 2,886,625 2,441,585
SRAM, LLC Consumer goods: Durable Term Loan (05/21) Loan 1M USD SOFR+ 2.75 % 0.50 % 7.44 % 5/12/2028 2,269,091 2,267,265 2,277,600
STANDARD INDUSTRIES INC. Construction & Building Term Loan B Loan 1M USD SOFR+ 1.75 % 0.50 % 6.35 % 9/22/2028 412,750 410,577 414,719
Staples, Inc. Wholesale Term Loan B Loan 3M USD SOFR+ 5.75 % 0.50 % 10.69 % 9/4/2029 4,274,263 4,218,826 4,064,098
Star Parent, Inc. Services: Business Term Loan B (09/23) Loan 3M USD SOFR+ 3.75 % 0.00 % 8.35 % 9/27/2030 1,243,750 1,227,427 1,219,907
Storable, Inc High Tech Industries Term Loan B Loan 1M USD SOFR+ 3.50 % 0.50 % 8.07 % 4/17/2028 486,250 485,953 487,971
Superannuation & Investments US LLC Banking, Finance, Insurance & Real Estate Term Loan Loan 1M USD SOFR+ 3.75 % 0.50 % 8.44 % 12/1/2028 972,500 966,461 977,061
SupplyOne, Inc Wholesale Term Loan B (03/24) Loan 1M USD SOFR+ 3.75 % 0.00 % 8.32 % 3/27/2031 497,500 492,777 502,475
Sweetwater Borrower, LLC Retail Term Loan (8/21) Loan 1M USD SOFR+ 4.25 % 0.75 % 8.94 % 8/2/2028 2,116,481 2,050,738 2,137,646
Syncsort Incorporated High Tech Industries Term Loan B (10/21) Loan 3M USD SOFR+ 4.00 % 0.75 % 8.85 % 4/24/2028 2,426,216 2,425,683 2,401,953
Ta TT Buyer LLC Media: Broadcasting & Subscription Term Loan B (6/24) Loan 3M USD SOFR+ 4.75 % 0.50 % 9.35 % 4/2/2029 982,494 975,193 984,646
Tenable Holdings, Inc. Services: Business Term Loan B (6/21) Loan 1M USD SOFR+ 2.75 % 0.50 % 7.44 % 7/7/2028 972,500 971,438 973,716
Teneo Holdings LLC Banking, Finance, Insurance & Real Estate Term Loan B (03/24) Loan 1M USD SOFR+ 4.75 % 1.00 % 9.32 % 3/13/2031 3,482,500 3,449,222 3,506,460

62

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

November 30, 2024

(unaudited)

Issuer Name Industry Asset Name Asset
Type
Reference
Rate/Spread
SOFR/LIBOR Floor Current Rate (All In) Maturity
Date
Principal/
Number of Shares
Cost Fair
Value
Ten-X, LLC Banking, Finance, Insurance & Real Estate Term Loan 5/23 Loan 6M USD SOFR+ 6.00 % 0.00 % 10.27 % 5/25/2028 1,865,000 1,865,000 1,701,813
Thor Industries, Inc. Automotive Term Loan B (06/24) Loan 1M USD SOFR+ 2.25 % 0.00 % 6.82 % 11/15/2030 385,981 382,642 387,429
TIBCO Software Inc High Tech Industries Term Loan (Cov-Lite) (10/24) Loan 3M USD SOFR+ 3.75 % 0.50 % 8.31 % 3/21/2031 500,000 499,418 502,155
Torrid LLC Wholesale Term Loan 5/21 Loan 3M USD SOFR+ 5.50 % 0.75 % 10.36 % 6/14/2028 3,154,143 2,816,614 2,860,808
TORY BURCH LLC Retail Term Loan Loan 1M USD SOFR+ 3.25 % 0.50 % 7.94 % 4/15/2028 2,290,329 2,177,065 2,289,092
Tosca Services, LLC Containers, Packaging & Glass Term Loan A (08/24) Loan 1M USD SOFR+ 5.50 % 1.50 % 10.11 % 11/30/2028 80,509 79,712 82,120
Tosca Services, LLC (c) Containers, Packaging & Glass Superpriority Second-Out Term Loan B Loan 1M USD SOFR+ 1.50 % 0.00 % 6.21 % 11/30/2028 2,704 6,281 2,393
Trans Union LLC Banking, Finance, Insurance & Real Estate Term Loan B7 (02/24) Loan 1M USD SOFR+ 2.00 % 0.50 % 6.57 % 12/1/2028 605,987 605,312 605,987
TRITON WATER HOLDINGS, INC. Beverage, Food & Tobacco Term Loan (03/21) Loan 3M USD SOFR+ 3.25 % 0.50 % 8.12 % 3/31/2028 1,451,255 1,447,149 1,461,138
Tronox Finance LLC Chemicals, Plastics, & Rubber Term Loan B (09/24) Loan 3M USD SOFR+ 2.50 % 0.00 % 7.10 % 9/30/2031 346,923 346,577 348,144
Tronox Finance LLC Chemicals, Plastics, & Rubber Term Loan B (04/24) Loan 3M USD SOFR+ 2.75 % 0.00 % 7.35 % 4/4/2029 1,995,000 1,978,673 2,002,481
TruGreen Limited Partnership Services: Consumer Term Loan Loan 1M USD SOFR+ 4.00 % 0.75 % 8.67 % 11/2/2027 937,456 934,128 905,433
Ultra Clean Holdings, Inc. High Tech Industries Term Loan B (09/24) Loan 1M USD SOFR+ 3.25 % 0.00 % 7.82 % 2/25/2028 1,241,514 1,238,397 1,246,170
Unimin Corporation Metals & Mining Term Loan (12/20) Loan 3M USD SOFR+ 4.00 % 1.00 % 8.85 % 7/31/2026 496,815 485,857 495,573
Univision Communications Inc. Media: Broadcasting & Subscription Term Loan B (05/24) Loan 1M USD SOFR+ 3.50 % 0.50 % 8.19 % 1/31/2029 2,409,561 2,407,226 2,415,584
Univision Communications Inc. Media: Broadcasting & Subscription Term Loan B (6/22) Loan 3M USD SOFR+ 4.25 % 0.50 % 8.85 % 6/25/2029 244,375 239,031 245,394
Vaco Holdings, LLC Services: Business Term Loan (01/22) Loan 1M USD SOFR+ 5.00 % 0.75 % 9.67 % 1/19/2029 2,300,808 2,249,748 2,166,118

63

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

November 30, 2024

(unaudited)

Issuer Name Industry Asset Name Asset
Type
Reference
Rate/Spread
SOFR/LIBOR Floor Current Rate (All In) Maturity
Date
Principal/
Number of Shares
Cost Fair
Value
Vericast Corp. (c) Media: Advertising, Printing & Publishing Extended Term Loan (07/24) Loan 3M USD SOFR+ 7.75 % 1.00 % 12.35 % 6/15/2030 1,291,273 1,290,689 1,222,681
Verifone Systems, Inc. Banking, Finance, Insurance & Real Estate Term Loan (7/18) Loan 3M USD SOFR+ 4.00 % 0.00 % 8.78 % 8/20/2025 1,343,028 1,341,803 1,254,563
Vertex Aerospace Services Corp Aerospace & Defense Term Loan (10/21) Loan 1M USD SOFR+ 2.75 % 0.75 % 7.32 % 12/6/2030 975,175 972,727 977,886
Viasat Inc Telecommunications Term Loan (2/22) Loan 1M USD SOFR+ 4.50 % 0.50 % 9.07 % 3/5/2029 2,944,786 2,893,239 2,565,292
Virtus Investment Partners, Inc. Banking, Finance, Insurance & Real Estate Term Loan B (9/21) Loan 1M USD SOFR+ 2.25 % 0.00 % 6.94 % 9/28/2028 2,582,727 2,578,170 2,581,927
Vistra Operations Company LLC Energy: Electricity 2018 Incremental Term Loan Loan 1M USD SOFR+ 2.00 % 0.00 % 6.57 % 12/20/2030 1,875,222 1,869,672 1,884,242
VM Consolidated, Inc. Construction & Building Term Loan B Loan 1M USD SOFR+ 2.25 % 0.00 % 6.82 % 3/24/2028 1,823,697 1,823,255 1,832,815
Walker & Dunlop, Inc. Banking, Finance, Insurance & Real Estate Term Loan Loan 1M USD SOFR+ 2.25 % 0.50 % 6.92 % 12/15/2028 492,468 485,253 494,009
Warner Music Group Corp. (WMG Acquisition Corp.) Hotel, Gaming & Leisure Term Loan J Loan 1M USD SOFR+ 1.75 % 0.00 % 6.32 % 1/24/2031 1,250,000 1,249,986 1,248,700
Watlow Electric Manufacturing Company High Tech Industries Term Loan B (03/21) Loan 3M USD SOFR+ 3.50 % 0.50 % 8.09 % 3/2/2028 2,728,183 2,721,055 2,748,153
WeddingWire, Inc. Services: Consumer Term Loan (09/23) Loan 1M USD SOFR+ 4.50 % 0.00 % 9.07 % 1/29/2028 4,784,879 4,783,712 4,805,837
WEX Inc. Services: Business Term Loan B (11/24) Loan 1M USD SOFR+ 2.00 % 0.00 % 6.69 % 4/1/2028 2,902,913 2,897,842 2,906,541
Windsor Holdings III, LLC Chemicals, Plastics, & Rubber Term Loan B (09/24) Loan 1M USD SOFR+ 3.50 % 0.00 % 8.10 % 8/1/2030 496,256 496,256 501,715
Wyndham Hotels & Resorts, Inc. Hotel, Gaming & Leisure Term Loan (05/24) Loan 1M USD SOFR+ 1.75 % 0.00 % 6.32 % 5/24/2030 990,019 985,956 994,355
Xperi Corporation High Tech Industries Term Loan B (05/24) Loan 1M USD SOFR+ 3.00 % 0.00 % 7.61 % 6/8/2028 1,864,531 1,862,101 1,869,193
Zayo Group, LLC Telecommunications Term Loan 4/22 Loan 1M USD SOFR+ 4.25 % 0.50 % 8.82 % 3/9/2027 975,000 961,738 936,868
ZEBRA BUYER (Allspring) LLC Banking, Finance, Insurance & Real Estate Term Loan 4/21 Loan 3M USD SOFR+ 3.25 % 0.50 % 8.14 % 11/1/2028 1,852,261 1,844,855 1,859,781

64

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

November 30, 2024

(unaudited)

Issuer Name Industry Asset Name Asset
Type
Reference
Rate/Spread
SOFR/LIBOR Floor Current Rate (All In) Maturity
Date
Principal/
Number of Shares
Cost Fair
Value
Zekelman Industries, Inc. Metals & Mining Term Loan B (03/24) Loan 1M USD SOFR+ 2.25 % 0.00 % 6.85 % 1/24/2031 1,446,759 1,445,713 1,451,504
Zest Acquisition Corp. Healthcare & Pharmaceuticals Term Loan (1/23) Loan 3M USD SOFR+ 5.25 % 0.00 % 9.84 % 2/8/2028 1,965,000 1,896,455 1,989,563
Zodiac Pool Solutions Consumer goods: Durable Term Loan (1/22) Loan 1M USD SOFR+ 1.93 % 0.50 % 6.60 % 1/29/2029 486,250 485,654 486,549
TOTAL INVESTMENTS $ 551,522,106 $ 525,731,937

Number of Shares Cost Fair Value
Cash and cash equivalents
U.S. Bank Money Market (a) 26,917,052 $ 26,917,052 $ 26,917,052
Total cash and cash equivalents 26,917,052 $ 26,917,052 $ 26,917,052

(a) Included within cash and cash equivalents in Saratoga CLO’s Statements of Assets and Liabilities as of November 30, 2024.

(b) As of November 30, 2024, the investment was in default and on non-accrual status.

(c) Investments include Payment-in-Kind Interest.

(d) All or a portion of this investment has an unfunded commitment as of November 30, 2024.

LIBOR - London Interbank Offered Rate

SOFR - Secured Overnight Financing Rate

1M SOFR - The 1-month SOFR rate as of November 30, 2024 was 4.53%.

3M SOFR - The 3-month SOFR rate as of November 30, 2024 was 4.47%.

6M SOFR - The 6-month SOFR rate as of November 30, 2024 was 4.38%.

Prime - The Prime Rate as of November 30, 2024 was 7.75%.

See accompanying notes to financial statements

65

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

February 29, 2024

Issuer Name Industry Asset Name Asset
Type
Reference
Rate/Spread
SOFR/LIBOR Floor Current Rate (All In) Maturity
Date
Principal/
Number of Shares
Cost Fair
Value
Altisource Solutions S.a r.l. Banking, Finance, Insurance & Real Estate Common Stock Equity 15,981 $ - $ 44,587
Envision Parent Inc Healthcare & Pharmaceuticals Common Stock Equity 92,837 - -
Envision Parent Inc Healthcare & Pharmaceuticals Warrants Equity 4,410 175,000 42,998
Isagenix International, LLC Beverage, Food & Tobacco Common Stock Equity 86,398 - -
Resolute Investment Managers (American Beacon), Inc. Banking, Finance, Insurance & Real Estate Common Stock Equity 24,320 1,034,581 468,000
URS TOPCO LLC Transportation: Cargo Common Stock Equity 25,330 440,405 465,000
1011778 B.C Unltd Liability Co Beverage, Food & Tobacco Term Loan B (09/23) Loan 1M USD SOFR+ 2.25 % 0.00 % 7.58 % 9/12/2030 $ 1,447,500 1,427,292 1,440,002
19TH HOLDINGS GOLF, LLC Consumer goods: Durable Term Loan Loan 1M USD SOFR+ 3.25 % 0.50 % 8.67 % 2/7/2029 2,473,646 2,383,742 2,416,950
888 Acquisitions Limited Hotel, Gaming & Leisure Term Loan B Loan 6M USD SOFR+ 5.25 % 0.00 % 10.82 % 7/8/2028 2,472,826 2,173,473 2,418,745
Adtalem Global Education Inc. Services: Business Term Loan B Loan 1M USD SOFR+ 3.50 % 0.75 % 8.83 % 8/12/2028 582,329 578,482 583,423
Aegis Sciences Corporation Healthcare & Pharmaceuticals Term Loan Loan 3M USD SOFR+ 5.50 % 1.00 % 11.08 % 5/9/2025 2,308,370 2,303,734 2,206,410
Agiliti Health Inc. Healthcare & Pharmaceuticals Term Loan B (03/23) Loan 3M USD SOFR+ 3.00 % 0.00 % 8.33 % 5/1/2030 1,674,704 1,662,945 1,668,424
AHEAD DB Holdings, LLC Services: Business Term Loan (04/21) Loan 3M USD SOFR+ 3.75 % 0.75 % 9.20 % 10/18/2027 2,925,000 2,856,780 2,914,031
Air Canada Transportation: Consumer Term Loan B (07/21) Loan 1M USD SOFR+ 3.50 % 0.75 % 8.93 % 8/11/2028 1,970,000 1,853,394 1,970,276
AIS HoldCo, LLC Services: Business Term Loan Loan 3M USD SOFR+ 5.00 % 0.00 % 10.57 % 8/15/2025 4,551,925 4,499,117 4,392,607
AIT Worldwide Logistics Holdings, Inc. Transportation: Cargo Term Loan (04/21) Loan 1M USD SOFR+ 4.75 % 0.75 % 10.17 % 4/6/2028 2,474,684 2,334,728 2,471,590

66

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

February 29, 2024

Issuer Name Industry Asset Name Asset
Type
Reference
Rate/Spread
SOFR/LIBOR Floor Current Rate (All In) Maturity
Date
Principal/
Number of Shares
Cost Fair
Value
Alchemy US Holdco 1, LLC Metals & Mining Term Loan Loan 1M USD LIBOR+ 7.32 % 0.00 % 7.42 % 10/10/2025 1,654,803 1,647,646 1,646,943
AlixPartners, LLP Banking, Finance, Insurance & Real Estate Term Loan B (01/21) Loan 1M USD SOFR+ 2.50 % 0.50 % 7.94 % 2/4/2028 243,125 242,907 243,064
Alkermes, Inc. Healthcare & Pharmaceuticals Term Loan B (3/21) Loan 1M USD SOFR+ 2.50 % 0.50 % 7.93 % 3/12/2026 2,104,577 2,095,205 2,101,947
Allen Media, LLC Media: Diversified & Production Term Loan (7/21) Loan 3M USD SOFR+ 5.50 % 0.00 % 11.00 % 2/10/2027 4,349,069 4,329,175 3,803,870
Alliant Holdings Intermediate, LLC Banking, Finance, Insurance & Real Estate Term Loan (12/23) Loan 1M USD SOFR+ 3.50 % 0.50 % 8.82 % 11/6/2030 803,044 802,787 803,197
Allied Universal Holdco LLC Services: Business Term Loan 4/21 Loan 1M USD SOFR+ 3.75 % 0.50 % 9.18 % 5/12/2028 1,955,000 1,948,856 1,945,948
Alterra Mountain Company (Intrawest Resort Holdings) Hotel, Gaming & Leisure Term Loan B Add-on Loan 1M USD SOFR+ 3.75 % 0.00 % 9.07 % 5/31/2030 250,000 250,000 250,000
Altisource Solutions S.a r.l. (c) Banking, Finance, Insurance & Real Estate Term Loan B (03/18) Loan 3M USD SOFR+ 5.00 % 1.00 % 10.45 % 4/30/2025 1,110,821 1,110,656 877,549
Altium Packaging LLC Containers, Packaging & Glass Term Loan (01/21) Loan 1M USD SOFR+ 2.75 % 0.50 % 8.19 % 1/29/2028 486,250 484,910 483,819
Amer Sports Oyj (MASCOT BIDCO OY) Consumer goods: Durable USD Term Loan B (01/24) Loan 3M USD SOFR+ 3.25 % 0.00 % 8.58 % 2/7/2031 500,000 497,525 499,375
American Axle & Manufacturing Inc. Automotive Term Loan (12/22) Loan 1M USD SOFR+ 3.50 % 0.50 % 8.92 % 12/13/2029 480,000 467,515 479,798
American Greetings Corporation Media: Advertising, Printing & Publishing Term Loan (01/23) Loan 1M USD SOFR+ 6.00 % 1.00 % 11.33 % 4/5/2028 2,982,733 2,981,076 2,983,478
American Trailer World Corp Automotive Term Loan Loan 1M USD SOFR+ 3.75 % 0.75 % 9.18 % 3/3/2028 1,357,439 1,355,695 1,323,788
AmWINS Group, LLC Banking, Finance, Insurance & Real Estate Term Loan 2/21 Loan 1M USD SOFR+ 2.25 % 0.75 % 7.69 % 2/17/2028 1,940,029 1,924,089 1,930,484
Anastasia Parent LLC Consumer goods: Non-durable Term Loan Loan 3M USD SOFR+ 3.75 % 0.00 % 9.36 % 8/11/2025 947,500 946,257 681,859
Anchor Packaging, LLC Containers, Packaging & Glass Term Loan B Loan 1M USD SOFR+ 3.50 % 0.00 % 8.93 % 7/18/2026 1,959,296 1,939,016 1,955,632
ANI Pharmaceuticals, Inc. Healthcare & Pharmaceuticals Term Loan B Loan 1M USD SOFR+ 6.00 % 0.75 % 11.44 % 11/19/2027 2,940,000 2,901,304 2,940,000
AP Core Holdings II LLC High Tech Industries Term Loan B1 Loan 1M USD SOFR+ 5.50 % 0.75 % 10.94 % 9/1/2027 1,775,000 1,757,513 1,734,317
AP Core Holdings II LLC High Tech Industries Term Loan B2 Loan 1M USD SOFR+ 5.50 % 0.75 % 10.94 % 9/1/2027 500,000 495,081 487,320
APEX GROUP TREASURY LLC Banking, Finance, Insurance & Real Estate Term Loan Loan 3M USD SOFR+ 5.00 % 0.50 % 10.32 % 7/26/2028 495,000 468,246 494,381
Apollo Commercial Real Estate Finance, Inc. Banking, Finance, Insurance & Real Estate Term Loan B Loan 1M USD SOFR+ 2.75 % 0.00 % 8.19 % 5/15/2026 2,908,629 2,890,508 2,857,728
Apollo Commercial Real Estate Finance, Inc. Banking, Finance, Insurance & Real Estate Term Loan B1 (2/21) Loan 1M USD SOFR+ 3.50 % 0.50 % 8.94 % 3/6/2028 972,500 966,275 943,325
AppLovin Corporation High Tech Industries Term Loan (10/21) Loan 1M USD SOFR+ 3.00 % 0.50 % 8.43 % 10/21/2028 1,473,750 1,471,272 1,474,207
AppLovin Corporation High Tech Industries Term Loan (08/23) Loan 1M USD SOFR+ 3.00 % 0.50 % 8.43 % 8/15/2030 969,617 969,617 970,374
AqGen Ascensus, Inc. Banking, Finance, Insurance & Real Estate Term Loan Loan 1M USD SOFR+ 3.50 % 0.50 % 8.94 % 8/2/2028 500,000 496,312 496,375
Aramark Services, Inc. Services: Consumer Term Loan B (4/21) Loan 1M USD SOFR+ 2.50 % 0.00 % 7.94 % 4/1/2028 1,753,715 1,748,558 1,750,436
Aramark Services, Inc. Services: Consumer Term Loan Loan 1M USD SOFR+ 1.75 % 0.00 % 7.19 % 1/15/2027 2,331,250 2,292,785 2,324,699

67

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

February 29, 2024

Issuer Name Industry Asset Name Asset
Type
Reference
Rate/Spread
SOFR/LIBOR Floor Current Rate (All In) Maturity
Date
Principal/
Number of Shares
Cost Fair
Value
ARC FALCON I INC. Chemicals, Plastics, & Rubber Term Loan Loan 1M USD SOFR+ 3.50 % 0.50 % 8.93 % 9/23/2028 981,274 978,810 972,550
Arches Buyer Inc. Services: Consumer Term Loan B Loan 1M USD SOFR+ 3.25 % 0.50 % 8.68 % 12/6/2027 1,469,697 1,463,299 1,405,398
ARCIS GOLF LLC Services: Consumer Term Loan B Loan 1M USD SOFR+ 3.75 % 0.50 % 9.19 % 11/24/2028 497,980 493,335 498,602
Aretec Group, Inc. Banking, Finance, Insurance & Real Estate Term Loan B Loan 1M USD SOFR+ 4.50 % 0.00 % 9.93 % 8/9/2030 2,642,718 2,627,451 2,651,650
Aspire Bakeries Holdings, LLC Beverage, Food & Tobacco Term loan Loan 1M USD SOFR+ 4.25 % 0.00 % 9.57 % 12/13/2030 900,000 891,160 900,000
Asplundh Tree Expert, LLC Services: Business Term Loan 2/21 Loan 1M USD SOFR+ 1.75 % 0.00 % 7.18 % 9/7/2027 967,500 965,030 966,068
AssuredPartners Capital, Inc. Banking, Finance, Insurance & Real Estate Term Loan B (2/20) Loan 1M USD SOFR+ 3.50 % 0.00 % 8.94 % 2/12/2027 979,592 977,377 979,866
Assuredpartners Inc. Banking, Finance, Insurance & Real Estate Term Loan Loan 1M USD SOFR+ 3.50 % 0.50 % 8.83 % 2/12/2027 491,250 490,654 491,250
Assuredpartners Inc. Banking, Finance, Insurance & Real Estate Incremental Term Loan (7/21) Loan 1M USD SOFR+ 3.50 % 0.50 % 8.94 % 2/12/2027 975,000 975,000 975,000
Asurion, LLC Banking, Finance, Insurance & Real Estate Term Loan B10 Loan 1M USD SOFR+ 4.00 % 0.00 % 9.43 % 8/19/2028 1,975,000 1,895,414 1,957,719
Asurion, LLC Banking, Finance, Insurance & Real Estate Term Loan B8 Loan 1M USD SOFR+ 3.25 % 0.00 % 8.69 % 12/18/2026 2,934,604 2,928,879 2,915,442
ATHENAHEALTH GROUP INC. Healthcare & Pharmaceuticals Term Loan B (2/22) Loan 1M USD SOFR+ 3.25 % 0.50 % 8.58 % 2/15/2029 1,317,171 1,313,077 1,304,619
Avolon TLB Borrower 1 (US) LLC Capital Equipment Term Loan B6 Loan 1M USD SOFR+ 2.00 % 0.00 % 7.32 % 6/22/2028 1,483,750 1,429,872 1,483,038
Axalta Coating Systems US Holdings Chemicals, Plastics, & Rubber Term Loan B (08/23) Loan 3M USD SOFR+ 2.50 % 0.50 % 7.85 % 12/20/2029 867,888 860,595 868,183
AZURITY PHARMACEUTICALS, INC. Healthcare & Pharmaceuticals Term Loan B Loan 1M USD SOFR+ 6.62 % 0.75 % 12.06 % 9/20/2027 450,000 440,909 445,500
B&G Foods, Inc. Beverage, Food & Tobacco Term Loan Loan 1M USD SOFR+ 2.50 % 0.00 % 7.83 % 10/10/2026 556,042 553,804 553,540
BAKELITE UK INTERMEDIATE LTD. Chemicals, Plastics, & Rubber Term Loan Loan 3M USD SOFR+ 4.00 % 0.50 % 9.50 % 5/29/2029 985,000 981,238 980,075
Baldwin Risk Partners, LLC Banking, Finance, Insurance & Real Estate Term Loan Loan 1M USD SOFR+ 3.50 % 0.50 % 8.94 % 10/14/2027 1,960,048 1,946,212 1,946,171
Barnes Group Inc. Aerospace & Defense Term Loan B Loan 1M USD SOFR+ 3.00 % 0.00 % 8.43 % 8/9/2030 249,375 247,649 249,500
Bausch Health Companies Inc. Healthcare & Pharmaceuticals Term Loan B (1/22) Loan 1M USD SOFR+ 5.25 % 0.50 % 10.67 % 2/1/2027 1,850,000 1,710,365 1,465,552
Belfor Holdings Inc. Services: Consumer Term Loan B-1 (11/23) Loan 1M USD SOFR+ 3.75 % 0.50 % 9.08 % 10/25/2030 1,600,000 1,584,928 1,602,000
Belron Finance US LLC Automotive Term Loan B Loan 3M USD SOFR+ 2.00 % 0.50 % 7.58 % 4/13/2028 1,945,000 1,945,000 1,943,172
Belron Finance US LLC Automotive Term Loan B Loan 3M USD SOFR+ 2.25 % 0.50 % 7.66 % 4/18/2029 248,750 248,750 248,544
Bengal Debt Merger Sub LLC Beverage, Food & Tobacco Term Loan Loan 3M USD SOFR+ 3.25 % 0.50 % 8.70 % 1/24/2029 1,970,000 1,969,251 1,852,785
Blackstone Mortgage Trust, Inc. Banking, Finance, Insurance & Real Estate Term Loan (6/21) Loan 1M USD SOFR+ 2.75 % 0.50 % 8.19 % 4/23/2026 1,450,228 1,444,650 1,439,352
Blackstone Mortgage Trust, Inc. Banking, Finance, Insurance & Real Estate Term Loan B Loan 1M USD SOFR+ 2.25 % 0.00 % 7.69 % 4/23/2026 969,620 966,168 962,348
Blue Tree Holdings, Inc. Chemicals, Plastics, & Rubber Term Loan (2/21) Loan 3M USD SOFR+ 2.50 % 0.00 % 8.11 % 3/4/2028 972,500 971,083 967,229

68

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

February 29, 2024

Issuer Name Industry Asset Name Asset
Type
Reference
Rate/Spread
SOFR/LIBOR Floor Current Rate (All In) Maturity
Date
Principal/
Number of Shares
Cost Fair
Value
Bombardier Recreational Products, Inc. Consumer goods: Durable Term Loan Loan 1M USD SOFR+ 2.75 % 0.00 % 8.08 % 1/22/2031 1,440,189 1,436,033 1,437,942
Bombardier Recreational Products, Inc. Consumer goods: Durable Term Loan B3 Loan 1M USD SOFR+ 2.75 % 0.50 % 8.18 % 12/13/2029 493,769 482,991 493,833
Boost Newco Borrower, LLC (Worldpay) Banking, Finance, Insurance & Real Estate Term Loan B Loan 1M USD SOFR+ 3.00 % 0.50 % 8.33 % 1/31/2031 500,000 497,629 501,460
Boxer Parent Company, Inc. High Tech Industries Term Loan USD (11/23) Loan 1M USD SOFR+ 4.25 % 0.00 % 9.58 % 12/29/2028 1,012,255 1,007,334 1,015,018
BrightSpring Health Services (Phoenix Guarantor) Healthcare & Pharmaceuticals Term Loan (02/24) Loan 1M USD SOFR+ 3.25 % 0.00 % 8.58 % 2/21/2031 972,500 972,500 961,355
BroadStreet Partners, Inc. Banking, Finance, Insurance & Real Estate Term Loan B3 Loan 1M USD SOFR+ 3.00 % 0.00 % 8.44 % 1/22/2027 2,918,464 2,915,588 2,913,007
Brookfield WEC Holdings Inc. Energy: Electricity Term Loan B Loan 1M USD SOFR+ 2.75 % 0.00 % 8.08 % 1/17/2031 1,447,688 1,447,688 1,442,028
BROWN GROUP HOLDING, LLC Aerospace & Defense Term Loan B-2 Loan 1M USD SOFR+ 3.00 % 0.00 % 8.33 % 7/1/2029 493,750 483,706 492,856
Buckeye Partners, L.P. Utilities: Oil & Gas Term Loan B2 Loan 1M USD SOFR+ 2.50 % 0.00 % 7.83 % 11/15/2030 333,333 332,779 333,393
Buckeye Partners, L.P. Utilities: Oil & Gas Term Loan  B 3 Loan 1M USD SOFR+ 2.00 % 0.00 % 7.33 % 11/1/2026 1,595,639 1,589,524 1,595,910
BW Gas & Convenience Holdings LLC Beverage, Food & Tobacco Term Loan B Loan 1M USD SOFR+ 3.50 % 0.50 % 8.94 % 3/31/2028 2,437,500 2,421,791 2,400,938
Callaway Golf Company Retail Term Loan B Loan 1M USD SOFR+ 3.50 % 0.00 % 8.93 % 3/16/2030 496,250 491,660 496,200
Calpine Corporation Utilities: Electric Term Loan B-10 (01/20) Loan 3M USD LIBOR+ 2.00 % 0.00 % 3.87 % 8/12/2026 2,000,000 1,990,000 1,983,760
Camping World, Inc. Retail Term Loan B (5/21) Loan 1M USD SOFR+ 2.50 % 0.75 % 7.94 % 6/5/2028 2,462,025 2,277,630 2,401,238
CAPSTONE BORROWER INC Services: Business Term Loan (06/23) Loan 3M USD SOFR+ 3.75 % 0.00 % 9.10 % 6/15/2030 998,077 984,312 993,396
CareerBuilder, LLC Services: Business Term Loan B3 Loan 3M USD SOFR+ 6.75 % 0.00 % 12.36 % 7/31/2026 3,930,582 3,912,784 589,587
Castle US Holding Corporation Media: Advertising, Printing & Publishing Term Loan B (USD) Loan 3M USD SOFR+ 3.75 % 0.00 % 9.35 % 1/27/2027 1,946,639 1,939,553 1,354,627
CASTLELAKE AVIATION LLC Aerospace & Defense Term Loan B Loan 3M USD SOFR+ 2.75 % 0.50 % 8.40 % 10/21/2027 990,000 983,747 989,228
Catalent Pharma Solutions, Inc. Healthcare & Pharmaceuticals Term Loan B4 Loan 1M USD SOFR+ 3.00 % 0.50 % 8.32 % 2/22/2028 600,000 595,597 601,500
Catalent Pharma Solutions, Inc. Healthcare & Pharmaceuticals Term Loan B3 (2/21) Loan 1M USD SOFR+ 2.00 % 0.50 % 7.43 % 2/22/2028 598,462 587,525 597,588
CBL & Associates Limited Partnership Retail Term Loan 11/21 Loan 1M USD SOFR+ 2.75 % 1.00 % 8.19 % 11/1/2025 2,464,605 2,167,043 2,214,029
CCC Intelligent Solutions Inc. Services: Business Term Loan B Loan 1M USD SOFR+ 2.25 % 0.50 % 7.69 % 9/16/2028 245,000 244,633 244,030
CCI Buyer, Inc Telecommunications Term Loan Loan 3M USD SOFR+ 4.00 % 0.75 % 9.35 % 12/17/2027 243,125 241,678 241,195
CCRR Parent, Inc. Healthcare & Pharmaceuticals Term Loan Loan 1M USD SOFR+ 4.25 % 0.50 % 9.68 % 3/5/2028 990,000 949,452 920,700
CCRR Parent, Inc. Healthcare & Pharmaceuticals Term Loan B Loan 1M USD SOFR+ 3.75 % 0.75 % 9.19 % 3/5/2028 972,500 969,580 866,741
CCS-CMGC Holdings, Inc. Healthcare & Pharmaceuticals Term Loan Loan 1M USD SOFR+ 5.50 % 0.00 % 10.83 % 9/25/2025 2,375,000 2,368,777 1,863,520
CDK GLOBAL, INC. High Tech Industries Term Loan B (10/23) Loan 3M USD SOFR+ 4.00 % 0.00 % 9.35 % 7/6/2029 992,500 967,482 994,406

69

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

February 29, 2024

Issuer Name Industry Asset Name Asset
Type
Reference
Rate/Spread
SOFR/LIBOR Floor Current Rate (All In) Maturity
Date
Principal/
Number of Shares
Cost Fair
Value
Cengage Learning, Inc. Media: Advertising, Printing & Publishing Term Loan B (6/21) Loan 3M USD SOFR+ 4.75 % 1.00 % 10.33 % 7/14/2026 2,932,500 2,917,832 2,930,682
CENTURI GROUP, INC. Construction & Building Term Loan B Loan 1M USD SOFR+ 2.50 % 0.50 % 7.94 % 8/27/2028 868,330 862,415 868,191
CenturyLink, Inc. Telecommunications Term Loan B (1/20) Loan 1M USD SOFR+ 2.25 % 0.00 % 7.69 % 3/15/2027 3,838,165 3,835,627 2,781,480
Charlotte Buyer, Inc. Services: Business Term Loan B Loan 1M USD SOFR+ 5.25 % 0.50 % 10.57 % 2/11/2028 1,485,000 1,404,122 1,487,866
Chemours Company, (The) Chemicals, Plastics, & Rubber Term Loan B2 Loan 1M USD SOFR+ 3.50 % 0.50 % 8.83 % 8/10/2028 2,393,717 2,355,365 2,345,842
Churchill Downs Incorporated Hotel, Gaming & Leisure Term Loan B1 (3/21) Loan 1M USD SOFR+ 2.00 % 0.00 % 7.43 % 3/17/2028 486,250 485,591 485,642
CIMPRESS PUBLIC LIMITED COMPANY Media: Advertising, Printing & Publishing USD Term Loan Loan 1M USD SOFR+ 3.50 % 0.50 % 8.94 % 5/17/2028 1,959,849 1,885,810 1,951,676
CITADEL SECURITIES LP Banking, Finance, Insurance & Real Estate Term Loan B (01/24) Loan 1M USD SOFR+ 2.25 % 0.00 % 7.58 % 7/29/2030 4,863,365 4,862,868 4,857,286
Citco Funding LLC Banking, Finance, Insurance & Real Estate Term Loa 1st Lien Incremental Loan 3M USD SOFR+ 3.25 % 0.50 % 8.57 % 4/27/2028 997,500 992,828 997,919
Clarios Global LP Automotive Term Loan (12/23) Loan 1M USD SOFR+ 3.00 % 0.00 % 8.33 % 5/6/2030 1,197,000 1,191,616 1,196,629
Claros Mortgage Trust, Inc Banking, Finance, Insurance & Real Estate Term Loan B-1 (11/21) Loan 1M USD SOFR+ 4.50 % 0.50 % 9.92 % 8/9/2026 3,404,430 3,390,583 3,132,076
CLYDESDALE ACQUISITION HOLDINGS, INC. Containers, Packaging & Glass Term Loan B Loan 1M USD SOFR+ 3.68 % 0.50 % 9.10 % 4/13/2029 1,477,500 1,448,088 1,475,343
Columbus McKinnon Corporation Capital Equipment Term Loan (4/21) Loan 3M USD SOFR+ 2.75 % 0.50 % 8.39 % 5/14/2028 406,951 406,326 407,207
Conduent, Inc. Services: Business Term Loan B Loan 1M USD SOFR+ 4.25 % 0.50 % 9.69 % 10/16/2028 2,762,330 2,701,073 2,702,470
Connect Finco SARL Telecommunications Term Loan (1/21) Loan 1M USD SOFR+ 3.50 % 1.00 % 8.83 % 12/11/2026 2,887,500 2,809,993 2,882,678
Consolidated Communications, Inc. Telecommunications Term Loan B Loan 1M USD SOFR+ 3.50 % 0.75 % 8.94 % 10/2/2027 2,714,005 2,553,865 2,544,379
CORAL-US CO-BORROWER LLC Telecommunications Term Loan B-5 Loan 1M USD SOFR+ 2.25 % 0.00 % 7.68 % 1/31/2028 4,000,000 3,990,860 3,950,000
Corelogic, Inc. Services: Business Term Loan (4/21) Loan 1M USD SOFR+ 3.50 % 0.50 % 8.94 % 6/2/2028 2,443,750 2,436,006 2,372,344
Cortes NP Acquisition Corp (Vertiv) Capital Equipment Term Loan B (12/23) Loan 1M USD SOFR+ 2.50 % 0.00 % 7.94 % 3/2/2027 1,940,138 1,940,138 1,941,903
Creative Artists Agency, LLC Media: Diversified & Production Term Loan B (02/23) Loan 1M USD SOFR+ 3.50 % 0.00 % 8.83 % 11/27/2028 1,588,004 1,577,748 1,588,449
CROCS INC Consumer goods: Durable Term Loan B (01/24) Loan 1M USD SOFR+ 2.25 % 0.50 % 7.58 % 2/19/2029 1,230,000 1,190,854 1,230,923
Cross Financial Corp Banking, Finance, Insurance & Real Estate Term Loan B2 Loan 1M USD SOFR+ 3.50 % 0.75 % 8.83 % 9/15/2027 487,500 487,355 486,891
Crown Subsea Communications Holding, Inc. Construction & Building Term Loan B (01/24) Loan 3M USD SOFR+ 4.75 % 0.75 % 10.07 % 1/30/2031 2,400,000 2,376,371 2,409,000
CSC Holdings LLC (Neptune Finco Corp.) Media: Broadcasting & Subscription Term Loan B-5 Loan 1M USD LIBOR+ 2.50 % 0.00 % 7.93 % 4/15/2027 480,000 480,000 448,277
CSC Holdings LLC (Neptune Finco Corp.) Media: Broadcasting & Subscription Term Loan 12/22 Loan 1M USD SOFR+ 4.50 % 0.00 % 9.82 % 4/15/2027 2,376,032 2,368,120 2,307,222
CTC Holdings, LP Banking, Finance, Insurance & Real Estate Term Loan B Loan 3M USD SOFR+ 5.00 % 0.50 % 10.48 % 2/15/2029 2,210,625 2,165,966 2,194,045
CTS Midco, LLC High Tech Industries Term Loan B Loan 3M USD SOFR+ 6.00 % 1.00 % 11.57 % 11/2/2027 1,937,017 1,903,074 1,830,481

70

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

February 29, 2024

Issuer Name Industry Asset Name Asset
Type
Reference
Rate/Spread
SOFR/LIBOR Floor Current Rate (All In) Maturity
Date
Principal/
Number of Shares
Cost Fair
Value
Daseke Inc Transportation: Cargo Term Loan 2/21 Loan 1M USD SOFR+ 4.00 % 0.75 % 9.44 % 3/5/2028 1,162,500 1,159,080 1,162,860
Dave & Buster’s Inc. Hotel, Gaming & Leisure Term Loan B (1/24) Loan 1M USD SOFR+ 3.25 % 0.50 % 8.63 % 6/29/2029 990,019 949,041 990,791
DCert Buyer, Inc. High Tech Industries Term Loan Loan 1M USD SOFR+ 4.00 % 0.00 % 9.33 % 10/16/2026 1,454,660 1,454,660 1,442,426
Delek US Holdings, Inc. Utilities: Oil & Gas Term Loan B (11/22) Loan 1M USD SOFR+ 3.50 % 0.50 % 8.93 % 11/16/2029 5,346,000 5,244,974 5,325,952
Delos Aircraft DAC Transportation: Consumer Term Loan B Loan 3M USD SOFR+ 2.00 % 0.00 % 7.35 % 10/31/2027 250,000 250,000 250,438
Delta 2 Lux Sarl Hotel, Gaming & Leisure Term Loan B Loan 3M USD SOFR+ 2.25 % 0.50 % 7.60 % 1/15/2030 2,000,000 1,991,389 1,997,000
Derby Buyer LLC Chemicals, Plastics, & Rubber Term Loan (09/23) Loan 1M USD SOFR+ 4.25 % 0.50 % 9.58 % 11/1/2030 625,000 616,061 625,394
DexKo Global, Inc. (Dragon Merger) Automotive Term Loan (9/21) Loan 3M USD SOFR+ 3.75 % 0.50 % 9.36 % 10/4/2028 982,500 979,722 978,206
DG Investment Intermediate Holdings 2, Inc. Aerospace & Defense Incremental Term Loan (3/22) Loan 1M USD SOFR+ 4.75 % 0.75 % 10.08 % 3/31/2028 493,750 477,680 492,051
Diamond Sports Group, LLC Media: Broadcasting & Subscription 1st Priority Term Loan Loan 1M USD SOFR+ 10.00 % 1.00 % 15.43 % 5/25/2026 152,224 149,462 146,896
DIRECTV FINANCING, LLC Media: Broadcasting & Subscription Term Loan Loan 3M USD SOFR+ 5.25 % 0.75 % 10.83 % 8/2/2029 3,190,000 3,169,423 3,181,036
DISCOVERY PURCHASER CORPORATION Chemicals, Plastics, & Rubber Term Loan Loan 3M USD SOFR+ 4.38 % 0.50 % 9.71 % 10/4/2029 1,485,028 1,383,712 1,476,207
Dispatch Acquisition Holdings, LLC Environmental Industries Term Loan B (3/21) Loan 3M USD SOFR+ 4.25 % 0.75 % 9.75 % 3/25/2028 487,500 484,443 452,463
DOMTAR CORPORATION Forest Products & Paper Term Loan 9/21 Loan 1M USD SOFR+ 5.50 % 0.75 % 10.94 % 11/30/2028 3,243,968 3,187,785 3,163,874
DOTDASH MEREDITH, INC. Media: Advertising, Printing & Publishing Term Loan B Loan 1M USD SOFR+ 4.00 % 0.50 % 9.43 % 11/30/2028 1,974,747 1,809,468 1,955,000
DRI HOLDING INC. Media: Advertising, Printing & Publishing Term Loan (12/21) Loan 1M USD SOFR+ 5.25 % 0.50 % 10.68 % 12/15/2028 3,932,462 3,808,999 3,605,596
DRW Holdings, LLC Banking, Finance, Insurance & Real Estate Term Loan (2/21) Loan 1M USD SOFR+ 3.75 % 0.00 % 9.19 % 3/1/2028 6,370,000 6,338,820 6,354,075
DTZ U.S. Borrower, LLC Construction & Building Term Loan Loan 1M USD SOFR+ 2.75 % 0.00 % 8.19 % 8/21/2025 198,929 198,685 198,432
DTZ U.S. Borrower, LLC Construction & Building Term Loan (01/23) Loan 1M USD SOFR+ 3.25 % 0.50 % 8.68 % 1/31/2030 2,024,241 2,022,091 1,999,788
DTZ U.S. Borrower, LLC Construction & Building Term Loan (08/23) Loan 1M USD SOFR+ 4.00 % 0.50 % 9.33 % 1/31/2030 1,100,000 1,074,202 1,097,250
EAB Global, Inc. Services: Business Term Loan (08/21) Loan 1M USD SOFR+ 3.50 % 0.50 % 8.94 % 8/16/2028 980,000 976,771 977,344
Echo Global Logistics, Inc. Services: Business Term Loan Loan 1M USD SOFR+ 3.50 % 0.50 % 8.93 % 11/23/2028 1,965,000 1,962,209 1,926,761
Edelman Financial Group Inc., The Banking, Finance, Insurance & Real Estate Term Loan B (3/21) Loan 1M USD SOFR+ 3.50 % 0.75 % 8.94 % 4/7/2028 2,166,328 2,161,731 2,158,616
Electrical Components Inter., Inc. Capital Equipment Term Loan (6/18) Loan 1M USD SOFR+ 4.25 % 0.00 % 9.68 % 6/26/2025 1,868,421 1,868,421 1,861,415
ELECTRON BIDCO INC. Healthcare & Pharmaceuticals Term Loan Loan 1M USD SOFR+ 3.00 % 0.50 % 8.44 % 11/1/2028 491,250 489,769 490,253
ELO Touch Solutions, Inc. Media: Diversified & Production Term Loan (12/18) Loan 1M USD SOFR+ 6.50 % 0.00 % 11.94 % 12/14/2025 2,522,373 2,488,308 2,485,798
Embecta Corp Healthcare & Pharmaceuticals Term Loan B Loan 1M USD SOFR+ 3.00 % 0.50 % 8.33 % 3/30/2029 2,598,596 2,581,552 2,366,360

71

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

February 29, 2024

Issuer Name Industry Asset Name Asset
Type
Reference
Rate/Spread
SOFR/LIBOR Floor Current Rate (All In) Maturity
Date
Principal/
Number of Shares
Cost Fair
Value
Emerson Climate Technologies Inc Services: Business Term Loan B (04/23) Loan 1M USD SOFR+ 2.50 % 0.00 % 7.79 % 5/31/2030 1,000,000 995,376 997,250
Endo Luxembourg Finance Company I S.a.r.l. Healthcare & Pharmaceuticals Term Loan (3/21) Loan Prime 6.00 % 0.75 % 14.50 % 3/27/2028 2,335,285 2,330,451 1,522,606
Endure Digital, Inc. High Tech Industries Term Loan B Loan 6M USD SOFR+ 3.50 % 0.75 % 9.42 % 2/10/2028 2,437,500 2,430,093 2,380,048
Entain Holdings (Gibraltar) Limited Hotel, Gaming & Leisure Term Loan B (10/22) Loan 3M USD SOFR+ 3.50 % 0.50 % 8.95 % 10/30/2029 1,487,496 1,472,128 1,489,355
EOS U.S. FINCO LLC Transportation: Cargo Term Loan Loan 3M USD SOFR+ 5.75 % 0.50 % 11.10 % 10/6/2029 975,000 908,088 871,104
Equiniti Group PLC Services: Business Term Loan B Loan 6M USD SOFR+ 4.50 % 0.50 % 9.93 % 12/11/2028 980,000 973,017 981,470
Evertec Group LLC Banking, Finance, Insurance & Real Estate Term Loan B (09/23) Loan 1M USD SOFR+ 3.50 % 0.50 % 8.83 % 10/30/2030 1,125,000 1,108,675 1,123,594
EyeCare Partners, LLC Healthcare & Pharmaceuticals Term Loan Loan 3M USD SOFR+ 3.75 % 0.00 % 9.39 % 2/18/2027 - 1,951 -
Fiesta Purchaser, Inc. Beverage, Food & Tobacco First Lien TLB Loan 1M USD SOFR+ 4.00 % 0.00 % 9.32 % 2/12/2031 500,000 495,088 499,315
Finco I LLC Banking, Finance, Insurance & Real Estate Term Loan B (08/23) Loan 3M USD SOFR+ 3.00 % 0.00 % 8.31 % 6/27/2029 2,816,795 2,813,980 2,815,386
First Brands Group, LLC Automotive 1st Lien Term Loan (3/21) Loan 3M USD SOFR+ 5.00 % 1.00 % 10.57 % 3/30/2027 4,862,500 4,816,997 4,868,578
First Eagle Investment Management Banking, Finance, Insurance & Real Estate Refinancing Term Loan Loan 3M USD SOFR+ 2.50 % 0.00 % 7.95 % 2/1/2027 5,091,652 5,082,259 5,068,332
First Student Bidco Inc. Transportation: Consumer Term Loan B Loan 3M USD SOFR+ 3.00 % 0.50 % 8.61 % 7/21/2028 715,360 711,800 709,694
First Student Bidco Inc. Transportation: Consumer Term Loan C Loan 3M USD SOFR+ 3.00 % 0.50 % 8.61 % 7/21/2028 216,966 215,877 215,248
Fitness International, LLC (LA Fitness) Services: Consumer Term Loan  B (1/24) Loan 1M USD SOFR+ 5.25 % 1.00 % 10.58 % 2/5/2029 1,200,000 1,164,361 1,165,500
Flutter Financing B.V. Hotel, Gaming & Leisure Third Amendment 2028-B Term Loan Loan 3M USD SOFR+ 3.25 % 0.50 % 8.86 % 7/21/2028 309,759 304,101 310,103
Flutter Financing B.V. Hotel, Gaming & Leisure Term Loan B3 (11/23) Loan 3M USD SOFR+ 2.25 % 0.50 % 7.70 % 11/25/2030 3,000,000 2,992,850 2,984,370
FOCUS FINANCIAL PARTNERS, LLC Banking, Finance, Insurance & Real Estate Term Loan B7 Loan 1M USD SOFR+ 2.75 % 0.50 % 8.08 % 6/30/2028 1,472,388 1,458,275 1,461,345
Franchise Group, Inc. Services: Consumer First Out Term Loan Loan 6M USD SOFR+ 4.75 % 0.75 % 10.36 % 3/10/2026 799,104 795,310 703,211
Franchise Group, Inc. Services: Consumer Term Loan B Loan 3M USD SOFR+ 4.75 % 0.75 % 10.33 % 3/10/2026 2,977,500 2,874,281 2,612,756
Franklin Square Holdings, L.P. Banking, Finance, Insurance & Real Estate Term Loan Loan 1M USD SOFR+ 2.25 % 0.00 % 7.68 % 8/1/2025 4,263,723 4,255,884 4,258,394
Froneri International (R&R Ice Cream) Beverage, Food & Tobacco Term Loan B-2 Loan 1M USD SOFR+ 2.25 % 0.00 % 7.68 % 1/29/2027 1,930,000 1,928,989 1,928,340
Garrett LX III S.a r.l. Automotive Dollar Term Loan Loan 3M USD SOFR+ 3.25 % 0.50 % 8.82 % 4/30/2028 1,466,250 1,461,820 1,465,634
Gemini HDPE LLC Chemicals, Plastics, & Rubber Term Loan B (12/20) Loan 3M USD SOFR+ 3.00 % 0.50 % 8.57 % 12/31/2027 2,183,488 2,172,849 2,163,466
Genesee & Wyoming, Inc. Transportation: Cargo Term Loan (11/19) Loan 3M USD SOFR+ 2.00 % 0.00 % 7.45 % 12/30/2026 1,443,750 1,440,683 1,443,577
GGP Inc. Banking, Finance, Insurance & Real Estate Term Loan B Loan 1M USD LIBOR+ 2.50 % 0.00 % 2.96 % 8/27/2025 2,781,634 2,604,347 2,766,864

72

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

February 29, 2024

Issuer Name Industry Asset Name Asset
Type
Reference
Rate/Spread
SOFR/LIBOR Floor Current Rate (All In) Maturity
Date
Principal/
Number of Shares
Cost Fair
Value
GIP Pilot Acquisition Partners, L.P. Energy: Oil & Gas Term Loan Loan 3M USD SOFR+ 3.00 % 0.00 % 8.33 % 10/4/2030 500,000 497,577 499,585
Global Tel*Link Corporation Telecommunications Term Loan B Loan 1M USD SOFR+ 4.25 % 0.00 % 9.68 % 11/29/2025 4,846,612 4,750,154 4,708,290
Go Daddy Operating Company, LLC High Tech Industries Term Loan 2/21 Loan 1M USD SOFR+ 2.00 % 0.00 % 7.44 % 8/10/2027 947,411 947,411 946,984
GOLDEN WEST PACKAGING GROUP LLC Forest Products & Paper Term Loan (11/21) Loan 1M USD SOFR+ 5.25 % 0.75 % 10.69 % 12/1/2027 1,875,000 1,862,167 1,556,250
GOTO GROUP, INC. High Tech Industries First Lien Term Loan Loan 1M USD SOFR+ 4.75 % 0.00 % 10.17 % 4/30/2028 1,254,792 730,596 1,198,326
GOTO GROUP, INC. High Tech Industries Second-Out Term Loan (02/24) Loan 1M USD SOFR+ 4.75 % 0.00 % 10.17 % 4/30/2028 1,732,808 1,646,943 1,199,970
Graham Packaging Co Inc Containers, Packaging & Glass Term Loan (2/21) Loan 1M USD SOFR+ 3.00 % 0.75 % 8.44 % 8/7/2027 945,831 942,144 944,554
Great Outdoors Group, LLC Retail Term Loan B2 Loan 1M USD SOFR+ 3.75 % 0.75 % 9.19 % 3/6/2028 970,169 967,400 969,994
Griffon Corporation Consumer goods: Durable Term Loan B Loan 3M USD SOFR+ 2.25 % 0.50 % 7.75 % 1/24/2029 144,063 143,842 143,838
Grosvenor Capital Management Holdings, LLLP Banking, Finance, Insurance & Real Estate Amendment 5 Term Loan Loan 1M USD SOFR+ 2.50 % 0.50 % 7.94 % 2/24/2028 2,807,931 2,806,739 2,807,061
Groupe Solmax Inc. Environmental Industries Term Loan (6/21) Loan 3M USD SOFR+ 4.75 % 0.75 % 10.36 % 5/27/2028 2,473,405 2,125,105 2,402,740
GYP HOLDINGS III CORP. Construction & Building Term Loan  (1/24) Loan 1M USD SOFR+ 2.25 % 0.00 % 7.58 % 5/12/2030 249,375 248,230 249,375
Harbor Freight Tools USA, Inc. Retail Term Loan B (06/21) Loan 1M USD SOFR+ 2.75 % 0.50 % 8.19 % 10/19/2027 3,344,665 3,330,419 3,319,212
Helix Gen Funding, LLc Energy: Electricity Term Loan Loan 3M USD SOFR+ 4.75 % 1.00 % 10.10 % 12/31/2027 932,597 915,944 933,763
Hertz Corporation (The) Transportation: Consumer Term Loan B Loan 1M USD SOFR+ 3.75 % 0.00 % 9.07 % 6/30/2028 500,000 490,436 481,875
Hillman Group Inc. (The) (New) Consumer goods: Durable Term Loan B-1 (2/21) Loan 1M USD SOFR+ 2.75 % 0.50 % 8.19 % 7/14/2028 3,172,373 3,168,887 3,167,266
Hilton Domestic Operating Company Inc. Hotel, Gaming & Leisure Term Loan B 4 Loan 1M USD SOFR+ 2.00 % 0.00 % 7.42 % 11/8/2030 1,500,000 1,496,471 1,501,020
Hilton Grand Vacations Borrower LLC Hotel, Gaming & Leisure Term Loan (3/21) Loan 1M USD SOFR+ 2.75 % 0.50 % 8.19 % 8/2/2028 497,455 497,455 496,834
Hilton Grand Vacations Borrower LLC Hotel, Gaming & Leisure Term Loan B Loan 1M USD SOFR+ 2.75 % 0.00 % 8.18 % 8/2/2028 500,000 500,000 499,375
HLF Financing SARL (Herbalife) Consumer goods: Non-durable Term Loan B (08/18) Loan 1M USD SOFR+ 2.50 % 0.00 % 7.94 % 8/18/2025 3,116,400 3,113,557 3,044,598
Holley Purchaser, Inc Automotive Term Loan (11/21) Loan 1M USD SOFR+ 3.75 % 0.75 % 9.19 % 11/17/2028 2,254,003 2,247,557 2,188,795
Hudson River Trading LLC Banking, Finance, Insurance & Real Estate Term Loan (3/21) Loan 1M USD SOFR+ 3.00 % 0.00 % 8.44 % 3/17/2028 5,835,000 5,798,864 5,792,171
Hunter Douglas Inc Consumer goods: Durable Term Loan B-1 Loan 3M USD SOFR+ 3.50 % 0.50 % 8.82 % 2/26/2029 2,474,937 2,235,702 2,442,466
Hyperion Refinance S.a.r.l. Banking, Finance, Insurance & Real Estate Term Loan B Loan 3M USD SOFR+ 3.50 % 0.50 % 8.81 % 2/15/2031 3,000,000 2,985,024 2,983,440
Idera, Inc. High Tech Industries Term Loan (02/21) Loan 3M USD SOFR+ 3.75 % 0.75 % 9.21 % 3/2/2028 4,762,143 4,756,197 4,730,379
IMA Financial Group, Inc. Banking, Finance, Insurance & Real Estate Term Loan (10/21) Loan 1M USD SOFR+ 3.75 % 0.50 % 9.19 % 11/1/2028 2,458,728 2,449,919 2,452,581
INDY US BIDCO, LLC Services: Business Term Loan (11/21) Loan 1M USD SOFR+ 3.75 % 0.00 % 9.08 % 3/6/2028 2,193,266 2,192,568 2,119,243
INEOS 226 Ltd. Chemicals, Plastics, & Rubber Term Loan 3/23 Loan 1M USD SOFR+ 3.75 % 0.00 % 9.18 % 3/13/2030 497,500 492,907 490,450

73

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

February 29, 2024

Issuer Name Industry Asset Name Asset
Type
Reference
Rate/Spread
SOFR/LIBOR Floor Current Rate (All In) Maturity
Date
Principal/
Number of Shares
Cost Fair
Value
Ineos US Finance LLC Chemicals, Plastics, & Rubber Term Loan C Loan 1M USD SOFR+ 3.50 % 0.00 % 8.93 % 2/18/2030 995,000 985,838 985,259
INEOS US PETROCHEM LLC Chemicals, Plastics, & Rubber Term Loan B Loan 1M USD SOFR+ 4.25 % 0.00 % 9.68 % 4/2/2029 2,714,874 2,657,733 2,667,363
Informatica Inc. High Tech Industries Term Loan B (10/21) Loan 1M USD SOFR+ 2.75 % 0.00 % 8.19 % 10/27/2028 491,250 491,064 491,250
Ingram Micro Inc. Wholesale Term Loan (09/23) Loan 3M USD SOFR+ 3.00 % 0.50 % 8.61 % 6/30/2028 1,095,000 1,087,525 1,093,631
Inmar, Inc. Services: Business Term Loan (06/23) Loan 1M USD SOFR+ 5.50 % 1.00 % 10.83 % 5/1/2026 3,333,250 3,240,468 3,305,117
Innophos, Inc. Chemicals, Plastics, & Rubber Term Loan B Loan 1M USD SOFR+ 3.25 % 0.00 % 8.58 % 2/4/2027 481,250 480,346 475,475
INSTANT BRANDS HOLDINGS INC. Consumer goods: Durable Instant Brands TL Loan Prime 4.00 % 0.75 % 14.50 % 4/7/2028 10,085 10,085 10,085
INSTANT BRANDS HOLDINGS INC. (b) Consumer goods: Durable Term Loan 4/21 Loan Prime 4.00 % 0.75 % 14.50 % 4/7/2028 3,942,576 3,929,234 256,267
INSTANT BRANDS HOLDINGS INC. (c) Consumer goods: Durable PIK DIP Term Loan Loan 1M USD SOFR+ 3.00 % 1.00 % 15.45 % 1/31/2024 1,523,653 1,523,115 1,557,935
IRB Holding Corporation Beverage, Food & Tobacco Term Loan B Loan 1M USD SOFR+ 2.75 % 0.75 % 8.18 % 12/15/2027 494,962 490,830 494,101
Isagenix International, LLC (c) Beverage, Food & Tobacco Term Loan Loan 6M USD SOFR+ 2.50 % 0.00 % 2.50 % 4/13/2028 1,258,790 838,779 1,082,559
Isolved Inc. Services: Business Term Loan Loan 6M USD SOFR+ 4.00 % 0.50 % 9.48 % 10/5/2030 625,000 618,886 626,563
Jane Street Group Banking, Finance, Insurance & Real Estate Term Loan Loan 1M USD SOFR+ 2.50 % 0.00 % 7.94 % 1/26/2028 3,880,000 3,878,565 3,869,602
Journey Personal Care Corp. Consumer goods: Non-durable Term Loan B Loan 1M USD SOFR+ 4.25 % 0.75 % 9.69 % 3/1/2028 2,925,000 2,876,836 2,850,647
JP Intermediate B, LLC Consumer goods: Non-durable Term Loan 7/23 Loan 3M USD SOFR+ 5.50 % 1.00 % 11.07 % 11/20/2027 3,456,884 3,442,560 276,551
Kleopatra Finco S.a r.l. Containers, Packaging & Glass Term Loan (1/21) (USD) Loan 6M USD SOFR+ 4.73 % 0.50 % 10.27 % 2/12/2026 1,458,750 1,456,824 1,400,400
Kodiak BP, LLC Construction & Building Term Loan Loan 3M USD SOFR+ 3.25 % 0.75 % 8.86 % 3/13/2028 486,159 485,291 485,211
Koppers Inc Chemicals, Plastics, & Rubber Term Loan B Loan 1M USD SOFR+ 3.50 % 0.50 % 8.93 % 4/10/2030 995,006 967,558 998,121
KREF Holdings X LLC Banking, Finance, Insurance & Real Estate Term Loan (11/21) Loan 1M USD SOFR+ 3.50 % 0.50 % 8.93 % 9/1/2027 486,325 479,475 464,440
Lakeland Tours, LLC (c) Hotel, Gaming & Leisure Holdco Fixed Term Loan Loan Fixed 0.00 % 0.00 % 8.00 % 9/27/2027 1,127,568 568,253 761,108
Lealand Finance Company B.V. (c) Energy: Oil & Gas Exit Term Loan Loan 1M USD SOFR+ 1.00 % 0.00 % 6.44 % 6/30/2025 355,751 355,751 138,149
LHS BORROWER, LLC Construction & Building Term Loan (02/22) Loan 1M USD SOFR+ 4.75 % 0.50 % 10.18 % 2/16/2029 2,475,771 2,084,045 2,310,216
Lifetime Brands, Inc Consumer goods: Non-durable Term Loan Loan 1M USD SOFR+ 5.50 % 1.00 % 10.94 % 8/26/2027 1,659,313 1,653,207 1,595,015
Liquid Tech Solutions Holdings, LLC Services: Business Term Loan Loan 1M USD SOFR+ 4.75 % 0.75 % 10.19 % 3/17/2028 975,000 972,922 957,938
LOYALTY VENTURES INC. (b) Services: Business Term Loan B Loan Prime 5.50 % 0.50 % 14.00 % 11/3/2027 2,913,525 2,902,171 25,493
LPL Holdings, Inc. Banking, Finance, Insurance & Real Estate Term Loan B1 Loan 1M USD SOFR+ 1.75 % 0.00 % 7.18 % 11/11/2026 1,195,404 1,194,671 1,194,125
LSF11 A5 HOLDCO LLC Chemicals, Plastics, & Rubber Term Loan (01/23) Loan 1M USD SOFR+ 4.25 % 0.50 % 9.68 % 10/14/2028 1,492,500 1,473,942 1,491,754

74

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

February 29, 2024

Issuer Name Industry Asset Name Asset
Type
Reference
Rate/Spread
SOFR/LIBOR Floor Current Rate (All In) Maturity
Date
Principal/
Number of Shares
Cost Fair
Value
LSF11 A5 HOLDCO LLC Chemicals, Plastics, & Rubber Term Loan Loan 1M USD SOFR+ 3.50 % 0.50 % 8.94 % 10/16/2028 245,625 244,848 244,473
LSF11 TRINITY BIDCO INC Aerospace & Defense Term Loan B Loan 1M USD SOFR+ 4.00 % 0.00 % 9.32 % 6/14/2030 980,756 967,038 980,756
LSF9 Atlantis Holdings, LLC
(A Wireless)
Retail Term Loan  (2/24) Loan 1M USD SOFR+ 6.50 % 0.75 % 11.83 % 3/31/2029 2,775,000 2,700,276 2,775,860
MAGNITE, INC. Services: Business Term Loan B (01/24) Loan 1M USD SOFR+ 4.50 % 0.00 % 9.82 % 2/6/2031 3,250,000 3,218,266 3,241,875
Marriott Ownership Resorts, Inc. Hotel, Gaming & Leisure Term Loan (11/19) Loan 1M USD SOFR+ 1.75 % 0.00 % 7.18 % 8/29/2025 1,317,074 1,317,074 1,312,543
Match Group, Inc, The Services: Consumer Term Loan (1/20) Loan 3M USD SOFR+ 1.75 % 0.00 % 7.27 % 2/15/2027 250,000 249,741 249,063
Max US Bidco Inc. Beverage, Food & Tobacco Term Loan B Loan 3M USD SOFR+ 5.00 % 0.50 % 10.35 % 10/3/2030 2,000,000 1,870,298 1,832,500
Mayfield Agency Borrower Inc. (FeeCo) Banking, Finance, Insurance & Real Estate First Lien Term Loan B (12/23) Loan 1M USD SOFR+ 4.25 % 0.00 % 9.58 % 2/28/2028 3,432,772 3,346,276 3,432,772
McGraw-Hill Education, Inc. Media: Advertising, Printing & Publishing Term Loan (07/21) Loan 1M USD SOFR+ 4.75 % 0.50 % 10.19 % 7/28/2028 1,955,000 1,940,387 1,946,281
MedAssets Software Inter Hldg, Inc. High Tech Industries Term Loan (11/21) (USD) Loan 1M USD SOFR+ 4.00 % 0.50 % 9.44 % 12/18/2028 491,250 488,835 409,275
Mermaid Bidco Inc. High Tech Industries Term Loan B2 Loan 3M USD SOFR+ 4.50 % 0.75 % 9.88 % 12/22/2027 1,966,412 1,947,595 1,968,870
Michaels Companies Inc Retail Term Loan B (Magic Mergeco) Loan 3M USD SOFR+ 4.25 % 0.75 % 9.86 % 4/8/2028 2,442,400 2,429,364 1,996,417
MKS Instruments, Inc. High Tech Industries Term Loan B Loan 1M USD SOFR+ 2.50 % 0.50 % 7.82 % 8/17/2029 1,971,537 1,967,675 1,966,253
Momentive Performance Materials Inc. Chemicals, Plastics, & Rubber Term Loan (03/23) Loan 1M USD SOFR+ 4.50 % 0.00 % 9.83 % 3/28/2028 496,250 479,007 485,084
Moneygram International, Inc. Services: Business Term Loan Loan 3M USD SOFR+ 5.50 % 0.50 % 10.88 % 5/31/2030 2,993,750 2,617,290 2,936,989
Mosel Bidco SE High Tech Industries Term Loan B Loan 3M USD SOFR+ 4.75 % 0.50 % 10.10 % 9/16/2030 500,000 495,262 500,625
MPH Acquisition Holdings LLC (Multiplan) Services: Business Term Loan B (08/21) Loan 3M USD SOFR+ 4.25 % 0.50 % 9.85 % 9/1/2028 2,962,121 2,734,973 2,861,320
NAB Holdings, LLC (North American Bancard) Banking, Finance, Insurance & Real Estate Term Loan (11/21) Loan 3M USD SOFR+ 2.75 % 0.50 % 8.25 % 11/23/2028 2,940,000 2,935,048 2,929,504
Napa Management Services Corp Healthcare & Pharmaceuticals Term Loan B (02/22) Loan 1M USD SOFR+ 5.25 % 0.75 % 10.68 % 2/22/2029 2,969,773 2,447,043 2,806,436
Natgasoline LLC Chemicals, Plastics, & Rubber Term Loan Loan 1M USD SOFR+ 3.50 % 0.00 % 8.94 % 11/14/2025 3,305,649 3,294,914 3,289,120
National Mentor Holdings, Inc. Healthcare & Pharmaceuticals Term Loan 2/21 Loan 1M USD SOFR+ 3.75 % 0.75 % 9.18 % 3/2/2028 2,708,195 2,701,639 2,522,007
National Mentor Holdings, Inc. Healthcare & Pharmaceuticals Term Loan C 2/21 Loan 3M USD SOFR+ 3.75 % 0.75 % 9.20 % 3/2/2028 87,464 87,200 81,450
New Trojan Parent, Inc. (c) Consumer goods: Durable Term Loan Loan 1M USD SOFR+ 5.25 % 0.50 % 10.69 % 1/6/2028 - 40,239 -
Nexstar Broadcasting, Inc. (Mission Broadcasting) Media: Broadcasting & Subscription Term Loan Loan 1M USD SOFR+ 2.50 % 0.00 % 7.94 % 9/18/2026 657,625 654,056 655,705
Next Level Apparel, Inc. Retail Term Loan Loan 1M USD SOFR+ 7.50 % 1.00 % 12.92 % 8/9/2026 2,605,709 2,579,219 2,019,425
NortonLifeLock Inc. High Tech Industries Term Loan B Loan 1M USD SOFR+ 2.00 % 0.50 % 7.43 % 9/12/2029 997,195 993,475 994,014
Nouryon Finance B.V. Chemicals, Plastics, & Rubber Term Loan B Loan 1M USD SOFR+ 4.00 % 0.00 % 9.42 % 4/3/2028 497,500 492,525 497,192

75

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

February 29, 2024

Issuer Name Industry Asset Name Asset
Type
Reference
Rate/Spread
SOFR/LIBOR Floor Current Rate (All In) Maturity
Date
Principal/
Number of Shares
Cost Fair
Value
Nouryon Finance B.V. Chemicals, Plastics, & Rubber Term Loan (05/23) Loan 3M USD SOFR+ 4.00 % 0.00 % 9.42 % 4/3/2028 498,747 494,084 498,228
Novae LLC Automotive Term Loan B Loan 3M USD SOFR+ 5.00 % 0.75 % 10.52 % 12/22/2028 1,965,000 1,954,113 1,948,632
Nuvei Technologies Corp. High Tech Industries Term Loan B Loan 1M USD SOFR+ 3.00 % 0.50 % 8.43 % 12/19/2030 2,100,000 2,084,250 2,100,336
Olaplex, Inc. Consumer goods: Non-durable Term Loan (2/22) Loan 1M USD SOFR+ 3.50 % 0.50 % 8.93 % 2/23/2029 2,467,387 2,376,707 2,249,442
Open Text Corporation High Tech Industries Term Loan B (08/23) Loan 1M USD SOFR+ 2.75 % 0.50 % 8.18 % 1/31/2030 1,380,397 1,343,151 1,381,267
Organon & Co. Healthcare & Pharmaceuticals Term Loan USD Loan 1M USD SOFR+ 3.00 % 0.50 % 8.43 % 6/2/2028 2,118,750 2,112,577 2,120,085
Oxbow Carbon, LLC Metals & Mining Term Loan B (04/23) Loan 1M USD SOFR+ 4.00 % 0.50 % 9.43 % 5/2/2030 497,500 488,294 496,669
PACIFIC DENTAL SERVICES, LLC Healthcare & Pharmaceuticals Term Loan Loan 1M USD SOFR+ 3.50 % 0.75 % 8.94 % 4/21/2028 895,408 894,474 893,734
Pacific Gas & Electric Utilities: Electric Term Loan Loan 1M USD SOFR+ 2.50 % 0.50 % 7.83 % 6/23/2027 250,000 248,893 249,923
PACTIV EVERGREEN GROUP HOLDINGS INC. Containers, Packaging & Glass Term Loan B Loan 1M USD SOFR+ 3.25 % 0.50 % 8.69 % 9/20/2028 975,000 971,827 975,994
Padagis LLC Healthcare & Pharmaceuticals Term Loan Loan 3M USD SOFR+ 4.75 % 0.50 % 10.34 % 7/6/2028 941,176 934,588 896,471
PAR PETROLEUM LLC Energy: Oil & Gas Term Loan 2/23 Loan 3M USD SOFR+ 4.25 % 0.50 % 9.69 % 2/27/2030 2,483,737 2,460,184 2,482,198
PATAGONIA HOLDCO LLC Telecommunications Term Loan B Loan 3M USD SOFR+ 5.75 % 0.50 % 11.06 % 8/1/2029 1,975,000 1,671,950 1,816,013
Pathway Partners Vet Management Company LLC Services: Business Term Loan Loan 1M USD SOFR+ 3.75 % 0.00 % 9.19 % 3/30/2027 481,544 475,840 411,321
PCI Gaming Authority Hotel, Gaming & Leisure Term Loan Loan 1M USD SOFR+ 2.50 % 0.00 % 7.94 % 5/29/2026 794,490 793,022 794,156
PEARLS (Netherlands) Bidco B.V. Chemicals, Plastics, & Rubber USD Term Loan (02/22) Loan 3M USD SOFR+ 3.75 % 0.50 % 9.06 % 2/28/2029 982,500 981,042 972,066
PEDIATRIC ASSOCIATES HOLDING COMPANY, LLC Healthcare & Pharmaceuticals Term Loan (12/22) Loan 1M USD SOFR+ 3.25 % 0.50 % 8.69 % 12/29/2028 1,474,639 1,470,327 1,325,332
Penn National Gaming, Inc Hotel, Gaming & Leisure Term Loan B Loan 1M USD SOFR+ 2.75 % 0.50 % 8.18 % 5/3/2029 985,000 981,209 979,720
Peraton Corp. Aerospace & Defense Term Loan B Loan 1M USD SOFR+ 3.75 % 0.75 % 9.18 % 2/1/2028 5,236,340 5,225,013 5,236,340
PHYSICIAN PARTNERS, LLC Healthcare & Pharmaceuticals Term Loan Loan 3M USD SOFR+ 4.00 % 0.50 % 9.46 % 12/23/2028 2,958,680 2,899,926 2,608,254
Pitney Bowes Inc Services: Business Term Loan B Loan 1M USD SOFR+ 4.00 % 0.00 % 9.44 % 3/17/2028 3,899,823 3,878,054 3,880,324
Plastipak Holdings Inc. Containers, Packaging & Glass Term Loan B (11/21) Loan 1M USD SOFR+ 2.50 % 0.50 % 7.93 % 12/1/2028 1,795,294 1,789,191 1,791,309
Playtika Holding Corp. High Tech Industries Term Loan B (3/21) Loan 1M USD SOFR+ 2.75 % 0.00 % 8.19 % 3/13/2028 4,376,250 4,370,414 4,362,377
PMHC II, INC. Chemicals, Plastics, & Rubber Term Loan (02/22) Loan 3M USD SOFR+ 4.25 % 0.50 % 9.72 % 4/21/2029 1,975,000 1,967,432 1,926,968
PointClickCare Technologies, Inc. High Tech Industries Term Loan B Loan 3M USD SOFR+ 3.00 % 0.75 % 8.61 % 12/29/2027 486,250 484,831 485,642
Polymer Process Holdings, Inc. Containers, Packaging & Glass Term Loan Loan 1M USD SOFR+ 4.75 % 0.75 % 10.19 % 2/12/2028 5,348,750 5,313,507 5,071,310
Pre-Paid Legal Services, Inc. Services: Consumer Term Loan (12/21) Loan 1M USD SOFR+ 3.75 % 0.50 % 9.19 % 12/15/2028 2,947,500 2,929,343 2,939,512

76

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

February 29, 2024

Issuer Name Industry Asset Name Asset
Type
Reference
Rate/Spread
SOFR/LIBOR Floor Current Rate (All In) Maturity
Date
Principal/
Number of Shares
Cost Fair
Value
Presidio, Inc. Services: Business Term Loan B (1/20) Loan 3M USD SOFR+ 3.50 % 0.00 % 8.91 % 1/22/2027 482,500 482,164 483,103
Prime Security Services Borrower, LLC (ADT) Services: Consumer Term Loan B (10/23) Loan 3M USD SOFR+ 2.50 % 0.00 % 7.83 % 10/11/2030 2,000,000 1,980,728 1,998,300
PRIORITY HOLDINGS, LLC Services: Consumer Term Loan Loan 1M USD SOFR+ 5.75 % 1.00 % 11.19 % 4/27/2027 2,925,000 2,906,770 2,921,344
PriSo Acquisition Corporation Construction & Building Term Loan (01/21) Loan 3M USD SOFR+ 3.25 % 0.75 % 8.84 % 12/28/2027 486,242 484,862 472,311
Project Leopard Holdings, Inc. (NEW) High Tech Industries Term Loan B (06/22) Loan 3M USD SOFR+ 5.25 % 0.50 % 10.66 % 7/20/2029 990,000 931,883 907,711
Propulsion (BC) Finco Aerospace & Defense Term Loan Loan 3M USD SOFR+ 3.75 % 0.50 % 9.10 % 9/14/2029 750,000 742,504 748,748
PUG LLC Services: Consumer Term Loan B (02/20) Loan 1M USD SOFR+ 3.50 % 0.00 % 8.94 % 2/12/2027 475,176 474,168 466,010
Quartz AcquireCo, LLC High Tech Industries Term Loan B Loan 1M USD SOFR+ 3.50 % 0.00 % 8.83 % 6/28/2030 997,500 988,167 996,253
QUEST BORROWER LIMITED High Tech Industries Term Loan (1/22) Loan 3M USD SOFR+ 4.25 % 0.50 % 9.71 % 2/1/2029 1,970,000 1,954,941 1,552,734
R1 RCM INC. Healthcare & Pharmaceuticals Term Loan (12/23) Loan 1M USD SOFR+ 3.00 % 0.00 % 8.36 % 6/21/2029 1,200,000 1,185,480 1,200,000
R1 RCM INC. Healthcare & Pharmaceuticals Term Loan Loan 1M USD SOFR+ 3.00 % 0.50 % 8.33 % 6/21/2029 1,200,000 1,185,733 1,200,000
Rackspace Technology Global, Inc. High Tech Industries Term Loan (1/21) Loan 1M USD SOFR+ 2.75 % 0.75 % 8.19 % 2/15/2028 2,944,353 2,869,199 1,278,173
RAND PARENT LLC Transportation: Cargo Term Loan B Loan 3M USD SOFR+ 4.25 % 0.00 % 9.60 % 3/16/2030 2,481,250 2,400,653 2,476,213
RealPage, Inc. High Tech Industries Term Loan (04/21) Loan 1M USD SOFR+ 3.00 % 0.50 % 8.44 % 4/24/2028 977,500 976,326 950,501
Rent-A-Center, Inc. Retail Term Loan B2 (9/21) Loan 6M USD SOFR+ 3.25 % 0.50 % 9.12 % 2/17/2028 1,860,192 1,827,856 1,856,323
Research Now Group, Inc Media: Advertising, Printing & Publishing Term Loan Loan 3M USD SOFR+ 5.50 % 1.00 % 11.07 % 12/20/2024 4,252,891 4,231,426 2,426,275
Resideo Funding Inc. Services: Consumer Term Loan (1/21) Loan 1M USD SOFR+ 2.25 % 0.50 % 7.69 % 2/11/2028 1,458,750 1,457,581 1,454,651
Resolute Investment Managers (American Beacon), Inc. Banking, Finance, Insurance & Real Estate Term Loan (12/23) Loan 3M USD SOFR+ 6.50 % 1.00 % 12.11 % 4/30/2027 1,968,154 1,968,154 1,936,172
Restoration Hardware, Inc. Retail Term Loan (9/21) Loan 1M USD SOFR+ 2.50 % 0.50 % 7.94 % 10/20/2028 3,427,375 3,422,882 3,328,838
Reynolds Consumer Products LLC Containers, Packaging & Glass Term Loan Loan 1M USD SOFR+ 1.75 % 0.00 % 7.18 % 1/29/2027 1,117,917 1,117,917 1,117,078
Reynolds Group Holdings Inc. Containers, Packaging & Glass Term Loan B2 Loan 1M USD SOFR+ 3.25 % 0.00 % 8.69 % 2/5/2026 1,933,578 1,929,763 1,936,692
Russell Investments US Inst’l Holdco, Inc. Banking, Finance, Insurance & Real Estate Term Loan (10/20) Loan 1M USD SOFR+ 3.50 % 1.00 % 8.93 % 6/2/2025 5,503,217 5,487,956 5,313,356
RV Retailer LLC Automotive Term Loan Loan 1M USD SOFR+ 3.75 % 0.75 % 9.17 % 2/8/2028 2,927,756 2,890,768 2,728,317
Ryan Specialty Group LLC Banking, Finance, Insurance & Real Estate Term Loan Loan 1M USD SOFR+ 2.75 % 0.75 % 8.08 % 9/1/2027 1,463,497 1,454,416 1,463,497
S&S HOLDINGS LLC Services: Business Term Loan Loan 3M USD SOFR+ 5.00 % 0.50 % 10.42 % 3/10/2028 2,433,693 2,393,141 2,405,560
Sally Holdings LLC Retail Term Loan B Loan 1M USD SOFR+ 2.25 % 0.00 % 7.58 % 2/28/2030 496,250 492,943 495,421
Schweitzer-Mauduit International, Inc. High Tech Industries Term Loan B Loan 1M USD SOFR+ 3.75 % 0.75 % 9.19 % 4/20/2028 1,297,546 1,293,069 1,294,847

77

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

February 29, 2024

Issuer Name Industry Asset Name Asset
Type
Reference
Rate/Spread
SOFR/LIBOR Floor Current Rate (All In) Maturity
Date
Principal/
Number of Shares
Cost Fair
Value
Scientific Games Holdings LP Hotel, Gaming & Leisure Term Loan B Loan 3M USD SOFR+ 3.25 % 0.50 % 8.58 % 4/4/2029 493,750 492,933 492,516
Sedgwick Claims Management Services, Inc. Services: Business Term Loan B 2/23 Loan 1M USD SOFR+ 3.75 % 0.00 % 9.08 % 2/17/2028 992,500 984,017 993,294
SETANTA AIRCRAFT LEASING DAC Aerospace & Defense Term Loan Loan 3M USD SOFR+ 2.00 % 0.00 % 7.61 % 11/2/2028 1,000,000 998,338 1,000,560
Sitel Worldwide Corporation Services: Business USD Term Loan (7/21) Loan 1M USD SOFR+ 3.75 % 0.50 % 9.19 % 8/28/2028 1,955,000 1,948,734 1,873,144
SiteOne Landscape Supply, LLC Services: Business Term Loan (3/21) Loan 1M USD SOFR+ 2.00 % 0.50 % 7.44 % 3/18/2028 1,267,378 1,261,906 1,267,378
SMG US Midco 2, Inc. Services: Business Term Loan (01/20) Loan 3M USD SOFR+ 2.50 % 0.00 % 8.07 % 1/23/2025 480,000 480,000 479,702
Smyrna Ready Mix Concrete, LLC Construction & Building Term Loan B Loan 1M USD SOFR+ 3.50 % 0.00 % 8.82 % 4/1/2029 514,217 510,811 514,860
Sotheby’s Services: Business Term Loan (7/21) Loan 3M USD SOFR+ 4.50 % 0.50 % 10.08 % 1/15/2027 3,191,015 3,159,783 3,159,903
Sparta U.S. HoldCo LLC Chemicals, Plastics, & Rubber Term Loan (04/21) Loan 1M USD SOFR+ 3.25 % 0.75 % 8.69 % 8/2/2028 1,960,000 1,953,602 1,955,453
Specialty Pharma III Inc. Services: Business Term Loan Loan 1M USD SOFR+ 4.25 % 0.75 % 9.68 % 3/31/2028 1,955,000 1,942,520 1,857,250
Spin Holdco, Inc. Services: Consumer Term Loan 3/21 Loan 3M USD SOFR+ 4.00 % 0.75 % 9.62 % 3/4/2028 2,917,500 2,907,433 2,644,510
SRAM, LLC Consumer goods: Durable Term Loan (05/21) Loan 1M USD SOFR+ 2.75 % 0.50 % 8.19 % 5/12/2028 2,523,636 2,521,215 2,517,327
STANDARD INDUSTRIES INC. Construction & Building Term Loan B Loan 1M USD SOFR+ 2.25 % 0.50 % 7.68 % 9/22/2028 620,250 616,132 619,785
Staples, Inc. Wholesale Term Loan (03/19) Loan 1M USD SOFR+ 5.00 % 0.00 % 10.44 % 4/16/2026 4,296,252 4,227,884 4,185,881
Star Parent, Inc. Services: Business Term Loan B (09/23) Loan 3M USD SOFR+ 4.00 % 0.00 % 9.35 % 9/19/2030 1,250,000 1,232,293 1,233,600
Storable, Inc High Tech Industries Term Loan B Loan 1M USD SOFR+ 3.50 % 0.50 % 8.83 % 4/17/2028 490,000 489,451 489,084
Superannuation & Investments US LLC Banking, Finance, Insurance & Real Estate Term Loan Loan 1M USD SOFR+ 3.75 % 0.50 % 9.19 % 12/1/2028 980,000 972,893 979,510
Sweetwater Borrower, LLC Retail Term Loan (8/21) Loan 1M USD SOFR+ 4.25 % 0.75 % 9.69 % 8/2/2028 2,197,331 2,118,286 2,186,345
Syncsort Incorporated High Tech Industries Term Loan B (10/21) Loan 3M USD SOFR+ 4.00 % 0.75 % 9.59 % 4/24/2028 2,444,975 2,444,257 2,421,748
Ta TT Buyer LLC Media: Broadcasting & Subscription Term Loan 3/22 Loan 3M USD SOFR+ 5.00 % 0.50 % 10.35 % 4/2/2029 987,475 979,563 987,060
Tenable Holdings, Inc. Services: Business Term Loan B (6/21) Loan 1M USD SOFR+ 2.75 % 0.50 % 8.19 % 7/7/2028 980,000 978,620 977,962
Teneo Holdings LLC Banking, Finance, Insurance & Real Estate Term Loan Loan 1M USD SOFR+ 5.25 % 1.00 % 10.68 % 7/15/2025 4,337,912 4,305,238 4,332,490
Ten-X, LLC Banking, Finance, Insurance & Real Estate Term Loan 5/23 Loan 1M USD SOFR+ 6.00 % 0.00 % 11.33 % 5/25/2028 1,880,000 1,879,762 1,809,030
The Dun & Bradstreet Corporation Services: Business Term Loan (01/24) Loan 1M USD SOFR+ 2.75 % 0.00 % 8.07 % 1/18/2029 1,148,788 1,146,995 1,145,629
Thor Industries, Inc. Automotive Term Loan B2 Loan 1M USD SOFR+ 2.75 % 0.00 % 8.07 % 11/15/2030 847,276 839,124 847,276
Torrid LLC Wholesale Term Loan 5/21 Loan 3M USD SOFR+ 5.50 % 0.75 % 11.11 % 6/14/2028 3,293,297 2,885,799 2,766,369
TORY BURCH LLC Retail Term Loan Loan 1M USD SOFR+ 3.25 % 0.50 % 8.69 % 4/15/2028 2,308,083 2,173,521 2,279,878

78

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

February 29, 2024

Issuer Name Industry Asset Name Asset
Type
Reference
Rate/Spread
SOFR/LIBOR Floor Current Rate (All In) Maturity
Date
Principal/
Number of Shares
Cost Fair
Value
Tosca Services, LLC Containers, Packaging & Glass Term Loan (2/21) Loan 3M USD SOFR+ 3.50 % 0.75 % 9.07 % 8/18/2027 485,000 481,026 403,360
Trans Union LLC Banking, Finance, Insurance & Real Estate Term Loan B7 (02/24) Loan 1M USD SOFR+ 2.00 % 0.50 % 7.33 % 12/1/2028 609,032 608,154 608,161
Transdigm, Inc. Aerospace & Defense Term Loan H Loan 3M USD SOFR+ 3.25 % 0.00 % 8.60 % 2/22/2027 1,973,436 1,970,279 1,977,580
TRITON WATER HOLDINGS, INC. Beverage, Food & Tobacco Term Loan (03/21) Loan 3M USD SOFR+ 3.25 % 0.50 % 8.86 % 3/31/2028 1,462,504 1,457,793 1,435,389
Tronox Finance LLC Chemicals, Plastics, & Rubber Term Loan Loan 1M USD SOFR+ 2.50 % 0.00 % 7.94 % 3/10/2028 346,923 346,548 345,584
Tronox Finance LLC Chemicals, Plastics, & Rubber Incremental Term Loan Loan 3M USD SOFR+ 3.50 % 0.50 % 8.85 % 8/11/2028 2,000,000 1,981,659 1,997,500
TruGreen Limited Partnership Services: Consumer Term Loan Loan 1M USD SOFR+ 4.00 % 0.75 % 9.43 % 10/29/2027 944,761 940,433 912,034
Uber Technologies, Inc. Transportation: Consumer Term Loan 2/23 Loan 3M USD SOFR+ 2.75 % 0.00 % 8.13 % 3/3/2030 395,438 394,559 396,284
Ultra Clean Holdings, Inc. High Tech Industries Incremental Term Loan 3/21 Loan 1M USD SOFR+ 3.75 % 0.00 % 9.19 % 8/27/2025 763,480 761,941 764,755
Unimin Corporation Metals & Mining Term Loan (12/20) Loan 3M USD SOFR+ 4.00 % 1.00 % 9.59 % 7/31/2026 496,815 481,603 494,207
United Natural Foods, Inc Beverage, Food & Tobacco Term Loan B Loan 1M USD SOFR+ 3.25 % 0.00 % 8.69 % 10/22/2025 1,241,834 1,218,443 1,239,922
Univision Communications Inc. Media: Broadcasting & Subscription Term Loan B (6/21) Loan 1M USD SOFR+ 3.25 % 0.75 % 8.69 % 3/15/2026 2,421,809 2,418,336 2,418,031
Univision Communications Inc. Media: Broadcasting & Subscription Term Loan B (6/22) Loan 3M USD SOFR+ 4.25 % 0.50 % 9.60 % 6/25/2029 246,250 240,243 246,250
Utz Quality Foods, LLC Beverage, Food & Tobacco Term Loan B Loan 1M USD SOFR+ 3.00 % 0.00 % 8.44 % 1/20/2028 1,478,977 1,478,749 1,478,252
Vaco Holdings, LLC Services: Business Term Loan (01/22) Loan 6M USD SOFR+ 5.00 % 0.75 % 10.43 % 1/19/2029 2,318,552 2,260,590 2,287,251
Vericast Corp. (c) Media: Advertising, Printing & Publishing Term Loan (12/23) Loan 3M USD SOFR+ 7.75 % 0.00 % 13.36 % 6/16/2026 1,208,512 1,207,739 1,111,831
Verifone Systems, Inc. Banking, Finance, Insurance & Real Estate Term Loan (7/18) Loan 3M USD SOFR+ 4.00 % 0.00 % 9.59 % 8/20/2025 1,353,744 1,351,272 1,170,988
Vertex Aerospace Services Corp Aerospace & Defense Term Loan (10/21) Loan 1M USD SOFR+ 3.25 % 0.75 % 8.68 % 12/6/2028 982,538 979,566 982,459
VFH Parent LLC Banking, Finance, Insurance & Real Estate Term Loan (01/22) Loan 1M USD SOFR+ 3.00 % 0.50 % 8.43 % 1/12/2029 2,975,130 2,970,557 2,970,667
Viasat Inc Telecommunications Term Loan (2/22) Loan 1M USD SOFR+ 4.50 % 0.50 % 9.83 % 3/5/2029 2,967,381 2,908,179 2,909,903
Virtus Investment Partners, Inc. Banking, Finance, Insurance & Real Estate Term Loan B (9/21) Loan 1M USD SOFR+ 2.25 % 0.00 % 7.69 % 9/28/2028 2,823,409 2,817,201 2,819,880
Vistra Operations Company LLC Energy: Electricity 2018 Incremental Term Loan Loan 1M USD SOFR+ 2.00 % 0.00 % 7.33 % 12/20/2030 1,889,393 1,880,083 1,880,135
Vizient, Inc Healthcare & Pharmaceuticals Term Loan 4/22 Loan 1M USD SOFR+ 2.25 % 0.50 % 7.68 % 5/16/2029 492,500 488,534 492,731
VM Consolidated, Inc. Construction & Building Term Loan B (01/24) Loan 1M USD SOFR+ 2.75 % 0.00 % 8.08 % 3/24/2028 1,841,374 1,840,186 1,843,676
Vouvray US Finance LLC High Tech Industries Term Loan Loan 1M USD SOFR+ 6.00 % 1.00 % 11.33 % 9/30/2025 466,250 466,250 472,078
Walker & Dunlop, Inc. Banking, Finance, Insurance & Real Estate Term Loan B (12/22) Loan 1M USD SOFR+ 3.00 % 0.50 % 8.43 % 12/15/2028 496,250 487,839 495,009
Warner Music Group Corp. (WMG Acquisition Corp.) Hotel, Gaming & Leisure First Lien TL I (01/24) Loan 1M USD SOFR+ 2.00 % 0.00 % 7.33 % 1/24/2031 1,250,000 1,249,906 1,247,463

79

Saratoga Investment Corp. CLO 2013-1, Ltd.

Schedule of Investments

February 29, 2024

Issuer Name Industry Asset Name Asset
Type
Reference
Rate/Spread
SOFR/LIBOR Floor Current Rate (All In) Maturity
Date
Principal/
Number of Shares
Cost Fair
Value
Watlow Electric Manufacturing Company High Tech Industries Term Loan B Loan 3M USD SOFR+ 3.75 % 0.50 % 9.33 % 3/2/2028 2,831,632 2,822,010 2,826,337
WeddingWire, Inc. Services: Consumer Term Loan (09/23) Loan 1M USD SOFR+ 4.50 % 0.00 % 9.82 % 1/29/2028 4,808,923 4,806,669 4,784,879
WEX Inc. Services: Business Term Loan Loan 1M USD SOFR+ 2.00 % 0.00 % 7.33 % 3/31/2028 2,924,849 2,918,448 2,919,379
WildBrain Ltd. Media: Diversified & Production Term Loan Loan 1M USD SOFR+ 4.25 % 0.75 % 9.69 % 3/27/2028 3,005,025 2,952,048 2,899,849
Windsor Holdings III, LLC Chemicals, Plastics, & Rubber Term Loan Loan 1M USD SOFR+ 4.50 % 0.00 % 9.82 % 8/1/2030 500,000 500,000 500,390
Wyndham Hotels & Resorts, Inc. Hotel, Gaming & Leisure Term Loan  5/23 Loan 1M USD SOFR+ 2.25 % 0.00 % 7.68 % 5/24/2030 995,000 990,380 996,124
Xperi Corporation High Tech Industries Term Loan Loan 1M USD SOFR+ 3.50 % 0.00 % 8.94 % 6/8/2028 1,983,094 1,979,717 1,977,303
Zayo Group, LLC Telecommunications Term Loan 4/22 Loan 1M USD SOFR+ 4.25 % 0.50 % 9.65 % 3/9/2027 982,500 965,514 884,555
ZEBRA BUYER (Allspring) LLC Banking, Finance, Insurance & Real Estate Term Loan 4/21 Loan 3M USD SOFR+ 3.25 % 0.50 % 8.89 % 11/1/2028 1,866,509 1,857,862 1,862,142
Zekelman Industries, Inc. Metals & Mining Term Loan (01/20) Loan 1M USD SOFR+ 2.00 % 0.00 % 7.44 % 1/25/2027 954,029 954,029 953,733
Zest Acquisition Corp. Healthcare & Pharmaceuticals Term Loan (1/23) Loan 1M USD SOFR+ 5.50 % 0.00 % 10.83 % 2/8/2028 1,980,000 1,897,656 1,940,400
Zodiac Pool Solutions Consumer goods: Durable Term Loan (1/22) Loan 1M USD SOFR+ 1.93 % 0.50 % 7.35 % 1/29/2029 490,000 489,237 488,772
TOTAL INVESTMENTS $ 630,995,710 $ 607,551,774

Number of Shares Cost Fair Value
Cash and cash equivalents
U.S. Bank Money Market (a) 12,104,832 $ 12,104,832 $ 12,104,832
Total cash and cash equivalents 12,104,832 $ 12,104,832 $ 12,104,832

(a) Included within cash and cash equivalents in Saratoga CLO’s Statements of Assets and Liabilities as of February 29, 2024.
(b) As of February 29, 2024, the investment was in default and on non-accrual status.
(c) Investments include Payment-in-Kind Interest.

LIBOR - London Interbank Offered Rate

SOFR - Secured Overnight Financing Rate

1M USD LIBOR - The 1-month USD LIBOR rate as of February 29, 2024 was 5.44%.

3M USD LIBOR - The 3-month USD LIBOR rate as of February 29, 2024 was 5.60%.

1M SOFR - The 1-month SOFR rate as of February 29, 2024 was 5.32%.

3M SOFR - The 3-month SOFR rate as of February 29, 2024 was 5.33%.

6M SOFR - The 6-month SOFR rate as of February 29, 2024 was 5.27%.

Prime - The Prime Rate as of February 29, 2024 was 8.50%.

See accompanying notes to financial statements

80

Note 5. Investment in SLF JV

On October 26, 2021, the Company and TJHA entered into the LLC Agreement to co-manage SLF JV. SLF JV is invested in Saratoga Investment Corp Senior Loan Fund 2022-1, Ltd (“SLF 2021”), which is a wholly owned subsidiary of SLF JV. SLF 2021 was formed for the purpose of making investments in a diversified portfolio of broadly syndicated first lien and second lien term loans or bonds in the primary and secondary markets.

On September 30, 2022, SLF 2021 was renamed to Saratoga Investment Corp Senior Loan Fund 2022-1, Ltd. (“SLF 2022”).

The Company and TJHA have equal voting interest on all material decisions with respect to SLF JV, including those involving its investment portfolio, and equal control of corporate governance. No management fee is charged to SLF JV as control and management of SLF JV is shared equally.

The Company and TJHA have committed to provide up to a combined $ 50.0 million of financing to SLF JV through cash contributions, with the Company providing $ 43.75 million and TJHA providing $ 6.25 million, resulting in an 87.5 % and 12.5 % ownership between the two parties. The financing is issued in the form of an unsecured note and equity. The unsecured note pays a fixed rate of 10 % per annum and is due and payable in full on October 20, 2033. As of November 30, 2024, the Company and TJHA’s investment in SLF JV consisted of an unsecured note of $ 17.6 million and $ 2.5 million, respectively; and membership interest of $ 17.6 million and $ 2.5 million, respectively. As of November 30, 2024 and February 29, 2024, the Company’s investment in the unsecured note of SLF JV had a fair value of $ 16.2 million and $ 15.8 million, respectively, and the Company’s investment in the membership interests of SLF JV had a fair value of $ 4.8 million and $ 9.4 million, respectively.

The Company has determined that SLF JV is an investment company under ASC 946; however, in accordance with such guidance the Company will generally not consolidate its investment in a company other than a wholly owned investment company subsidiary. SLF JV is not a wholly owned investment company subsidiary as the Company and TJHA each have an equal 50 % voting interest in SLF JV and thus neither party has a controlling financial interest. Furthermore, ASC 810 concludes that in a joint venture where both members have equal decision making authority, it is not appropriate for one member to consolidate the joint venture since neither has control. Accordingly, the Company does not consolidate SLF JV.

For the three months ended November 30, 2024 and November 30, 2023, the Company earned $ 0.4 million and $ 0.4 million, respectively, of interest income related to SLF JV, which is included in interest income on control investments. For the nine months ended November 30, 2024 and November 30, 2023, the Company earned $ 1.3 million and $ 1.3 million, respectively, of interest income related to SLF JV, which is included in interest income on control investments. As of November 30, 2024 and February 29, 2024, $ 0.2 million and $ 0.2 million, respectively, of interest income related to SLF JV was included in interest receivable on the consolidated statements of assets and liabilities.

For the three months ended November 30, 2024 and November 30, 2023, the Company earned $ 0.9 million and $ 1.3 million, respectively, of dividend income related to SLF JV, which is included in dividend income on control investments. For the nine months ended November 30, 2024 and November 30, 2023, the Company earned $ 3.2 million and $ 4.7 million, respectively, of dividend income related to SLF JV, which is included in dividend income on control investments. As of November 30, 2024 and February 29, 2024, $ 0.0 million and $ 0.0 million, respectively, of dividend income related to SLF JV was included in dividend receivable on the consolidated statements of assets and liabilities.

SLF JV’s initial investment in SLF 2022 was in the form of an unsecured loan. The unsecured loan paid a floating rate of LIBOR plus 7.00 % per annum and was paid in full on June 9, 2023. The unsecured loan was repaid in full on October 28, 2022, as part of the CLO closing.

On October 28, 2022, SLF 2022 issued $ 402.1 million of the 2022 JV CLO Notes through the JV CLO trust. The 2022 JV CLO Notes were issued pursuant to the JV Indenture, with the Trustee. As part of the transaction, the Company purchased 87.50 % of the Class E Notes from SLF 2022 with a par value of $ 12.25 million. As of November 30, 2024 and February 29, 2024, the fair value of these Class E Notes were $ 12.3 million and $ 12.3 million, respectively.

81

Note 6. Income Taxes

SIA-AAP, Inc., SIA-ARC, Inc., SIA-Avionte, Inc., SIA-AX, Inc., SIA-G4, Inc., SIA-GH, Inc.,, SIA-MDP, Inc., SIA-PP Inc., SIA-SZ, Inc., SIA-TG, Inc., SIA-TT Inc., and SIA-Vector, Inc. each 100 % owned by the Company, are each filing standalone C Corporation tax returns for U.S. federal and state tax purposes. As separately regarded entities for tax purposes, these entities are subject to U.S. federal income tax at corporate rates. For tax purposes, any distributions by the entities to the parent company would generally need to be distributed to the Company’s shareholders. Generally, such distributions of the entities’ income to the Company’s shareholders will be considered as qualified dividends for tax purposes. The entities’ taxable net income will differ from U.S. GAAP net income because of deferred tax temporary differences arising from net operating losses and unrealized appreciation and deprecation of securities held. Deferred tax assets and liabilities are measured using enacted corporate federal and state tax rates expected to apply to taxable income in the years in which those net operating losses are utilized and the unrealized gains and losses are realized. Deferred tax assets and deferred tax liabilities are netted off by entity, as allowed. The recoverability of deferred tax assets is assessed and a valuation allowance is recorded to the extent that it is more likely than not that any portion of the deferred tax asset will not be realized on the basis of a history of operating losses combined with insufficient projected taxable income or other taxable events in the Corporate Blockers. In February 2022, SIA-GH, Inc., SIA-TT Inc. and SIA-VR, Inc. received an approved plan of liquidation following the sale of equity held by each of the portfolio companies. In June 2024, SIA-MAC, Inc. and SIA-VR, Inc. were dissolved.

The Company may distribute a portion of its realized net long term capital gains in excess of realized net short term capital losses to its stockholders, but may also decide to retain a portion, or all, of its net capital gains and elect to pay the 21 % U.S. federal tax on the net capital gain, potentially in the form of a “deemed distribution” to its stockholders.  Income tax (provision) relating to an election to retain its net capital gains, including in the form of a deemed distribution, is included as a component of income tax (provision) benefit from realized gains on investments, depending on the character of the underlying taxable income (ordinary or capital gains), on the consolidated statements of operations.

Deferred tax assets and liabilities, and related valuation allowance as of November 30, 2024 and February 29, 2024 were as follows:

November 30,
2024
February 29,
2024
Total deferred tax assets $ 1,606,915 $ 2,650,580
Total deferred tax liabilities ( 4,649,058 ) ( 3,901,995 )
Valuation allowance on net deferred tax assets ( 1,539,238 ) ( 2,539,735 )
Net deferred tax liability $ ( 4,581,381 ) $ ( 3,791,150 )

As of November 30, 2024, the valuation allowance on deferred tax assets was $ 1.5 million, which represents the federal and state tax effect of net operating losses and unrealized losses that the Company does not believe will be realized through future taxable income. Any adjustments to the Company’s valuation allowance will depend on estimates of future taxable income and will be made in the period such determination is made.

Net income tax expense for the three months ended November 30, 2024 includes $ 0.1 million deferred tax expense (benefit) on net change in unrealized appreciation (depreciation) on investments, $ 0.0 million income tax provision/benefit from realized gain/(loss) on investments and $ 0.03 million net change in total operating expense in the consolidated statement of operations, respectively. Net income tax expense for the three months ended November 30, 2023 includes $ 0.4 million deferred tax expense (benefit) on net change in unrealized appreciation (depreciation) on investments, $ 0.0 million income tax provision/benefit from realized gain/(loss) on investments and $ 0.2 million net change in total operating expense, in the consolidated statement of operations, respectively.

Net income tax expense for the nine months ended November 30, 2024 includes $ 0.7 million deferred tax expense (benefit) on net change in unrealized appreciation (depreciation) on investments, $ 0.0 million income tax provision/benefit from realized gain/(loss) on investments and $ 0.1 million net change in total operating expense in the consolidated statement of operations, respectively. Net income tax expense for the nine months ended November 30, 2023 includes $ 0.6 million deferred tax expense (benefit) on net change in unrealized appreciation (depreciation) on investments, $ 0.0 million income tax provision/benefit from realized gain/(loss) on investments and ($ 0.0 ) million net change in total operating expense, in the consolidated statement of operations, respectively.

Deferred tax temporary differences may include differences for state taxes and joint venture interests.

82

Federal and state income tax (provisions) benefit on investments for three months ended November 30, 2024 and November 30, 2023:

For the three months ended For the nine months ended
November 30,
2024
November 30,
2023
November 30,
2024
November 30,
2023
Current
Federal $
-
$
-
$
-
$
-
State
-
-
-
Net current expense
-
-
-
-
Deferred
Federal 86,609 699,986 677,189 661,245
State 76,892 ( 64,192 ) 113,042 ( 55,512 )
Net deferred expense 163,501 635,794 790,231 605,733
Net tax provision $ 163,501 $ 635,794 $ 790,231 $ 605,733

Note 7. Agreements and Related Party Transactions

Investment Advisory and Management Agreement

On July 30, 2010, the Company entered into the Management Agreement with the Manager. The initial term of the Management Agreement was two years from its effective date, with one-year renewals thereafter subject to certain approvals by the Company’s board of directors and/or the Company’s stockholders. Most recently, on July 8, 2024, the Company’s board of directors approved the renewal of the Management Agreement for an additional one-year term. Pursuant to the Management Agreement, the Manager implements the Company’s business strategy on a day-to-day basis and performs certain services for the Company, subject to oversight by the board of directors. The Manager is responsible for, among other duties, determining investment criteria, sourcing, analyzing and executing investments transactions, asset sales, financings and performing asset management duties. Under the Management Agreement, the Company pays the Manager a management fee for investment advisory and management services consisting of a base management fee and an incentive management fee.

Base Management Fee and Incentive Management Fee

The base management fee of 1.75% per year is calculated based on the average value of our gross assets (other than cash or cash equivalents, but including assets purchased with borrowed funds) at the end of the two most recently completed fiscal quarters. The base management fee is paid quarterly following the filing of the most recent quarterly report on Form 10-Q.

The incentive management fee consists of the following two parts:

The first, payable quarterly in arrears, equals 20 % of the Company’s pre-incentive fee net investment income, expressed as a rate of return on the value of our net assets at the end of the immediately preceding quarter, that exceeds a 1.875 % quarterly hurdle rate measured as of the end of each fiscal quarter, subject to a “catch-up” provision. Under this provision, in any fiscal quarter, the Manager receives no incentive fee unless our pre-incentive fee net investment income exceeds the hurdle rate of 1.875%. The Manager will receive 100% of pre-incentive fee net investment income, if any, that exceeds the hurdle rate but is less than or equal to 2.344% in any fiscal quarter; and 20% of the amount of our pre-incentive fee net investment income, if any, that exceeds 2.344% in any fiscal quarter. There is no accumulation of amounts on the hurdle rate from quarter to quarter, and accordingly there is no claw back of amounts previously paid if subsequent quarters are below the quarterly hurdle rate, and there is no delay of payment if prior quarters are below the quarterly hurdle rate.

The second part of the incentive fee is determined and payable in arrears as of the end of each fiscal year (or upon termination of the Management Agreement) and equals 20.0 % of the Company’s “incentive fee capital gains,” which equals the Company’s realized capital gains on a cumulative basis from May 31, 2010 through the end of the fiscal year, if any, computed net of all realized capital losses and unrealized capital depreciation on a cumulative basis on each investment in the Company’s portfolio, less the aggregate amount of any previously paid capital gain incentive fee. Importantly, the capital gains portion of the incentive fee is based on realized gains and realized and unrealized losses from May 31, 2010. Therefore, realized and unrealized losses incurred prior to such time will not be taken into account when calculating the capital gains portion of the incentive fee, and the Manager will be entitled to 20.0% of incentive fee capital gains that arise after May 31, 2010. In addition, for the purpose of the “incentive fee capital gains” calculations, the cost basis for computing realized gains and losses on investments held by us as of May 31, 2010 will equal the fair value of such investments as of such date.

83

For the three months ended November 30, 2024 and November 30, 2023, the Company incurred $ 4.4 million and $ 4.9 million in base management fees, respectively. For the three months ended November 30, 2024 and November 30, 2023, the Company incurred $ 3.1 million and $ 3.3 million in incentive fees related to pre-incentive fee net investment income, respectively. For the three months ended November 30, 2024 and November 30, 2023, the Company accrued an expense (benefit) of $ 0.0 million and ($ 1.0 ) million in incentive fees related to capital gains.

For the nine months ended November 30, 2024 and November 30, 2023, the Company incurred $ 14.2 million and $ 14.3 million in base management fees, respectively. For the nine months ended November 30, 2024 and November 30, 2023, the Company incurred $ 11.2 million and $ 9.8 million in incentive fees related to pre-incentive fee net investment income, respectively. For the nine months ended November 30, 2024 and November 30, 2023, the Company accrued an expense (benefit) of $ 0.0 million and ($ 5.0 ) million in incentive fees related to capital gains.

The accrual is calculated using both realized and unrealized capital gains for the period. The actual incentive fee related to capital gains will be determined and payable in arrears at the end of the fiscal year and will include only realized capital gains for the period. As of November 30, 2024, the base management fees accrual was $ 4.4 million and the incentive fees accrual was $ 3.1 million and is included in base management and incentive fees payable in the accompanying consolidated statements of assets and liabilities. As of February 29, 2024, the base management fees accrual was $ 5.0 million and the incentive fees accrual was $ 3.2 million and is included in base management and incentive fees payable in the accompanying consolidated statements of assets and liabilities.

Administration Agreement

On July 30, 2010, the Company entered into a separate administration agreement (the “Administration Agreement”) with the Manager, pursuant to which the Manager, as the Company’s administrator, has agreed to furnish the Company with the facilities and administrative services necessary to conduct day-to-day operations and provide managerial assistance on the Company’s behalf to those portfolio companies to which the Company is required to provide such assistance. The initial term of the Administration Agreement was two years from its effective date, with one-year renewals thereafter subject to certain approvals by the Company’s board of directors and/or the Company’s stockholders, with the most renewal occurring on July 8, 2024. Since its inception the amount of expenses payable or reimbursable by the Company under the Administration Agreement has been subject to a cap that is reviewed annually in connection with the renewal of the Administration Agreement. Most recently, on August 1, 2024, the Company’s board of directors approved the renewal of the Administration Agreement for an additional one-year term and determined to increase the cap on the payment or reimbursement of expenses by the Company from $ 4.3 million to $ 5.0 million, effective August 1, 2024. The Company’s board of directors will continue to assess the cap on payment or reimbursement of expenses on an annual basis.

For the three months ended November 30, 2024 and November 30, 2023, the Company recognized $ 1.3 million and $ 1.1 million in administrator expenses, respectively, pertaining to bookkeeping, recordkeeping and other administrative services provided to the Company in addition to the Company’s allocable portion of rent and other overhead related expenses. For the nine months ended November 30, 2024 and November 30, 2023, the Company recognized $ 3.5 million and $ 2.8 million in administrator expenses, respectively, pertaining to bookkeeping, recordkeeping and other administrative services provided to the Company in addition to the Company’s allocable portion of rent and other overhead related expenses. As of November 30, 2024 and February 29, 2024, $ 0.8 million and $ 0.5 million, respectively, of administrator expenses were accrued and included in due to manager in the accompanying consolidated statements of assets and liabilities.

Saratoga CLO

On December 14, 2018, the Company completed the third refinancing and issuance of the 2013-1 Reset CLO Notes. This refinancing, among other things, extended the Saratoga CLO reinvestment period to January 2021, and extended its legal maturity to January 2030. In addition, and as part of the refinancing, the Saratoga CLO has also been upsized from $ 300 million in assets to approximately $ 500 million.

In conjunction with the third refinancing and issuance of the 2013-1 Reset CLO Notes on December 14, 2018, the Company is no longer entitled to receive an incentive management fee from Saratoga CLO. See Note 4. Investment in Saratoga CLO for additional information.

84

On February 26, 2021, the Company completed the fourth refinancing of the Saratoga CLO. This refinancing, among other things, extended the Saratoga CLO reinvestment period to April 2024, extended its legal maturity to April 2033, and extended the non-call period to February 2022. In addition, and as part of the refinancing, the Saratoga CLO was upsized from $ 500 million in assets to approximately $ 650 million. As part of this refinancing and upsizing, the Company invested an additional $ 14.0 million in all of the newly issued subordinated notes of the Saratoga CLO, and purchased $ 17.9 million in aggregate principal amount of the Class F-R-3 Notes tranche at par. Concurrently, the existing $ 2.5 million of Class F-R-2 Notes, $ 7.5 million of Class G-R-2 Notes and $ 25.0 million CLO 2013-1 Warehouse 2 Loan were repaid. The Company also paid $ 2.6 million of transaction costs related to the refinancing and upsizing on behalf of the Saratoga CLO, to be reimbursed from future equity distributions. At November 30, 2021, the outstanding receivable of 2.6 million was repaid in full.

On August 9, 2021, the Company exchanged its existing $ 17.9 million Class F-R-3 Notes for $ 8.5 million Class F-1-R-3 Notes and $ 9.4 million Class F-2-R-3 Notes at par. On August 11, 2021, the Company sold its Class F-1-R-3 Notes to third parties, resulting in a realized loss of $ 0.1 million.

On June 10, 2024, the Company completed its fifth refinancing of the Saratoga CLO. This refinancing, among other things, did not extend the Saratoga CLO reinvestment period nor extend its legal maturity, while adjusting the interest rate of two of the existing Notes. The Issuer issued $ 422.5 million of notes, consisting of Class A-1-R-4 and Class A-2-R-4. The 2013-1 2024 Reset CLO Notes were issued pursuant to the Indenture with the same Trustee. Proceeds of the issuance of the 2013-1 2024 Reset CLO Notes were used along with existing assets of the Saratoga CLO to redeem the existing Class A-1-R-3 and Class A-2-R-3 Notes. No other Notes were refinanced as part of this refinancing. The Saratoga CLO paid $ 0.5 million of transaction costs related to the refinancing.

For the three months ended November 30, 2024 and November 30, 2023, the Company recognized management fee income of $ 0.8 million and $ 0.8 million, respectively, related to the Saratoga CLO.

For the nine months ended November 30, 2024 and November 30, 2023, the Company recognized management fee income of $ 2.4 million and $ 2.5 million, respectively, related to the Saratoga CLO.

For the nine months ended November 30, 2024 and November 30, 2023, the Company neither bought nor sold any investments from the Saratoga CLO.

SLF JV

On October 26, 2021, the Company and TJHA entered into an LLC Agreement to co-manage the SLF JV. SLF JV is a joint venture that invests in the debt or equity interests of collateralized loan obligations, loan, notes and other debt instruments. The Company records interest income from its investment in an unsecured loan with SLF JV on an accrual basis and records dividend income from its membership interest when earned. All operating decisions are shared with a 50 % voting interest in SLF JV.

On October 28, 2022, SLF 2022 issued $ 402.1 million of the 2022 JV CLO Notes through the JV CLO trust. The 2022 JV CLO Notes were issued pursuant to the JV Indenture, with the Trustee.

As of November 30, 2024, the Company’s investment in the SLF JV had a fair value of $ 21.0 million, consisting of an unsecured loan of $ 16.2 million and membership interest of $ 4.8 million. As of November 30, 2023, the Company’s investment in the SLF JV had a fair value of $ 25.4 million, consisting of an unsecured loan of $ 17.6 million and membership interest of $ 7.8 million. For the three months ended November 30, 2024, the Company had $ 0.4 million of interest income related to SLF JV, of which $ 0.2 million was included in interest receivable on the consolidated statements of assets and liabilities as of November 30, 2024. For the three months ended November 30, 2023, the Company had $ 0.4 million of interest income related to SLF JV, of which $ 0.2 million was included in interest receivable on the consolidated statements of assets and liabilities as of November 30, 2023. For the three months ended November 30, 2024, the Company had $ 0.9 million of dividend income related to SLF JV, of which $ 0.0 million was included in dividend receivable on the consolidated statements of assets and liabilities as of November 30, 2024. For the three months ended November 30, 2023, the Company had $ 1.3 million of dividend income related to SLF JV, of which $ 0.0 million was included in dividend receivable on the consolidated statements of assets and liabilities and Liabilities as of November 30, 2023.

85

For the nine months ended November 30, 2024, the Company had $ 1.3 million of interest income related to SLF JV, of which $ 0.2 million was included in interest receivable on the consolidated statements of assets and liabilities as of November 30, 2024. For the nine months ended November 30, 2023, the Company had $ 1.3 million of interest income related to SLF JV, of which $ 0.2 million was included in interest receivable on the consolidated statements of assets and liabilities as of November 30, 2023. For the nine months ended November 30, 2024, the Company had $ 3.2 million of dividend income related to SLF JV, of which $ 0.0 million was included in dividend receivable on the consolidated statements of assets and liabilities as of November 30, 2024. For the nine months ended November 30, 2023, the Company had $ 4.7 million of dividend income related to SLF JV, of which $ 0.0 million was included in dividend receivable on the consolidated statements of assets and liabilities as of November 30, 2023.

As part of the JV CLO trust transaction, the Company purchased 87.50 % of the Class E Notes from SLF 2022 with a par value of $ 12.25 million.

Note 8. Borrowings

As a BDC, we are only allowed to employ leverage to the extent that our asset coverage, as defined in the 1940 Act, equals at least 200 % after giving effect to such leverage, or 150 % if certain requirements under the 1940 Act are met. On April 16, 2018, as permitted by the Small Business Credit Availability Act, which was signed into law on March 23, 2018, our board of directors, including a majority of our directors who are not “interested persons” (as defined in Section 2(a)(19) of the 1940 Act”) of the Company (“independent directors”), approved a minimum asset coverage ratio of 150 %. The 150 % asset coverage ratio became effective on April 16, 2019. The amount of leverage that we employ at any time depends on our assessment of the market and other factors at the time of any proposed borrowing. Our asset coverage ratio, as defined in the 1940 Act, was 160.1 % as of November 30, 2024 and 161.1 % as of February 29, 2024.

Revolving Credit Facilities and Term Facility

On April 11, 2007, we entered into a $ 100.0 million revolving securitized credit facility (the “Revolving Facility”). On May 1, 2007, we entered into a $ 25.7 million term securitized credit facility (the “Term Facility” and, together with the Revolving Facility, the “Facilities”), which was fully drawn at closing. In December 2007, we consolidated the Facilities by using a draw under the Revolving Facility to repay the Term Facility. In response to the market wide decline in financial asset prices, which negatively affected the value of our portfolio, we terminated the revolving period of the Revolving Facility effective January 14, 2009 and commenced a two-year amortization period during which all principal proceeds from the collateral were used to repay outstanding borrowings. A significant percentage of our total assets had been pledged under the Revolving Facility to secure our obligations thereunder. Under the Revolving Facility, funds were borrowed from or through certain lenders and interest was payable monthly at the greater of the commercial paper rate and our lender’s prime rate plus 4.00% plus a default rate of 2.00% or, if the commercial paper market was unavailable, the greater of the prevailing LIBOR rates and our lender’s prime rate plus 6.00% plus a default rate of 3.00%.

Madison Credit Facility

On July 30, 2010, we used the net proceeds from (i) the stock purchase transaction and (ii) a portion of the funds available to us under the $ 45.0 million senior secured revolving credit facility with Madison Capital Funding LLC (the “Madison Credit Facility”), in each case, to pay the full amount of principal and accrued interest, including default interest, outstanding under the Revolving Facility. As a result, the Revolving Facility was terminated in connection therewith. Substantially all of our total assets, other than those held by SBIC LP, SBIC II LP and SBIC III LP, were pledged under the Madison Credit Facility to secure our obligations thereunder.

On October 4, 2021, all outstanding amounts on the Madison Credit Facility were repaid and the Madison Credit Facility was terminated. The repayment and termination of the Madison Credit Facility resulted in a realized loss on the extinguishment of debt of $ 0.8 million.

86

Encina Credit Facility

On October 4, 2021, the Company entered into the Credit and Security Agreement (the “Encina Credit Agreement”) relating to a $ 50.0 million senior secured revolving credit facility with Encina, supported by loans held by SIF II and pledged to the Encina Credit Facility. The terms of the Encina Credit Facility required a minimum drawn amount of $ 12.5 million at all times during the first six months following the closing date, which increased to the greater of $ 25.0 million or 50 % of the commitment amount in effect at any time thereafter. Advances under the Encina Credit Facility originally bore interest at a floating rate per annum equal to LIBOR plus 4.0 %, with LIBOR having a floor of 0.75 %, with customary provisions related to the selection by Encina and the Company of a replacement benchmark rate.

On January 27, 2023, we entered into the first amendment to the Encina Credit Agreement to, among other things:

increase the borrowings available under the Encina Credit Facility from up to $50.0 million to up to $65.0 million;

change the underlying benchmark used to compute interest under the Encina Credit Agreement from LIBOR to Term SOFR for a one-month tenor plus a 0.10% credit spread adjustment;

increase the applicable effective margin rate on borrowings from 4.00% to 4.25%;

extend the revolving period from October 4, 2024 to January 27, 2026;

extend the period during which the borrower may request one or more increases in the borrowings available under the Encina Credit Facility (each such increase, a “Facility Increase”) from October 4, 2023 to January 27, 2025, and increased the maximum borrowings available pursuant to the Encina Facility Increase from $75.0 million to $150.0 million;

revise the eligibility criteria for eligible collateral loans to exclude certain industries in which an obligor or related guarantor may be involved; and

amend the provisions permitting the borrower to request an extension in the Commitment Termination Date (as defined in the Encina Credit Agreement) to allow requests to extend any applicable Commitment Termination Date, rather than a one-time request to extend the original Commitment Termination Date, subject to a notice requirement.

In addition to any fees or other amounts payable under the terms of the Encina Credit Facility, an administrative agent fee per annum equal to $ 0.1 million is payable in equal monthly installments in arrears.

As of November 30, 2024 and February 29, 2024, there were $ 32.5 million and $ 35.0 million outstanding borrowings under the Encina Credit Facility. During the applicable periods, the Company was in compliance with all of the limitations and requirements under the Encina Credit Agreement. Financing costs of $ 2.0 million related to the Encina Credit Facility have been capitalized and are being amortized over the term of the facility, with all existing financing costs amortized through January 27, 2026 from the date of the amendment and extension.

For the three months ended November 30, 2024 and November 30, 2023, we recorded $ 0.8 million and $ 0.9 million of interest expense related to the Encina Credit Facility, respectively, which includes commitment and administrative agent fees. For the three months ended November 30, 2024 and November 30, 2023, we recorded $ 0.1 million and $ 0.1 million of deferred financing costs related to the Encina Credit Facility, respectively. Interest expense and amortization of deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. During the three months ended November 30, 2024 and November 30, 2023, the weighted average interest rate on the outstanding borrowings under the Encina Credit Facility was 9.40 % and 9.79 %, respectively, and the average dollar amount of outstanding borrowings under the Encina Credit Facility was $ 32.5 million and $ 35.0 million, respectively.

87

For the nine months ended November 30, 2024 and November 30, 2023, we recorded $ 2.6 million and $ 3.0 million of interest expense related to the Encina Credit Facility, respectively, which includes commitment and administrative agent fees. For the nine months ended November 30, 2024 and November 30, 2023, we recorded $ 0.3 million and $ 0.3 million of deferred financing costs related to the Encina Credit Facility, respectively. Interest expense and amortization of deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. During the nine months ended November 30, 2024 and November 30, 2023, the weighted average interest rate on the outstanding borrowings under the Encina Credit Facility was 9.73 % and 9.62 %, respectively, and the average dollar amount of outstanding borrowings under the Encina Credit Facility was $ 33.3 million and $ 38.9 million, respectively.

The Encina Credit Facility contains limitations as to how borrowed funds may be used, such as restrictions on industry concentrations, asset size, weighted average life, currency denomination and collateral interests. The Encina Credit Facility also includes certain requirements relating to portfolio performance, the violation of which could result in the limit of further advances and, in some cases, result in an event of default, allowing the lenders to accelerate repayment of amounts owed thereunder. Availability on the Encina Credit Facility will be subject to a borrowing base calculation, based on, among other things, applicable advance rates (which vary from 50.0% to 75.0% of par or fair value depending on the type of loan asset) and the value of certain “eligible” loan assets included as part of the borrowing base. Funds may be borrowed at the greater of the prevailing one-month SOFR rate, plus an applicable effective margin of 4.25%. In addition, the Company will pay the lender a commitment fee of 0.75% per year (or 0.50% if the ratio of advances outstanding to aggregate commitments is greater than or equal to 50%) on the unused amount of the Encina Credit Facility.

Our borrowing base under the Encina Credit Facility is $ 85.1 million subject to the Encina Credit Facility cap of $ 65.0 million at November 30, 2024. For purposes of determining the borrowing base, most assets are assigned the values set forth in our most recent Annual Report on Form 10-K or Quarterly Report on Form 10-Q filed with the U.S. Securities and Exchange Commission (“SEC”). Accordingly, the November 30, 2024 borrowing base relies upon the valuations set forth in the Quarterly Report on Form 10-Q for the period ended August 31, 2024. The valuations presented in this Quarterly Report on Form 10-Q will not be incorporated into the borrowing base until after this Quarterly Report on Form 10-Q is filed with the SEC.

Live Oak Facility

On March 27, 2024, the Company and its wholly owned special purpose subsidiary, SIF III, entered into a credit and security agreement (the “Live Oak Credit Agreement”), by and among SIF III, as borrower, the Company, as collateral manager and equityholder, the lenders from time to time parties thereto, Live Oak, as administrative agent and collateral agent, U.S. Bank National Association, as custodian, and U.S. Bank Trust Company, National Association, as collateral administrator, relating to Live Oak Credit Facility.

The Live Oak Credit Facility originally provided for borrowings in U.S. dollars in an aggregate amount of up to $ 50.0 million. During the first two years following the closing date, SIF III may request one or more increases in the commitment amount from $ 50.0 million to an amount not to exceed $ 150.0 million, subject to certain terms and conditions and a customary fee. The terms of the Live Oak Credit Agreement require a minimum drawn amount of $ 12.5 million at all times during the period ending March 27, 2025 and, thereafter, the greater of: (i) $ 25.0 million and (ii) 50 % of the facility amount in effect at such time. The Live Oak Credit Facility matures on March 27, 2027. Advances are available during the term of the Live Oak Credit Facility and must be repaid in full at maturity. SIF III may request an extension of the maturity date by an additional one year, subject to the agreement of the lenders and an extension fee.

On June 14, 2024, the Company entered into the first amendment to the Live Oak Credit Agreement (the “Amendment”). The Amendment, among other things:

increased the borrowings available under the Live Oak Credit Facility from up to $ 50.0 million to up to $ 75.0 million, subject to a borrowing base requirement;

added new lenders (as identified in the Amendment) to the Live Oak Credit Agreement;

replaced administrative agent approval with “Required Lender” (as defined in the Live Oak Credit Agreement) approval with respect to certain matters;

88

replaced Required Lender approval with 100 % lender approval with respect to certain matters; and

changed the definition of Required Lender to require the approval of at least two unaffiliated lenders.

Advances under the Live Oak Credit Facility are subject to a borrowing base calculation, and the Live Oak Credit Facility has various eligibility criteria for loans to be included in the borrowing base. Advances under the Live Oak Credit Facility bear interest at a floating rate per annum equal to Adjusted Term SOFR plus an applicable margin between 3.50 % and 4.25 % based on the Live Oak Credit Facility’s utilization. The Live Oak Credit Agreement also provides for an unused fee of 0.50 % on the unused commitments. SIF III’s obligations to the lenders under the Live Oak Credit Facility are secured by a first priority security interest in substantially all of SIF III’s assets. In addition, SIF III’s obligations to the lenders under the Live Oak Credit Facility are secured by a pledge by the Company of its equity interests in SIF III, which is evidenced by the equity pledge agreement, dated as of March 27, 2024, by and between the Company, as pledgor, and Live Oak, as collateral agent for the benefit of the secured parties.

In connection with the Live Oak Credit Agreement, the Company entered into a loan sale and contribution agreement with SIF III, dated as of March 27, 2024, by and between the Company, as seller, and SIF III, as purchaser, pursuant to which the Company will sell or contribute certain loans held by the Company to SIF III to be used to support the borrowing base under the Live Oak Credit Facility. The Live Oak Credit Facility permits loan proceeds and excess cash in SIF III’s collection accounts to be distributed to us at any time based on three business days advance notice, subject to compliance with various conditions, including the absence of a default or event of default, the absence of an over-advance against the borrowing base and the absence of a violation of the financial covenants.

As of November 30, 2024 there was $ 20.0 million in outstanding borrowings under the Live Oak Credit Facility. During the applicable period, the Company was in compliance with all of the limitations and requirements under the Live Oak Credit Agreement.

For the three months ended November 30, 2024, we recorded $ 0.5 million of interest expense related to the Live Oak Credit Facility, which includes commitment and administrative agent fees. For the three months ended November 30, 2024, we recorded $ 0.1 million of deferred financing costs related to the Live Oak Credit Facility. Interest expense and amortization of deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. During the three months ended November 30, 2024, the weighted average interest rate on the outstanding borrowings under the Live Oak Credit Facility was 9.00 %, and the average dollar amount of outstanding borrowings under the Live Oak Credit Facility was $ 20.0 million.

For the nine months ended November 30, 2024, we recorded $ 1.4 million of interest expense related to the Live Oak Credit Facility, which includes commitment and administrative agent fees. For the nine months ended November 30, 2024, we recorded $ 0.2 million of deferred financing costs related to the Live Oak Credit Facility. Interest expense and amortization of deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. During the nine months ended November 30, 2024, the weighted average interest rate on the outstanding borrowings under the Live Oak Credit Facility was 9.34 %, and the average dollar amount of outstanding borrowings under the Live Oak Credit Facility was $ 17.3 million.

Our borrowing base under the Live Oak Credit Facility is $ 86.4 million subject to the Live Oak Credit Facility cap of $ 75.0 million at November 30, 2024. For purposes of determining the borrowing base, most assets are assigned the values set forth in our most recent Annual Report on Form 10-K or Quarterly Report on Form 10-Q filed with the U.S. Securities and Exchange Commission (“SEC”). Accordingly, the November 30, 2024 borrowing base relies upon the valuations set forth in the Quarterly Report on Form 10-Q for the period ended August 31, 2024. The valuations presented in this Quarterly Report on Form 10-Q will not be incorporated into the borrowing base until after this Quarterly Report on Form 10-Q is filed with the SEC.

89

SBA Debentures

The Company’s wholly owned subsidiaries, SBIC II LP and SBIC III LP, received SBIC licenses from the SBA on August 14, 2019 and September 29, 2022, respectively. Each of the SBIC Subsidiaries provide up to $ 175.0 million in long-term capital in the form of debentures guaranteed by the SBA. The Company’s wholly owned subsidiary, SBIC LP, repaid its outstanding debentures and subsequently surrendered its license to the SBA on January 3, 2024, providing the Company access to all undistributed capital of SBIC LP, and SBIC LP subsequently merged with and into the Company. Under current SBIC regulations, for two or more SBICs under common control, the maximum amount of outstanding SBA debentures cannot exceed $ 350.0 million.

SBICs are designed to stimulate the flow of private equity capital to eligible small businesses. Under SBA regulations, SBICs may make loans to eligible small businesses and invest in the equity securities of small businesses. Under present SBA regulations, eligible small businesses include businesses that have a tangible net worth not exceeding $ 24.0 million and have average annual fully taxed net income not exceeding $ 8.0 million for the two most recent fiscal years. In addition, an SBIC must devote 25.0 % of its investment activity to “smaller enterprises” as defined by the SBA. A smaller enterprise is one that has a net worth not exceeding $ 6.0 million and has average annual fully taxed net income not exceeding $ 2.0 million for the two most recent fiscal years. SBA regulations also provide alternative size standard criteria to determine eligibility, which depend on the industry in which the business is engaged and are based on such factors as the number of employees and gross sales. According to SBA regulations, SBICs may make long-term loans to small businesses, invest in the equity securities of such businesses and provide them with consulting and advisory services.

The SBIC Subsidiaries are able to borrow funds from the SBA against each SBIC’s regulatory capital (which generally approximates equity capital in the respective SBIC). The SBIC Subsidiaries are subject to customary regulatory requirements including but not limited to, a periodic examination by the SBA and requirements to maintain certain minimum financial ratios and other covenants. Receipt of an SBIC license does not assure that the SBIC Subsidiaries will receive SBA-guaranteed debenture funding, which is dependent upon the SBIC Subsidiaries complying with SBA regulations and policies. The SBA, as a creditor, will have a superior claim to each SBIC Subsidiary’s assets over the Company’s stockholders and debtholders in the event that the Company liquidates such SBIC Subsidiary or the SBA exercises its remedies under the SBA-guaranteed debentures issued by the SBIC Subsidiary upon an event of default.

The Company received exemptive relief from the SEC to permit it to exclude the debentures guaranteed by the SBA of the SBIC Subsidiaries from the definition of senior securities in the asset coverage test under the 1940 Act. This allows the Company increased flexibility under the asset coverage requirement by permitting it to borrow up to $ 350.0 million more than it would otherwise be able to absent the receipt of this exemptive relief.

As of November 30, 2024, we have funded SBIC II LP and SBIC III LP with an aggregate total of equity capital of $ 87.5 million and $ 66.7 million, respectively, and have $ 214.0 million in SBA-guaranteed debentures outstanding, of which $ 175.0 million was held by SBIC II LP and $ 39.0 million held in SBIC III LP.

As noted above, as of November 30, 2024, there was $ 214.0 million of SBA debentures outstanding and as of February 29, 2024, there was $ 214.0 million of SBA debentures outstanding. The carrying amount of the amount outstanding of SBA debentures approximates its fair value, which is based on a waterfall analysis showing adequate collateral coverage and would be classified as a Level 3 liability within the fair value hierarchy. Financing costs of $6.0 million, and $0.4 million related to the SBA debentures issued by SBIC II LP and SBIC III LP, respectively, have been capitalized and are being amortized over the term of the commitment and drawdown.

For the three months ended November 30, 2024 and November 30, 2023, the Company recorded $ 1.8 million and $ 1.6 million of interest expense related to the SBA debentures, respectively. For the three months ended November 30, 2024 and November 30, 2023, the Company recorded $ 0.2 million and $ 0.3 million of amortization of deferred financing costs related to the SBA debentures, respectively. Interest expense and amortization of deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. The weighted average interest rate during the three months ended November 30, 2024 and November 30, 2023 on the outstanding borrowings of the SBA debentures was 3.30 % and 3.25 %, respectively. During the three months ended November 30, 2024 and November 30, 2023, the average dollar amount of SBA debentures outstanding was $ 214.0 million and $ 200.4 million, respectively.

90

For the nine months ended November 30, 2024 and November 30, 2023, the Company recorded $ 5.3 million and $ 4.6 million of interest expense related to the SBA debentures, respectively. For the nine months ended November 30, 2024 and November 30, 2023, the Company recorded $ 0.7 million and $ 0.7 million of amortization of deferred financing costs related to the SBA debentures, respectively. Interest expense and amortization of deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. The weighted average interest rate during the nine months ended November 30, 2024 and November 30, 2023 on the outstanding borrowings of the SBA debentures was 3.33 % and 3.01 %, respectively. During the nine months ended November 30, 2024 and November 30, 2023, the average dollar amount of SBA debentures outstanding was $ 214.0 million and $ 201.7 million, respectively.

Notes

7.75% 2025 Notes

On July 9, 2020, the Company issued $ 5.0 million in aggregate principal amount of 7.75 % fixed-rate notes due in 2025 (the “7.75% 2025 Notes”) for net proceeds of $ 4.8 million after deducting underwriting commissions of approximately $ 0.2 million. Offering costs incurred were approximately $ 0.1 million. Interest on the 7.75% 2025 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 7.75% per year. The 7.75% 2025 Notes mature on July 9, 2025 and may be redeemed in whole or in part at any time or from time to time at the Company’s option subject to a fee depending on the date of repayment. The net proceeds from the offering were used for general corporate purposes in accordance with the Company’s investment objective and strategies. Financing costs of $ 0.3 million related to the 7.75% 2025 Notes have been capitalized and are being amortized over the term of the 7.75% 2025 Notes.

As of November 30, 2024, the total amount of 7.75% 2025 Notes outstanding was $ 5.0 million. The 7.75% 2025 Notes are not listed and have a par value of $ 25.00 per note. The carrying amount of the outstanding 7.75% 2025 Notes had a fair value of $ 5.0 million, which is based on a market yield analysis and would be classified as a Level 3 liability within the fair value hierarchy. As of February 29, 2024, the carrying amount and fair value of the 7.75% 2025 Notes was $ 5.0 million and $ 5.0 million, respectively.

For the three months ended November 30, 2024 and November 30, 2023, the Company recorded $ 0.1 million and $ 0.1 million, respectively, of interest expense and $ 0.01 million and $ 0.01 million, respectively, of amortization of deferred financing costs related to the 7.75% 2025 Notes. Interest expense and amortization of deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. During the three months ended November 30, 2024 and November 30, 2023, the average dollar amount of 7.75% 2025 Notes outstanding was $ 5.0 million and $ 5.0 million respectively.

For the nine months ended November 30, 2024 and November 30, 2023, the Company recorded $ 0.3 million and $ 0.3 million, respectively, of interest expense and $ 0.04 million and $ 0.04 million, respectively, of amortization of deferred financing costs related to the 7.75% 2025 Notes. Interest expense and amortization of deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. During the nine months ended November 30, 2024 and November 30, 2023, the average dollar amount of 7.75% 2025 Notes outstanding was $ 5.0 million and $ 5.0 million respectively.

6.25% 2027 Notes

On December 29, 2020, the Company issued $ 5.0 million in aggregate principal amount of 6.25 % fixed-rate notes due in 2027 (the “6.25% 2027 Notes”). Offering costs incurred were approximately $ 0.1 million. Interest on the 6.25% 2027 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 6.25% per year. The 6.25% 2027 Notes mature on December 29, 2027 and may be redeemed in whole or in part at any time or from time to time at the Company’s option, on or after December 29, 2024. The net proceeds from the offering were used for general corporate purposes in accordance with the Company’s investment objective and strategies. Financing costs of $ 0.1 million related to the 6.25% 2027 Notes have been capitalized and are being amortized over the term of the Notes.

91

On January 28, 2021, the Company issued an additional $ 10.0 million in aggregate principal amount of the 6.25% 2027 Notes for net proceeds of $ 9.7 million after deducting underwriting commissions of approximately $ 0.3 million (the “Additional 6.25% 2027 Notes”). Offering costs incurred were approximately $ 0.1 million. The Additional 6.25% 2027 Notes are treated as a single series with the existing 6.25% 2027 Notes under the indenture and have the same terms as the existing 6.25% 2027 Notes. Interest on the 6.25% 2027 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 6.25% per year. The 6.25% 2027 Notes mature on January 28, 2027 and commencing January 28, 2023, may be redeemed in whole or in part at any time or from time to time at the Company’s option. The net proceeds from the offering were used for general corporate purposes in accordance with the Company’s investment objective and strategies. Financing costs of $ 0.4 million related to the 6.25% 2027 Notes have been capitalized and are being amortized over the term of the 6.25% 2027 Notes. The 6.25% 2027 Notes are not listed and have a par value of $ 25.00 per note.

As of November 30, 2024, the total amount of 6.25% 2027 Notes outstanding was $ 15.0 million. The 6.25% 2027 Notes are not listed and have a par value of $ 25.00 per note. The carrying amount of the outstanding 6.25% 2027 Notes had a fair value of $ 14.5 million, which is based on a market yield analysis and would be classified as a Level 3 liability within the fair value hierarchy. As of February 29, 2024, the carrying amount and fair value of the 6.25% 2027 Notes was $ 15.0 million and $ 14.2 million, respectively.

For the three months ended November 30, 2024 and November 30, 2023, the Company recorded $ 0.2 million and $ 0.2 million, respectively, of interest expense and $ 0.02 million and $ 0.02 million, respectively, of amortization of deferred financing costs related to the 6.25% 2027 Notes. Interest expense and amortization of deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. During the three months ended November 30, 2024 and November 30, 2023 the average dollar amount of 6.25% 2027 Notes outstanding was $ 15.0 million and $ 15.0 million respectively.

For the nine months ended November 30, 2024 and November 30, 2023, the Company recorded $ 0.7 million and $ 0.7 million, respectively, of interest expense and $ 0.05 million and $ 0.05 million, respectively, of amortization of deferred financing costs related to the 6.25% 2027 Notes. Interest expense and amortization of deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. During the nine months ended November 30, 2024 and November 30, 2023 the average dollar amount of 6.25% 2027 Notes outstanding was $ 15.0 million and $ 15.0 million respectively.

4.375% 2026 Notes

On March 10, 2021, the Company issued $ 50.0 million in aggregate principal amount of 4.375 % fixed-rate notes due in 2026 (the “4.375% 2026 Notes”) for net proceeds of $ 49.0 million after deducting underwriting commissions of approximately $ 1.0 million. Offering costs incurred were approximately $ 0.3 million. Interest on the 4.375% 2026 Notes is paid semi-annually in arrears on February 28 and August 28, at a rate of 4.375% per year. The 4.375% 2026 Notes mature on February 28, 2026 and may be redeemed in whole or in part at any time on or after November 28, 2025 at par plus a “make-whole” premium, and thereafter at par. The net proceeds from the offering were used for general corporate purposes in accordance with the Company’s investment objective and strategies. Financing costs of $ 1.3 million related to the 4.375% 2026 Notes have been capitalized and are being amortized over the term of the 4.375% 2026 Notes.

On July 15, 2021, the Company issued an additional $ 125.0 million in aggregate principal amount of the 4.375% 2026 Notes (the “Additional 4.375% 2026 Notes”) for net proceeds for approximately $ 123.8 million, based on the public offering price of 101.00 % of the aggregate principal amount of the Additional 4.375% 2026 Notes, after deducting the underwriting commissions of $ 2.5 million. Offering costs incurred were approximately $ 0.2 million. The Additional 4.375% 2026 Notes are treated as a single series with the existing 4.375% 2026 Notes under the indenture and have the same terms as the existing 4.375% 2026 Notes. The net proceeds from the offering were used to redeem all of the outstanding 6.25% 2025 Notes (as described above), and for general corporate purposes in accordance with the Company’s investment objective and strategies. Financing costs of $ 2.7 million have been capitalized and are being amortized over the term of the additional 4.375% 2026 Notes.

92

As of November 30, 2024, the total amount of 4.375% 2026 Notes outstanding was $ 175.0 million. The 4.375% 2026 Notes are not listed and are issued in minimum denominations of $ 2,000 and integral multiples of $ 1,000 in excess thereof. The carrying amount of the outstanding 4.375% 2026 Notes had a fair value of $ 168.0 million, which is based on a market yield analysis and would be classified as a Level 3 liability within the fair value hierarchy. As of February 29, 2024, the carrying amount and fair value of the 4.375% 2026 Notes was $ 175.0 million and $ 163.4 million, respectively.

For the three months ended November 30, 2024 and November 30, 2023, the Company recorded $ 1.9 million and $ 1.9 million, respectively, of interest expense, $ 0.1 million and $ 0.1 million, respectively, of amortization of deferred financing costs and $ 0.08 million and $ 0.08 million, respectively, of amortization of premium on issuance of 4.375% Notes due 2026 (inclusive of the issuance of the Additional 4.375% 2026 Notes). Interest expense, amortization of deferred financing costs and amortization of premium on issuance of notes are reported as interest and debt financing expense on the consolidated statements of operations. During the three months ended November 30, 2024 and November 30, 2023, the average dollar amount of 4.375% 2026 Notes outstanding was $ 175.0 million and $ 175.0 million, respectively.

For the nine months ended November 30, 2024 and November 30, 2023, the Company recorded $ 5.7 million and $ 5.7 million, respectively, of interest expense, $ 0.4 million and $ 0.4 million, respectively, of amortization of deferred financing costs and $ 0.2 million and $ 0.2 million, respectively, of amortization of premium on issuance of 4.375% Notes due 2026 (inclusive of the issuance of the Additional 4.375% 2026 Notes). Interest expense, amortization of deferred financing costs and amortization of premium on issuance of notes are reported as interest and debt financing expense on the consolidated statements of operations. During the nine months ended November 30, 2024 and November 30, 2023, the average dollar amount of 4.375% 2026 Notes outstanding was $ 175.0 million and $ 175.0 million, respectively.

4.35% 2027 Notes

On January 19, 2022, the Company issued $ 75.0 million in aggregate principal amount of 4.35 % fixed-rate notes due in 2027 (the “4.35% 2027 Notes”) for net proceeds of $ 73.0 million, based on the public offering price of 99.317 % of the aggregate principal amount of the 4.35% 2027 Notes, after deducting the underwriting commissions of approximately $ 1.5 million. Offering costs incurred were approximately $ 0.3 million. Interest on the 4.35% 2027 Notes is paid semi-annually in arrears on February 28 and August 28, at a rate of 4.35% per year. The 4.35% 2027 Notes mature on February 28, 2027 and may be redeemed in whole or in part at the Company’s option at any time prior to November 28, 2026, at par plus a “make-whole” premium, and thereafter at par. The net proceeds from the offering were used for general corporate purposes in accordance with the Company’s investment objective and strategies. Financing costs of $ 1.8 million related to the 4.35% 2027 Notes have been capitalized and are being amortized over the term of the 4.35% 2027 Notes.

As of November 30, 2024, the total amount of 4.35% 2027 Notes outstanding was $ 75.0 million. The 4.35% 2027 Notes are not listed. The carrying amount of the outstanding 4.35% 2027 Notes had a fair value of $ 69.8 million, which is based on a market yield analysis and would be classified as a Level 3 liability within the fair value hierarchy. As of February 29, 2024, the carrying amount and fair value of the 4.35% 2027 Notes was $ 75.0 million and $ 64.5 million, respectively.

For the three months ended November 30, 2024 and November 30, 2023, the Company recorded $ 0.8 million and $ 0.8 million, respectively, of interest expense, $ 0.1 million and $ 0.1 million, respectively, of amortization of deferred financing costs and $ 0.02 million and $ 0.02 million, respectively, of amortization of on issuance of the 4.35% Notes due 2027 (inclusive of the issuance of the Additional 4.35% 2027 Notes). Interest expense, amortization of deferred financing costs, and amortization of discount on issuance of notes and deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. During the three months ended November 30, 2024 and November 30, 2023, the average dollar amount of 4.35% 2027 Notes outstanding was $ 75.0 million and $ 75.0 million, respectively.

For the nine months ended November 30, 2024 and November 30, 2023, the Company recorded $ 2.4 million and $ 2.4 million, respectively, of interest expense, $ 0.3 million and $ 0.3 million, respectively, of amortization of deferred financing costs and $ 0.08 million and $ 0.08 million, respectively, of amortization of on issuance of the 4.35% Notes due 2027 (inclusive of the issuance of the Additional 4.35% 2027 Notes). Interest expense, amortization of deferred financing costs, and amortization of discount on issuance of notes and deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. During the nine months ended November 30, 2024 and November 30, 2023, the average dollar amount of 4.35% 2027 Notes outstanding was $ 75.0 million and $ 75.0 million, respectively.

93

6.00% 2027 Notes

On April 27, 2022, the Company issued $ 87.5 million in aggregate principal amount of 6.00% fixed-rate notes due 2027 (the “6.00% 2027 Notes”) for net proceeds of $ 84.8 million after deducting underwriting commissions of approximately $ 2.7 million. Offering costs incurred were approximately $ 0.1 million. On May 10, 2022, the underwriters partially exercised their option to purchase an additional $ 10.0 million in aggregate principal amount of the 6.00% 2027 Notes. Net proceeds to the Company were $ 9.7 million after deducting underwriting commissions of approximately $ 0.3 million. Interest on the 6.00% 2027 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 6.00% per year. The 6.00% 2027 Notes mature on April 30, 2027 and commencing April 27, 2024, may be redeemed in whole or in part at any time or from time to time at the Company’s option. The net proceeds from the offering were used for general corporate purposes in accordance with the Company’s investment objective and strategies. Financing costs of $ 3.3 million related to the 6.00% 2027 Notes have been capitalized and are being amortized over the term of the 6.00% 2027 Notes. The 6.00% 2027 Notes are listed on the NYSE under the trading symbol “SAT” with a par value of $ 25.00 per note.

On August 15, 2022, the Company issued an additional $ 8.0 million in aggregate principal amount of the 6.00% 2027 Notes (the “Additional 6.00% 2027 Notes”) for net proceeds of $ 7.8 million, based on the public offering price of 97.80 % of the aggregate principal amount of the 6.00 % 2027 Notes. Additional offering costs incurred were approximately $ 0.2 million. The Additional 6.00% 2027 Notes are treated as a single series with the existing 6.00% 2027 Notes under the indenture and have the same terms as the existing 6.00% 2027 Notes. The net proceeds from the offering were used for general corporate purposes in accordance with the Company’s investment objective and strategies. Additional financing costs of $ 0.3 million related to the 6.00% 2027 Notes have been capitalized and are being amortized over the term of the 6.00% 2027 Notes.

As of November 30, 2024, the carrying amount and fair value of the 6.00% 2027 Notes was $ 105.5 million and $ 103.4 million, respectively. The fair value of the 6.00% 2027 Notes, which are publicly traded, is based upon closing market quotes as of the measurement date and would be classified as a Level 1 liability within the fair value hierarchy. As of February 29, 2024, the carrying amount and fair value of the 6.00% 2027 Notes was $ 105.5 million and $ 100.7 million, respectively.

For the three months ended November 30, 2024 and November 30, 2023, the Company recorded $ 1.6 million and $ 1.6 million, respectively, of interest expense, $ 0.2 million and $ 0.2 million, respectively, of amortization of deferred financial costs and $ 0.01 million and $ 0.01 million, respectively, of amortization of discount on issuance of 6.00% Notes due 2027. Interest expense and amortization of discount and deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. During the three months ended November 30, 2024 and November 30, 2023, the average dollar amount of 6.00% 2027 Notes outstanding was $ 105.5 million and $ 105.5 million, respectively.

For the nine months ended November 30, 2024 and November 30, 2023, the Company recorded $ 4.7 million and $ 4.7 million, respectively, of interest expense, $ 0.6 million and $ 0.6 million, respectively, of amortization of deferred financial costs and $ 0.03 million and $ 0.03 million, respectively, of amortization of discount on issuance of 6.00% Notes due 2027. Interest expense and amortization of discount and deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. During the nine months ended November 30, 2024 and November 30, 2023, the average dollar amount of 6.00% 2027 Notes outstanding was $ 105.5 million and $ 105.5 million, respectively.

7.00% 2025 Notes

On September 8, 2022, the Company issued $ 12.0 million in aggregate principal amount of 7.00 % fixed-rate notes due 2025 (the “7.00% 2025 Notes”) for net proceeds of $ 11.6 million after deducting underwriting discounts of approximately $ 0.4 million. Additional offering costs incurred were approximately $ 0.05 million. Interest on the 7.00% 2025 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 7.00% per year. The 7.00% 2025 Notes mature on September 8, 2025 and commencing September 8, 2024, may be redeemed in whole or in part at any time or from time to time at the Company’s option. The net proceeds from the offering were used for general corporate purposes in accordance with the Company’s investment objective and strategies. Financing costs of $ 0.04 million related to the 7.00% 2025 Notes have been capitalized and are being amortized over the term of the 7.00% 2025 Notes.

94

As of November 30, 2024, the total amount of 7.00% 2025 Notes outstanding was $12.0 million. The 7.00% 2025 Notes are not listed. The carrying amount of the outstanding 7.00% 2025 Notes had a fair value of $ 11.9 million, which is based on a market yield analysis and would be classified as a Level 3 liability within the fair value hierarchy. As of February 29, 2024, the carrying amount and fair value of the 7.00% 2025 Notes was $ 12.0 million and $ 11.8 million, respectively.

For the three months ended November 30, 2024 and November 30, 2023, the Company recorded $ 0.2 million and $ 0.2 million, respectively, of interest expense, $ 0.03 million and $ 0.03 million, respectively, of amortization of deferred financial costs and $ 0.03 million and $ 0.03 million, respectively, of amortization of discount on issuance of 7.00% 2025 Notes. Interest expense and amortization of discount and deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. During the three months ended November 30, 2024 and November 30, 2023, the average dollar amount of 7.00% 2025 Notes outstanding was $ 12.0 million and $ 12.0 million, respectively.

For the nine months ended November 30, 2024 and November 30, 2023, the Company recorded $ 0.6 million and $ 0.6 million, respectively, of interest expense, $ 0.1 million and $ 0.09 million, respectively, of amortization of deferred financial costs and $ 0.09 million and $ 0.08 million, respectively, of amortization of discount on issuance of 7.00% 2025 Notes. Interest expense and amortization of discount and deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. During the nine months ended November 30, 2024 and November 30, 2023, the average dollar amount of 7.00% 2025 Notes outstanding was $ 12.0 million and $ 12.0 million, respectively.

8.00% 2027 Notes

On October 27, 2022, the Company issued $ 40.0 million in aggregate principal amount of our 8.00% fixed-rate notes due 2027 (the “8.00% 2027 Notes”) for net proceeds of $ 38.7 million after deducting underwriting commissions of approximately $ 1.3 million. Offering costs incurred were approximately $ 0.2 million. On November 10, 2022, the underwriters partially exercised their option to purchase an additional $ 6.0 million in aggregate principal amount of the 8.00% 2027 Notes. Net proceeds to the Company were $ 5.8 million after deducting underwriting commissions of approximately $ 0.2 million. Interest on the 8.00% 2027 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 8.00% per year . The 8.00% 2027 Notes mature on October 31, 2027 and commencing October 27, 2024, may be redeemed in whole or in part at any time or from time to time at the Company’s option. The net proceeds from the offering were used for general corporate purposes in accordance with the Company’s investment objective and strategies. Financing costs of $ 1.7 million related to the 8.00% 2027 Notes have been capitalized and are being amortized over the term of the 8.00% 2027 Notes. The 8.00% 2027 Notes are listed on the NYSE under the trading symbol “SAJ” with a par value of $ 25.00 per note.

As of November 30, 2024, the carrying amount and fair value of the 8.00% 2027 Notes was $ 46.0 million and $ 46.1 million, respectively. The fair value of the 8.00% 2027 Notes, which are publicly traded, is based upon closing market quotes as of the measurement date and would be classified as a Level 1 liability within the fair value hierarchy. As of February 29, 2024, the carrying amount and fair value of the 8.00% 2027 Notes was $ 46.0 million and $ 46.2 million, respectively.

For the three months ended November 30, 2024 and November 30, 2023, the Company recorded $ 0.9 million and $ 0.9 million, respectively, of interest expense and $ 0.09 million and $ 0.09 million, respectively, of amortization of deferred financing costs related to the 8.00% 2027 Notes. Interest expense and amortization of deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. During the three months ended November 30, 2024 and November 30, 2023, the average dollar amount of 8.00% 2027 Notes outstanding was $ 46.0 million and $ 46.0 million, respectively.

95

For the nine months ended November 30, 2024 and November 30, 2023, the Company recorded $ 2.8 million and $ 2.8 million, respectively, of interest expense and $ 0.3 million and $ 0.3 million, respectively, of amortization of deferred financing costs related to the 8.00% 2027 Notes. Interest expense and amortization of deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. During the nine months ended November 30, 2024 and November 30, 2023, the average dollar amount of 8.00% 2027 Notes outstanding was $ 46.0 million and $ 46.0 million, respectively.

8.125% 2027 Notes

On December 13, 2022, the Company issued $ 52.5 million in aggregate principal amount of 8.125 % fixed-rate notes due 2027 (the “8.125% 2027 Notes”) for net proceeds of $ 50.8 million after deducting underwriting commissions of approximately $ 1.6 million. Offering costs incurred were approximately $ 0.1 million. On December 21, 2022, the underwriters fully exercised their option to purchase an additional $7.9 million in aggregate principal amount of the 8.125% 2027 Notes. Net proceeds to the Company were $7.6 million after deducting underwriting commissions of approximately $0.2 million. Interest on the 8.125% 2027 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 8.125% per year. The 8.125% 2027 Notes mature on December 31, 2027 and commencing December 13, 2024, may be redeemed in whole or in part at any time or from time to time at the Company’s option. The net proceeds from this offering were used to make investments in middle-market companies (including investments made through our SBIC Subsidiaries) in accordance with the Company’s investment objective and strategies and for general corporate purposes. Financing costs of $2.0 million related to the 8.125% 2027 Notes have been capitalized and are being amortized over the term of the 8.125% 2027 Notes. The 8.125% 2027 Notes are listed on the NYSE under the trading symbol “SAY” with a par value of $ 25.00 per note.

As of November 30, 2024, the carrying amount and fair value of the 8.125% 2027 Notes was $ 60.4 million and $ 61.1 million, respectively. The fair value of the 8.125% 2027 Notes, which are publicly traded, is based upon closing market quotes as of the measurement date and would be classified as a Level 1 liability within the fair value hierarchy. As of February 29, 2024, the carrying amount and fair value of the 8.125% 2027 Notes was $ 60.4 million and $ 60.8 million, respectively.

For the three months ended November 30, 2024 and November 30, 2023, the Company recorded $ 1.2 million and $ 1.2 million, respectively, of interest expense and $ 0.1 million and $ 0.1 million, respectively, of amortization of deferred financing costs related to the 8.125% 2027 Notes. Interest expense and amortization of discount and deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. During the three months ended November 30, 2024 and November 30, 2023 the average dollar amount of 8.125% 2027 Notes outstanding was $ 60.4 million and $ 60.4 million respectively.

For the nine months ended November 30, 2024 and November 30, 2023, the Company recorded $ 3.7 million and $ 3.7 million, respectively, of interest expense and $ 0.3 million and $ 0.3 million, respectively, of amortization of deferred financing costs related to the 8.125% 2027 Notes. Interest expense and amortization of discount and deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. During the nine months ended November 30, 2024 and November 30, 2023 the average dollar amount of 8.125% 2027 Notes outstanding was $ 60.4 million and $ 60.4 million respectively.

8.75% 2025 Notes

On March 31, 2023, the Company issued $ 10.0 million in aggregate principal amount of 8.75% fixed-rate notes due 2024 (the “8.75% 2025 Notes”) for net proceeds of $ 9.7 million after deducting underwriting discounts of approximately $ 0.4 million. On May 1, 2023, the Company issued an additional $ 10.0 million in aggregate principal amount of the 8.75% 2025 Notes for net proceeds of $ 9.7 million after deducting underwriting discounts of approximately $ 0.4 million. Offering costs incurred were approximately $ 0.03 million. Interest on the 8.75% 2025 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 8.75% per year. On February 2, 2024, pursuant to the terms of the indenture governing the 8.75% 2025 Notes, the Company elected to exercise its option to extend the maturity date of the 8.75% 2025 Notes from March 31, 2024 to March 31, 2025. Net proceeds from this offering were used to make investments in middle-market companies (including investments made through the SBIC Subsidiaries) in accordance with the Company’s investment objective and strategies and general corporate purposes. Financing costs and discounts of $0.7 million related to the 8.75% 2025 Notes have been capitalized and are being amortized over the term of the 8.75% 2025 Notes.

96

As of November 30, 2024, the total amount of 8.75% 2025 Notes outstanding was $ 20.0 million. The 8.75% 2025 Notes are not listed. The carrying amount of the outstanding 8.75% 2025 Notes had a fair value of $ 20.0 million, which is based on a market yield analysis and would be classified as a Level 3 liability within the fair value hierarchy. As of February 29, 2024, the carrying amount and fair value of the 8.75% 2025 Notes was $ 20.0 million and $ 20.1 million, respectively.

For the three months ended November 30, 2024 and November 30, 2023, the Company recorded $ 0.4 million and $ 0.4 million, respectively, of interest expense, $ 0.03 million and $ 0.2 million, respectively, of amortization of deferred financial costs and $ 0.03 million and $ 0.2 million, respectively, of amortization of discount related to the 8.75% 2025 Notes. Interest expense and amortization of discount and deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. During the three months ended November 30, 2024 and November 30, 2023 the average dollar amount of 8.75% 2025 Notes outstanding was $ 20.0 million and $ 20.0 million respectively.

For the nine months ended November 30, 2024 and November 30, 2023, the Company recorded $ 1.3 million and $ 1.1 million, respectively, of interest expense, $ 0.08 million and $ 0.0 million, respectively, of amortization of deferred financial costs and $ 0.08 million and $ 0.4 million, respectively, of amortization of discount related to the 8.75% 2025 Notes. Interest expense and amortization of discount and deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. During the nine months ended November 30, 2024 and November 30, 2023 the average dollar amount of 8.75% 2025 Notes outstanding was $ 20.0 million and $ 16.7 million respectively.

8.50% 2028 Notes

On April 14, 2023, the Company issued $ 50.0 million in aggregate principal amount of 8.50% fixed-rate notes due 2028 (the “8.50% 2028 Notes”) for net proceeds of $ 48.4 million after deducting underwriting commissions of approximately $ 1.6 million. Offering costs incurred were approximately $ 0.03 million. On April 26, 2023, the underwriters fully exercised their option to purchase an additional $ 7.5 million in aggregate principal amount of the 8.50% 2028 Notes. Net proceeds to the Company were $ 7.3 million after deducting underwriting commissions of approximately $ 0.2 million. Interest on the 8.50% 2028 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 8.50% per year.  The 8.50% 2028 Notes mature on April 15, 2028, and commencing April 14, 2025, may be redeemed in whole or in part at any time or from time to time at the Company’s option. Net proceeds from this offering were used to repay a portion of the outstanding indebtedness under the Encina Credit Facility, make investments in middle-market companies (including investments made through our SBIC Subsidiaries) in accordance with the Company’s investment objective and strategies and for general corporate purposes. Financing costs of $ 2.0 million related to the 8.50% 2028 Notes have been capitalized and are being amortized over the term of the 8.50% 2028 Notes.

As of November 30, 2024, the total amount of 8.50% 2028 Notes outstanding was $ 57.5 million. The 8.50% 2028 Notes are listed on the NYSE under the trading symbol “SAZ” with a par value of $ 25.00 per note. As of November 30, 2024, the carrying amount and fair value of the 8.50% 2028 Notes was $ 57.5 million and $ 58.6 million, respectively. The fair value of the 8.50% 2028 Notes, which are publicly traded, is based upon closing market quotes as of the measurement date and would be classified as a Level 1 liability within the fair value hierarchy. As of February 29, 2024, the carrying amount and fair value of the 8.50% 2028 Notes was $ 57.5 million and $ 58.3 million, respectively.

For the three months ended November 30, 2024 and November 30, 2023, the Company recorded $ 1.2 million and $ 1.2 million, respectively, of interest expense and $ 0.1 million and $ 0.1 million, respectively, of amortization of deferred financing costs related to the 8.50% 2028 Notes. Interest expense and amortization of deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. During the three months ended November 30, 2024 and November 30, 2023 the average dollar amount of 8.50% 2028 Notes outstanding was $ 57.5 million and $ 57.5 million respectively.

For the nine months ended November 30, 2024 and November 30, 2023, the Company recorded $ 3.7 million and $ 3.1 million, respectively, of interest expense and $ 0.3 million and $ 0.3 million, respectively, of amortization of deferred financing costs related to the 8.50% 2028 Notes. Interest expense and amortization of deferred financing costs are reported as interest and debt financing expense on the consolidated statements of operations. During the nine months ended November 30, 2024 and November 30, 2023 the average dollar amount of 8.50% 2028 Notes outstanding was $ 57.5 million and $ 47.8 million respectively.

97

SENIOR SECURITIES

(dollar amounts in thousands, except per share data)

Class and Year (1)(2) Total Amount Outstanding Exclusive of Treasury Securities (3) Asset Coverage per Unit (4) Involuntary Liquidating Preference per Share (5) Average Market Value per Share (6)
(in thousands)
Credit Facility with Encina Lender Finance, LLC
Fiscal year 2025 (as of November 30, 2024) $ 32,500 $ 1,601
-
N/A
Fiscal year 2024 (as of February 29, 2024) $ 35,000 $ 1,610
-
N/A
Fiscal year 2023 (as of February 28, 2023) $ 32,500 $ 1,659
-
N/A
Fiscal year 2022 (as of February 28, 2022) $ 12,500 $ 2,093
-
N/A
Credit Facility with Live Oak Banking Company
Fiscal year 2025 (as of November 30, 2024) $ 20,000 $ 1,601
-
N/A
Credit Facility with Madison Capital Funding (14)
Fiscal year 2021 (as of February 28, 2021) $
-
$ 3,471
-
N/A
Fiscal year 2020 (as of February 29, 2020) $
-
$ 6,071
-
N/A
Fiscal year 2019 (as of February 28, 2019) $
-
$ 2,345
-
N/A
Fiscal year 2018 (as of February 28, 2018) $
-
$ 2,930
-
N/A
Fiscal year 2017 (as of February 28, 2017) $
-
$ 2,710
-
N/A
Fiscal year 2016 (as of February 29, 2016) $
-
$ 3,025
-
N/A
Fiscal year 2015 (as of February 28, 2015) $ 9,600 $ 3,117
-
N/A
Fiscal year 2014 (as of February 28, 2014) $
-
$ 3,348
-
N/A
Fiscal year 2013 (as of February 28, 2013) $ 24,300 $ 5,421
-
N/A
Fiscal year 2012 (as of February 29, 2012) $ 20,000 $ 5,834
-
N/A
Fiscal year 2011 (as of February 28, 2011) $ 4,500 $ 20,077
-
N/A
Fiscal year 2010 (as of February 28, 2010) $
-
$
-
-
N/A
Fiscal year 2009 (as of February 28, 2009) $
-
$
-
-
N/A
Fiscal year 2008 (as of February 29, 2008) $
-
$
-
-
N/A
Fiscal year 2007 (as of February 28, 2007) $
-
$
-
-
N/A
7.50% Notes due 2020(7)
Fiscal year 2017 (as of February 28, 2017) $
-
$
-
-
N/A
Fiscal year 2016 (as of February 29, 2016) $ 61,793 $ 3,025
-
$ 25.24 (8)
Fiscal year 2015 (as of February 28, 2015) $ 48,300 $ 3,117
-
$ 25.46 (8)
Fiscal year 2014 (as of February 28, 2014) $ 48,300 $ 3,348
-
$ 25.18 (8)
Fiscal year 2013 (as of February 28, 2013) $
-
$
-
-
N/A
Fiscal year 2012 (as of February 29, 2012) $
-
$
-
-
N/A
Fiscal year 2011 (as of February 28, 2011) $
-
$
-
-
N/A
Fiscal year 2010 (as of February 28, 2010) $
-
$
-
-
N/A
Fiscal year 2009 (as of February 28, 2009) $
-
$
-
-
N/A
Fiscal year 2008 (as of February 29, 2008) $
-
$
-
-
N/A
Fiscal year 2007 (as of February 28, 2007) $
-
$
-
-
N/A
6.75% Notes due 2023(9)
Fiscal year 2020 (as of February 29, 2020) $
-
$
-
-
N/A
Fiscal year 2019 (as of February 28, 2019) $ 74,451 $ 2,345
-
$ 25.74 (10)
Fiscal year 2018 (as of February 28, 2018) $ 74,451 $ 2,930
-
$ 26.05 (10)
Fiscal year 2017 (as of February 28, 2017) $ 74,451 $ 2,710
-
$ 25.89 (10)
8.75% Notes due 2025
Fiscal year 2025 (as of November 30, 2024) $ 20,000 $ 1,601
-
$ 25.00 (12)
Fiscal year 2024 (as of February 29, 2024) $ 20,000 $ 1,610
-
$ 25.00 (12)
6.25% Notes due 2025(13)
Fiscal year 2022 (as of February 28, 2022)
-
-
-
N/A
Fiscal year 2021 (as of February 28, 2021) $ 60,000 $ 3,471
-
$ 24.24 (11)
Fiscal year 2020 (as of February 29, 2020) $ 60,000 $ 6,071
-
$ 25.75 (11)
Fiscal year 2019 (as of February 28, 2019) $ 60,000 $ 2,345
-
$ 24.97 (11)

98

Class and Year (1)(2) Total Amount Outstanding Exclusive of Treasury Securities (3) Asset Coverage per Unit (4) Involuntary Liquidating Preference per Share (5) Average Market Value per Share (6)
(in thousands)
7.00% Notes due 2025
Fiscal year 2025 (as of November 30, 2024) $ 12,000 $ 1,601
-
$ 25.00 (12)
Fiscal year 2024 (as of February 29, 2024) $ 12,000 $ 1,610
-
$ 25.00 (12)
Fiscal year 2023 (as of February 28, 2023) $ 12,000 $ 1,659
-
$ 25.00 (12)
7.25% Notes due 2025(17)
Fiscal year 2023 (as of February 28, 2023)
-
-
-
N/A
Fiscal year 2022 (as of February 28, 2022) $ 43,125 $ 2,093
-
$ 25.46 (11)
Fiscal year 2021 (as of February 28, 2021) $ 43,125 $ 3,471
-
$ 25.77 (11)
7.75% Notes due 2025
Fiscal year 2025 (as of November 30, 2024) $ 5,000 $ 1,601
-
$ 25.00 (12)
Fiscal year 2024 (as of February 29, 2024) $ 5,000 $ 1,610
-
$ 25.00 (12)
Fiscal year 2023 (as of February 28, 2023) $ 5,000 $ 1,659
-
$ 25.00 (12)
Fiscal year 2022 (as of February 28, 2022) $ 5,000 $ 2,093
-
$ 25.00 (12)
Fiscal year 2021 (as of February 28, 2021) $ 5,000 $ 3,471
-
$ 25.00 (12)
4.375% Notes due 2026
Fiscal year 2025 (as of November 30, 2024) $ 175,000 $ 1,601
-
$ 25.00 (12)
Fiscal year 2024 (as of February 29, 2024) $ 175,000 $ 1,610
-
$ 25.00 (12)
Fiscal year 2023 (as of February 28, 2023) $ 175,000 $ 1,659
-
$ 25.00 (12)
Fiscal year 2022 (as of February 28, 2022) $ 175,000 $ 2,093
-
$ 25.00 (12)
4.35% Notes due 2027
Fiscal year 2025 (as of November 30, 2024) $ 75,000 $ 1,601
-
$ 25.00 (12)
Fiscal year 2024 (as of February 29, 2024) $ 75,000 $ 1,610
-
$ 25.00 (12)
Fiscal year 2023 (as of February 28, 2023) $ 75,000 $ 1,659
-
$ 25.00 (12)
Fiscal year 2022 (as of February 28, 2022) $ 75,000 $ 2,093
-
$ 25.00 (12)
6.00% Notes due 2027
Fiscal year 2025 (as of November 30, 2024) $ 105,500 $ 1,601
-
$ 24.29 (15)
Fiscal year 2024 (as of February 29, 2024) $ 105,500 $ 1,610
-
$ 23.51 (15)
Fiscal year 2023 (as of February 28, 2023) $ 105,500 $ 1,659
-
$ 23.97 (15)
6.25% Notes due 2027
Fiscal year 2025 (as of November 30, 2024) $ 15,000 $ 1,601
-
$ 25.00 (12)
Fiscal year 2024 (as of February 29, 2024) $ 15,000 $ 1,610
-
$ 25.00 (12)
Fiscal year 2023 (as of February 28, 2023) $ 15,000 $ 1,659
-
$ 25.00 (12)
Fiscal year 2022 (as of February 28, 2022) $ 15,000 $ 2,093
-
$ 25.00 (12)
Fiscal year 2021 (as of February 28, 2021) $ 15,000 $ 3,471
-
$ 25.00 (12)
8.00% Notes due 2027
Fiscal year 2025 (as of November 30, 2024) $ 46,000 $ 1,601
-
$ 25.22 (15)
Fiscal year 2024 (as of February 29, 2024) $ 46,000 $ 1,610
-
$ 25.00 (15)
8.125% Notes due 2027
Fiscal year 2025 (as of November 30, 2024) $ 60,375 $ 1,601
-
$ 25.28 (15)
Fiscal year 2024 (as of February 29, 2024) $ 60,375 $ 1,610
-
$ 25.05 (15)
Fiscal year 2023 (as of February 28, 2023) $ 60,375 $ 1,659
-
$ 25.10 (15)
8.50% Notes due 2028
Fiscal year 2025 (as of November 30, 2024) $ 57,500 $ 1,601
-
$ 25.42 (16)
Fiscal year 2024 (as of February 29, 2024) $ 57,500 $ 1,610
-
$ 25.17 (16)

(1) We have excluded our SBA-guaranteed debentures from this table because the SEC has granted us exemptive relief that permits us to exclude such debentures from the definition of senior securities in the 150 % asset coverage ratio we are required to maintain under the 1940 Act.
(2) This table does not include the senior securities of our predecessor entity, GSC Investment Corp., relating to a revolving securitized credit facility with Deutsche Bank, in light of the fact that the Company was under different management during the time that such credit facility was outstanding.

99

(3) Total amount of senior securities outstanding at the end of the period presented.
(4) Asset coverage per unit is the ratio of our total assets, less all liabilities and indebtedness not represented by senior securities, to the aggregate amount of senior securities representing indebtedness. Asset coverage per unit is expressed in terms of dollar amounts per $ 1,000 of indebtedness, calculated on a total basis.
(5) The amount to which such class of senior security would be entitled upon the involuntary liquidation of the issuer in preference to any security junior to it. The “—” indicates information which the Securities and Exchange Commission expressly does not require to be disclosed for certain types of senior securities.
(6) Not applicable for credit facility because not registered for public trading.
(7) On January 13, 2017, the Company redeemed in full its 2020 Notes. The Company used a portion of the net proceeds from the 2023 Notes offering, which was completed in December 2016, to redeem the 2020 Notes in full.
(8) Based on the average daily trading price of the 2020 Notes on the NYSE.
(9) On December 21, 2019 and February 7, 2020, the Company redeemed $ 50.0 million and $ 24.45 million, respectively, in aggregate principal amount of the $ 74.45 million in aggregate principal amount of issued and outstanding 2023 Notes.
(10) Based on the average daily trading price of the 2023 Notes on the NYSE.
(11) Based on the average daily trading price of the 2025 Notes on the NYSE.
(12) The carrying value of this unlisted security approximates its fair value, based on a waterfall analysis showing adequate collateral coverage.
(13) On August 31, 2021, the Company redeemed $ 60.0 million in aggregate principal amount of the issued and outstanding 6.25% 2025 Notes. The Company used a portion of the net proceeds from the 4.375% 2026 Notes offering, which was completed in July 2021, to redeem the 6.25% 2025 Notes in full.
(14) On October 4, 2021, the Company repaid all remaining amounts outstanding under the Madison Credit Facility and the credit agreement relating to the Madison Credit Facility was terminated.
(15) Based on the average daily trading price of the 2027 Notes on the NYSE.
(16) Based on the average daily trading price of the 2028 Notes on the NYSE.
(17) On July 14, 2022, the Company redeemed $ 43.1 million in aggregate principal amount of the issued and outstanding 7.25% 2025 Notes.

Note 9. Commitments and Contingencies

Contractual Obligations

The following table shows our payment obligations for repayment of debt and other contractual obligations at November 30, 2024:

Payment Due by Period
Long-Term Debt Obligations Total Less Than
1 Year
1 - 3
Years
3 - 5
Years
More Than
5 Years
($ in thousands)
Encina credit facility $ 32,500 $
-
$ 32,500 $
-
$
-
Live Oak credit facility 20,000
-
20,000
-
-
SBA debentures 214,000
-
-
-
214,000
8.75% 2025 Notes 20,000 20,000
-
-
-
7.00% 2025 Notes 12,000 12,000
-
-
-
7.75% 2025 Notes 5,000 5,000
-
-
-
4.375% 2026 Notes 175,000
-
175,000
-
-
4.35% 2027 Notes 75,000
-
75,000
-
-
6.00% 2027 Notes 105,500
-
105,500
-
-
6.25% 2027 Notes 15,000
-
-
15,000
-
8.00% 2027 Notes 46,000
-
46,000
-
-
8.125% 2027 Notes 60,375
-
60,375
-
-
8.50% 2028 Notes 57,500
-
-
57,500
-
Total Long-Term Debt Obligations $ 837,875 $ 37,000 $ 514,375 $ 72,500 $ 214,000

100

Off-Balance Sheet Arrangements

As of November 30, 2024 and February 29, 2024, the Company’s off-balance sheet arrangements consisted of $ 128.1 million and $ 132.4 million, respectively, of unfunded commitments outstanding to provide debt financing to its portfolio companies or to fund limited partnership interests. Such commitments are generally up to the Company’s discretion to approve, or the satisfaction of certain financial and nonfinancial covenants and involve, to varying degrees, elements of credit risk in excess of the amount recognized in the Company’s consolidated statements of assets and liabilities and are not reflected in the Company’s consolidated statements of assets and liabilities.

A summary of the unfunded commitments outstanding as of November 30, 2024 and February 29, 2024 is shown in the table below (dollars in thousands):

November 30,
2024
February 29,
2024
At Company’s discretion
ActiveProspect, Inc. $ 10,000 $ 10,000
Artemis Wax Corp. 23,500 23,500
Ascend Software, LLC 5,000 5,000
C2 Educational Systems 2,000
-
Davisware, LLC 1,000
-
Granite Comfort, LP
-
750
JDXpert 4,500 5,000
LFR Chicken LLC 10,000
-
Pepper Palace, Inc. 1,200 1,898
Procurement Partners, LLC
-
4,250
Saratoga Senior Loan Fund I JV, LLC 8,548 8,548
Sceptre Hospitality Resources, LLC
-
5,000
Stretch Zone Franchising, LLC
-
3,750
VetnCare MSO, LLC 10,000 10,000
Total $ 75,748 $ 77,696
At portfolio company’s discretion - satisfaction of certain financial and nonfinancial covenants required
Alpha Aesthetics Partners OpCo, LLC $ 3,653 $ 6,500
ARC Health OpCo LLC
-
2,585
Axero Holdings, LLC - Revolver 500 500
Axiom Medical Consulting, LLC 1,500 2,000
BQE Software, Inc. 2,250 3,250
C2 Educational Systems
-
3,000
Cloudpermit Intermediate Holding Company 5,000
-
Davisware, LLC 2,000 750
Exigo, LLC - Revolver 625 1,042
Gen4 Dental Partners Holdings, LLC 2,857
-
GoReact 2,500 2,500
Granite Comfort, LP 11,637 11,637
Inspect Point Holding, LLC 1,500 1,500
Modis Dental Partners OpCo, LLC 8,900
-
Pepper Palace, Inc. - Revolver 600 2,500
Stretch Zone Franchising, LLC 1,500 1,500
VetnCare MSO, LLC 7,319 15,319
Zollege PBC
-
150
52,341 54,733
Total $ 128,089 $ 132,429

The Company believes its assets will provide adequate coverage to satisfy these unfunded commitments. As of November 30, 2024, the Company had cash and cash equivalents of $ 147.6 million, $ 32.5 million in available borrowings under the Encina Credit Facility, and $ 55.0 million in available borrowings under the Live Oak Credit Facility.

101

Note 10. Directors Fees

The independent directors each receive an annual fee of $ 70,000 . They also receive $ 3,000 plus reimbursement of reasonable out-of-pocket expenses incurred in connection with attending each board meeting and receive $ 1,500 plus reimbursement of reasonable out-of-pocket expenses incurred in connection with attending each committee meeting. In addition, the chairman of the Audit Committee receives an annual fee of $ 12,500 and the chairman of each other committee of the board of directors receives an annual fee of $ 6,000 for their additional services in these capacities. In addition, we have purchased directors’ and officers’ liability insurance on behalf of our directors and officers. Independent directors have the option to receive their directors’ fees in the form of our common stock issued at a price per share equal to the greater of NAV or the market price at the time of payment. No compensation is paid to directors who are “interested persons” of the Company (as defined in Section 2(a)(19) of the 1940 Act). For the three months ended November 30, 2024 and November 30, 2023, the Company incurred $ 0.1 million and $ 0.1 million for directors’ fees and expenses, respectively. For the nine months ended November 30, 2024 and November 30, 2023, the Company incurred $ 0.3 million and $ 0.3 million for directors’ fees and expenses, respectively. As of November 30, 2024 and February 29, 2024, $ 0.0 million and $ 0.0 million in directors’ fees and expenses were accrued and unpaid, respectively. As of November 30, 2024, the Company had not issued any common stock to our directors as compensation for their services.

Note 11. Stockholders’ Equity

Share Repurchases

On September 24, 2014, the Company announced the approval of an open market share repurchase plan that originally allowed it to repurchase up to 200,000 shares of its common stock at prices below its NAV as reported in its then most recently published consolidated financial statements (the “Share Repurchase Plan”). Since September 24, 2014, the Share Repurchase Plan has been extended annually, and the Company has periodically increased the amount of shares of common stock that may be purchased under the Share Repurchase Plan, most recently to 1.7 million shares of common stock. On January 7, 2025, the Company’s board of directors extended the Share Repurchase Plan for another year to January 15, 2026. As of November 30, 2024, the Company had purchased 1,035,203 shares of common stock, at the average price of $ 22.05 for approximately $ 22.8 million pursuant to the Share Repurchase Plan. During the three and nine months ended November 30, 2024, the Company did not purchase any shares of common stock pursuant to the Share Repurchase Plan.

Public Equity Offering

On July 13, 2018, the Company issued 1,150,000 shares of its common stock priced at $ 25.00 per share (par value $ 0.001 per share) at an aggregate total of $ 28.75 million. The net proceeds, after deducting underwriting commissions of $ 1.15 million and offering costs of approximately $ 0.2 million, amounted to approximately $ 27.4 million. The Company also granted the underwriters a 30-day option to purchase up to an additional 172,500 shares of its common stock, which was not exercised.

Equity ATM Program

On March 16, 2017, the Company entered into an equity distribution agreement with Ladenburg Thalmann & Co. Inc., through which the Company offered for sale, from time to time, up to $ 30.0 million of the Company’s common stock through an ATM offering. Subsequent to this, BB&T Capital Markets and B. Riley FBR, Inc. were also added to the agreement. On July 11, 2019, the amount of the common stock to be offered was increased to $ 70.0 million, and on October 8, 2019, the amount of the common stock to be offered was increased to $ 130.0 million. This agreement was terminated as of July 29, 2021, and as of that date, the Company had sold 3,922,018 shares for gross proceeds of $ 97.1 million at an average price of $ 24.77 for aggregate net proceeds of $ 95.9 million (net of transaction costs).

On July 30, 2021, the Company entered into an equity distribution agreement (the “Equity Distribution Agreement”) with Ladenburg Thalmann & Co. Inc. (“Ladenburg”) and Compass Point Research and Trading, LLC (“Compass Point”), through which the Company may offer for sale, from time to time, up to $ 150.0 million of the Company’s common stock through the Agents (as defined below), or to them, as principal for their account (the “ATM Program”).

On July 6, 2023, the Company amended the Equity Distribution Agreement to increase the maximum amount of shares of our common stock to be sold through the ATM Program to $ 300.0 million from $ 150.0 million. On July 19, 2023, the Company amended the Equity Distribution Agreement to add an additional distribution agent, Raymond James & Associates, Inc. (“Raymond James”). On May 15, 2024, the Company amended the Equity Distribution Agreement to add an additional distribution agent, Lucid Capital Markets, LLC (“Lucid” and together with Ladenburg, Compass Point, and Raymond James, the “Agents”). The sales price per share of the Company’s common stock offered under the ATM Program, less the Agents’ commission, will not be less than the NAV per share of the Company’s common stock at the time of such sale. Consistent with the terms of the ATM Program, the Manager may, from time to time and in its sole discretion, contribute proceeds necessary to ensure that no sales are made at a price below the then-current NAV per share.

As of November 30, 2024, the Company sold 6,652,316 shares for gross proceeds of $ 175.5 million at an average price of $ 26.37 for aggregate net proceeds of $ 173.9 million (net of transaction costs). During the three and nine months ended November 30, 2024, the Company sold 108,438 shares for gross proceeds of $ 2.9 million at an average price of $ 27.07 for aggregate net proceeds of $ 2.9 million (net of transaction costs).

102

The Company adopted Rule 3-04/Rule 8-03(a)(5) under Regulation S-X (Note 2). Pursuant to Regulation S-X, the Company has presented a reconciliation of the changes in each significant caption of stockholders’ equity as shown in the tables below:

Capital Total
Distributable
Common Stock in Excess Earnings
Shares Amount of Par Value (Loss) Net Assets
Balance at February 28, 2023 11,890,500 $ 11,891 $ 321,893,806 $ 25,052,345 $ 346,958,042
Increase (Decrease) from Operations:
Net investment income - - - 15,958,950 15,958,950
Net realized gain (loss) from investments - - - 90,691 90,691
Net change in unrealized appreciation (depreciation) on investments - - - ( 16,322,307 ) ( 16,322,307 )
Net change in provision for deferred taxes on unrealized (appreciation) depreciation on investments - - - 59,407 59,407
Decrease from Shareholder Distributions:
Distributions of investment income - - - ( 8,193,402 ) ( 8,193,402 )
Capital Share Transactions:
Stock dividend distribution 45,818 47 1,058,797 - 1,058,844
Repurchases of common stock ( 88,576 ) ( 90 ) ( 2,157,515 ) - ( 2,157,605 )
Repurchase fees - - ( 1,772 ) - ( 1,772 )
Balance at May 31, 2023 11,847,742 $ 11,848 $ 320,793,316 $ 16,645,684 $ 337,450,848
Increase (Decrease) from Operations:
Net investment income - - - 13,964,784 13,964,784
Realized losses on extinguishment of debt - - - ( 110,056 ) ( 110,056 )
Net change in unrealized appreciation (depreciation) on investments - - - ( 5,737,571 ) ( 5,737,571 )
Net change in provision for deferred taxes on unrealized (appreciation) depreciation on investments - - - ( 221,206 ) ( 221,206 )
Decrease from Shareholder Distributions:
Distributions of investment income - - - ( 8,352,335 ) ( 8,352,335 )
Capital Share Transactions:
Proceeds from issuance of common stock 852,412 852 22,497,265 - 22,498,117
Capital contribution from Manager - - 2,050,288 - 2,050,288
Stock dividend distribution 29,627 30 749,283 - 749,313
Offfering costs - - ( 213,427 ) - ( 213,427 )
Balance at August 31, 2023 12,729,781 $ 12,730 $ 345,876,725 $ 16,189,300 $ 362,078,755
Increase (Decrease) from Operations:
Net investment income - - - 14,166,063 14,166,063
Net realized gain (loss) from investments - - - 60,565 60,565
Net change in unrealized appreciation (depreciation) on investments - - - ( 17,866,353 ) ( 17,866,353 )
Net change in provision for deferred taxes on unrealized (appreciation) depreciation on investments - - - ( 415,894 ) ( 415,894 )
Decrease from Shareholder Distributions:
Distributions of investment income - - - ( 9,286,642 ) ( 9,286,642 )
Capital Share Transactions:
Proceeds from issuance of common stock 350,000 350 9,012,150 - 9,012,500
Capital contribution from Manager - - 1,043,000 - 1,043,000
Stock dividend distribution 35,196 35 858,960 - 858,995
Offering costs - - ( 92,240 ) - ( 92,240 )
Balance at November 30, 2023 13,114,977 $ 13,115 $ 356,698,595 $ 2,847,039 $ 359,558,749

103

Capital Total
Distributable
Common Stock in Excess Earnings
Shares Amount of Par Value (Loss) Net Assets
Increase (Decrease) from Operations:
Net investment income - - - 12,784,511 12,784,511
Net realized gain (loss) from investments - - - 2,327 2,327
Net change in unrealized appreciation (depreciation) on investments - - - ( 7,164,613 ) ( 7,164,613 )
Net change in provision for deferred taxes on unrealized (appreciation) depreciation on investments - - - ( 315,473 ) ( 315,473 )
Decrease from Shareholder Distributions:
Distributions of investment income - - - ( 9,803,576 ) ( 9,803,576 )
Capital Share Transactions:
Proceeds from issuance of common stock 501,105 501 13,028,269 - 13,028,770
Capital contribution from Manager - - 1,382,009 - 1,382,009
Stock dividend distribution 37,394 38 915,155 - 915,193
Offering costs - - ( 163,789 ) - ( 163,789 )
Tax reclassification of stockholders’ equity in accordance with generally accepted accounting principles - - ( 779,040 ) 779,040 -
Balance at February 29, 2024 13,653,476 $ 13,654 $ 371,081,199 $ ( 870,745 ) $ 370,224,108
Increase (Decrease) from Operations:
Net investment income - - - 14,335,005 14,335,005
Net realized gain (loss) from investments - - - ( 21,194,997 ) ( 21,194,997 )
Net change in unrealized appreciation (depreciation) on investments - - - 13,931,431 13,931,431
Net change in provision for deferred taxes on unrealized (appreciation) depreciation on investments - - - ( 461,001 ) ( 461,001 )
Decrease from Shareholder Distributions:
Distributions of investment income - - - ( 9,967,036 ) ( 9,967,036 )
Capital Share Transactions:
Stock dividend distribution 45,490 45 987,527 - 987,572
Balance at May 31, 2024 13,698,966 $ 13,699 $ 372,068,726 $ ( 4,227,343 ) $ 367,855,082
Increase (Decrease) from Operations:
Net investment income - - - 18,197,398 18,197,398
Net realized gain (loss) from investments - - - ( 33,448,727 ) ( 33,448,727 )
Net change in unrealized appreciation (depreciation) on investments - - - 28,728,155 28,728,155
Net change in provision for deferred taxes on unrealized (appreciation) depreciation on investments - - - ( 159,187 ) ( 159,187 )
Decrease from Shareholder Distributions:
Distributions of investment income - - - ( 10,137,233 ) ( 10,137,233 )
Capital Share Transactions:
Stock dividend distribution 46,803 47 1,018,307 - 1,018,354
Balance at August 31, 2024 $ 13,745,769 $ 13,746 $ 373,087,033 $ ( 1,046,937 ) $ 372,053,842
Increase (Decrease) from Operations:
Net investment income - - - 12,435,655 12,435,655
Net realized gain (loss) from investments - - - 5,444,745 5,444,745
Net change in unrealized appreciation (depreciation) on investments - - - ( 8,918,583 ) ( 8,918,583 )
Net change in provision for deferred taxes on unrealized (appreciation) depreciation on investments - - - ( 126,875 ) ( 126,875 )
Decrease from Shareholder Distributions:
Distributions of investment income - - - ( 10,171,868 ) ( 10,171,868 )
Capital Share Transactions:
Proceeds from issuance of common stock 108,438 108 2,777,318 - 2,777,426
Capital contribution from Manager - - 199,652 - 199,652
Stock dividend distribution 54,999 55 1,214,181 - 1,214,236
Offering costs - - ( 42,575 ) - ( 42,575 )
Balance at November 30, 2024 $ 13,909,206 $ 13,909 $ 377,235,609 $ ( 2,383,863 ) $ 374,865,655

104

Note 12. Earnings Per Share

In accordance with the provisions of FASB ASC Topic 260, Earnings per Share , basic earnings per share is computed by dividing earnings available to common shareholders by the weighted average number of shares outstanding during the period. Other potentially dilutive common shares, and the related impact to earnings, are considered when calculating earnings per share on a diluted basis.

The following information sets forth the computation of the weighted average basic and diluted net increase (decrease) in net assets resulting from operations per share for the three and nine months ended November 30, 2024 and November 30, 2023 (dollars in thousands except share and per share amounts):

For the three months ended For the nine months ended
Basic and Diluted November 30,
2024
November 30,
2023
November 30,
2024
November 30,
2023
Net increase (decrease) in net assets resulting from operations $ 8,835 $ ( 4,056 ) $ 28,763 $ 3,627
Weighted average common shares outstanding 13,789,951 13,052,896 13,733,008 12,355,815
Weighted average earnings (loss) per common share $ 0.64 $ ( 0.31 ) $ 2.09 $ 0.29

Note 13. Dividend

On November 7, 2024, the Company declared a dividend of $ 0.74 per share for the quarter ended November 30, 2024, and a special dividend of $ 0.35 per share, both dividends payable on December 19, 2024 , to common stockholders of record on December 4, 2024. Shareholders have the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to the DRIP.

The following table summarizes dividends declared for the nine months ended November 30, 2024 (dollars in thousands except per share amounts):

Date Declared Record Date Payment Date Amount
Per Share
Total Amount*
November 7, 2024 December 4, 2024 December 19, 2024 $ 1.09 $ 15,549
August 22, 2024 September 11, 2024 September 26, 2024 0.74 10,172
May 23, 2024 June 13, 2024 June 27, 2024 0.74 10,137
Total dividends declared $ 2.57 $ 35,858

* Total amount is calculated based on the number of shares outstanding at the date of record.

The following table summarizes dividends declared for the nine months ended November 30, 2023 (dollars in thousands except per share amounts):

Date Declared Record Date Payment Date Amount
Per Share
Total Amount*
November 15, 2023 December 11, 2023 December 28, 2023 $ 0.72 $ 8,888
August 14, 2023 September 14, 2023 September 28, 2023 0.71 9,287
May 22, 2023 June 13, 2023 June 29, 2023 0.70 8,352
Total dividends declared $ 2.13 $ 26,527

* Total amount is calculated based on the number of shares outstanding at the date of record.

105

Note 14. Financial Highlights

The following is a schedule of financial highlights as of and for the nine months ended November 30, 2024 and November 30, 2023:

Per share data November 30, 2024 November 30, 2023
Net asset value at beginning of period $ 27.12 $ 29.18
Net investment income(1) 3.27 3.57
Net realized and unrealized gain and losses on investments(1) ( 1.18 ) ( 3.27 )
Realized losses on extinguishment of debt
-
( 0.01 )
Net increase in net assets resulting from operations 2.09 0.29
Distributions declared from net investment income ( 2.21 ) ( 2.10 )
Total distributions to stockholders ( 2.21 ) ( 2.10 )
Issuance of common stock at net asset value (2) ( 0.01 ) ( 0.30 )
Capital contribution from Manager for the issuance of common stock (14) 0.02 0.36
Repurchases of common stock(3)
-
0.03
Dilution(4) ( 0.06 ) ( 0.04 )
Net asset value at end of period $ 26.95 $ 27.42
Net assets at end of period $ 374,865,655 $ 359,558,749
Shares outstanding at end of period 13,909,206 13,114,977
Per share market value at end of period $ 25.69 $ 26.21
Total return based on market value(5)(6) 20.19 % 3.62 %
Total return based on net asset value(5)(7) 9.77 % 2.35 %
Ratio/Supplemental data:
Ratio of net investment income to average net assets(8) 17.07 % 17.15 %
Expenses:
Ratios of operating expenses and income taxes to average net assets*(9) 8.13 % 8.09 %
Ratio of incentive management fees to average net assets(5) 3.03 % 1.37 %
Ratio of interest and debt financing expenses to average net assets(9) 13.99 % 13.87 %
Ratio of total expenses and income taxes to average net assets*(8) 25.15 % 23.33 %
Portfolio turnover rate(5)(10) 11.93 % 1.80 %
Asset coverage ratio per unit(11) 1,601 1,593
Average market value per unit
Revolving Credit Facilities(12) N/A N/A
SBA Debentures Payable(12) N/A N/A
8.75% Notes Payable 2025(12) N/A N/A
7.00% Notes Payable 2025(12) N/A N/A
7.25% Notes Payable 2025(13) N/A N/A
7.75% Notes Payable 2025(12) N/A N/A
4.375% Notes Payable 2026(12) N/A N/A
4.35% Notes Payable 2027(12) N/A N/A
6.00% Notes Payable 2027 $ 24.29 $ 23.34
6.25% Notes Payable 2027(12) N/A N/A
8.00% Notes Payable 2027 $ 25.22 $ 24.93
8.125% Notes Payable 2027 $ 25.28 $ 24.97
8.50% Notes Payable 2028 $ 25.42 $ 25.07

* Certain prior period amounts have been reclassified to conform to current period presentation.
(1) Per share amounts are calculated using the weighted average shares outstanding during the period.

106

(2) The continuous issuance of common stock may cause an incremental decrease in NAV per share due to the sale of shares at the then prevailing public offering price and the receipt of net proceeds per share by the Company less than NAV per share on each subscription closing date. The per share data was derived by computing (i) the sum of (A) the number of shares issued in connection with subscriptions and/or distribution reinvestment on each share transaction date multiplied by (B) the differences between the net proceeds per share and the NAV per share on each share transaction date, divided by (ii) the total shares outstanding during the period.
(3) Represents the anti-dilutive impact on the NAV of the Company due to the repurchase of common shares. See Note 11. Stockholders’ Equity.
(4) Represents the dilutive effect of issuing common stock below NAV per share during the period in connection with the satisfaction of the Company’s annual RIC distribution requirement and may include the impact of the different share amounts used for different items (weighted average basic common shares outstanding for the corresponding year and actual common shares outstanding at the end of the year) in the per common share data calculation and rounding impacts. See Note 13. Dividend.
(5) Ratios are not annualized.
(6) Total investment return is calculated assuming a purchase of common shares at the current market value on the first day and a sale at the current market value on the last day of the periods reported. Dividends and distributions, if any, are assumed for purposes of this calculation to be reinvested at prices obtained under the DRIP. Total investment return does not reflect brokerage commissions.
(7) Total investment return is calculated assuming a purchase of common shares at the current NAV on the first day and a sale at the current net asset value on the last day of the periods reported. Dividends and distributions, if any, are assumed for purposes of this calculation to be reinvested at prices obtained under the DRIP. Total investment return does not reflect brokerage commissions.
(8) Ratios are annualized. Incentive management fees included within the ratio are not annualized.
(9) Ratios are annualized.
(10) Portfolio turnover rate is calculated using the lesser of year-to-date sales or year-to-date purchases over the average of the invested assets at fair value.
(11) Asset coverage ratio per unit is the ratio of the carrying value of our total consolidated assets, less all liabilities and indebtedness not represented by senior securities, to the aggregate amount of senior securities representing indebtedness. Asset coverage ratio per unit is expressed in terms of dollar amounts per $ 1,000 of indebtedness. Asset coverage ratio per unit does not include unfunded commitments. The inclusion of unfunded commitments in the calculation of the asset coverage ratio per unit would not cause us to be below the required amount of regulatory coverage.
(12) The Revolving Credit Facilities, SBA Debentures, 8.75% Notes Payable 2025, 7.00% Notes Payable 2025, 7.75% Notes Payable 2025, 4.375% Notes Payable 2026, 4.35% Notes Payable 2027 and 6.25% Notes Payable 2027 are not registered for public trading.
(13) On July 14, 2022, the Company redeemed $43.1 million in aggregate principal amount of the $43.1 million in aggregate principal amount of issued and outstanding 7.25% 2025 Notes and are no longer listed on the NYSE.
(14) The Manager agreed to reimburse the Company to the extent the per share price of the shares to the public, less underwriting fees, was less than net asset value per share.

Note 15. Subsequent Events

The Company has evaluated subsequent events through the filing of this Form 10-Q and determined that there have been no events that have occurred that would require adjustments to the Company’s consolidated financial statements and disclosures in the consolidated financial statements as of and for the quarter ended November 30, 2024.

107

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion should be read in conjunction with our consolidated financial statements and related notes and other financial information appearing elsewhere in this Quarterly Report on Form 10-Q. In addition to historical information, the following discussion and other parts of this Quarterly Report contain forward-looking information that involves risks and uncertainties. Our actual results could differ materially from those anticipated by such forward-looking information due to the factors discussed under “Note about Forward-Looking Statements” and Part I, Item 1A. “Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended February 29, 2024.

The forward-looking statements are based on our beliefs, assumptions and expectations of our future performance, taking into account all information currently available to us. These beliefs, assumptions and expectations can change as a result of many possible events or factors, not all of which are known to us or are within our control. If a change occurs, our business, financial condition, liquidity and results of operations may vary materially from those expressed in our forward-looking statements.

The forward-looking statements contained in this Quarterly Report on Form 10-Q involve risks and uncertainties, including statements as to:

our future operating results;

the introduction, withdrawal, success and timing of business initiatives and strategies;

changes in political, economic or industry conditions, the elevated interest rate environment or financial and capital markets, which could result in changes in the value of our assets;

the relative and absolute investment performance and operations of our Manager;

the impact of increased competition;

our ability to turn potential investment opportunities into transactions and thereafter into completed and successful investments;

the unfavorable resolution of any future legal proceedings;

our business prospects and the operational and financial performance of our portfolio companies, including their ability to achieve our respective objectives as a result of the current economic conditions caused by, among other things, elevated levels of inflation, and an elevated interest rate environment, and the effects of the disruptions caused thereby on our ability to continue to effectively manage our business;

interest rate volatility, including an elevated interest rate environment, could adversely affect our results, particularly if we elect to use leverage as part of our investment strategy;

the impact of investments that we expect to make and future acquisitions and divestitures;

our contractual arrangements and relationships with third parties;

the dependence of our future success on the general economy and its impact on the industries in which we invest;

the ability of our portfolio companies to achieve their objectives;

our expected financings and investments;

our regulatory structure and tax treatment, including our ability to operate as a business development company (“BDC”), or to operate our small business investment company (“SBIC”) subsidiaries, and to continue to qualify to be taxed as a regulated investment company (“RIC”);
the adequacy of our cash resources and working capital;

the timing of cash flows, if any, from the operations of our portfolio companies;

the impact of supply chain constraints and labor difficulties on our portfolio companies and the global economy;
the elevated level of inflation, and its impact on our portfolio companies and on the industries in which we invest;

108

the impact of legislative and regulatory actions and reforms and regulatory, supervisory or enforcement actions of government agencies relating to us or our Manager;

the impact of changes to tax legislation and, generally, our tax position;

our ability to access capital and any future financings by us;

the ability of our Manager to attract and retain highly talented professionals; and

the ability of our Manager to locate suitable investments for us and to monitor and effectively administer our investments.

Such forward-looking statements may include statements preceded by, followed by or that otherwise include terms such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “project,” “should,” “will” and “would” or the negative of these terms or other comparable terminology.

We have based the forward-looking statements included in this Quarterly Report on Form 10-Q on information available to us on the date of this Quarterly Report on Form 10-Q, and we assume no obligation to update any such forward-looking statements. Actual results could differ materially from those anticipated in our forward-looking statements, and future results could differ materially from historical performance. We undertake no obligation to revise or update any forward-looking statements, whether as a result of new information, future events or otherwise, unless required by law or SEC rule or regulation. You are advised to consult any additional disclosures that we may make directly to you or through reports that we in the future may file with the U.S. Securities and Exchange Commission (the “SEC”), including annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K.

The following analysis of our financial condition and results of operations should be read in conjunction with our consolidated financial statements and the related notes thereto contained elsewhere in this Quarterly Report on Form 10-Q.

OVERVIEW

We are a Maryland corporation that has elected to be regulated as a BDC under the Investment Company Act of 1940, as amended (the “1940 Act”). Our investment objective is to create attractive risk-adjusted returns by generating current income and long-term capital appreciation from our investments. We invest primarily in senior and unitranche leveraged loans and mezzanine debt issued by private U.S. middle-market companies, which we define as companies having earnings before interest, tax, depreciation and amortization (“EBITDA”) of between $2 million and $50 million, both through direct lending and through participation in loan syndicates. We may also invest up to 30.0% of the portfolio in opportunistic investments in order to seek to enhance returns to stockholders. Such investments may include investments in distressed debt, which may include securities of companies in bankruptcy, foreign debt, private equity, securities of public companies that are not thinly traded and structured finance vehicles such as collateralized loan obligation funds. Although we have no current intention to do so, to the extent we invest in private equity funds, we will limit our investments in entities that are excluded from the definition of “investment company” under Section 3(c)(1) or Section 3(c)(7) of the 1940 Act, which includes private equity funds, to no more than 15.0% of our net assets. We have elected and qualified to be treated as a RIC under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”).

Corporate History

We commenced operations, at the time known as GSC Investment Corp., on March 23, 2007 and completed an initial public offering of shares of common stock on March 28, 2007. Prior to July 30, 2010, we were externally managed and advised by GSCP (NJ), L.P., an entity affiliated with GSC Group, Inc. In connection with the consummation of a recapitalization transaction on July 30, 2010, as described below we engaged Saratoga Investment Advisors to replace GSCP (NJ), L.P. as our investment adviser and changed our name to Saratoga Investment Corp.

109

Our wholly owned subsidiaries, Saratoga Investment Corp. SBIC II LP (“SBIC II LP”) and Saratoga Investment Corp. SBIC III LP (“SBIC III LP”, and together with SBIC II LP, the “SBIC Subsidiaries”), received SBIC licenses from the SBA on August 14, 2019 and September 29, 2022, respectively. Each of the SBIC Subsidiaries provides up to $175.0 million in long-term capital in the form of debentures guaranteed by the SBA. Our wholly owned subsidiary SBIC LP repaid its outstanding debentures and subsequently surrendered its license to the SBA on January 3, 2024, providing the Company access to all undistributed capital of SBIC LP, and SBIC LP subsequently merged with and into the Company. Under current SBIC regulations, for two or more SBICs under common control, the maximum amount of outstanding SBA debentures cannot exceed $350.0 million with at least $175.0 million in combined regulatory capital.

On February 26, 2021, we completed the fourth refinancing of the Saratoga CLO. This refinancing, among other things, extended the Saratoga CLO reinvestment period to April 2024, and extended its legal maturity to April 2033, and added a non-call period ending February 2022. In addition, and as part of the refinancing, the Saratoga CLO was upsized from $500 million in assets to approximately $650 million. As part of this refinancing and upsizing, we invested an additional $14.0 million in all of the newly issued subordinated notes of the Saratoga CLO and purchased $17.9 million in aggregate principal amount of the Class F-R-3 Notes tranche at par. Concurrently, the existing $2.5 million of Class F-R-2 Notes, $7.5 million of Class G-R-2 Notes and $25.0 million CLO 2013-1 Warehouse 2 Loan were repaid. We also paid $2.6 million of transaction costs related to the refinancing and upsizing on behalf of the Saratoga CLO, to be reimbursed from future equity distributions. At August 31, 2021, the outstanding receivable of $2.6 million was repaid.

On June 10, 2024, the Company completed its fifth refinancing of the Saratoga CLO. This refinancing, among other things, did not extend the Saratoga CLO reinvestment period nor extend its legal maturity, while adjusting the interest rate of two of the existing Notes. The Issuer issued $422.5 million of notes (the “2013-1 2024 Reset CLO Notes”), consisting of Class A-1-R-4 and Class A-2-R-4. The 2013-1 2024 Reset CLO Notes were issued pursuant to the Indenture with the same Trustee. Proceeds of the issuance of the 2013-1 2024 Reset CLO Notes were used along with existing assets of the Saratoga CLO to redeem the existing Class A-1-R-3 and Class A-2-R-3 Notes. No other Notes were refinanced as part of this refinancing. The Saratoga CLO paid $0.5 million of transaction costs related to the refinancing.

We have formed a wholly owned special purpose entity, Saratoga Investment Funding II LLC, a Delaware limited liability company (“SIF II”), for the purpose of entering into a senior secured revolving credit facility with Encina Lender Finance, LLC (“Encina”), supported by loans held by SIF II and pledged to Encina under the credit facility (the “Encina Credit Facility). The Encina Credit Facility closed on October 4, 2021. During the first two years following the closing date, SIF II may request an increase in the commitment amount under the Encina Credit Facility to up to $75.0 million. The terms of the Encina Credit Facility require a minimum drawn amount of $12.5 million at all times during the first six months following the closing date, which increases to the greater of $25.0 million or 50% of the commitment amount in effect at any time thereafter. The term of the Encina Credit Facility is three years. Advances under the Encina Credit Facility bear interest at a floating rate per annum equal to LIBOR plus 4.0%, with LIBOR having a floor of 0.75%, with customary provisions related to our and Encina’s selection of a replacement benchmark rate. Concurrently with the closing of the Encina Credit Facility, all remaining amounts outstanding on our existing revolving credit facility with Madison Capital Funding, LLC were repaid and the facility was terminated. On January 27, 2023, among other things, the borrowings available under the Encina Credit Facility was increased from up to $50.0 million to up to $65.0 million, the underlying benchmark rate used to compute interest changed from LIBOR to Term SOFR for one-month tenor plus a 0.10% credit spread adjustment; the applicable effective margin rate on borrowings increased from 4.00% to 4.25% and the maturity date was extended from October 4, 2024 to January 27, 2026.

110

We have formed a wholly owned special purpose entity, Saratoga Investment Funding III LLC, a Delaware limited liability company (“SIF III”), for the purpose of entering into a senior secured revolving credit facility with Live Oak Banking Company (“Live Oak”), supported by loans held by SIF III and pledged to Live Oak under the credit facility (the “Live Oak Credit Facility). The Live Oak Credit Facility closed on March 27, 2024. During the first two years following the closing date, SIF III may request an increase in the commitment amount under the Live Oak Credit Facility to up to $150.0 million. The terms of the Live Oak Credit Facility require a minimum drawn amount of $12.5 million at all times during the period ending March 27, 2025, which increases to the greater of $25.0 million or 50% of the facility amount in effect at any time thereafter. The term of the Live Oak Credit Facility is three years. Advances under the Live Oak Credit Facility bear interest at a floating rate per annum equal to Adjusted Term SOFR plus an applicable margin between 3.50% and 4.25% based on the Live Oak Credit Facility’s utilization. On June 14, 2024, the Live Oak Credit Facility was amended to, among other things: (i) increase the borrowings available under the Live Oak Credit Facility from up to $50.0 million to up to $75.0 million, subject to a borrowing base requirement; (ii) add new lenders to the Live Oak Credit Agreement; (iii) replace administrative agent approval with “Required Lender” (as defined in the Live Oak Credit Agreement) approval with respect to certain matters; (iv) replace Required Lender approval with 100% lender approval with respect to certain matters; and (v) change the definition of Required Lender to require the approval of at least two unaffiliated lenders.

On October 26, 2021, we entered into a Limited Liability Company Agreement with TJHA JV I LLC (“TJHA”) to co-manage Saratoga Senior Loan Fund I JV LLC (“SLF JV”). SLF JV is invested in Saratoga Investment Corp Senior Loan Fund 2021-1 Ltd (“SLF 2021”), which is a wholly owned subsidiary of SLF JV. SLF 2021 was formed for the purpose of making investments in a diversified portfolio of broadly syndicated first lien and second lien term loans or bonds in the primary and secondary markets.

On September 30, 2022, SLF 2021 was renamed to Saratoga Investment Corp Senior Loan Fund 2022-1, Ltd. (“SLF 2022”).

We and TJHA have equal voting interest on all material decisions with respect to SLF JV, including those involving its investment portfolio, and equal control of corporate governance. No management fee is charged to SLF JV as control and management of SLF JV is shared equally.

We and TJHA have committed to provide up to a combined $50.0 million of financing to SLF JV through cash contributions, where we provided $43.75 million and TJHA provides $6.25 million, resulting in an 87.5% and 12.5% ownership between the two parties. The financing is issued in the form of an unsecured note and equity. The unsecured note will pay a fixed rate of 10.0% per annum and is due and payable in full on October 20, 2033. As of November 30, 2024 our and TJHA’s investment in SLF JV consisted of an unsecured note of $17.6 million and $2.5 million, respectively; and membership interest of $17.6 million and $2.5 million, respectively. As of February 29, 2024, our and TJHA’s investment in SLF JV consisted of an unsecured note of $17.6 million and $2.5 million, respectively; and membership interest of $17.6 million and $2.5 million, respectively. As of November 30, 2024 and February 29, 2024, the Company’s investment in the unsecured note of SLF JV had a fair value of $16.2 million and $15.8 million, respectively, and the Company’s investment in the membership interests of SLF JV had a fair value of $4.8 million and $9.4 million, respectively.

SLF JV’s initial investment in SLF 2022 was in the form of an unsecured loan. The unsecured loan paid a floating rate of LIBOR plus 7.00% per annum and was paid in full on June 9, 2023. The unsecured loan was repaid in full on October 28, 2022, as part of the CLO closing.

We have determined that SLF JV is an investment company under (“FASB”) Accounting Standards Codification (“ASC”) Topic 946, Financial Services—Investment Companies ; however, in accordance with such guidance we will generally not consolidate our investment in a company other than a wholly owned investment company subsidiary. SLF JV is not a wholly owned investment company subsidiary as we and TJHA each have an equal 50% voting interest in SLF JV and thus neither party has a controlling financial interest. Furthermore, FASB ASC Topic 810, Consolidation , concludes that in a joint venture where both members have equal decision making authority, it is not appropriate for one member to consolidate the joint venture since neither has control. Accordingly, we do not consolidate SLF JV.

On October 28, 2022, SLF 2022 issued $402.1 million of debt through the JV CLO trust. The 2022 JV CLO Notes were issued pursuant to the JV Indenture, with the Trustee. As part of the transaction, we purchased 87.50% of the Class E Notes from SLF 2022 with a par value of $12.25 million. As of November 30, 2024 and February 29, 2024, the fair value of these Class E Notes were $12.3 million and $12.3 million, respectively.

111

Critical Accounting Policies and Estimates

Basis of Presentation

The preparation of financial statements in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) requires management to make certain estimates and assumptions affecting amounts reported in our consolidated financial statements. We have identified investment valuation, revenue recognition and the recognition of capital gains incentive fee expense as our most critical accounting estimates. We continuously evaluate our estimates, including those related to the matters described below. These estimates are based on the information that is currently available to us and on various other assumptions that we believe to be reasonable under the circumstances. Actual results could differ materially from those estimates under different assumptions or conditions. A discussion of our critical accounting policies and estimates follows.

Investment Valuation

We account for investments at fair value in accordance with the FASB ASC Topic 820, Fair Value Measurement (“ASC 820”). ASC 820 defines fair value, establishes a framework for measuring fair value, establishes a fair value hierarchy based on the quality of inputs used to measure fair value and enhances disclosure requirements for fair value measurements. Under ASC 820 we are required to assume that its investments are to be sold or its liabilities are to be transferred at the balance sheet date in the principal market to independent market participants, or in the absence of a principal market, in the most advantageous market, which may be a hypothetical market. Market participants are defined as buyers and sellers in the principal or most advantageous market that are independent, knowledgeable, and willing and able to transact.

Investments for which market quotations are readily available are fair valued at such market quotations obtained from independent third-party pricing services and market makers subject to any decision by our board of directors to approve a fair value determination to reflect significant events affecting the value of these investments. We value investments for which market quotations are not readily available at fair value as approved, in good faith, by our board of directors based on input from Saratoga Investment Advisors, the audit committee of our board of directors and a third party independent valuation firm. We use multiple techniques for determining fair value based on the nature of the investment and experience with those types of investments and specific portfolio companies. The selections of the valuation techniques and the inputs and assumptions used within those techniques often require subjective judgements and estimates. These techniques include market comparables, discounted cash flows and enterprise value waterfalls. Fair value is best expressed as a range of values from which we determine a single best estimate. The types of inputs and assumptions that may be considered in determining the range of values of our investments include the nature and realizable value of any collateral, the portfolio company’s ability to make payments, market yield trend analysis and volatility in future interest rates, call and put features, the markets in which the portfolio company does business, comparison to publicly traded companies, discounted cash flows and other relevant factors.

We undertake a multi-step valuation process each quarter when valuing investments for which market quotations are not readily available, as described below:

each investment is initially valued by the responsible investment professionals of Saratoga Investment Advisors and preliminary valuation conclusions are documented and discussed with our senior management; and

an independent valuation firm engaged by our board of directors independently reviews a selection of these preliminary valuations each quarter so that the valuation of each investment for which market quotes are not readily available is reviewed by the independent valuation firm at least once each fiscal year. We use a third-party independent valuation firm to value our investment in the subordinated notes of Saratoga CLO and the Class F-2-R-3 Notes tranche of the Saratoga CLO every quarter.

In addition, all our investments are subject to the following valuation process:

the audit committee of our board of directors reviews and approves each preliminary valuation and Saratoga Investment Advisors and an independent valuation firm (if applicable) will supplement the preliminary valuation to reflect any comments provided by the audit committee; and

our board of directors discusses the valuations and approves the fair value of each investment, in good faith, based on the input of Saratoga Investment Advisors, independent valuation firm (to the extent applicable) and the audit committee of our board of directors.

112

Our investment in Saratoga CLO is carried at fair value, which is based on a discounted cash flows that utilizes prepayment, re-investment and loss assumptions based on historical experience and projected performance, economic factors, the characteristics of the underlying cash flow, and market comparables for equity interests in collateralized loan obligation funds similar to Saratoga CLO, when available, as determined by Saratoga Investment Advisors and recommended to our board of directors. Specifically, we use Intex cash flows, or an appropriate substitute, to form the basis for the valuation of our investment in Saratoga CLO. The cash flows use a set of inputs including projected default rates, recovery rates, reinvestment rates and prepayment rates in order to arrive at estimated valuations. The inputs are based on available market data and projections provided by third parties as well as management estimates. We use the output from the Intex models (i.e., the estimated cash flows) to perform a discounted cash flow analysis on expected future cash flows to determine a valuation for our investment in Saratoga CLO.

Rule 2a-5 under the 1940 Act (“Rule 2a-5”) establishes a regulatory framework for determining fair value in good faith for purposes of the 1940 Act. Rule 2a-5 permits boards, subject to board oversight and certain other conditions, to designate the investment adviser to perform fair value determinations. Rule 2a-5 also defines when market quotations are “readily available” for purposes of the 1940 Act and the threshold for determining whether a fund must determine the fair value of a security. Rule 31a-4 under the 1940 Act (“Rule 31a-4”) provides the recordkeeping requirements associated with fair value determinations. While our board of directors has not elected to designate Saratoga Investment Advisors as the valuation designee, we has adopted certain revisions to its valuation policies and procedures in order comply with the applicable requirements of Rule 2a-5 and Rule 31a-4.

Revenue Recognition

Income Recognition

Interest income, adjusted for amortization of premium and accretion of discount, is recorded on an accrual basis to the extent that such amounts are expected to be collected. The Company stops accruing interest on its investments when it is determined that interest is no longer collectible. Discounts and premiums on investments purchased are accreted/amortized over the life of the respective investment using the effective yield method. The amortized cost of investments represents the original cost adjusted for the accretion of discounts and amortization of premiums on investments.

Loans are generally placed on non-accrual status when there is reasonable doubt that principal or interest will be collected. Accrued interest is generally reserved when a loan is placed on non-accrual status. Interest payments received on non-accrual loans may be recognized as a reduction in principal depending upon management’s judgment regarding collectability. Non-accrual loans are restored to accrual status when past due principal and interest is paid and, in management’s judgment, are likely to remain current, although we may make exceptions to this general rule if the loan has sufficient collateral value and is in the process of collection.

Payment-in-Kind Interest

We may hold debt and preferred equity investments in our portfolio that contain a payment-in-kind (“PIK”) interest provision. The PIK interest, which represents contractually deferred interest added to the investment balance that is generally due at maturity, is generally recorded on the accrual basis to the extent such amounts are expected to be collected. We stop accruing PIK interest if we do not expect the issuer to be able to pay all principal and interest when due.

113

Revenues

We generate revenue in the form of interest income and capital gains on the debt investments that we hold and capital gains, if any, on equity interests that we may acquire. We expect our debt investments, whether in the form of leveraged loans or mezzanine debt, to have terms of up to ten years, and to bear interest at either a fixed or floating rate. Interest on debt will be payable generally either quarterly or semi-annually. In some cases, our debt or preferred equity investments may provide for a portion or all of the interest to be PIK. To the extent interest is PIK, it will be payable through the increase of the principal amount of the obligation by the amount of interest due on the then-outstanding aggregate principal amount of such obligation. The principal amount of the debt and any accrued but unpaid interest will generally become due at the maturity date. In addition, we may generate revenue in the form of commitment, origination, structuring, amendment, redemption or diligence fees, fees for providing managerial assistance or investment management services and possibly consulting fees. Any such fees will be generated in connection with our investments and recognized as earned. We may also invest in preferred equity or common equity securities that pay dividends on a current basis.

On January 22, 2008, we entered into a collateral management agreement with Saratoga CLO, pursuant to which we act as its collateral manager. The Saratoga CLO was initially refinanced in October 2013 with its reinvestment period extended to October 2016. On November 15, 2016, we completed a second refinancing of the Saratoga CLO with its reinvestment period extended to October 2018.

On December 14, 2018, we completed a third refinancing and upsize of the Saratoga CLO. The third Saratoga CLO refinancing, among other things, extended its reinvestment period to January 2021, and extended its legal maturity date to January 2030, and added a non-call period of January 2020. Following this refinancing, the Saratoga CLO portfolio increased from approximately $300.0 million in aggregate principal amount to approximately $500.0 million of predominantly senior secured first lien term loans. In addition to refinancing its liabilities, we invested an additional $13.8 million in all of the newly issued subordinated notes of the Saratoga CLO and also purchased $2.5 million in aggregate principal amount of the Class F-R-2 and $7.5 million aggregate principal amount of the Class G-R-2 notes tranches at par, with a coupon of 3M USD LIBOR plus 8.75% and 3M USD LIBOR plus 10.00%, respectively. As part of this refinancing, we also redeemed our existing $4.5 million aggregate amount of the Class F notes tranche at par and the $20.0 million CLO 2013-1 Warehouse Loan was repaid.

On February 11, 2020, we entered into an unsecured loan agreement (“CLO 2013-1 Warehouse 2 Loan”) with Saratoga Investment Corp. CLO 2013-1 Warehouse 2, Ltd (“CLO 2013-1 Warehouse 2”), a wholly owned subsidiary of Saratoga CLO, pursuant to which CLO 2013-1 Warehouse 2 may borrow from time to time up to $20.0 million from the Company in order to provide capital necessary to support warehouse activities. On October 23, 2020, the availability under the CLO 2013-1 Warehouse 2 Loan was increased to $25.0 million, which was immediately fully drawn and, which expires on August 20, 2021. The interest rate was also amended to be based on a pricing grid, starting at an annual rate of 3M USD LIBOR + 4.46%. During the fourth quarter ended February 28, 2021, the CLO 2013-1 Warehouse 2 Ltd was repaid in full.

On February 26, 2021, we completed the fourth refinancing of the Saratoga CLO. This refinancing, among other things, extended the Saratoga CLO reinvestment period to April 2024, extended its legal maturity to April 2033, and added a non-call period of February 2022. In addition, and as part of the refinancing, the Saratoga CLO was upsized from $500 million in assets to approximately $650 million. As part of this refinancing and upsizing, the Company invested an additional $14.0 million in all of the newly issued subordinated notes of the Saratoga CLO, and purchased $17.9 million in aggregate principal amount of the Class F-R-3 Notes tranche at par. Concurrently, the existing $2.5 million of Class F-R-2 Notes, $7.5 million of Class G-R-2 Notes and $25.0 million of the CLO 2013-1 Warehouse 2 Loan were repaid. We also paid $2.6 million of transaction costs related to the refinancing and upsizing on behalf of the Saratoga CLO, to be reimbursed from future equity distributions. At August 31, 2021, the outstanding receivable of $2.6 million was repaid in full.

On August 9, 2021, we exchanged our existing $17.9 million Class F-R-3 Notes for $8.5 million Class F-1-R-3 Notes and $9.4 million Class F-2-R-3 Notes at par. On August 11, 2021, we sold our Class F-1-R-3 Notes to third parties, resulting in a realized loss of $0.1 million.

On June 10, 2024, the Company completed its fifth refinancing of the Saratoga CLO. This refinancing, among other things, did not extend the Saratoga CLO reinvestment period nor extend its legal maturity, while adjusting the interest rate of two of the existing Notes. The Issuer issued $422.5 million of notes, consisting of Class A-1-R-4 and Class A-2-R-4. The 2013-1 2024 Reset CLO Notes were issued pursuant to the Indenture with the same Trustee. Proceeds of the issuance of the 2013-1 2024 Reset CLO Notes were used along with existing assets of the Saratoga CLO to redeem the existing Class A-1-R-3 and Class A-2-R-3 Notes. No other Notes were refinanced as part of this refinancing. The Saratoga CLO paid $0.5 million of transaction costs related to the refinancing.

114

The Saratoga CLO remains effectively 100% owned and managed by Saratoga Investment Corp. We receive a base management fee of 0.10% per annum and a subordinated management fee of 0.40% per annum of the outstanding principal amount of Saratoga CLO’s assets, paid quarterly to the extent of available proceeds. Prior to the second refinancing and the issuance of the 2013-1 Amended CLO Notes, we received a base management fee of 0.25% per annum and a subordinated management fee of 0.25% per annum of the outstanding principal amount of Saratoga CLO’s assets, paid quarterly to the extent of available proceeds.

Following the third refinancing and the issuance of the 2013-1 Reset CLO Notes on December 14, 2018, we are no longer entitled to an incentive management fee equal to 20.0% of excess cash flow to the extent the Saratoga CLO subordinated notes receive an internal rate of return paid in cash equal to or greater than 12.0%.

Interest income on our investment in Saratoga CLO is recorded using the effective interest method in accordance with the provisions of FASB ASC Topic 325-40, Investments-Other, Beneficial Interests in Securitized Financial Assets, based on the anticipated yield and the estimated cash flows over the projected life of the investment. Yields are revised when there are changes in actual or estimated cash flows due to changes in prepayments and/or re-investments, credit losses or asset pricing. Changes in estimated yield are recognized as an adjustment to the estimated yield over the remaining life of the investment from the date the estimated yield was changed.

On October 26, 2021, the Company and TJHA entered into the LLC Agreement to co-manage SLF JV. SLF JV is invested in Saratoga Investment Corp Senior Loan Fund 2022-1, Ltd (“SLF 2021”), which is a wholly owned subsidiary of SLF JV. SLF 2021 was formed for the purpose of making investments in a diversified portfolio of broadly syndicated first lien and second lien term loans or bonds in the primary and secondary markets.

The Company and TJHA have equal voting interest on all material decisions with respect to SLF JV, including those involving its investment portfolio, and equal control of corporate governance. No management fee is charged to SLF JV as control and management of SLF JV is shared equally.

The Company and TJHA have committed to provide up to a combined $50.0 million of financing to SLF JV through cash contributions, with the Company providing $43.75 million and TJHA providing $6.25 million, resulting in an 87.5% and 12.5% ownership between the two parties. The financing is issued in the form of an unsecured note and equity. The unsecured note pays a fixed rate of 10% per annum and is due and payable in full on October 20, 2033.

The Company records interest income from its investment in an unsecured loan with SLF JV on an accrual basis and records dividend income from its membership interest when earned. All operating decisions are shared with a 50% voting interest in SLF JV.

Expenses

Our primary operating expenses include the payment of investment advisory and management fees, professional fees, directors and officers insurance, fees paid to directors who are not “interested persons” (as defined in Section 2(a)(19) of the 1940 Act) of the Company (“independent directors”) and administrator expenses, including our allocable portion of our administrator’s overhead. Our investment advisory and management fees compensate our Manager for its work in identifying, evaluating, negotiating, closing and monitoring our investments. We bear all other costs and expenses of our operations and transactions, including those relating to:

organization;

calculating our net asset value (“NAV”) (including the cost and expenses of any independent valuation firm);

115

expenses incurred by our Manager payable to third parties, including agents, consultants or other advisers, in monitoring our financial and legal affairs and in monitoring our investments and performing due diligence on our prospective portfolio companies;

expenses incurred by our Manager payable for travel and due diligence on our prospective portfolio companies;

interest payable on debt, if any, incurred to finance our investments;

offerings of our common stock and other securities;

investment advisory and management fees;

fees payable to third parties, including agents, consultants or other advisers, relating to, or associated with, evaluating and making investments;

transfer agent and custodial fees;

federal and state registration fees;

all costs of registration and listing our common stock on any securities exchange;

U.S. federal, state and local taxes;

independent directors’ fees and expenses;

costs of preparing and filing reports or other documents required by governmental bodies (including the Securities and Exchange Commission (the “SEC”) and the SBA);

costs of any reports, proxy statements or other notices to common stockholders including printing costs;

our fidelity bond, directors and officers errors and omissions liability insurance, and any other insurance premiums;

direct costs and expenses of administration, including printing, mailing, long distance telephone, copying, secretarial and other staff, independent auditors and outside legal costs; and

administration fees and all other expenses incurred by us or, if applicable, the administrator in connection with administering our business (including payments under the Administration Agreement based upon our allocable portion of the administrator’s overhead in performing its obligations under an Administration Agreement, including rent and the allocable portion of the cost of our officers and their respective staffs (including travel expenses)).

Pursuant to the investment advisory and management agreement that we had with GSCP (NJ), L.P., our former investment adviser and administrator, we had agreed to pay GSCP (NJ), L.P. as investment adviser a quarterly base management fee of 1.75% of the average value of our total assets (other than cash or cash equivalents but including assets purchased with borrowed funds) at the end of the two most recently completed fiscal quarters and an incentive fee.

116

The incentive fee had two parts:

A fee, payable quarterly in arrears, equal to 20.0% of our pre-incentive fee net investment income, expressed as a rate of return on the value of the net assets at the end of the immediately preceding quarter, that exceeded a 1.875% quarterly hurdle rate measured as of the end of each fiscal quarter. Under this provision, in any fiscal quarter, our investment adviser received no incentive fee unless our pre-incentive fee net investment income exceeded the hurdle rate of 1.875%. Amounts received as a return of capital were not included in calculating this portion of the incentive fee. Since the hurdle rate was based on net assets, a return of less than the hurdle rate on total assets could still have resulted in an incentive fee.

A fee, payable at the end of each fiscal year, equal to 20.0% of our net realized capital gains, if any, computed net of all realized capital losses and unrealized capital depreciation, in each case on a cumulative basis on each investment in our portfolio, less the aggregate amount of capital gains incentive fees paid to the investment adviser through such date.

We deferred cash payment of any incentive fee otherwise earned by our former investment adviser if, during the then most recent four full fiscal quarters ending on or prior to the date such payment was to be made, the sum of (a) our aggregate distributions to our stockholders and (b) our change in net assets (defined as total assets less liabilities) (before taking into account any incentive fees payable during that period) was less than 7.5% of our net assets at the beginning of such period. These calculations were appropriately pro-rated for the first three fiscal quarters of operation and adjusted for any share issuances or repurchases during the applicable period. Such incentive fee would become payable on the next date on which such test had been satisfied for the most recent four full fiscal quarters or upon certain terminations of the investment advisory and management agreement. We commenced deferring cash payment of incentive fees during the quarterly period ended August 31, 2007 and continued to defer such payments through the quarterly period ended May 31, 2010. As of July 30, 2010, the date on which GSCP (NJ), L.P. ceased to be our investment adviser and administrator, we owed GSCP (NJ), L.P. $2.9 million in fees for services previously provided to us; of which $0.3 million has been paid by us. GSCP (NJ), L.P. agreed to waive payment by us of the remaining $2.6 million in connection with the consummation of the stock purchase transaction with Saratoga Investment Advisors and certain of its affiliates described elsewhere in this Quarterly Report.

The terms of the investment advisory and management agreement with Saratoga Investment Advisors, our current investment adviser, are substantially similar to the terms of the investment advisory and management agreement we had entered into with GSCP (NJ), L.P., our former investment adviser, except for the following material distinctions in the fee terms:

The capital gains portion of the incentive fee was reset with respect to gains and losses from May 31, 2010, and therefore losses and gains incurred prior to such time will not be taken into account when calculating the capital gains fee payable to Saratoga Investment Advisors and, as a result, Saratoga Investment Advisors will be entitled to 20.0% of net gains that arise after May 31, 2010. In addition, the cost basis for computing realized gains and losses on investments held by us as of May 31, 2010 equal the fair value of such investment as of such date. Under the investment advisory and management agreement with our former investment adviser, GSCP (NJ), L.P., the capital gains fee was calculated from March 21, 2007, and the gains were substantially outweighed by losses.

Under the “catch up” provision, 100.0% of our pre-incentive fee net investment income with respect to that portion of such pre-incentive fee net investment income that exceeds 1.875% but is less than or equal to 2.344% in any fiscal quarter is payable to Saratoga Investment Advisors. This will enable Saratoga Investment Advisors to receive 20.0% of all net investment income as such amount approaches 2.344% in any quarter, and Saratoga Investment Advisors will receive 20.0% of any additional net investment income. Under the investment advisory and management agreement with our former investment adviser, GSCP (NJ), L.P. only received 20.0% of the excess net investment income over 1.875%.

We will no longer have deferral rights regarding incentive fees in the event that the distributions to stockholders and change in net assets is less than 7.5% for the preceding four fiscal quarters.

117

Capital Gains Incentive Fee

We record an expense accrual relating to the capital gains incentive fee payable by us to the Manager when the unrealized gains on its investments exceed all realized capital losses on its investments given the fact that a capital gains incentive fee would be owed to the Manager if we were to liquidate our investment portfolio at such time. The actual incentive fee payable to the Company’s Manager related to capital gains will be determined and payable in arrears at the end of each fiscal year and will include only realized capital gains for the period.

Recent Accounting Pronouncements

In November 2023, the FASB issued ASU 2023-07, Improvements to Reportable Segment Disclosures . ASU 2023-07 enhances the disclosures required for reportable segments on an annual and interim basis. ASU 2023-07 is effective on a retrospective basis for annual periods beginning after December 15, 2023, and for interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted; however, the Company has not elected to adopt this provision as of the date of the financial statements contained in this quarterly report. The Company is still assessing the impact of the new guidance.

In December 2023, the FASB issued ASU 2023-09, Improvements to Income Tax Disclosures . The amendments in this update require more disaggregated information on income taxes paid. ASU 2023-09 is effective for years beginning after December 15, 2024. Early adoption is permitted, however the Company has not elected to early adopt this provision as of the date of the financial statements contained in this report. The Company is still assessing the impact of the new guidance.

Portfolio and Investment Activity

Investment Portfolio Overview

November 30,
2024
February 29,
2024
($ in millions)
Number of investments(1) 133 139
Number of portfolio companies(2) 48 55
Average investment per portfolio company(2) $ 19.6 $ 20.1
Average investment size(1) $ 7.2 $ 8.1
Weighted average maturity(3) 2.3 yrs 2.5 yrs
Number of industries (5) 40 43
Non-performing or delinquent investments (fair value) $ 2.7 $ 18.9
Fixed rate debt (% of interest earning portfolio)(3) $ 8.8(1.0 )% $ 5.5(0.5 )%
Fixed rate debt (weighted average current coupon)(3) 8.0 % 15.0 %
Floating rate debt (% of interest earning portfolio)(3) $ 834.9(99.0 )% $ 997.9(99.5 )%
Floating rate debt (weighted average current spread over SOFR)(3)(4) 7.3 % 7.5 %

(1) Excludes our investment in the subordinated notes of Saratoga CLO.
(2) Excludes our investment in the subordinated notes of Saratoga CLO and Class F-2-R-3 Notes tranche, as well as the unsecured notes and equity interests in the SLF JV and the Class E Note tranche of the SLF 2022.
(3) Excludes our investment in the subordinated notes of Saratoga CLO and equity interests, as well as the unsecured notes and equity interests in SLF JV and the Class E Note tranche of the SLF 2022.
(4) Calculation uses either 1-month or 3-month SOFR, depending on the contractual terms, and after factoring in any existing SOFR floors.
(5) Our investment in the subordinated notes of Saratoga CLO and Class F-R-3 Note tranche, as well as the unsecured notes and equity interests in the SLF JV and the Class E Note tranche of the SLF 2022 are included in Structured Finance Securities industry.

118

During the three months ended November 30, 2024, we invested $84.4 million in new and existing portfolio companies and had $160.4 million in aggregate amount of exits and repayments resulting in net investments of $(76.0) million for the period. During the three months ended November 30, 2023, we invested $35.6 million in new and existing portfolio companies and had $2.1 million in aggregate amount of exits and repayments resulting in net investments of $33.5 million for the period.

During the nine months ended November 30, 2024, we invested $126.3 million in new and existing portfolio companies and had $296.2 million in aggregate amount of exits and repayments resulting in net investments of $(169.9) million for the period. During the nine months ended November 30, 2023, we invested $202.9 million in new and existing portfolio companies and had $19.2 million in aggregate amount of exits and repayments resulting in net repayments of $183.7 million for the period.

Portfolio Composition

Our portfolio composition at November 30, 2024: and February 29, 2024: at fair value was as follows:

November 30, 2024 February 29, 2024
Percentage
of Total
Portfolio
Weighted
Average
Current
Yield
Percentage
of Total
Portfolio
Weighted
Average
Current
Yield
First lien term loans 86.8 % 11.6 % 85.7 % 12.6 %
Second lien term loans 0.6 16.8 1.6 5.1
Unsecured term loans 1.7 10.9 1.4 11.1
Structured finance securities 1.9 16.7 2.7 10.3
Equity interests 9.0 - 8.6 -
Total 100.0 % 10.8 % 100.0 % 11.4 %

At November 30, 2024, our investment in the subordinated notes of Saratoga CLO, a collateralized loan obligation fund, had a fair value of $1.3 million and constituted 0.1% of our portfolio. This investment constitutes a first loss position in a portfolio that, as of November 30, 2024 and February 29, 2024, was composed of $558.8 million and $640.8 million, respectively, in aggregate principal amount of primarily senior secured first lien term loans. In addition, as of November 30, 2024, we also own $4.3 million in aggregate principal of the F-2-R-3 Notes in the Saratoga CLO, which only rank senior to the subordinated notes.

This investment is subject to unique risks. (See Part 1. Item 1A. Risk Factors—“Our investment in Saratoga CLO constitutes a leveraged investment in a portfolio of subordinated notes representing the lowest-rated securities issued by a pool of predominantly senior secured first lien term loans and is subject to additional risks and volatility. All losses in the pool of loans will be borne by our subordinated notes and only after the value of our subordinated notes is reduced to zero will the higher-rated notes issued by the pool bear any losses” predominantly senior secured first lien term loans and is subject to additional risks and volatility” in our Annual Report on Form 10-K for the fiscal year ended February 29, 2024).

We do not consolidate the Saratoga CLO portfolio in our consolidated financial statements. Accordingly, the metrics below do not include the underlying Saratoga CLO portfolio investments. However, at November 30, 2024, $515.5 million or 98.1% of the Saratoga CLO portfolio investments in terms of market value had a CMR (as defined below) color rating of green or yellow and two Saratoga CLO portfolio investments were in default with a fair value of $0.04 million. At February 29, 2024, $603.0 million or 99.2% of the Saratoga CLO portfolio investments in terms of market value had a CMR color rating of green or yellow and two Saratoga CLO portfolio investments were in default with a fair value of $0.3 million. For more information relating to the Saratoga CLO, see the audited financial statements for Saratoga in our Annual Report on Form 10-K for the fiscal year ended February 29, 2024.

Saratoga Investment Advisors normally grades all of our investments using a credit and monitoring rating system (“CMR”). The CMR consists of a single component: a color rating. The color rating is based on several criteria, including financial and operating strength, probability of default, and restructuring risk. The color ratings are characterized as follows: (Green)—performing credit; (Yellow)—underperforming credit; (Red)—in principal payment default and/or expected loss of principal.

119

Portfolio CMR distribution

The CMR distribution for our investments at November 30, 2024 and February 29, 2024 was as follows:

Saratoga Investment Corp.

November 30, 2024 February 29, 2024
Color Score Investments
at
Fair Value
Percentage
of Total
Portfolio

Investments

at
Fair Value

Percentage
of Total
Portfolio
($ in thousands)
Green $ 857,217 89.3 % $ 1,000,298 87.8 %
Yellow 1,103 0.1 12,643 1.1
Red 1,574 0.2 6,273 0.6
N/A(1) 100,199 10.4 119,580 10.5
Total $ 960,093 100.0 % $ 1,138,794 100.0 %

(1) Comprised of our investment in the subordinated notes of Saratoga CLO and equity interests.

The CMR distribution of Saratoga CLO investments at November 30, 2024 and February 29, 2024 was as follows:

Saratoga CLO

November 30, 2024 February 29, 2024
Color Score Investments
at
Fair Value
Percentage
of Total
Portfolio
Investments
at Fair
Value
Percentage
of Total
Portfolio
($ in thousands)
Green $ 480,939 91.4 % $ 560,384 92.2 %
Yellow 34,513 6.6 42,580 7.0
Red 8,371 1.6 3,568 0.6
N/A(1) 1,909 0.4 1,020 0.2
Total $ 525,732 100.0 % $ 607,552 100.0 %

(1) Comprised of Saratoga CLO’s equity interests.

120

Portfolio composition by industry grouping at fair value

The following table shows our portfolio composition by industry grouping at fair value at November 30, 2024 and February 29, 2024:

Saratoga Investment Corp.

November 30, 2024 February 29, 2024
Investments
At
Fair Value
Percentage
of Total
Portfolio
Investments
At
Fair Value
Percentage
of Total
Portfolio
($ in thousands)
Healthcare Services $ 85,207 8.7 % $ 51,094 4.7 %
Consumer Services 59,554 6.2 64,689 5.7
HVAC Services and Sales 58,367 6.1 59,208 5.2
Real Estate Services 51,803 5.4 52,350 4.6
Education Software 47,814 5.0 45,579 4.0
Healthcare Software 45,943 4.8 120,500 10.6
Dental Practice Management 35,428 3.7 40,235 3.5
Mental Healthcare Services 32,448 3.4 37,377 3.3
Restaurant 31,534 3.3 22,580 2.0
Health/Fitness Franchisor 30,009 3.1 32,032 2.8
Municipal Government Software 29,720 3.1 - 0.0
Education Services 27,784 2.9 25,819 2.3
Talent Acquisition Software 27,453 2.9 26,896 2.4
Employee Collaboration Software 26,686 2.8 14,150 1.2
Financial Services 26,415 2.8 26,276 2.3
Research Software 26,374 2.7 26,255 2.3
Architecture & Engineering Software 25,755 2.7 25,247 2.2
Association Management Software 25,366 2.6 24,089 2.1
Direct Selling Software 24,070 2.5 24,073 2.1
Mentoring Software 21,897 2.3 22,069 1.9
Investment Fund 20,952 2.2 25,222 2.2
Insurance Software 20,385 2.1 19,821 1.7
IT Services 18,810 2.0 78,422 6.9
Marketing Orchestration Software 18,433 1.9 18,420 1.6
Structured Finance Securities(1) 17,852 1.9 30,626 2.7
Corporate Education Software 17,742 1.8 18,026 1.6
Non-profit Services 16,429 1.7 16,267 1.4
Veterinary Services 12,672 1.3 4,753 0.4
Lead Management Software 11,641 1.2 12,120 1.1
Alternative Investment Management Software 11,586 1.2 10,779 0.9
Field Service Management 11,481 1.2 10,708 0.9
Fire Inspection Business Software 10,150 1.1 9,916 0.9
Financial Services Software 10,012 1.0 9,916 0.9
Industrial Products 8,726 0.9 9,095 0.8
Office Supplies 5,446 0.6 7,181 0.6
Cyber Security 3,438 0.4 2,826 0.2
Staffing Services 3,137 0.3 3,288 0.3
Specialty Food Retailer 1,574 0.2 2,489 0.2
Facilities Maintenance - 0.0 231 0.0
Healthcare Supply - 0.0 - 0.0
Hospitality/Hotel - 0.0 41,447 3.6
Sports Management - - 27,000 2.4
Legal Software - - 20,709 1.8
Roofing Contractor Software - - 19,014 1.7
Total $ 960,093 100.0 % $ 1,138,794 100.0 %

(1) As of November 30, 2024 and February 29, 2024, the foregoing comprised of our investment in the subordinated notes and F-2-R-3 Notes of Saratoga CLO, as well as the unsecured notes and equity interests in the SLF JV and E-Notes of SLF 2022.

121

The following table shows Saratoga CLO’s portfolio composition by industry grouping at fair value at November 30, 2024 and February 29, 2024:

Saratoga CLO

November 30, 2024 February 29, 2024
Investments
at Fair Value
Percentage
of Total
Portfolio
Investments
at
Fair Value

Percentage

of Total
Portfolio

($ in thousands)
Banking, Finance, Insurance & Real Estate $ 108,199 20.7 % $ 116,253 19.0 %
Services: Business 51,207 9.7 65,524 10.8
High Tech Industries 43,113 8.2 50,996 8.4
Healthcare & Pharmaceuticals 29,663 5.6 40,453 6.7
Services: Consumer 29,287 5.6 30,433 5.0
Chemicals, Plastics, & Rubber 27,182 5.2 30,219 5.0
Retail 23,360 4.4 26,339 4.3
Telecommunications 22,417 4.3 22,718 3.7
Media: Advertising, Printing & Publishing 17,919 3.4 20,265 3.3
Hotel, Gaming & Leisure 17,637 3.4 20,217 3.3
Automotive 17,021 3.2 20,007 3.3
Consumer goods: Durable 14,765 2.8 17,555 2.9
Containers, Packaging & Glass 14,488 2.8 17,138 2.8
Construction & Building 13,732 2.6 16,663 2.7
Beverage, Food & Tobacco 13,162 2.5 13,150 2.2
Aerospace & Defense 10,573 2.0 13,068 2.2
Media: Broadcasting & Subscription 9,560 1.8 10,778 1.8
Consumer goods: Non-durable 8,127 1.5 10,698 1.8
Media: Diversified & Production 7,482 1.4 10,390 1.7
Transportation: Cargo 7,242 1.4 8,890 1.5
Utilities: Oil & Gas 6,541 1.2 8,046 1.3
Wholesale 6,522 1.2 7,255 1.2
Capital Equipment 4,769 0.9 5,694 0.9
Transportation: Consumer 4,494 0.9 4,720 0.8
Metals & Mining 3,778 0.7 4,256 0.7
Energy: Oil & Gas 3,333 0.6 4,024 0.7
Forest Products & Paper 3,043 0.6 3,592 0.6
Environmental Industries 2,681 0.5 3,120 0.5
Energy: Electricity 2,439 0.5 2,855 0.5
Utilities: Electric 1,994 0.4 2,234 0.4
Total $ 525,730 100.0 % $ 607,550 100.0 %

Portfolio composition by geographic location at fair value

The following table shows our portfolio composition by geographic location at fair value at November 30, 2024 and February 29, 2024. The geographic composition is determined by the location of the corporate headquarters of the portfolio company.

November 30, 2024 February 29, 2024
Investments
at
Fair Value
Percentage
of Total
Portfolio

Investments

at
Fair Value

Percentage
of Total
Portfolio
($ in thousands)
Midwest $ 329,864 34.3 % $ 264,966 23.3 %
Southeast 240,517 25.1 308,590 27.1
West 131,479 13.7 233,791 20.5
Northeast 123,815 12.9 144,562 12.7
Southwest 63,687 6.6 111,911 9.8
International/Other 18,810 2.0 - -
Other(1) 51,921 5.4 74,974 6.6
Total $ 960,093 100.0 % $ 1,138,794 100.0 %

(1) Comprised of our investments in the subordinated notes, F-2-R-3 Notes of Saratoga CLO, as well as the unsecured notes and equity interests in the SLF JV and foreign investments.

122

Results of operations

Operating results for the three and nine months ended November 30, 2024 and November 30, 2023 was as follows:

For the three months ended For the nine months ended
November 30,
2024
November 30,
2023
November 30,
2024
November 30,
2023
($ in thousands)
Total investment income $ 35,879 $ 36,340 $ 117,560 $ 106,487
Total operating expenses 23,443 22,174 72,592 62,397
Net investment income 12,436 14,166 44,968 44,090
Net realized gain (loss) from investments 5,445 61 (49,199 ) 151
Net change in unrealized appreciation (depreciation) on investments (8,919 ) (17,867 ) 33,741 (39,926 )
Net change in provision for deferred taxes on unrealized (appreciation) depreciation on investments (127 ) (416 ) (747 ) (578 )
Realized losses on extinguishment of debt - - - (110 )
Net increase (decrease) in net assets resulting from operations $ 8,835 $ (4,056 ) $ 28,763 $ 3,627

Investment income

The composition of our investment income for three and nine months ended November 30, 2024 and November 30, 2023 was as follows:

For the three months ended For the nine months ended

November 30,

2024

November 30,
2023
November 30,
2024
November 30,
2023
($ in thousands)
Interest from investments $ 30,761 $ 32,659 $ 104,432 $ 94,550
Interest from cash and cash equivalents 1,628 522 3,923 1,865
Management fee income 775 820 2,372 2,454
Dividend Income 1,121 1,811 3,746 5,284
Structuring and advisory fee income 741 312 1,187 1,786
Other income 853 216 1,900 548
Total investment income $ 35,879 $ 36,340 $ 117,560 $ 106,487

123

For the three months ended November 30, 2024, total investment income decreased $0.5 million, or 1.3%, to $35.9 million from $36.3 million for the three months ended November 30, 2023. Interest income from investments decreased $1.9 million, or 5.8%, to $30.8 million for the three months ended November 30, 2024 from $32.7 million for the three months ended November 30, 2023. Interest income from investments primarily decreased due to (i) 9.6% reduction in average investments year-over-year, combined with (ii) a decrease in the weighted average current yield on investments to 10.8% at November 30, 2024 from 11.4% at November 30, 2023.

For the nine months ended November 30, 2024, total investment income increased $11.1 million, or 10.4%, to $117.6 million from $106.5 million for the nine months ended November 30, 2023. Interest income from investments increased $9.9 million, or 10.5%, to $104.4 million for the nine months ended November 30, 2024 from $94.5 million for the nine months ended November 30, 2023. Interest income from investments primarily increased due to the recognition of $8.2 million interest income related to our Knowland investment that was previously on non-accrual.

For the three and nine months ended November 30, 2024 and November 30, 2023, total PIK income was $0.8 million and $0.6 million, respectively and $3.3 million and $1.9 million, respectively. The increase in both periods primarily related to the recognition of PIK income on our Knowland investment that was previously on non-accrual.

For the three months ended November 30, 2024 and November 30, 2023, interest from cash and cash equivalents was $1.6 million and $0.5 million, respectively. The increase of $1.1 million for the quarter ended November 30, 2024 was due to increased cash and cash equivalents balances during this period as compared to last year, primarily resulting from repayments received during the quarter.

For the nine months ended November 30, 2024 and November 30, 2023, interest from cash and cash equivalents was $3.9 million and $1.9 million, respectively. The increase of $2.0 million for the quarter ended November 30, 2024 was due to increased cash and cash equivalents balances during this period as compared to last year, primarily resulting from repayments received during the nine months period.

Management fee income reflects the fee income received for managing the Saratoga CLO. For the three months ended November 30, 2024 and November 30, 2023, total management fee income was $0.8 million and $0.8 million, respectively. For the nine months ended November 30, 2024 and November 30, 2023, total management fee income was $2.4 million and $2.5 million, respectively.

For the three and nine months ended November 30, 2024 and November 30, 2023, total dividend income was $1.1 million and $1.8 million, respectively and $3.7 million and $5.3 million respectively. Dividends received is recorded in the consolidated statements of operations when earned, and the decrease primarily reflects lower dividend income received on our membership interest in SLF JV during the three and nine months ended November 30, 2024 as compared to the three and nine months ended November 30, 2023.

For the three and nine months ended November 30, 2024 and November 30, 2023, total structuring and advisory fee income was $0.7 million and $0.3 million, respectively and $1.2 million and $1.8 million, respectively. Structuring and advisory fee income represents fee income earned and received performing certain investment and advisory activities during the closing of new investments.

124

For the three and nine months ended November 30, 2024 and November 30, 2023, other income was $0.9 million and $0.2 million, respectively, and $1.9 million and $0.5 million, respectively. Other income includes origination fees, monitoring and amendment fees and prepayment fees and is recorded in the consolidated statements of operations when earned, and the increase primarily reflects prepayment fees recognized on a higher level of repayments this year.

Operating expenses

The composition of our operating expenses for the three and nine months ended November 30, 2024 and November 30, 2023 was as follows:

For the three months ended For the nine months ended
November 30,
2024
November 30,
2023
November 30,
2024
November 30,
2023
($ in thousands)
Interest and debt financing expenses $ 13,044 $ 12,522 $ 39,135 $ 36,629
Base management fees 4,412 4,857 14,161 14,262
Incentive management fees expense (benefit) 3,110 2,244 11,245 4,828
Professional fees 670 434 1,796 1,407
Administrator expenses 1,250 1,075 3,458 2,798
Insurance 77 81 232 245
Directors fees and expenses 83 81 276 281
General & administrative and other expenses 760 660 2,191 1,958
Income tax expense (benefit) 37 220 98 (11 )
Total operating expenses $ 23,443 $ 22,174 $ 72,592 $ 62,397

For the three months ended November 30, 2024, total operating expenses increased $1.3 million, or 5.7%, compared to the three months ended November 30, 2023. For the nine months ended November 30, 2024, total operating expenses increased $10.2 million, or 16.3%, compared to the three months ended November 30, 2023.

For the three months ended November 30, 2024, interest and debt financing expenses increased $0.5 million, or 4.2%, compared to the three months ended November 30, 2023. The increase is primarily attributable to an increase of 3.6% in average outstanding debt from $809.0 million for the three months ended November 30, 2023 to $837.9 million for the three months ended November 30, 2024.

For the nine months ended November 30, 2024, interest and debt financing expenses increased $2.5 million, or 6.8%, compared to the nine months ended November 30, 2023. The increase is primarily attributable to an increase of 5.1% in average outstanding debt from $795.0 million for the nine months ended November 30, 2023 to $835.9 million for the nine months ended November 30, 2024.

For the three and nine months ended November 30, 2024 and November 30, 2023, the weighted average interest rate on our outstanding indebtedness was 5.56% and 5.58%, respectively and 6.06% and 5.43%, respectively. The increase in weighted average interest rate was primarily driven by the issuance of higher rate borrowings over the past year, primarily last year, reflecting the increase in base rates and spreads in the market at that time.

As of November 30, 2024 and February 29, 2024, the SBA debentures represented 25.5% and 26.1% of overall debt, respectively.

For the three months ended November 30, 2024, base management fees decreased $0.5 million, or 9.2%, from $4.4 million to $4.9 million compared to the three months ended November 30, 2023. The decrease in base management fees results from the 8.7% decrease in the average value of our total assets, less cash and cash equivalents, from $1,108.5 million for the three months ended November 30, 2023 to $1,011.2 million for the three months ended November 30, 2024.

125

For the nine months ended November 30, 2024, base management fees decreased $0.1 million, or 0.7%, from $14.3 million to $14.2 million compared to the nine months ended November 30, 2023. The decrease in base management fees results from the 0.1% decrease in the average value of our total assets, less cash and cash equivalents, from $1,082.1 million for the nine months ended November 30, 2023 to $1,074.0 million for the nine months ended November 30, 2024.

For the three months ended November 30, 2024, incentive management fees increased $0.9 million, or 38.6%, compared to the three months ended November 30, 2023. The incentive fee on income decreased from $3.3 million to $3.1 million for the three months ended November 30, 2023 and 2024, respectively, reflecting the decrease in net investment income during the three months ended November 30, 2024 as compared to the three months ended November 30, 2023. The incentive fee on capital gains decreased from a $(1.1) million benefit for the three months ended November 30, 2023 to a $0.0 million benefit for the three months ended November 30, 2024, reflecting the incentive fee on net realized and unrealized depreciation recognized during both these periods, with the liability floor capped at zero.

For the nine months ended November 30, 2024, incentive management fees increased $6.4 million, or 132.9%, compared to the nine months ended November 30, 2023. The incentive fee on income increased from $9.8 million to $11.2 million for the nine months ended November 30, 2023 and 2024, respectively, reflecting the increase in net investment income during the nine months ended November 30, 2024 as compared to the nine months ended November 30, 2023. The incentive fee on capital gains increased from a $(5.0) million benefit for the nine months ended November 30, 2023 to a $0.0 million benefit for the nine months ended November 30, 2024, reflecting the incentive fee on net realized and unrealized depreciation recognized during both these periods, with the liability floor capped at zero.

For the three months ended November 30, 2024, professional fees increased $0.2 million, or 54.3%, from $0.4 million for the three months ended November 30, 2023 to $0.7 million for the three months ended November 30, 2024.

For the nine months ended November 30, 2024, professional fees increased $0.4 million, or 27.6%, from $1.4 million for the nine months ended November 30, 2023 to $1.8 million for the nine months ended November 30, 2024.

For the three and nine months ended November 30, 2024, administrator expenses increased $0.2 million, or 16.3% and $0.7 million, or 23.6%, respectively compared to the three and nine months ended November 30, 2023, reflecting the contractual changes to the administrator agreement cap.

For the three and nine months ended November 30, 2024, general and administrative expenses increased $1.0 million, or 15.1% and $0.2 million, or 11.9%, respectively compared to the three and nine months ended November 30, 2023.

As discussed above, the increase in interest and debt financing expenses for the three months ended November 30, 2024 compared to the three months ended November 30, 2023 is attributable both to an increase in the average dollar amount of outstanding debt, as well as the higher cost of that debt. For the three months ended November 30, 2024 and November 30, 2023, the average borrowings outstanding under the Encina Credit Facility was $32.5 million and $35.0 million, respectively, and the average weighted average interest rate on the outstanding borrowing under the Encina Credit Facility was 9.40% and 9.79%, respectively. For the three months ended November 30, 2024 and November 30, 2023, the average borrowings outstanding under the Live Oak Credit Facility was $20.0 million and $0.0 million, respectively, and the average weighted average interest rate on the outstanding borrowing under the Live Oak Credit Facility was 9.00% and 0.0%, respectively. For the three months ended November 30, 2024 and November 30, 2023, the average borrowings outstanding of SBA debentures was $214.0 million and $200.4 million, respectively. For the three months ended November 30, 2024 and November 30, 2023, the weighted average interest rate on the outstanding borrowings of the SBA debentures was 3.30% and 3.25%, respectively. For the three months ended November 30, 2024 and November 30, 2023, the average borrowings outstanding of our Notes Payable was $571.4 million and $571.4 million, respectively. For the three months ended November 30, 2024 and November 30, 2023, the weighted average interest rate on the Notes Payable was 6.06% and 6.02%, respectively.

As discussed above, the increase in interest and debt financing expenses for the nine months ended November 30, 2024 compared to the nine months ended November 30, 2023 is attributable both to an increase in the average dollar amount of outstanding debt, as well as the higher cost of that debt. For the nine months ended November 30, 2024 and November 30, 2023, the average borrowings outstanding under the Encina Credit Facility was $33.3 million and $38.9 million, respectively, and the average weighted average interest rate on the outstanding borrowing under the Encina Credit Facility was 9.73% and 9.62%, respectively. For the nine months ended November 30, 2024 and November 30, 2023, the average borrowings outstanding under the Live Oak Credit Facility was $17.3 million and $0.0 million, respectively, and the average weighted average interest rate on the outstanding borrowing under the Live Oak Credit Facility was 9.34% and 0.0%, respectively. For the nine months ended November 30, 2024 and November 30, 2023, the average borrowings outstanding of SBA debentures was $214.0 million and $201.7 million, respectively. For the nine months ended November 30, 2024 and November 30, 2023, the weighted average interest rate on the outstanding borrowings of the SBA debentures was 3.33% and 3.01%, respectively. For the nine months ended November 30, 2024 and November 30, 2023, the average borrowings outstanding of our Notes Payable was $571.4 million and $558.3 million, respectively. For the nine months ended November 30, 2024 and November 30, 2023, the weighted average interest rate on the Notes Payable was 6.06% and 6.02%, respectively.

126

The weighted average dollar amount of our unsecured notes for the three and nine months ended November 30, 2024 and November 30, 2023 was as follows:

For the three months ended For the nine months ended
November 30,
2024
November 30,
2023
November 30,
2024
November 30,
2023
($ in thousands)
7.75% 2025 Notes $ 5.0 $ 5.0 $ 5.0 $ 5.0
6.25% 2027 Notes 15.0 15.0 15.0 15.0
4.375% 2026 Notes 175.0 175.0 175.0 175.0
4.35% 2027 Notes 75.0 75.0 75.0 75.0
6.00% 2027 Notes 105.5 105.5 105.5 105.5
7.00% 2025 Notes 12.0 12.0 12.0 12.0
8.00% 2027 Notes 46.0 46.0 46.0 46.0
8.125% 2027 Notes 60.4 60.4 60.4 60.4
8.75% 2024 Notes 20.0 20.0 20.0 16.7
8.50% 2028 Notes 57.5 57.5 57.5 47.8

For the three and nine months ended November 30, 2024 and November 30, 2023, there were income tax expense (benefits) of $0.0 million and $0.2 million, respectively and $0.1 million and ($0.01) million, respectively. This relates to net deferred federal and state income tax expense (benefit) with respect to operating gains and losses and income derived from equity investments held in entities that are treated as corporations for U.S. federal income tax purposes, as well as current U.S. federal and state income taxes on those operating gains and losses when realized.

Net realized gains (losses) on sales of investments

For the three months ended November 30, 2024, we had $160.4 million of sales, repayments, exits or restructurings resulting in $5.4 million of net realized gains. For the nine months ended November 30, 2024, we had $296.2 million of sales, repayments, exits or restructurings resulting in $49.2 million of net realized losses.

The most significant cumulative net change in realized gains (losses) for the nine months ended November 30, 2024 were the following (dollars in thousands):

Nine Months ended November 30, 2024

Issuer Asset Type Gross Proceeds Cost Net
Realized
Gain (Loss)
Zollege PBC First Lien Term Loan & Equity Interests $ 3,205 $ 18,316 $ (15,111 )
Netreo Holdings, LLC Equity Interests 2,260 7,706 (5,446 )
Book4Time, Inc. First Lien Term Loan, Second Lien Term Loan & Equity Interests 707 157 550
Pepper Palace, Inc. First Lien Term Loan & Equity Interests - - (34,007 )
Invita (fka HemaTerra Holding Company, LLC) Equity Interests 7,577 2,817 4,760

The $15.1 million of net realized losses was from the restructuring of our Zollege PBC investment.

The $5.4 million of net realized losses was from the sale of the equity position in our Netreo Holdings, LLC investment.

The $0.5 million of net realized gains was from the sale of the equity position in our Book4Time, Inc. investment.

The $34.0 million of net realized losses was from the restructuring of our Pepper Palace, Inc. investment.

The $4.8 million of net realized gains was from the sale of the equity position in our Invita (fka HemaTerra Holding Company, LLC) investment.

For the three months ended November 30, 2023, we had $2.1 million of sales, repayments, exits or restructurings. For the nine months ended November 30, 2023, we had $19.2 million of sales, repayments, exits or restructurings resulting in $0.2 million of net realized gains.

Nine Months ended November 30, 2023

Issuer Asset Type Gross
Proceeds
Cost Net
Realized
Gain (Loss)
PDDS Buyer, LLC Equity Interests $ - $ - $ 41,350
Censis Technologies, Inc. Equity Interests - - 6,773
GreyHeller LLC Equity Interests - - 42,568
Ohio Medical, LLC Equity Interests - - 60,565

We received escrow payments from the prior sales of our investments in PPDS Buyer, LLC, Censis Technologies, Inc., Ohio Medical, LLC and GreyHellerLLC.

127

Net change in unrealized appreciation (depreciation) on investments

For the nine months ended November 30, 2024, our investments had a net change in unrealized appreciation of $33.7 million compared to a net change in unrealized depreciation of $39.9 million for the nine months ended November 30, 2023.

The most significant cumulative net change in unrealized appreciation (depreciation) for the nine months ended November 30, 2024 were the following (dollars in thousands):

Nine Months ended November 30, 2024

Issuer Asset Type Cost Fair Value Total
Unrealized
Appreciation
(Depreciation)
YTD
Change in
Unrealized
Appreciation
(Depreciation)
Pepper Palace, Inc. First Lien Term Loan & Equity Interests $ 2,939 $ 1,574 $ (1,365 ) $ 31,585
Zollege PBC First Lien Term Loan & Equity Interests 2,020 4,204 16,349
Artemis Wax Corp First Lien Term Loan & Equity Interests 60,513 59,554 (959 ) (5,440 )
ARC Health OpCo LLC First Lien Term Loan & Equity Interests 37,524 32,448 (5,076 ) (4,940 )
Saratoga Investment Corp. CLO 2013-1, Ltd. Class F-2-R-3 Note Structured Finance Securities 9,375 4,332 (5,043 ) (4,543 )
Saratoga Senior Loan Fund I JV, LLC Equity Interests 35,202 20,952 (14,250 ) (4,271 )
Netreo Holdings, LLC First Lien Term Loan & Equity Interests - - - 3,803
Knowland Group, LLC Second Lien Term Loan - - - 3,236
Invita (fka HemaTerra Holding Company, LLC) First Lien Term Loan, Second Lien Term Loan & Equity Interests - - - (3,094 )
Saratoga Investment Corp. CLO 2013-1, Ltd. Structured Finance Securities 16,628 1,270 (15,358 ) (2,858 )
Axero Holdings, LLC First Lien Term Loan, Revolving Credit & Equity Interests 20,341 26,181 5,840 2,363
Destiny 3,969 11,292 7,323 1,397
ETU Holdings, Inc. First Lien Term Loan, Second Lien Term Loan & Equity Interests 16,781 13,118 (3,663 ) (1,229 )

The $31.6 million net change in unrealized appreciation in our investment in Pepper Palace, Inc. was driven by the restructuring of the investment, resulting in a reversal of previously recognized unrealized depreciation reclassified to realized loss.

The $16.3 million net change in unrealized appreciation in our investment in Zollege PBC was driven by the restructuring of the investment, resulting in a reversal of previously recognized unrealized depreciation reclassified to realized loss.

The $5.4 million of net change in unrealized depreciation in our investment Artemis Wax Corp. was driven by a decline in company performance, overall market conditions and capital structure changes.

The $4.9 million of net change in unrealized depreciation in our investment ARC Health OpCo LLC was driven by declines in company performance and capital structure changes.

The $4.5 million net change in unrealized depreciation in our investment Saratoga Investment Corp. CLO 2013-1, Ltd. Class F-2-R-3 Note was primarily driven by the impact of the performance of individual credits in the CLO portfolio.

The $4.3 million net change in unrealized depreciation in our investment Saratoga Senior Loan Fund I, JV, LLC was primarily driven by the impact of the performance of individual credits in the portfolio.

The $3.8 million net change in unrealized appreciation in our investment Netreo Holdings, LLC was driven by the sale of the equity position, resulting in a reversal of previously recognized unrealized appreciation reclassified to realized loss.

The $3.2 million net change in unrealized appreciation in our investment in Knowland Group, LLC was driven by the completed sales process and the full recovery of Saratoga’s principal.

The $3.1 million net change in unrealized depreciation in our investment Invita (fka HemaTerra Holding Company, LLC) was driven by market factors.

128

The $2.9 million net change in unrealized depreciation in our investment Saratoga Investment Corp. CLO 2013-1, Ltd. was primarily driven by the the performance of individual credits in the portfolio.

The $2.4 million net change in unrealized appreciation in our investment Axero Holdings, LLC was driven by strong financial portfolio company performance.

The $1.4 million net change in unrealized appreciation in our investment Modern Campus (fka Destiny Solutions Inc.) was driven by strong financial portfolio company performance.

The $1.2 million of net change in unrealized depreciation in our investment ETU Holdings, Inc.  was driven by a decline in company performance, overall market conditions and capital structure changes.

The most significant cumulative net change in unrealized appreciation (depreciation) for the nine months ended November 30, 2023 were the following (dollars in thousands):

Nine Months ended November 30, 2023

Issuer Asset Type Cost Fair Value Total
Unrealized
Appreciation
(Depreciation)
YTD
Change in
Unrealized
Appreciation
(Depreciation)
Pepper Palace, Inc. First Lien Term Loan & Equity Interests $ 35,418 $ 4,981 $ (30,437 ) $ (20,592 )
Saratoga Senior Loan Fund I JV, LLC Equity Interests 35,202 25,411 (9,791 ) (5,315 )
Netreo Holdings, LLC First Lien Term Loan & Equity Interests 38,935 35,672 (3,263 ) (11,544 )
Saratoga Investment Corp. CLO 2013-1, Ltd. Structured Finance Securities 23,412 8,939 (14,473 ) (6,707 )
ETU Holdings, Inc. First Lien Term Loan, Second Lien Term Loan & Equity Interests 15,806 13,521 (2,285 ) (2,368 )
Zollege PBC First Lien Term Loan & Equity Interests 17,516 14,604 (2,912 ) (1,592 )
Vector Controls Holding Co., LLC First Lien Term Loan & Equity Interests 1,465 9,461 7,996 1,478
Chronus LLC First Lien Term Loan & Equity Interests 22,865 21,963 (902 ) (1,399 )

The $20.6 million of unrealized depreciation in our investment Pepper Palace, Inc. was driven by further declines in company performance.

The $5.3 million of unrealized depreciation in our investment Saratoga Senior Loan Fund I, JV, LLC was driven by the reduction in the carrying value of a defaulted loan in the portfolio, as well as overall market conditions.

The $11.5 million of unrealized depreciation in our investment Netreo Holdings, LLC was driven by increased company leverage and decreased company performance.

The $6.7 million of unrealized depreciation in our investment Saratoga Investment Corp. CLO 2013-1, Ltd. was driven by the reduction in the carrying value of certain defaulted loans in the portfolio, as well as overall market conditions.

The $2.4 million of unrealized depreciation in our investment ETU Holdings, Inc. was driven by overall company performance.

The $1.6 million of unrealized depreciation in our investment Zollege PBC was driven by overall company performance.

The $1.5 million of unrealized appreciation in our investment Vector Controls Holding Co., LLC was driven by decreased company leverage and overall company performance.

The $1.4 million of unrealized depreciation in our investment Chronus LLC was driven by overall company performance .

129

Changes in net assets resulting from operations

For the three months ended November 30, 2024, we recorded a net increase in net assets resulting from operations of $8.8 million. Based on 13,789,951 weighted average common shares outstanding as of November 30, 2024, our per share net increase in net assets resulting from operations was $0.64 for the three months ended November 30, 2024. For the three months ended November 30, 2023, we recorded a net decrease in net assets resulting from operations of $4.1 million. Based on 13,052,896 weighted average common shares outstanding as of November 30, 2023, our per share net decrease in net assets resulting from operations was $0.31 for the three months ended November 30, 2023.

For the nine months ended November 30, 2024, we recorded a net increase in net assets resulting from operations of $28.8 million. Based on 13,733,008 weighted average common shares outstanding as of November 30, 2024, our per share net increase in net assets resulting from operations was $2.09 for the nine months ended November 30, 2024. For the nine months ended November 30, 2023, we recorded a net decrease in net assets resulting from operations of $3.6 million. Based on 12,355,815 weighted average common shares outstanding as of November 30, 2023, our per share net decrease in net assets resulting from operations was $0.29 for the nine months ended November 30, 2023.

FINANCIAL CONDITION, LIQUIDITY AND CAPITAL RESOURCES

We intend to continue to generate cash primarily from cash flows from operations, including interest earned from our investments in debt in middle-market companies, interest earned from the temporary investment of cash in U.S. government securities and other high-quality debt investments that mature in one year or less, the Encina Credit Facility and the Live Oak Credit Facility, our continued access to the SBA debentures future borrowings and future offerings of debt and equity securities.

Although we expect to fund the growth of our investment portfolio through the net proceeds from future equity offerings, including our dividend reinvestment plan (“DRIP”), our equity ATM Program (as defined below), and issuances of senior securities or future borrowings, to the extent permitted by the 1940 Act, we cannot assure you that our plans to raise capital will be successful. In this regard, because our common stock has historically traded at a price below our current NAV per share and we are limited in our ability to sell our common stock at a price below NAV per share, we have been and may continue to be limited in our ability to raise equity capital.

In addition, we intend to distribute to our stockholders substantially all of our operating taxable income in order to satisfy the distribution requirement applicable to RICs under the Code. In satisfying this distribution requirement, in accordance with certain applicable provisions of the Code and the Treasury regulations and a revenue procedure issued by the Internal Revenue Service (“IRS”), a RIC may treat a distribution of its own stock as fulfilling its RIC distribution requirements if each stockholder may elect to receive his or her entire distribution in either cash or stock of the RIC subject to a limitation that the aggregate amount of cash to be distributed to all stockholders must be at least 20% of the aggregate declared distribution. We may rely on the revenue procedure in future periods to satisfy our RIC distribution requirement.

Also, as a BDC, we generally are required to meet a coverage ratio of total assets, less liabilities and indebtedness not represented by senior securities, to total senior securities, which include all of our borrowings and any outstanding preferred stock, of at least 200%, reduced to 150% effective April 16, 2019 following the approval received from our board of directors, including a majority of our independent directors, on April 16, 2018. This requirement limits the amount that we may borrow. Our asset coverage ratio, as defined in the 1940 Act, was 160.1% as of November 30, 2024 and 161.1% as of February 29, 2024. To fund growth in our investment portfolio in the future, we anticipate needing to raise additional capital from various sources, including the equity markets and other public and private debt-related markets, which may or may not be available on favorable terms, if at all.

Consequently, we may not have the funds or the ability to fund new investments, to make additional investments in our portfolio companies, to fund our unfunded commitments to portfolio companies, to pay dividends or to repay borrowings. Also, the illiquidity of our portfolio investments may make it difficult for us to sell these investments when desired and, if we are required to sell these investments, we may realize significantly less than their recorded value.

Due to the diverse capital sources available to us at this time, we believe we have adequate liquidity to support our near term capital requirements.

Encina Credit Facility

Below is a summary of the terms of the Encina Credit Facility.

Commitment . We entered into the Credit and Security Agreement (the “Encina Credit Agreement”) relating to the Encina Credit Facility in the initial facility amount of $50.0 million (the “Encina Facility Amount”).

Availability . We can draw up to the lesser of (i) the Encina Facility Amount and (ii) the Borrowing Base. The Borrowing Base is an amount equal to (i) the difference of (A) the product of the applicable advance rate which varies from 50.0% to 75.0% depending on the type of loan asset (Defaulted Loans being excluded in that they carry an advance rate of 0%) and the value, determined in accordance with the Encina Credit Facility (the “Adjusted Borrowing Value”), of certain “eligible” loan assets pledged as security for the loan (the “Borrowing Base Value”) and (B) the Excess Concentration Amount, as calculated in accordance with the Encina Credit Facility, plus (ii) any amounts held in the Prefunding Account and, without duplication, Excess Cash held in the Collection Account, less (iii) the product of (a) the amount of any undrawn funding commitments we have under any loan asset and (b) the Unfunded Exposure Haircut Percentage, and less (iv) $100,000. Each loan asset we held as of the date on which the Encina Credit Facility was closed was valued as of that date and each loan asset that we acquire after such date will be valued at the lowest of its fair value, its face value (excluding accrued interest) and the purchase price paid for such loan asset. Adjustments to the value of a loan asset will be made to reflect, among other things and under certain circumstances, changes in its fair value, a default by the obligor on the loan asset, insolvency of the obligor, acceleration of the loan asset, and certain modifications to the terms of the loan asset.

130

The Encina Credit Facility contains limitations on the type of loan assets that are “eligible” to be included in the Borrowing Base and as to the concentration level of certain categories of loan assets in the Borrowing Base such as restrictions on geographic and industry concentrations, asset size and quality, payment frequency, status and terms, average life, and collateral interests. In addition, if an asset is to remain an “eligible” loan asset, we may not make changes to the payment, amortization, collateral and certain other terms of the loan assets without the consent of the administrative agent that will either result in subordination of the loan asset or be materially adverse to the lenders.

The Encina Credit Facility requires certain minimum drawn amounts. For the period beginning on the closing date and ended April 4, 2022, the minimum funding amount was $12.5 million. For the period beginning on April 5, 2022 through maturity, the minimum funding amount is the greater of $25.0 million and 50% of the Encina Facility Amount in effect from time to time.

Collateral . The Encina Credit Facility is secured by assets of SIF II and pledged to Encina under the Encina Credit Facility. SIF II is a wholly owned special purpose entity formed for the purpose of entering into the Encina Credit Facility.

Interest Rate and Fees . Under the Encina Credit Facility, funds were borrowed from or through certain lenders at the greater of the prevailing LIBOR rate and 0.75%, plus an applicable margin of 4.00%. The Encina Credit Agreement includes benchmark replacement provisions which permit the Administrative Agent and the borrower to select a replacement rate upon the unavailability of LIBOR. In addition, we pay the lenders a commitment fee of 0.75% per year (or 0.50% if the ratio of advances outstanding to aggregate commitments is greater than or equal to 50%) on the unused amount of the Encina Credit Facility for the duration of the term of the Encina Credit Facility. Accrued interest and commitment fees are payable monthly in arrears. We were also obligated to pay certain other fees to the lenders in connection with the closing of the Encina Credit Facility.

Collateral Tests . It is a condition precedent to any borrowing under the Encina Credit Facility that the principal amount outstanding under the Encina Credit Facility, after giving effect to the proposed borrowings, not exceed the Borrowing Base (the “Borrowing Base Test”). In addition to satisfying the Borrowing Base Test, the following tests must also be satisfied (together with Borrowing Base Test, the “Collateral Tests”):

o Interest Coverage Ratio. The ratio (expressed as a percentage) of interest collections with respect to pledged loan assets, less certain fees and expenses relating to the Encina Credit Facility, to accrued interest and commitment fees payable to the lenders under the Encina Credit Facility for the last 6 payment periods must equal at least 175.0%.

o Overcollateralization Ratio. The ratio (expressed as a percentage) of the aggregate Adjusted Borrowing Value of “eligible” pledged loan assets plus the fair value of certain ineligible pledged loan assets (in each case, subject to certain adjustments) to outstanding borrowings under the Encina Credit Facility plus the Unfunded Exposure Amount must equal at least 200.0%.

The Encina Credit Facility also may require payment of outstanding borrowings or replacement of pledged loan assets upon our breach of our representation and warranty that pledged loan assets included in the Borrowing Base are “eligible” loan assets. Such ineligible collateral loans will be excluded from the calculation of the Borrowing Base and may lead to a Borrowing Base Deficiency, which may be cured by effecting one or more (or any combination thereof) of the following actions: (A) deposit into or credit to the collection account cash and eligible investments, (B) repay outstanding borrowings (together with certain costs and expenses), (C) sell or substitute loan assets in accordance with the Encina Credit Facility, or (D) pledge additional loan assets as collateral. Compliance with the Collateral Tests is also a condition to the discretionary sale of pledged loan assets by us.

131

Priority of Payments . The priority of payments provisions of the Encina Credit Facility require, after payment of specified fees and expenses, that collections of interest from the loan assets and, to the extent that these are insufficient, collections of principal from the loan assets, be applied on each payment date to payment of outstanding borrowings if the Borrowing Base Test, the Overcollateralization Ratio and the Interest Coverage Ratio would not otherwise be met.

Operating Expenses . The priority of payments provision of the Encina Credit Facility provides for the payment of certain of our operating expenses out of collections on interest and principal in accordance with the priority established in such provision. The operating expenses payable pursuant to the priority of payment provisions is limited to $200,000 per annum.

Covenants; Representations and Warranties; Events of Default . The Encina Credit Agreement contains customary representations and warranties, affirmative covenants, negative covenants and events of default. The Encina Credit Agreement does not contain grace periods for breach by us of any negative covenants or of certain of the affirmative covenants, including, without limitation, those related to preservation of the existence and separateness of the Company. Other events of default under the Encina Credit Agreement include, among other things, the following:

o our failure to maintain an Interest Coverage Ratio of less than 175%;

o our failure to maintain an Overcollateralization Ratio of less than 200%;

o the filing of certain ERISA or tax liens on our assets or the Equity holder;

o failure by Specified Holders to collectively, directly or indirectly, own and control at least 51% of the outstanding equity interests of Saratoga Investment Advisor, or (y) possess the right to elect (through contract, ownership of voting securities or otherwise) at all times a majority of the board of directors (or similar governing body) of Saratoga Investment Advisor and to direct the management policies and decisions of Saratoga Investment Advisor, or (ii) the dissolution, termination or liquidation in whole or in part, transfer or other disposition, in each case, of all or substantially all of the assets of, Saratoga Investment Advisor;

o indictment or conviction of Saratoga Investment Advisors or any “key person” for a felony offense, or any fraud, embezzlement or misappropriation of funds by Saratoga Investment Advisors or any “key person” and, in the case of “key persons,” without a reputable, experienced individual reasonably satisfactory to Encina Lender Finance appointed to replace such key person within 30 days;

o resignation, termination, disability or death of a “key person” or failure of any “key person” to provide active participation in Saratoga Investment Advisors’ daily activities, all without a reputable, experienced individual reasonably satisfactory to Encina Lender Finance appointed within 30 days.

Fees and Expenses . We paid certain fees and reimbursed Encina Lender Finance, LLC for the aggregate amount of all documented, out-of-pocket costs and expenses, including the reasonable fees and expenses of lawyers, incurred by Encina Lender Finance, LLC in connection with the Encina Credit Facility and the carrying out of any and all acts contemplated thereunder up to and as of the date of closing. These amounts totaled $1.4 million.

On January 27, 2023, we entered into the first amendment to the Encina Credit Agreement to, among other things:

increase the borrowings available under the Encina Credit Facility from up to $50.0 million to up to $65.0 million;

change the underlying benchmark used to compute interest under the Encina Credit Agreement from LIBOR to Term SOFR for a one-month tenor plus a 0.10% credit spread adjustment;

increase the applicable effective margin rate on borrowings from 4.00% to 4.25%;

extend the revolving period from October 4, 2024 to January 27, 2026;

extend the period during which the borrower may request one or more increases in the borrowings available under the Encina Credit Facility (each such increase, a “Facility Increase”) from October 4, 2023 to January 27, 2025, and increased the maximum borrowings available pursuant to the Encina Facility Increase from $75.0 million to $150.0 million;

132

revised the eligibility criteria for eligible collateral loans to exclude certain industries in which an obligor or related guarantor may be involved; and

amended the provisions permitting the borrower to request an extension in the Commitment Termination Date (as defined in the Encina Credit Agreement) to allow requests to extend any applicable Commitment Termination Date, rather than a one-time request to extend the original Commitment Termination Date, subject to a notice requirement.

As of November 30, 2024, we had $32.5 million outstanding borrowings under the Encina Credit Facility. Our borrowing base under the Encina Credit Facility at November 30, 2024 was $85.1 million.

Live Oak Credit Facility

Below is a summary of the terms of the Live Oak Credit Facility.

Commitment. We entered into the Credit and Security Agreement (the “Live Oak Credit Agreement”) relating to the Live Oak Credit Facility in the initial facility amount of $50.0 million (the “Live Oak Facility Amount”).

Availability . We can draw up to the lesser of (i) the Live Oak Facility Amount and (ii) the Borrowing Base. The Borrowing Base is an amount equal to (i) the difference of (A) the product of the applicable advance rate which varies from 50.0% to 75.0% depending on the type of loan asset (Defaulted Loans being excluded in that they carry an advance rate of 0%) and the value, determined in accordance with the Encina Credit Facility (the “Adjusted Borrowing Value”), of certain “eligible” loan assets pledged as security for the loan (the “Borrowing Base Value”) and (B) the Excess Concentration Amount, as calculated in accordance with the Encina Credit Facility, plus (ii) any amounts held in the Prefunding Account and, without duplication, Excess Cash held in the Collection Account, less (iii) the product of (a) the amount of any undrawn funding commitments we have under any loan asset and (b) the Unfunded Exposure Haircut Percentage, and less (iv) $100,000. Each loan asset we held as of the date on which the Live Oak Credit Facility was closed was valued as of that date and each loan asset that we acquire after such date will be valued at the lowest of its fair value, its face value (excluding accrued interest) and the purchase price paid for such loan asset. Adjustments to the value of a loan asset will be made to reflect, among other things and under certain circumstances, changes in its fair value, a default by the obligor on the loan asset, insolvency of the obligor, acceleration of the loan asset, and certain modifications to the terms of the loan asset.

The Live Oak Credit Facility contains limitations on the type of loan assets that are “eligible” to be included in the Borrowing Base and as to the concentration level of certain categories of loan assets in the Borrowing Base such as restrictions on geographic and industry concentrations, asset size and quality, payment frequency, status and terms, average life, and collateral interests. In addition, if an asset is to remain an “eligible” loan asset, we may not make changes to the payment, amortization, collateral and certain other terms of the loan assets without the consent of the administrative agent that will either result in subordination of the loan asset or be materially averse to the lenders.

The Live Oak Credit Facility requires certain minimum drawn amounts. For the period beginning on the closing date of March 27, 2024, and ending March 27, 2025, the minimum funding amount was $12.5 million. For the period beginning on March 28, 2025, through maturity, the minimum funding amount is the greater of $25.0 million and 50% of the Live Oak Facility Amount in effect from time to time.

Collateral . The Live Oak Credit Facility is secured by assets of SIF III and pledged to Live Oak under the Live Oak Credit Facility. SIF III is a wholly owned special purpose entity formed for the purpose of entering into the Live Oak Credit Facility.

133

Interest Rate and Fees . Advances under the Live Oak Credit Facility bear interest at a floating rate per annum equal to the greater of the prevailing Adjusted Term SOFR and 0.75%, plus an applicable margin between 3.50% and 4.25% based on the Live Oak Credit Facility’s utilization. In addition, we pay the lenders a commitment fee of 0.50% per year on the unused amount of the Live Oak Credit Facility for the duration of the term of the Live Oak Credit Facility. Accrued interest and commitment fees are payable monthly in arrears. We were also obligated to pay certain other fees to the lenders in connection with the closing of the Live Oak Credit Facility.

Collateral Tests. It is a condition precedent to any borrowing under the Live Oak Credit Facility that the principal amount outstanding under the Live Oak Credit Facility, after giving effect to the proposed borrowings, not exceed the Borrowing Base (the “Borrowing Base Test”). In addition to satisfying the Borrowing Base Test, the following tests must also be satisfied (together with Borrowing Base Test, the “Collateral Tests”):

Interest Coverage Ratio . The ratio (expressed as a percentage) of interest collections with respect to pledged loan assets, less certain fees and expenses relating to the Live Oak Credit Facility, to accrued interest and commitment fees payable to the lenders under the Live Oak Credit Facility for the last 6 payment periods must equal at least 175.0%.

Overcollateralization Ratio . The ratio (expressed as a percentage) of the aggregate Adjusted Borrowing Value of “eligible” pledged loan assets plus the fair value of certain ineligible pledged loan assets (in each case, subject to certain adjustments) to outstanding borrowings under the Live Oak Credit Facility plus the Unfunded Exposure Amount must equal at least 200.0%.

The Live Oak Credit Facility also may require payment of outstanding borrowings or replacement of pledged loan assets upon our breach of our representation and warranty that pledged loan assets included in the Borrowing Base are “eligible” loan assets. Such ineligible collateral loans will be excluded from the calculation of the Borrowing Base and may lead to a Borrowing Base Deficiency, which may be cured by effecting one or more (or any combination thereof) of the following actions: (A) deposit into or credit to the Collection Account cash and Eligible Investments, (B) repay Advances (together with all accrued and unpaid costs and expenses of the Agents, Custodian, Collateral Administrator, Securities Intermediary and the Lenders), (C) sell or substitute Collateral Loans in accordance with Article X, or (D) pledge additional Collateral Loans as Collateral.

Priority of Payments. The priority of payments provisions of the Live Oak Credit Facility require, after payment of specified fees and expenses, that collections of interest from the loan assets and, to the extent that these are insufficient, collections of principal from the loan assets, be applied on each payment date to payment of outstanding borrowings if the Borrowing Base Test, the Overcollateralization Ratio and the Interest Coverage Ratio would not otherwise be met.

Operating Expenses . The priority of payments provision of the Live Oak Credit Facility provides for the payment of certain of our operating expenses out of collections on interest and principal in accordance with the priority established in such provision. The operating expenses payable pursuant to the priority of payment provisions is limited to $200,000 per annum.

Covenants; Representations and Warranties; Events of Default . The Live Oak Credit Agreement contains customary representations and warranties, affirmative covenants, negative covenants and events of default. The Live Oak Credit Agreement does not contain grace periods for breach by us of any negative covenants or of certain of the affirmative covenants, including, without limitation, those related to preservation of the existence and separateness of the Company. Other events of default under the Live Oak Credit Agreement include, among other things, the following:

o our failure to maintain an Interest Coverage Ratio of less than 175%;

o our failure to maintain an Overcollateralization Ratio of less than 200%;

o the filing of certain ERISA or tax liens on our assets or the Equity holder;

o failure by Specified Holders to collectively, directly or indirectly, own and control at least 51% of the outstanding equity interests of Saratoga Investment Advisor, or (y) possess the right to elect (through contract, ownership of voting securities or otherwise) at all times a majority of the board of directors (or similar governing body) of Saratoga Investment Advisor and to direct the management policies and decisions of Saratoga Investment Advisor, or (ii) the dissolution, termination or liquidation in whole or in part, transfer or other disposition, in each case, of all or substantially all of the assets of, Saratoga Investment Advisor;

134

o indictment or conviction of Saratoga Investment Advisors or any “key person” for a felony offense, or any fraud, embezzlement or misappropriation of funds by Saratoga Investment Advisors or any “key person” and, in the case of “key persons,” without a reputable, experienced individual reasonably satisfactory to Live Oak Lender Finance appointed to replace such key person within 30 days;

o resignation, termination, disability or death of a “key person” or failure of any “key person” to provide active participation in Saratoga Investment Advisors’ daily activities, all without a reputable, experienced individual reasonably satisfactory to Live Oak Lender Finance appointed within 30 days.

Fees and Expenses . We paid certain fees and reimbursed Live Oak Lender Finance, LLC for the aggregate amount of all documented, out-of-pocket costs and expenses, including the reasonable fees and expenses of lawyers, incurred by Live Oak Banking Company in connection with the Live Oak Credit Facility and the carrying out of any and all acts contemplated thereunder up to and as of the date of closing. These amounts totaled $0.8 million.

On June 14, 2024, we entered into the first amendment to the Live Oak Credit Agreement (the “Amendment”). The Amendment, among other things:

increased the borrowings available under the Live Oak Credit Facility from up to $50.0 million to up to $75.0 million, subject to a borrowing base requirement;

added new lenders (as identified in the Amendment) to the Live Oak Credit Agreement;

replaced administrative agent approval with “Required Lender” (as defined in the Live Oak Credit Agreement) approval with respect to certain matters;

replaced Required Lender approval with 100% lender approval with respect to certain matters; and

changed the definition of Required Lender to require the approval of at least two unaffiliated lenders.

As of November 30, 2024 there was $20.0 million in outstanding borrowings under the Live Oak Credit Facility. During the applicable period, the Company was in compliance with all of the limitations and requirements under the Live Oak Credit Agreement. Our borrowing base under the Live Oak Credit Facility at November 30, 2024 was $86.4 million.

SBA-guaranteed debentures

In addition, we, through two current wholly owned subsidiaries, sought and obtained licenses from the SBA to operate an SBIC. In this regard, our wholly owned subsidiaries, SBIC II LP, and SBIC III LP, received an SBIC license from the SBA on August 14, 2019, and September 29, 2022, respectively. SBICs are designated to stimulate the flow of private equity capital to eligible small businesses. Under SBA regulations, SBICs may make loans to eligible small businesses and invest in the equity securities of small businesses. Our wholly owned subsidiary SBIC LP fully repaid its outstanding debentures and subsequently surrendered its license to the SBA on January 3, 2023, and SBIC LP subsequently merged with and into the Company.

The SBIC license allows our SBIC Subsidiaries to obtain leverage by issuing SBA-guaranteed debentures. SBA-guaranteed debentures are non-recourse, interest only debentures with interest payable semi-annually and have a ten-year maturity. The principal amount of SBA-guaranteed debentures is not required to be paid prior to maturity but may be prepaid at any time without penalty. The interest rate of SBA-guaranteed debentures is fixed on a semi-annual basis at a market-driven spread over U.S. Treasury Notes with 10-year maturities.

135

The SBIC Subsidiaries are regulated by the SBA. SBA regulations currently limit the amount that our SBIC Subsidiaries may individually borrow up to a maximum of $175.0 million of SBA debentures if the SBIC Subsidiary has at least $87.5 million in regulatory capital, subject to the SBA’s approval. Under current SBIC regulations, for two or more SBICs under common control, the maximum amount of outstanding SBA debentures cannot exceed $350.0 million. The SBIC Subsidiaries are able to borrow funds from the SBA against regulatory capital (which generally approximates equity capital in the respective SBIC) and are subject to customary regulatory requirements, including, but not limited to, periodic examination by the SBA.

We received exemptive relief from the SEC to permit us to exclude the debt of our SBIC Subsidiaries guaranteed by the SBA from the definition of senior securities in the asset coverage test under the 1940 Act. This allows us increased flexibility under the asset coverage test by permitting us to borrow up to $350.0 million more than we would otherwise be able to absent the receipt of this exemptive relief. On April 16, 2018, as permitted by the Small Business Credit Availability Act, which was signed into law on March 23, 2018, our board of directors, including a majority of our independent directors, approved of our becoming subject to a minimum asset coverage ratio of 150% from 200% under Sections 18(a)(1) and 18(a)(2) of the Investment Company Act, as amended. The 150% asset coverage ratio became effective on April 16, 2019.

As of November 30, 2024 SBIC II LP had $87.5 million in regulatory capital and $175.0 million in SBA-guaranteed debentures outstanding and SBIC III LP had $66.7 million in regulatory capital and $39.0 million in SBA-guaranteed debentures outstanding.

Unsecured notes

7.75% 2025 Notes

On July 9, 2020, we issued $5.0 million aggregate principal amount of our 7.75% fixed-rate notes due in 2025 (the “7.75% 2025 Notes”) for net proceeds of $4.8 million after deducting underwriting commissions of approximately $0.2 million. Offering costs incurred were approximately $0.1 million. Interest on the 7.75% 2025 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 7.75% per year. The 7.75% 2025 Notes mature on July 9, 2025 and may be redeemed in whole or in part at any time or from time to time at our option, subject to a fee depending on the date of repayment. The net proceeds from the offering were used for general corporate purposes in accordance with our investment objective and strategies. Financing costs of $0.3 million related to the 7.75% 2025 Notes have been capitalized and are being amortized over the term of the Notes. The 7.75% 2025 Notes are not listed and have a par value of $25.00 per note.

At November 30, 2024, the total amount of 7.75% 2025 Notes outstanding was $5.0 million.

6.25% 2027 Notes

On December 29, 2020, we issued $5.0 million in aggregate principal amount of our 6.25% fixed-rate notes due in 2027 (the “6.25% 2027 Notes”).  Offering costs incurred were approximately $0.1 million.  Interest on the 6.25% 2027 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 6.25% per year. The 6.25% 2027 Notes mature on December 29, 2027 and may be redeemed in whole or in part at any time or from time to time at our option, on or after December 29, 2024. The net proceeds from the offering were used for general corporate purposes in accordance with our investment objective and strategies. Financing costs of $0.1 million related to the 6.25% 2027 Notes have been capitalized and are being amortized over the term of the Notes.

On January 28, 2021, we issued an additional $10.0 million in aggregate principal amount of the 6.25% 2027 Notes for net proceeds of $9.7 million after deducting underwriting commissions of approximately $0.3 million (the “Additional 6.25% 2027 Notes”). The Additional 6.25% 2027 Notes are treated as a single series with the existing 6.25% 2027 Notes under the indenture and have the same terms as the existing 6.25% 2027 Notes. Offering costs incurred were approximately $0.1 million. Interest on the 6.25% 2027 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 6.25% per year. The 6.25% 2027 Notes mature on January 28, 2027 and commencing January 28, 2023, may be redeemed in whole or in part at any time or from time to time at our option on or after December 29, 2024. The net proceeds from the offering were used for general corporate purposes in accordance with our investment objective and strategies. Financing costs of $0.4 million related to the 6.25% 2027 Notes have been capitalized and are being amortized over the term of the 6.25% 2027 Notes. The 6.25% 2027 Notes are not listed and have a par value of $25.00 per note.

136

At November 30, 2024, the total amount of 6.25% 2027 Notes outstanding was $15.0 million.

4.375% 2026 Notes

On March 10, 2021, we issued $50.0 million in aggregate principal amount of the 4.375% fixed rate notes due 2026 (the “4.375% 2026 Notes”) for net proceeds of $49.0 million after deducting underwriting commissions of approximately $1.0 million. Offering costs incurred were approximately $0.3 million.  Interest on the 4.375% 2026 Notes is paid semi-annually in arrears on February 28 and August 28, at a rate of 4.375% per year. The 4.375% 2026 Notes mature on February 28, 2026 and may be redeemed in whole or in part at any time on or after November 28, 2025 at par plus a “make-whole” premium, and thereafter at par. The net proceeds from the offering were used for general corporate purposes in accordance with our investment objective and strategies. Financing costs of $1.2 million related to the 4.375% 2026 Notes have been capitalized and are being amortized over the term of the 4.375% 2026 Notes.

On July 15, 2021, we issued an additional $125.0 million in aggregate principal amount of the 4.375% 2026 Notes (the “Additional 4.375% 2026 Notes”) for net proceeds for approximately $123.5 million, based on the public offering price of 101.00% of the aggregate principal amount of the Additional 4.375% 2026 Notes, after deducting the underwriting discount of $2.5 million and the offering expenses of approximately $0.2 million payable by the Company. The net proceeds from the offering were used to redeem all of the outstanding 6.25% 2025 Notes (as described above), and for general corporate purposes in accordance with our investment objective and strategies. The Additional 4.375% 2026 Notes are treated as a single series with the existing 4.375% 2026 Notes under the indenture and have the same terms as the existing 4.375% 2026 Notes.

At November 30, 2024, the total amount of 4.375% 2026 Notes outstanding was $175.0 million.

4.35% 2027 Notes

On January 19, 2022, we issued $75.0 million in aggregate principal amount of our 4.35% fixed-rate Notes due in 2027 (the “4.35% 2027 Notes”) for net proceeds of $73.0 million, based on the public offering price of 99.317% of the aggregate principal amount of the 4.35% 2027 Notes, after deducting the underwriting commissions of approximately $1.5 million. Offering costs incurred were approximately $0.3 million.  Interest on the 4.35% 2027 Notes is paid semi-annually in arrears on February 28 and August 28, at a rate of 4.35% per year. The 4.35% 2027 Notes mature on February 28, 2027 and may be redeemed in whole or in part at our option at any time prior to November 28, 2026, at par plus a “make-whole” premium, and thereafter at par . The net proceeds from the offering were used for general corporate purposes in accordance with our investment objective and strategies. Financing costs of $1.8 million related to the 4.35% 2027 Notes have been capitalized and are being amortized over the term of the 4.35% 2027 Notes.

At November 30, 2024 the total amount of 4.35% 2027 Notes outstanding was $75.0 million.

6.00% 2027 Notes

On April 27, 2022, we issued $87.5 million in aggregate principal amount of 6.00% fixed-rate notes due 2027 (the “6.00% 2027 Notes”) for net proceeds of $84.8 million after deducting underwriting commissions of approximately $2.7 million. Offering costs incurred were approximately $0.1 million. On May 10, 2022, the underwriters partially exercised their option to purchase an additional $10.0 million in aggregate principal amount of the 6.00% 2027 Notes. Net proceeds were $9.7 million after deducting underwriting commissions of approximately $0.3 million. Interest on the 6.00% 2027 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 6.00% per year. The 6.00% 2027 Notes mature on April 30, 2027 and commencing April 27, 2024, may be redeemed in whole or in part at any time or from time to time at our option. The net proceeds from the offering were used for general corporate purposes in accordance with our investment objective and strategies. Financing costs of $3.3 million related to the 6.00% 2027 Notes have been capitalized and are being amortized over the term of the 6.00% 2027 Notes. The 6.00% 2027 Notes are listed on the NYSE under the trading symbol “SAT” with a par value of $25.00 per note.

137

On August 15, 2022, we issued an additional $8.0 million in aggregate principal amount of the 6.00% 2027 Notes (the “Additional 6.00% 2027 Notes”) for net proceeds of $7.8 million, based on the public offering price of 97.80% of the aggregate principal amount of the 6.00% 2027 Notes. The Additional 6.00% 2027 Notes are treated as a single series with the existing 6.00% 2027 Notes under the indenture and have the same terms as the existing 6.00% 2027 Notes. The net proceeds from the offering were used for general corporate purposes in accordance with our investment objective and strategies. Additional offering costs incurred were approximately $0.03 million. Additional financing costs of $0.03 million related to the 6.00% 2027 Notes have been capitalized and are being amortized over the term of the 6.00% 2027 Notes.

At November 30, 2024 the total amount of 6.00% 2027 Notes outstanding was $105.5 million.

7.00% 2025 Notes

On September 8, 2022, we issued $12.0 million in aggregate principal amount of 7.00% fixed-rate notes due 2025 (the “7.00% 2025 Notes”) for net proceeds of $11.6 million after deducting customary fees and offering expenses of approximately $0.4 million. Interest on the 7.00% 2025 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 7.00% per year. The 7.00% 2025 Notes mature on September 8, 2025 and commencing September 8, 2024, may be redeemed in whole or in part at any time or from time to time at our option. The net proceeds from the offering were used for general corporate purposes in accordance with our investment objective and strategies. Financing costs of $0.05 million related to the 7.00% 2025 Notes have been capitalized and are being amortized over the term of the 7.00% 2025 Notes.

At November 30, 2024 the total amount of 7.00% 2025 Notes outstanding was $12.0 million.

8.00% 2027 Notes

On October 27, 2022, we issued $40.0 million in aggregate principal amount of our 8.00% fixed-rate notes due 2027 (the “8.00% 2027 Notes”) for net proceeds of $38.7 million after deducting underwriting commissions of approximately $1.3 million. Offering costs incurred were approximately $0.1 million. On November 10, 2022, the underwriters partially exercised their option to purchase an additional $6.0 million in aggregate principal amount of the 8.00% 2027 Notes. Net proceeds were $5.8 million after deducting underwriting commissions of approximately $0.2 million. Interest on the 8.00% 2027 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 8.00% per year. The 8.00% 2027 Notes mature on October 31, 2027 and commencing October 27, 2024, may be redeemed in whole or in part at any time or from time to time at our option. The net proceeds from the offering were used for general corporate purposes in accordance with our investment objective and strategies. Financing costs of $1.73 million related to the 8.00% 2027 Notes have been capitalized and are being amortized over the term of the 8.00% 2027 Notes. The 8.00% 2027 Notes are listed on the NYSE under the trading symbol “SAJ” with a par value of $25.00 per note.

At November 30, 2024 the total amount of 8.00% 2027 Notes outstanding was $46.0 million.

8.125% 2027 Notes

On December 13, 2022, we issued $52.5 million in aggregate principal amount of 8.125% fixed-rate notes due 2027 (the “8.125% 2027 Notes”) for net proceeds of $50.8 million after deducting underwriting commissions of approximately $1.6 million. Offering costs incurred were approximately $0.1 million. On December 21, 2022, the underwriters fully exercised their option to purchase an additional $7.875 million in aggregate principal amount of the 8.125% 2027 Notes. Net proceeds were $7.6 million after deducting underwriting commissions of approximately $0.2 million. Interest on the 8.125% 2027 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 8.125% per year. The 8.125% 2027 Notes mature on December 31, 2027 and commencing December 13, 2024, may be redeemed in whole or in part at any time or from time to time at our option. The net proceeds from this offering were used to make investments in middle-market companies (including investments made through our SBIC Subsidiaries) in accordance with our investment objective and strategies and for general corporate purposes. Financing costs of $2.0 million related to the 8.125% 2027 Notes have been capitalized and are being amortized over the term of the 8.125% 2027 Notes. The 8.125% 2027 Notes are listed on the NYSE under the trading symbol “SAY” with a par value of $25.00 per note.

138

At November 30, 2024, the total amount of 8.125% 2027 Notes outstanding was $60.4 million.

8.75% 2025 Notes

On March 31, 2023, we issued $10.0 million in aggregate principal amount of 8.75% fixed-rate notes due 2024 (the “8.75% 2025 Notes”) for net proceeds of $9.7 million after deducting underwriting discounts of approximately $0.4 million. On May 1, 2023, we issued an additional $10.0 million in aggregate principal amount of the 8.75% 2024 Notes for net proceeds of $9.7 million after deducting underwriting discounts of approximately $0.4 million. Offering costs incurred were approximately $0.03 million. Interest on the 8.75% 2025 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 8.75% per year.  On February 2, 2024, pursuant to the terms of the indenture governing the 8.75% 2025 Notes, we elected to exercise our option to extend the maturity date of the 8.75% 2025 Notes from March 31, 2024 to March 31, 2025. Net proceeds from this offering were used to make investments in middle-market companies (including investments made through our SBIC Subsidiaries) in accordance with our investment objective and strategies and general corporate purposes. Financing costs and discounts of $0.7 million related to the 8.75% 2025 Notes have been capitalized and are being amortized over the term of the 8.75% 2025 Notes.

At November 30, 2024, the total amount of 8.75% 2025 Notes outstanding was $20.0 million.

8.50% 2028 Notes

On April 14, 2023, we issued $50.0 million in aggregate principal amount of 8.50% fixed-rate notes due 2028 (the “8.50% 2028 Notes”) for net proceeds of $48.4 million after deducting underwriting commissions of approximately $1.6 million. Offering costs incurred were approximately $0.03 million. On April 26, 2023, the underwriters fully exercised their option to purchase an additional $7.5 million in aggregate principal amount of the 8.50% 2028 Notes. Net proceeds were $7.3 million after deducting underwriting commissions of approximately $0.2 million. Interest on the 8.50% 2028 Notes is paid quarterly in arrears on February 28, May 31, August 31 and November 30, at a rate of 8.50% per year.  The 8.50% 2028 Notes mature on April 15, 2028, and commencing April 14, 2025, may be redeemed in whole or in part at any time or from time to time at our option. Net proceeds from this offering were used to repay a portion of the outstanding indebtedness under the Encina Credit Facility, make investments in middle-market companies (including investments made through our SBIC Subsidiaries) in accordance with our investment objective and strategies and for general corporate purposes. Financing costs of $2.0 million related to the 8.50% 2028 Notes have been capitalized and are being amortized over the term of the 8.50% 2028 Notes. The 8.50% 2028 Notes are listed on the NYSE under the trading symbol “SAZ” with a par value of $25.00 per note.

At November 30, 2024, the total amount of 8.50% 2028 Notes outstanding was $57.5 million.

At November 30, 2024 and February 29, 2024, the fair value of investments, cash and cash equivalents and cash and cash equivalents, reserve accounts were as follows:

November 30, 2024 February 29, 2024
Fair Value Percentage
of Total
Fair Value Percentage
of Total
($ in thousands)
Cash and cash equivalents $ 147,615 12.2 % $ 8,693 0.8 %
Cash and cash equivalents, reserve accounts 102,549 8.5 31,814 2.7
First lien term loans 833,223 68.8 976,423 82.8
Second lien term loans 6,140 0.5 18,097 1.5
Unsecured term loans 16,199 1.3 30,626 2.6
Structured finance securities 17,852 1.5 15,818 1.3
Equity interests 86,679 7.2 97,830 8.3
Total $ 1,210,257 100.0 % $ 1,179,301 100.0 %

139

Equity Capital Activities

Share Repurchases

On September 24, 2014, we announced the approval of the Share Repurchase Plan. Since September 24, 2014, the Share Repurchase Plan has been extended annually, and we have periodically increased the amount of shares of common stock that may be purchased under the Share Repurchase Plan. Most recently, on January 7, 2025, our board of directors extended the Share Repurchase Plan for another year to January 15, 2026, which currently permits up to 1.7 million of shares of common stock may be repurchased under the Share Repurchase Plan. As of November 30, 2024, we purchased 1,035,203 shares of common stock, at the average price of $22.05 for approximately $22.8 million pursuant to the Share Repurchase Plan. During the three and nine months ended November 30, 2024, we did not purchase any shares pursuant to the Share Repurchase Plan.

Public Equity Offering

On July 13, 2018, we issued 1,150,000 shares of common stock priced at $25.00 per share (par value $0.001 per share) at an aggregate total of $28.75 million. The net proceeds, after deducting underwriting commissions of $1.15 million and offering costs of approximately $0.2 million, amounted to approximately $27.4 million. We also granted the underwriters a 30-day option to purchase up to an additional 172,500 shares of common stock, which was not exercised.

Equity ATM Program

On March 16, 2017, we entered into an equity distribution agreement with Ladenburg Thalmann & Co. Inc., through which we may offer for sale, from time to time, up to $30.0 million of our common stock through an ATM offering. Subsequent to this, we amended our equity distribution agreement to add BB&T Capital Markets and B. Riley FBR, Inc. as sales agents in our ATM offering. On July 11, 2019, the amount of the common stock to be offered was increased to $70.0 million, and on October 8, 2019, the amount of the common stock to be offered was increased to $130.0 million. This agreement was terminated as of July 29, 2021, and as of that date, we had sold 3,922,018 shares for gross proceeds of $97.1 million at an average price of $24.77 for aggregate net proceeds of $95.9 million (net of transaction costs).

On July 30, 2021, we entered into an equity distribution agreement (the “Equity Distribution Agreement”) with Ladenburg Thalmann& Co. Inc. (“Ladenburg”) and Compass Point Research and Trading, LLC (“Compass Point”), each as distribution agents, through which we may offer for sale, from time to time, up to $150.0 million of our common stock through the Agents (as defined below), or to them, as principal for their account (the “ATM Program”).

On July 6, 2023, we amended the Equity Distribution Agreement to increase the maximum amount of shares of our common stock to be sold through the ATM Program to $300.0 million from $150.0 million On July 19, 2023, we amended the Equity Distribution Agreement to add an additional distribution agent, Raymond James & Associates, Inc. (“Raymond James”). On May 15, 2024, we amended the Equity Distribution Agreement to add an additional distribution agent, Lucid Capital Markets, LLC (“Lucid” and together with Ladenburg, Compass Point, and Raymond James, the “Agents”). The sales price per share of our common stock offered under the ATM Program, less the Agents’ commission, will not be less than the NAV per share of our common stock at the time of such sale. Consistent with the terms of the ATM Program, the Manager may, from time to time and in its sole discretion, contribute proceeds necessary to ensure that no sales are made at a price below the then-current NAV per share.

140

As of November 30, 2024, we sold 6,652,316 shares for gross proceeds of $175.5 million at an average price of $26.37 for aggregate net proceeds of $173.9 million (net of transaction costs). During the three and nine months ended November 30, 2024, the Company sold 108,438 shares for gross proceeds of $2.9 million at an average price of $27.07 for aggregate net proceeds of $2.9 million (net of transaction costs) under the ATM Program.

Dividend Distributions

We have distributed or intend to distribute sufficient dividends to eliminate taxable income for our completed tax years. If we fail to satisfy the 90% distribution requirement or otherwise fail to qualify as a RIC in any tax year, we would be subject to U.S. federal income tax in that year on all of our taxable income imposed at corporate rates, regardless of whether we made any distributions to our shareholders. Shareholders have the option to receive payment of the dividend in cash, or receive shares of common stock, pursuant to the DRIP. Our distributions from November 30, 2024 back to inception were as follows:

Payment date Cash
Dividend
Tax Year Ended February 28, 2025
December 19, 2024 $ 1.09 (48)
September 26, 2024 0.74 (47)
June 27, 2024 0.74 (46)
March 28, 2024 0.73 (45)
$ 3.31
Tax Year Ended February 29, 2024
December 28, 2023 $ 0.72 (44)
September 28, 2023 0.71 (43)
June 29, 2023 0.70 (42)
March 30, 2023 0.69 (1)
$ 2.82
Tax Year Ended February 28, 2023
January 4, 2023 $ 0.68 (2)
September 29, 2022 0.54 (3)
June 29, 2022 0.53 (4)
March 28, 2022 0.53 (5)
$ 2.28
Tax Year Ended February 28, 2022
January 19, 2022 $ 0.53 (6)
September 28, 2021 0.52 (7)
June 29, 2021 0.44 (8)
April 22, 2021 0.43 (9)
$ 1.92
Tax Year Ended February 28, 2021
February 10, 2021 $ 0.42 (10)
November 10, 2020 0.41 (11)
August 12, 2020 0.40 (12)
$ 1.03
Tax Year Ended February 29, 2020
February 6, 2020 $ 0.56 (13)
September 26, 2019 0.56 (14)
June 27, 2019 0.55 (15)
March 28, 2019 0.54 (16)
$ 2.21
Tax Year Ended February 28, 2019
January 2, 2019 $ 0.53 (17)
September 27, 2018 0.52 (18)
June 27, 2018 0.51 (19)
March 26, 2018 0.50 (20)
$ 2.06
Tax Year Ended February 28, 2018
December 27, 2017 $ 0.49 (21)
September 26, 2017 0.48 (22)
June 27, 2017 0.47 (23)
March 28, 2017 0.46 (24)
$ 1.90

141

Payment date Cash
Dividend
Tax Year Ended February 28, 2017
February 9, 2017 $ 0.45 (25)
November 9, 2016 0.44 (26)
September 5, 2016 0.20 (27)
August 9, 2016 0.43 (28)
April 27, 2016 0.41 (29)
$ 1.93
Tax Year Ended February 29, 2016
February 29, 2016 $ 0.40 (30)
November 30, 2015 0.36 (31)
August 31, 2015 0.33 (32)
June 5, 2015 1.00 (33)
May 29, 2015 0.27 (34)
$ 2.36
Tax Year Ended February 28, 2015
February 27, 2015 $ 0.22 (35)
November 28, 2014 0.18 (36)
$ 0.40
Tax Year Ended February 28, 2014
December 27, 2013 $ 2.65 (37)
$ 2.65
Tax Year Ended February 28, 2013
December 31, 2012 $ 4.25 (38)
$ 4.25
Tax Year Ended February 29, 2012
December 30, 2011 $ 3.00 (39)
$ 3.00
Tax Year Ended February 28, 2011
December 29, 2010 $ 4.40 (40)
$ 4.40
Tax Year Ended February 28, 2010
December 31, 2009 $ 18.25 (41)
$ 18.25

(1) Based on shareholder elections, the dividend consisted of approximately $7.1 million in cash and 45,818 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $23.11 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on March 17, 20, 21, 22, 23, 24, 27, 28, 29, and 30, 2023.

(2) Based on shareholder elections, the dividend consisted of approximately $6.8 million in cash and 53,615 newly issued shares of common stock, or 0.5% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $24.26 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on December 20, 21, 22, 23, 27, 28, 29 and 30 2022 and January 3 and 4, 2023.

142

(3) Based on shareholder elections, the dividend consisted of approximately $5.3 million in cash and 52,312 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $22.00 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on September 16, 19, 20, 21, 22, 23, 26, 27, 28 and 29, 2022.
(4) Based on shareholder elections, the dividend consisted of approximately $5.1 million in cash and 48,590 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $22.40 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on June 15, 16, 17, 21, 22, 23, 24, 27, 28 and 29, 2022.
(5) Based on shareholder elections, the dividend consisted of approximately $5.3 million in cash and 42,825 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $25.89 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on March 15, 16, 17, 18, 21, 22, 23, 24, 25 and 28, 2022.
(6) Based on shareholder elections, the dividend consisted of approximately $5.3 million in cash and 41,520 newly issued shares of common stock, or 0.3% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $26.85 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on January 5, 6, 7, 10, 11, 12, 13, 14, 18 and 19, 2022.
(7) Based on shareholder elections, the dividend consisted of approximately $4.9 million in cash and 38,016 newly issued shares of common stock, or 0.3% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $26.77 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on September 15, 16, 17, 20, 21, 22, 23, 24, 27 and 28, 2021.
(8) Based on shareholder elections, the dividend consisted of approximately $4.1 million in cash and 33,100 newly issued shares of common stock, or 0.3% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $25.03 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on June 16, 17, 18, 21, 22, 23, 24, 25, 28 and 29, 2021.
(9) Based on shareholder elections, the dividend consisted of approximately $3.9 million in cash and 38,580 newly issued shares of common stock, or 0.3% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $23.69 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on April 9,12, 13, 14, 15, 16, 19, 20, 21 and 22, 2021.
(10) Based on shareholder elections, the dividend consisted of approximately $3.8 million in cash and 41,388 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $21.75 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on January 28, 29 and February 1, 2, 3, 4, 5, 8, 9 and 10, 2021.
(11) Based on shareholder elections, the dividend consisted of approximately $3.8 million in cash and 45,706 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $17.63 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on October 28, 29, 30 and November 2, 3, 4, 5, 6, 9 and 10, 2020.
(12) Based on shareholder elections, the dividend consisted of approximately $3.7 million in cash and 47,098 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $16.45 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on July 30, 31 and August 3, 4, 5, 6, 7, 10, 11 and 12, 2020.
(13) Based on shareholder elections, the dividend consisted of approximately $5.4 million in cash and 35,682 newly issued shares of common stock, or 0.3% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $25.44 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on January 24, 27, 28, 29, 30, 31 and February 3, 4, 5 and 6, 2020.

143

(14) Based on shareholder elections, the dividend consisted of approximately $4.5 million in cash and 34,575 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $23.34 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on September 13, 16, 17, 18, 19, 20, 23, 24, 25 and 26, 2019.
(15) Based on shareholder elections, the dividend consisted of approximately $3.6 million in cash and 31,545 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $22.65 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on June 14, 17, 18, 19, 20, 21, 24, 25, 26 and 27, 2019.
(16) Based on shareholder elections, the dividend consisted of approximately $3.5 million in cash and 31,240 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $21.36 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on March 15, 18, 19, 20, 21, 22, 25, 26, 27 and 28, 2019.
(17) Based on shareholder elections, the dividend consisted of approximately $3.4 million in cash and 30,796 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $18.88 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on December 18, 19, 20, 21, 24, 26, 27, 28, 31, 2018 and January 2, 2019.
(18) Based on shareholder elections, the dividend consisted of approximately $3.3 million in cash and 25,862 newly issued shares of common stock, or 0.3% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $22.35 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on September 14, 17, 18, 19, 20, 21, 24, 25, 26 and 27, 2018.
(19) Based on shareholder elections, the dividend consisted of approximately $2.7 million in cash and 21,562 newly issued shares of common stock, or 0.3% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $23.72 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on June 14, 15, 18, 19, 20, 21, 22, 25, 26 and 27, 2018.
(20) Based on shareholder elections, the dividend consisted of approximately $2.6 million in cash and 25,354 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $19.91 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on March 13, 14, 15, 16, 19, 20, 21, 22, 23 and 26, 2018.
(21) Based on shareholder elections, the dividend consisted of approximately $2.5 million in cash and 25,435 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $21.14 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on December 13, 14, 15, 18, 19, 20, 21, 22, 26 and 27, 2017.
(22) Based on shareholder elections, the dividend consisted of approximately $2.2 million in cash and 33,551 newly issued shares of common stock, or 0.6% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $20.19 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on September 13, 14, 15, 18, 19, 20, 21, 22, 25 and 26, 2017.
(23) Based on shareholder elections, the dividend consisted of approximately $2.3 million in cash and 26,222 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $20.04 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on June 14, 15, 16, 19, 20, 21, 22, 23, 26 and 27, 2017.
(24) Based on shareholder elections, the dividend consisted of approximately $2.0 million in cash and 29,096 newly issued shares of common stock, or 0.5% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $21.38 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on March 15, 16, 17, 20, 21, 22, 23, 24, 27 and 28, 2017.

144

(25) Based on shareholder elections, the dividend consisted of approximately $1.6 million in cash and 50,453 newly issued shares of common stock, or 0.9% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $20.25 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on January 27, 30, 31 and February 1, 2, 3, 6, 7, 8 and 9, 2017.
(26) Based on shareholder elections, the dividend consisted of approximately $1.5 million in cash and 58,548 newly issued shares of common stock, or 1.0% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $17.12 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on October 27, 28, 31 and November 1, 2, 3, 4, 7, 8 and 9, 2016.
(27) Based on shareholder elections, the dividend consisted of approximately $0.7 million in cash and 24,786 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $17.06 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on August 22, 23, 24, 25, 26, 29, 30, 31 and September 1 and 2, 2016.
(28) Based on shareholder elections, the dividend consisted of approximately $1.5 million in cash and 58,167 newly issued shares of common stock, or 1.0% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $16.32 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on July 27, 28, 29 and August 1, 2, 3, 4, 5, 8 and 9, 2016.
(29) Based on shareholder elections, the dividend consisted of approximately $1.5 million in cash and 56,728 newly issued shares of common stock, or 1.0% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $15.43 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on April 14, 15, 18, 19, 20, 21, 22, 25, 26 and 27, 2016.
(30) Based on shareholder elections, the dividend consisted of approximately $1.4 million in cash and 66,765 newly issued shares of common stock, or 1.2% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $13.11 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on February 16, 17, 18, 19, 22, 23, 24, 25, 26 and 29, 2016.
(31) Based on shareholder elections, the dividend consisted of approximately $1.1 million in cash and 61,029 newly issued shares of common stock, or 1.1% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $14.53 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on November 16, 17, 18, 19, 20, 23, 24, 25, 27 and 30, 2015.
(32) Based on shareholder elections, the dividend consisted of approximately $1.1 million in cash and 47,861 newly issued shares of common stock, or 0.9% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $15.28 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on August 18, 19, 20, 21, 24, 25, 26, 27, 28 and 31, 2015.
(33) Based on shareholder elections, the dividend consisted of approximately $3.4 million in cash and 126,230 newly issued shares of common stock, or 2.3% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $16.47 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on May 22, 26, 27, 28, 29 and June 1, 2, 3, 4, and 5, 2015.
(34) Based on shareholder elections, the dividend consisted of approximately $0.9 million in cash and 33,766 newly issued shares of common stock, or 0.6% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $16.78 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on May 15, 18, 19, 20, 21, 22, 26, 27, 28 and 29, 2015.
(35) Based on shareholder elections, the dividend consisted of approximately $0.8 million in cash and 26,858 newly issued shares of common stock, or 0.5% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $14.97 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on February 13, 17, 18, 19, 20, 23, 24, 25, 26 and 27, 2015.

145

(36) Based on shareholder elections, the dividend consisted of approximately $0.6 million in cash and 22,283 newly issued shares of common stock, or 0.4% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $14.37 per share, which equaled 95.0% of the volume weighted average trading price per share of the common stock on November 14, 17, 18, 19, 20, 21, 24, 25, 26 and 28, 2014.
(37) Based on shareholder elections, the dividend consisted of approximately $2.5 million in cash and 649,500 shares of common stock, or 13.7% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 20.0% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $15.439 per share, which equaled the volume weighted average trading price per share of the common stock on December 11, 13 and 16, 2013.
(38) Based on shareholder elections, the dividend consisted of $3.3 million in cash and 853,455 shares of common stock, or 22.0% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 20.0% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $15.444 per share, which equaled the volume weighted average trading price per share of the common stock on December 14, 17 and 19, 2012.
(39) Based on shareholder elections, the dividend consisted of $2.0 million in cash and 599,584 shares of common stock, or 18.0% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 20.0% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $13.117067 per share, which equaled the volume weighted average trading price per share of the common stock on December 20, 21 and 22, 2011.
(40) Based on shareholder elections, the dividend consisted of $1.2 million in cash and 596,235 shares of common stock, or 22.0% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 10.0% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $17.8049 per share, which equaled the volume weighted average trading price per share of the common stock on December 20, 21 and 22, 2010.
(41) Based on shareholder elections, the dividend consisted of $2.1 million in cash and 864,872 shares of common stock, or 104.0% of our outstanding common stock prior to the dividend payment. The amount of cash elected to be received was greater than the cash limit of 13.7% of the aggregate dividend amount, thus resulting in the payment of a combination of cash and stock to shareholders who elected to receive cash. The number of shares of common stock comprising the stock portion was calculated based on a price of $1.5099 per share, which equaled the volume weighted average trading price per share of the common stock on December 24 and 28, 2009.
(42) Based on shareholder elections, the dividend consisted of approximately $7.6 million in cash and 29,627 newly issued shares of common stock, or 0.2% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $25.29 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on June 15, 16, 20, 21, 22, 23, 26, 27, 28, and 29, 2023.
(43) Based on shareholder elections, the dividend consisted of approximately $8.4 million in cash and 35,196 newly issued shares of common stock, or 0.3% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $24.41 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on September 15, 18, 19, 20, 21, 22, 25, 26, 27, and 28, 2023.
(44) Based on shareholder elections, the dividend consisted of approximately $8.9 million in cash and 37,394 newly issued shares of common stock, or 0.3% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $24.47 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on December 14, 15, 18, 19, 20, 21, 22, 26, 27, and 28, 2023.
(45) Based on shareholder elections, the dividend consisted of approximately $9.0 million in cash and 45,490 newly issued shares of common stock, or 0.3% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $22.85 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on March 15, 18, 19, 20, 21, 22, 25, 26, 27, and 28, 2024.
(46) Based on shareholder elections, the dividend consisted of approximately $9.1 million in cash and 46,803 newly issued shares of common stock, or 10.0% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $21.76 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on June 13, 14, 17, 18, 20, 21, 24, 25, 26, and 27, 2024.

146

(47) Based on shareholder elections, the dividend consisted of approximately $9.0 million in cash and 54,999 newly issued shares of common stock, or 10.0% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $22.08 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on September 13, 16, 17, 18, 19, 20, 23, 24, 25, and 26, 2024.
(48) Based on shareholder elections, the dividend consisted of approximately $13.7 million in cash and 81,471 newly issued shares of common stock, or 11.9% of our outstanding common stock prior to the dividend payment. The number of shares of common stock comprising the stock portion was calculated based on a price of $22.80 per share, which equaled 95% of the volume weighted average trading price per share of the common stock on December 6, 9, 10, 11, 12, 13, 16, 17, 18, and 19, 2024.

We cannot provide any assurance that these measures will provide sufficient sources of liquidity to support our operations and growth.

Our asset coverage ratio, as defined in the 1940 Act, was 160.1% as of November 30, 2024 and 161.1% as of February 29, 2024.

Subsequent Events

The Company has evaluated subsequent events through the filing of this Form 10-Q and determined that there have been no events that have occurred that would require adjustments to the Company’s consolidated financial statements and disclosures in the consolidated financial statements as of and for the quarter ended November 30, 2024.

Contractual obligations

The following table shows our payment obligations for repayment of debt and other contractual obligations at November 30, 2024:

Payment Due by Period
Long-Term Debt Obligations Total Less Than
1 Year
1 - 3
Years
3 - 5
Years
More Than
5 Years
($ in thousands)
Encina credit facility $ 32,500 $ - $ 32,500 $ - $ -
Live Oak credit facility 20,000 - 20,000 - -
SBA debentures 214,000 - - - 214,000
8.75% 2025 Notes 20,000 20,000 - - -
7.00% 2025 Notes 12,000 12,000 - - -
7.75% 2025 Notes 5,000 5,000 - - -
4.375% 2026 Notes 175,000 - 175,000 - -
4.35% 2027 Notes 75,000 - 75,000 - -
6.00% 2027 Notes 105,500 - 105,500 - -
6.25% 2027 Notes 15,000 - - 15,000 -
8.00% 2027 Notes 46,000 - 46,000 - -
8.125% 2027 Notes 60,375 - 60,375 - -
8.50% 2028 Notes 57,500 - - 57,500 -
Total Long-Term Debt Obligations $ 837,875 $ 37,000 $ 514,375 $ 72,500 $ 214,000

147

Off-balance sheet arrangements

As of November 30, 2024 and February 29, 2024, our off-balance sheet arrangements consisted of $128.1 million and $132.4 million, respectively, of unfunded commitments outstanding to provide debt financing to its portfolio companies or to fund limited partnership interests. Such commitments are generally up to our discretion to approve, or the satisfaction of certain financial and nonfinancial covenants and involve, to varying degrees, elements of credit risk in excess of the amount recognized in our consolidated statements of assets and liabilities and are not reflected in our consolidated statements of assets and liabilities.

A summary of the unfunded commitments outstanding as of November 30, 2024 and February 29, 2024 is shown in the table below (dollars in thousands):

November 30,
2024
February 29,
2024
At Company's discretion
ActiveProspect, Inc. $ 10,000 $ 10,000
Artemis Wax Corp. 23,500 23,500
Ascend Software, LLC 5,000 5,000
C2 Educational Systems 2,000 -
Davisware, LLC 1,000 -
Granite Comfort, LP - 750
JDXpert 4,500 5,000
LFR Chicken LLC 10,000 -
Pepper Palace, Inc. 1,200 1,898
Procurement Partners, LLC - 4,250
Saratoga Senior Loan Fund I JV, LLC 8,548 8,548
Sceptre Hospitality Resources, LLC - 5,000
Stretch Zone Franchising, LLC - 3,750
VetnCare MSO, LLC 10,000 10,000
Total $ 75,748 $ 77,696
At portfolio company's discretion - satisfaction of certain financial and nonfinancial covenants required
Alpha Aesthetics Partners OpCo, LLC $ 3,653 $ 6,500
ARC Health OpCo LLC - 2,585
Axero Holdings, LLC - Revolver 500 500
Axiom Medical Consulting, LLC 1,500 2,000
BQE Software, Inc. 2,250 3,250
C2 Educational Systems - 3,000
Cloudpermit Intermediate Holding Company 5,000 -
Davisware, LLC 2,000 750
Exigo, LLC - Revolver 625 1,042
Gen4 Dental Partners Holdings, LLC 2,857 -
GoReact 2,500 2,500
Granite Comfort, LP 11,637 11,637
Inspect Point Holding, LLC 1,500 1,500
Modis Dental Partners OpCo, LLC 8,900 -
Pepper Palace, Inc. - Revolver 600 2,500
Stretch Zone Franchising, LLC 1,500 1,500
VetnCare MSO, LLC 7,319 15,319
Zollege PBC - 150
52,341 54,733
Total $ 128,089 $ 132,429

We believe our assets will provide adequate coverage to satisfy these unfunded commitments. As of November 30, 2024, we had cash and cash equivalents of $147.6 million, $32.5 million in available borrowings under the Encina Credit Facility, and $55.0 million in available borrowings under the Live Oak Credit Facility.

148

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Our business activities contain elements of market risk. We consider the fluctuation in interest rates to be our principal market risk. Managing this risk is essential to our business. Accordingly, we have systems and procedures designed to identify and analyze our risks, to establish appropriate policies and thresholds and to continually monitor this risk and thresholds by means of administrative and information technology systems and other policies and processes.

Interest rate risk is defined as the sensitivity of our current and future earnings to interest rate volatility, including relative changes in different interest rates, variability of spread relationships, the difference in re-pricing intervals between our assets and liabilities and the effect that interest rates may have on our cash flows. Changes in the general level of interest rates can affect our net interest income, which is the difference between the interest income earned on interest earning assets and our interest expense incurred in connection with our interest-bearing debt and liabilities. Changes in interest rates can also affect, among other things, our ability to acquire leveraged loans, high yield bonds and other debt investments and the value of our investment portfolio.

Our investment income is affected by fluctuations in various interest rates, including SOFR and the prime rate. Substantially all of our portfolio is, and we expect will continue to be, comprised of floating rate investments that utilize SOFR or an alternate rate. From March 2022 to July 2023, the Federal Reserve periodically raised interest rates to combat inflation concerns and maintained the same benchmark rate from July 2023 to September 2024. While the Federal Reserve cut its benchmark rate in the third quarter of 2024 for the first time since March 2020 and indicated that there may be additional rate cuts in 2024, including the most recent cut in November 2024, future reductions to benchmark rates are not certain. Additionally, there can be no assurance that the Federal Reserve will not make upwards adjustments to the federal funds rate in the future. In a high interest rate environment, our cost of funds would increase, which could reduce our net investment income if there is not a corresponding increase in interest income generated by our investment portfolio. It is possible that the Federal Reserve’s tightening cycle could result in a recession in the United States, which would likely decrease interest rates. A prolonged reduction in interest rates will reduce our gross investment income and could result in a decrease in our net investment income if such decreases in base rates, such as SOFR, are not offset by corresponding increases in the spread over such base rates that we earn on any portfolio investments, a decrease in in our operating expenses, including with respect to our income incentive fee, or a decrease in the interest rate of our floating interest rate liabilities. Our interest expense is affected by fluctuations in SOFR on our Encina Credit Facility and Live Oak Credit Facility. In addition, all of our assets have been transitioned from LIBOR to an acceptable replacement rate, such as SOFR. At November 30, 2024, we had $785.4 million of borrowings outstanding. In addition, as of November 30, 2024, there were $32.5 million borrowings outstanding under the Encina Credit Facility and $20.0 million borrowings outstanding under the Live Oak Credit Facility.

We have analyzed the potential impact of changes in interest rates on interest income from investments. Assuming that our investments as of November 30, 2024 were to remain constant for a full fiscal year and no actions were taken to alter the existing interest rate terms, a hypothetical change of a 1.0% increase in interest rates would cause a corresponding increase of approximately $8.6 million to our interest income. Conversely, a hypothetical change of a 1.0% decrease in interest rates would cause a corresponding decrease of approximately $8.5 million to our interest income.

Changes in interest rates would have no impact to our current interest and debt financing expense, as all our borrowings except for our credit facilities are fixed rate.

Although management believes that this measure is indicative of our sensitivity to interest rate changes, it does not adjust for potential changes in credit quality, size and composition of the assets on the consolidated statements of assets and liabilities and other business developments that could magnify or diminish our sensitivity to interest rate changes, nor does it account for divergences in SOFR and the commercial paper rate, which have historically moved in tandem but, in times of unusual credit dislocations, have experienced periods of divergence. Accordingly, no assurances can be given that actual results would not materially differ from the potential outcome simulated by this estimate.

149

For further information, the following table shows the approximate annualized increase or decrease in the components of net investment income due to hypothetical base rate changes in interest rates, assuming no changes in our investments and borrowings as of November 30, 2024.

Increase
Increase
(Decrease)
(Increase)
Decrease
Increase
(Decrease) in Net
Increase
(Decrease) in Net
(Decrease) in Net
Investment
in Interest in Interest Interest Interest Income
Basis Point Change Income Expense Income Income* per Share
($ in thousands)
-400 $ (25,955 ) $ 2,017 $ (23,938 ) $ (19,150 ) $ (1.38 )
-300 (23,825 ) 1,575 (22,250 ) (17,800 ) (1.28 )
-200 (17,054 ) 1,050 (16,004 ) (12,803 ) (0.92 )
-100 (8,527 ) 525 (8,002 ) (6,402 ) (0.46 )
-50 (4,264 ) 263 (4,001 ) (3,201 ) (0.23 )
-25 (2,132 ) 131 (2,001 ) (1,601 ) (0.12 )
25 2,142 (131 ) 2,011 1,609 0.12
50 4,284 (263 ) 4,021 3,217 0.23
100 8,567 (525 ) 8,042 6,434 0.46
200 17,134 (1,050 ) 16,084 12,867 0.93
300 25,702 (1,575 ) 24,127 19,302 1.39
400 34,269 (2,100 ) 32,169 25,735 1.85

* Adjusts Net Interest Income for the impact of the first incentive fee on Net Investment Income

ITEM 4. CONTROLS AND PROCEDURES

(a) As of the end of the period covered by this report, we carried out an evaluation, under the supervision and with the participation of our management, including our chief executive officer and our chief financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)). Based on that evaluation, our chief executive officer and our chief financial officer have concluded that our current disclosure controls and procedures are effective in facilitating timely decisions regarding required disclosure of any material information relating to us that is required to be disclosed by us in the reports we file or submit under the Exchange Act. However, in evaluating the disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

(b) There have been no changes in the Company’s internal control over financial reporting (as defined in Rule 13a-15(f) of the Exchange Act) that occurred during the quarter ended November 30, 2024 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

150

PART II. OTHER INFORMATION

Item 1. Legal Proceedings

Neither we nor our wholly owned subsidiaries, Saratoga Investment Funding LLC, Saratoga Investment Funding II, LLC, Saratoga Investment Corp. SBIC LP, Saratoga Investment Corp. SBIC II LP, or Saratoga Investment Corp. SBIC III LP, are currently subject to any material legal proceedings.

Item 1A. Risk Factors

In addition to information set forth in this report, you should carefully consider the “Risk Factors” discussed in our most recent Annual Report on Form 10-K filed with the SEC, which could materially affect our business, financial condition and/or operating results. There have been no material changes during the nine months ended November 30, 2024 to the risk factors discussed in “Item 1A. Risk Factors” of our Annual Report on Form 10-K for the fiscal year ended February 29, 2024. Additional risks or uncertainties not currently known to us or that we currently deem to be immaterial also may materially affect our business, financial condition and/or operating results.

We are exposed to risks associated with changes in interest rates including potential effects on our cost of capital and net investment income.

General interest rate fluctuations and changes in credit spreads on floating rate loans may have a substantial negative impact on our investments and investment opportunities and, accordingly, may have a material adverse effect on our rate of return on invested capital. From March 2022 to July 2023, the Federal Reserve periodically raised interest rates to combat inflation concerns and maintained the same benchmark rate from July 2023 to September 2024. While the Federal Reserve cut its benchmark rate in the third quarter of 2024 for the first time since March 2020 and indicated that there may be additional rate cuts in 2025, following the most recent cut in December 2024, future reductions to benchmark rates are not certain. Additionally, there can be no assurance that the Federal Reserve will not make upwards adjustments to the federal funds rate in the future. An increase in interest rates would make it more expensive to use debt to finance our investments. Decreases in credit spreads on debt that pays a floating rate of return would have an impact on the income generation of our floating rate assets. Trading prices for debt that pays a fixed rate of return tend to fall as interest rates rise. Trading prices tend to fluctuate more for fixed rate securities that have longer maturities. Although we have no policy governing the maturities of our investments, under current market conditions we expect that we will invest in a portfolio of debt generally having maturities of up to ten years. This means that we will be subject to greater risk (other things being equal) than an entity investing solely in shorter-term securities.

Because we may borrow to fund our investments, a portion of our net investment income may be dependent upon the difference between the interest rate at which we borrow funds and the interest rate at which we invest these funds. A portion of our investments will have fixed interest rates, while a portion of our borrowings will likely have floating interest rates. As a result, a significant change in market interest rates could have a material adverse effect on our net investment income. In periods of rising interest rates, our cost of funds could increase, which would reduce our net investment income if there is not a corresponding increase in interest income generated by our investment portfolio. Further, rising interest rates could also adversely affect our performance if we hold investments with floating interest rates, subject to specified minimum (or “floor”) interest rates, while at the same time engaging in borrowings subject to floating interest rates not subject to such minimums. In such a scenario, rising interest rates may temporarily increase our interest expense, even though our interest income from investments is not increasing in a corresponding manner if market rates remain lower than the existing floor rate. If general interest rates rise, there is also a risk that the portfolio companies in which we hold floating rate securities will be unable to pay escalating interest amounts, which could result in a default under their loan documents with us. Rising interest rates could also cause portfolio companies to shift cash from other productive uses to the payment of interest, which may have a material adverse effect on their business and operations and could, over time, lead to increased defaults. In addition, rising interest rates may increase pressure on us to provide fixed rate loans to our portfolio companies, which could adversely affect our net investment income, as increases in our cost of borrowed funds would not be accompanied by increased interest income from such fixed-rate investments.

151

We may hedge against such interest rate fluctuations by using standard hedging instruments such as futures, options and forward contracts, subject to applicable legal requirements, including without limitation, all necessary registrations (or exemptions from registration) with the Commodity Futures Trading Commission. These activities may limit our ability to participate in the benefits of lower interest rates with respect to the hedged borrowings. Adverse developments resulting from changes in interest rates or hedging transactions could have a material adverse effect on our business, financial condition and results of operations.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Issuer Purchases of Equity Securities

On September 24, 2014, the Company announced the approval of an open market share repurchase plan that originally allowed it to repurchase up to 200,000 shares of its common stock at prices below its NAV as reported in its then most recently published consolidated financial statements (the “Share Repurchase Plan”). Since September 24, 2014, the Share Repurchase Plan has been extended annually, and the Company has periodically increased the amount of shares of common stock that may be purchased under the Share Repurchase Plan, most recently to 1.7 million shares of common stock. On January 8, 2024, the Company’s board of directors extended the Share Repurchase Plan for another year to January 15, 2025. As of November 30, 2024, the Company had purchased 1,035,203 shares of common stock, at the average price of $22.05 for approximately $22.8 million pursuant to the Share Repurchase Plan. During the three and nine months ended November 30, 2024, the Company did not purchase any shares of common stock pursuant to the Share Repurchase Plan.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

(a) None .

(b) None.

(c) For the period covered by this Quarterly Report on Form 10-Q, no director or officer of the Company has entered into (i) any contract, instruction or written plan for the purchase or sale of securities of the Company intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act or (ii) any non-Rule 10b5-1 trading arrangement.

152

ITEM 6. EXHIBITS

The following exhibits are filed as part of this report or hereby incorporated by reference to exhibits previously filed with the SEC:

EXHIBIT INDEX

Exhibit
Number
Description
3.1(a) Articles of Incorporation of Saratoga Investment Corp. (incorporated by reference to Saratoga Investment Corp.’s Quarterly Report on Form 10-Q filed on July 13, 2007).
3.1(b) Articles of Amendment of Saratoga Investment Corp. (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K filed on August 3, 2010).
3.1(c) Articles of Amendment of Saratoga Investment Corp. (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K filed on August 13, 2010).
3.2 Third Amended and Restated Bylaws of Saratoga Investment Corp. (incorporated by reference to Saratoga Investment Corp.’s Quarterly Report on Form 10-Q filed January 6, 2021).
4.1 Specimen certificate of Saratoga Investment Corp.’s common stock, par value $0.001 per share (incorporated by reference to Saratoga Investment Corp.’s Registration Statement on Form N-2, File No. 333-169135, filed on September 1, 2010).
4.2 Registration Rights Agreement dated July 30, 2010 between GSC Investment Corp., GSC CDO III L.L.C., and the investors party thereto (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K filed on August 3, 2010).
4.3 Dividend Reinvestment Plan (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K filed on September 24, 2014).
4.4 Form of Indenture by and between the Company and U.S. Bank National Association, as trustee (incorporated by reference to Saratoga Investment Corp.’s Pre-Effective Amendment No. 2 to the Registration Statement on Form N-2, File No. 333-186323 filed on April 30, 2013).
4.5 Form of Articles Supplementary Establishing and Fixing the Rights and Preferences of Preferred Stock (incorporated by reference to Saratoga Investment Corp.’s Pre-Effective Amendment No. 1 to the Registration Statement on Form N-2, File No. 333-196526, filed on December 5, 2014).
4.6 Fifth Supplemental Indenture between Saratoga Investment Corp. and U.S. Bank National Association, as trustee, relating to 7.75% Notes due 2025 (incorporated by reference to Saratoga Investment Corp.’s Quarterly Report on Form 10-Q, filed on January 10, 2023).
4.7 Seventh Supplemental Indenture between Saratoga Investment Corp. and U.S. Bank National Association, as trustee, relating to 6.25% Notes due 2027 (incorporated by reference to Saratoga Investment Corp.’s Quarterly Report on Form 10-Q, filed on January 10, 2023).
4.8 Eighth Supplemental Indenture between the Saratoga Investment Corp. and U.S. Bank National Association, as trustee, relating to the 4.375% Note due 2026 (incorporated by reference to Exhibit 4.2 to Saratoga Investment Corp.’s Current Report on Form 8-K (File No. 814-00732) filed on March 10, 2021).
4.9 Ninth Supplemental Indenture between Saratoga Investment Corp. and U.S. Bank National Association, as trustee, relating to the 4.35% Note due 2027 (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K (File No. 814-00732) filed on January 19, 2022).
4.10 Tenth Supplemental Indenture between Saratoga Investment Corp. and U.S. Bank National Association, as trustee, relating to the 6.00% Note due 2027 (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K (File No. 814-00732) filed on April 27, 2022).
4.11 Eleventh Supplemental Indenture between Saratoga Investment Corp. and U.S. Bank Trust Company, National Association (as successor in interest to U.S. Bank National Association), as trustee, relating to the 7.00% Notes due 2025 (incorporated by reference to Saratoga Investment Corp.’s Quarterly Report on Form 10-Q, filed on January 10, 2023).

153

4.12 Twelfth Supplemental Indenture between Saratoga Investment Corp. and U.S. Bank Trust Company, National Association, as trustee, relating to the 8.00% Notes due 2027 (incorporated by reference to the Saratoga Investment Corp.’s Current Report on Form 8-K (File No. 813-00732) filed on October 27, 2022).
4.13 Thirteenth Supplemental Indenture between Saratoga Investment Corp. and U.S. Bank Trust Company, National Association (as successor in interest to U.S. Bank National Association), as trustee, relating to the 8.125% Notes due 2027 (incorporated by reference to the Registrant’s Current Report on Form 8-K, filed on December 13, 2022).
4.15 Fifteenth Supplemental Indenture between Saratoga Investment Corp. and U.S. Bank Trust Company, National Association (as successor in interest to U.S. Bank National Association), as trustee, relating to the 8.50% Notes due 2028 (incorporated by reference to Saratoga Investment Corp.’s Current Report on Form 8-K filed on April 14, 2023).
4.16 Form of 7.75% Notes due 2025 (incorporated by reference to Exhibit 4.6 hereto).
4.17 Form of 6.25% Notes due 2027 (incorporated by reference to Exhibit 4.7 hereto).
4.18 Form of 4.375% Notes due 2026 (incorporated by reference to Exhibit 4.8 hereto).
4.19 Form of 4.35% Notes due 2027 (incorporated by reference to Exhibit 4.9 hereto).
4.20 Form of 6.00% Notes due 2027 (incorporated by reference to Exhibit 4.10 hereto).
4.21 Form of 7.00% Notes due 2025 (incorporated by reference to Exhibit 4.11 hereto).
4.22 Form of 8.00% Notes due 2027 (incorporated by reference to Exhibit 4.12 hereto).
4.23 Form of 8.125% Notes due 2027 (incorporated by reference to Exhibit 4.13 hereto).
4.25 Form of 8.50% Notes due 2028 (incorporated by reference to Exhibit 4.15 hereto).
31.1* Certification of Chief Executive Officer Pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934
31.2* Certification of Chief Financial Officer Pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934
32.1* Certification of Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C.1350)
32.2* Certification of Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350)
101.INS Inline XBRL Instance Document.
101.SCH Inline XBRL Taxonomy Extension Schema Document.
101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF Inline XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB Inline XBRL Taxonomy Extension Label Linkbase Document.
101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document.
104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

* Filed herewith

154

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

SARATOGA INVESTMENT CORP.
Date: January 8, 2025 By: /s/ CHRISTIAN L. OBERBECK
Christian L. Oberbeck
Chief Executive Officer
By: /s/ HENRI J. STEENKAMP
Henri J. Steenkamp
Chief Financial Officer and
Chief Compliance Officer

155

Represents an investment that is not a “qualifying asset” under Section 55(a) of the Investment Company Act of 1940, as amended (the 1940 Act”). As of February 29, 2024, non-qualifying assets represent 6.2% of the Company’s portfolio at fair value. As a BDC, the Company generally has to invest at least 70% of its total assets in qualifying assets. Percentages are based on net assets of $370,224,108 as of February 29, 2024. As defined in the 1940 Act, this portfolio company is an “affiliate” as we own between 5.0% and 25.0% of the outstanding voting securities. Modis Dental Partners OpCo, LLC and Alpha Aesthetics Partners OpCo, LLC are no longer affiliates as of February 29, 2024. Transactions during the year ended February 29, 2024 in which the issuer was an affiliate are as follows: As defined in the 1940 Act, we “control” this portfolio company because we own more than 25% of the portfolio company’s outstanding voting securities. Transactions during the year ended February 29, 2024 in which the issuer was both an affiliate and a portfolio company that we control are as follows: Non-income producing at February 29, 2024. All or a portion of this investment has an unfunded commitment as of February 29, 2024. (See Note 9 to the consolidated financial statements). As of February 29, 2024, the investment was on non-accrual status. The fair value of these investments was approximately $18.9 million, which represented 1.7% of the Company’s portfolio (see Note 2 to the consolidated financial statements). false --02-28 Q3 2025 0001377936 0001377936 2024-03-01 2024-11-30 0001377936 us-gaap:CommonStockMember 2024-03-01 2024-11-30 0001377936 sar:SixPointZeroTwoTHousandTwentySevenNotesMember 2024-03-01 2024-11-30 0001377936 sar:EightPointZeroZeroTwoThousandTwentySevenNotesMember 2024-03-01 2024-11-30 0001377936 sar:EightPointOneTwentyFiveTwoThousandTwentySevenNotesMember 2024-03-01 2024-11-30 0001377936 sar:NotesPayableFourMember 2024-03-01 2024-11-30 0001377936 2025-01-07 0001377936 us-gaap:InvestmentUnaffiliatedIssuerMember 2024-11-30 0001377936 us-gaap:InvestmentUnaffiliatedIssuerMember 2024-02-29 0001377936 us-gaap:InvestmentAffiliatedIssuerNoncontrolledMember 2024-11-30 0001377936 us-gaap:InvestmentAffiliatedIssuerNoncontrolledMember 2024-02-29 0001377936 us-gaap:InvestmentAffiliatedIssuerMember 2024-11-30 0001377936 us-gaap:InvestmentAffiliatedIssuerMember 2024-02-29 0001377936 us-gaap:InvestmentAffiliatedIssuerControlledMember 2024-11-30 0001377936 us-gaap:InvestmentAffiliatedIssuerControlledMember 2024-02-29 0001377936 2024-11-30 0001377936 2024-02-29 0001377936 us-gaap:RevolvingCreditFacilityMember 2024-11-30 0001377936 us-gaap:RevolvingCreditFacilityMember 2024-02-29 0001377936 sar:SBADebenturesMember 2024-11-30 0001377936 sar:SBADebenturesMember 2024-02-29 0001377936 sar:TwoThousandAndTwentyFiveNotes1Member 2024-11-30 0001377936 sar:TwoThousandAndTwentyFiveNotes1Member 2024-02-29 0001377936 sar:SevenPointZeroPercentageTwoThousandTwentyFiveNotesMember 2024-11-30 0001377936 sar:SevenPointZeroPercentageTwoThousandTwentyFiveNotesMember 2024-02-29 0001377936 sar:SevenPointSeventyFivePercentageTwoThousandTwentyFiveNotesMember 2024-11-30 0001377936 sar:SevenPointSeventyFivePercentageTwoThousandTwentyFiveNotesMember 2024-02-29 0001377936 sar:FourPointThreeHunderendSeventyFiveTwoThousandTwintySixNotesMember 2024-11-30 0001377936 sar:FourPointThreeHunderendSeventyFiveTwoThousandTwintySixNotesMember 2024-02-29 0001377936 sar:FourPointThirtyFiveTwoThousandTwentySevenNotesMember 2024-11-30 0001377936 sar:FourPointThirtyFiveTwoThousandTwentySevenNotesMember 2024-02-29 0001377936 sar:SixPointTwentyFiveTwoThousandTwentySevenNotesMember 2024-11-30 0001377936 sar:SixPointTwentyFiveTwoThousandTwentySevenNotesMember 2024-02-29 0001377936 sar:SixPointZeroTwoTHousandTwentySevenNotesMember 2024-11-30 0001377936 sar:SixPointZeroTwoTHousandTwentySevenNotesMember 2024-02-29 0001377936 sar:EightPointZeroZeroTwoThousandTwentySevenNotesMember 2024-11-30 0001377936 sar:EightPointZeroZeroTwoThousandTwentySevenNotesMember 2024-02-29 0001377936 sar:EightPointOneTwentyFiveTwoThousandTwentySevenNotesMember 2024-11-30 0001377936 sar:EightPointOneTwentyFiveTwoThousandTwentySevenNotesMember 2024-02-29 0001377936 sar:EightPointFiftyPercentageTwoThosandTwentyEightNotesMember 2024-11-30 0001377936 sar:EightPointFiftyPercentageTwoThosandTwentyEightNotesMember 2024-02-29 0001377936 us-gaap:InvestmentUnaffiliatedIssuerMember 2024-09-01 2024-11-30 0001377936 us-gaap:InvestmentUnaffiliatedIssuerMember 2023-09-01 2023-11-30 0001377936 us-gaap:InvestmentUnaffiliatedIssuerMember 2024-03-01 2024-11-30 0001377936 us-gaap:InvestmentUnaffiliatedIssuerMember 2023-03-01 2023-11-30 0001377936 us-gaap:InvestmentAffiliatedIssuerMember 2024-09-01 2024-11-30 0001377936 us-gaap:InvestmentAffiliatedIssuerMember 2023-09-01 2023-11-30 0001377936 us-gaap:InvestmentAffiliatedIssuerMember 2024-03-01 2024-11-30 0001377936 us-gaap:InvestmentAffiliatedIssuerMember 2023-03-01 2023-11-30 0001377936 us-gaap:InvestmentAffiliatedIssuerControlledMember 2024-09-01 2024-11-30 0001377936 us-gaap:InvestmentAffiliatedIssuerControlledMember 2023-09-01 2023-11-30 0001377936 us-gaap:InvestmentAffiliatedIssuerControlledMember 2024-03-01 2024-11-30 0001377936 us-gaap:InvestmentAffiliatedIssuerControlledMember 2023-03-01 2023-11-30 0001377936 2024-09-01 2024-11-30 0001377936 2023-09-01 2023-11-30 0001377936 2023-03-01 2023-11-30 0001377936 2023-02-28 0001377936 2023-11-30 0001377936 Altvia MidCo, LLC. - Alternative Investment Management Software - First Lien Term Loan (3M USD TERM SOFR+8.50%),12.97% Cash, 7/18/2027 2024-03-01 2024-11-30 0001377936 Altvia MidCo, LLC. - Alternative Investment Management Software - First Lien Term Loan (3M USD TERM SOFR+8.50%),12.97% Cash, 7/18/2027 2024-11-30 0001377936 Altvia MidCo, LLC. - Alternative Investment Management Software - Series A-1 Preferred Shares 2024-03-01 2024-11-30 0001377936 Altvia MidCo, LLC. - Alternative Investment Management Software - Series A-1 Preferred Shares 2024-11-30 0001377936 Alternative Investment Management Software 2024-11-30 0001377936 BQE Software, Inc. - Architecture & Engineering Software - First Lien Term Loan (3M USD TERM SOFR+6.75%), 11.22% Cash, 4/13/2028 2024-03-01 2024-11-30 0001377936 BQE Software, Inc. - Architecture & Engineering Software - First Lien Term Loan (3M USD TERM SOFR+6.75%), 11.22% Cash, 4/13/2028 2024-11-30 0001377936 BQE Software, Inc. - Architecture & Engineering Software - Delayed Draw Term Loan (3M USD TERM SOFR+6.75%), 11.22% Cash, 4/13/2028 2024-03-01 2024-11-30 0001377936 BQE Software, Inc. - Architecture & Engineering Software - Delayed Draw Term Loan (3M USD TERM SOFR+6.75%), 11.22% Cash, 4/13/2028 2024-11-30 0001377936 Architecture & Engineering Software 2024-11-30 0001377936 GrowthZone, LLC - Association Management Software- First Lien Term Loan (3M USD TERM SOFR+8.25%), 12.72% Cash, 5/10/2028 2024-03-01 2024-11-30 0001377936 GrowthZone, LLC - Association Management Software- First Lien Term Loan (3M USD TERM SOFR+8.25%), 12.72% Cash, 5/10/2028 2024-11-30 0001377936 Golden TopCo LP - Association Management Software - Class A-2 Common Units 2024-03-01 2024-11-30 0001377936 Golden TopCo LP - Association Management Software - Class A-2 Common Units 2024-11-30 0001377936 Association Management Software 2024-11-30 0001377936 Artemis Wax Corp. - Consumer Services - Delayed Draw Term Loan (1M USD TERM SOFR+7.50%), 12.03% Cash, 5/20/2026 2024-03-01 2024-11-30 0001377936 Artemis Wax Corp. - Consumer Services - Delayed Draw Term Loan (1M USD TERM SOFR+7.50%), 12.03% Cash, 5/20/2026 2024-11-30 0001377936 Artemis Wax Corp. - Consumer Services - Series B-1 Preferred Stock 2024-03-01 2024-11-30 0001377936 Artemis Wax Corp. - Consumer Services - Series B-1 Preferred Stock 2024-11-30 0001377936 Artemis Wax Corp. - Consumer Services - Series D Preferred Stock 2024-03-01 2024-11-30 0001377936 Artemis Wax Corp. - Consumer Services - Series D Preferred Stock 2024-11-30 0001377936 Consumer Services 2024-11-30 0001377936 Schoox, Inc - Corporate Education Software - Series 1 Membership Interest 2024-03-01 2024-11-30 0001377936 Schoox, Inc - Corporate Education Software - Series 1 Membership Interest 2024-11-30 0001377936 Corporate Education Software 2024-11-30 0001377936 GreyHeller LLC - Cyber Security - Common Stock 2024-03-01 2024-11-30 0001377936 GreyHeller LLC - Cyber Security - Common Stock 2024-11-30 0001377936 Cyber Security 2024-11-30 0001377936 Gen4 Dental Partners Holdings, LLC - Dental Practice Management - First Lien Term Loan (6M USD TERM SOFR+5.50%), 9.88% Cash, 5/13/2030 2024-03-01 2024-11-30 0001377936 Gen4 Dental Partners Holdings, LLC - Dental Practice Management - First Lien Term Loan (6M USD TERM SOFR+5.50%), 9.88% Cash, 5/13/2030 2024-11-30 0001377936 Gen4 Dental Partners Holdings, LLC - Dental Practice Management - Delayed Draw Term Loan (6M USD TERM SOFR+5.50%), 9.88% Cash, 5/13/2030 2024-03-01 2024-11-30 0001377936 Gen4 Dental Partners Holdings, LLC - Dental Practice Management - Delayed Draw Term Loan (6M USD TERM SOFR+5.50%), 9.88% Cash, 5/13/2030 2024-11-30 0001377936 Gen4 Dental Partners Holdings, LLC - Dental Practice Management - Revolving Credit Facility (6M USD TERM SOFR+5.50%), 9.88% Cash, 5/13/2030 2024-03-01 2024-11-30 0001377936 Gen4 Dental Partners Holdings, LLC - Dental Practice Management - Revolving Credit Facility (6M USD TERM SOFR+5.50%), 9.88% Cash, 5/13/2030 2024-11-30 0001377936 Gen4 Dental Partners Holdings, LLC - Dental Practice Management - Series A Preferred Units 2024-03-01 2024-11-30 0001377936 Gen4 Dental Partners Holdings, LLC - Dental Practice Management - Series A Preferred Units 2024-11-30 0001377936 Modis Dental Partners OpCo, LLC - Dental Practice Management - First Lien Term Loan (1M USD TERM SOFR+9.43%), 13.96% Cash, 4/18/2028 2024-03-01 2024-11-30 0001377936 Modis Dental Partners OpCo, LLC - Dental Practice Management - First Lien Term Loan (1M USD TERM SOFR+9.43%), 13.96% Cash, 4/18/2028 2024-11-30 0001377936 Modis Dental Partners OpCo, LLC - Dental Practice Management - Delayed Draw Term Loan (1M USD TERM SOFR+9.43%), 13.96% Cash, 4/18/2028 2024-03-01 2024-11-30 0001377936 Modis Dental Partners OpCo, LLC - Dental Practice Management - Delayed Draw Term Loan (1M USD TERM SOFR+9.43%), 13.96% Cash, 4/18/2028 2024-11-30 0001377936 Modis Dental Partners OpCo, LLC - Dental Practice Management - Class A Preferred Units 2024-03-01 2024-11-30 0001377936 Modis Dental Partners OpCo, LLC - Dental Practice Management - Class A Preferred Units 2024-11-30 0001377936 New England Dental Partners - Dental Practice Management - First Lien Term Loan (3M USD TERM SOFR+8.00%), 12.62% Cash, 11/25/2025 2024-03-01 2024-11-30 0001377936 New England Dental Partners - Dental Practice Management - First Lien Term Loan (3M USD TERM SOFR+8.00%), 12.62% Cash, 11/25/2025 2024-11-30 0001377936 New England Dental Partners - Dental Practice Management - Delayed Draw Term Loan (3M USD TERM SOFR+8.00%), 12.62% Cash, 11/25/2025 2024-03-01 2024-11-30 0001377936 New England Dental Partners - Dental Practice Management - Delayed Draw Term Loan (3M USD TERM SOFR+8.00%), 12.62% Cash, 11/25/2025 2024-11-30 0001377936 Dental Practice Management 2024-11-30 0001377936 Exigo, LLC - Direct Selling Software - First Lien Term Loan (1M USD TERM SOFR+6.25%), 10.88% Cash, 3/16/2027 2024-03-01 2024-11-30 0001377936 Exigo, LLC - Direct Selling Software - First Lien Term Loan (1M USD TERM SOFR+6.25%), 10.88% Cash, 3/16/2027 2024-11-30 0001377936 Exigo, LLC - Direct Selling Software - Revolving Credit Facility (1M USD TERM SOFR+6.25%), 10.88% Cash, 3/16/2027 2024-03-01 2024-11-30 0001377936 Exigo, LLC - Direct Selling Software - Revolving Credit Facility (1M USD TERM SOFR+6.25%), 10.88% Cash, 3/16/2027 2024-11-30 0001377936 Exigo, LLC - Direct Selling Software - Common Units 2024-03-01 2024-11-30 0001377936 Exigo, LLC - Direct Selling Software - Common Units 2024-11-30 0001377936 Direct Selling Software 2024-11-30 0001377936 C2 Educational Systems, Inc. - Education Services - First Lien Term Loan (3M USD TERM SOFR+8.50%), 12.97% Cash, 5/31/2025 2024-03-01 2024-11-30 0001377936 C2 Educational Systems, Inc. - Education Services - First Lien Term Loan (3M USD TERM SOFR+8.50%), 12.97% Cash, 5/31/2025 2024-11-30 0001377936 C2 Educational Systems, Inc. - Education Services - Delayed Draw Term Loan (3M USD TERM SOFR+8.50%), 12.97% Cash, 5/31/2025 2024-03-01 2024-11-30 0001377936 C2 Educational Systems, Inc. - Education Services - Delayed Draw Term Loan (3M USD TERM SOFR+8.50%), 12.97% Cash, 5/31/2025 2024-11-30 0001377936 C2 Educational Systems, Inc. - Education Services - Series A-1 Preferred Stock 2024-03-01 2024-11-30 0001377936 C2 Educational Systems, Inc. - Education Services - Series A-1 Preferred Stock 2024-11-30 0001377936 Education Services 2024-11-30 0001377936 Modern Campus (fka Destiny Solutions Inc.) - Education Software - Limited Partner Interests 2024-03-01 2024-11-30 0001377936 Modern Campus (fka Destiny Solutions Inc.) - Education Software - Limited Partner Interests 2024-11-30 0001377936 GoReact - Education Software - First Lien Term Loan (3M USD TERM SOFR+7.50%), 12.17% Cash/1.00% PIK, 1/17/2025 2024-03-01 2024-11-30 0001377936 GoReact - Education Software - First Lien Term Loan (3M USD TERM SOFR+7.50%), 12.17% Cash/1.00% PIK, 1/17/2025 2024-11-30 0001377936 GoReact - Education Software - Delayed Draw Term Loan (3M USD TERM SOFR+7.50%), 12.17% Cash/1.00% PIK, 1/17/2025 2024-03-01 2024-11-30 0001377936 GoReact - Education Software - Delayed Draw Term Loan (3M USD TERM SOFR+7.50%), 12.17% Cash/1.00% PIK, 1/17/2025 2024-11-30 0001377936 Identity Automation Systems - Education Software - Common Stock Class A-2 Units 2024-03-01 2024-11-30 0001377936 Identity Automation Systems - Education Software - Common Stock Class A-2 Units 2024-11-30 0001377936 Identity Automation Systems - Education Software - Common Stock Class A-1 Units 2024-03-01 2024-11-30 0001377936 Identity Automation Systems - Education Software - Common Stock Class A-1 Units 2024-11-30 0001377936 Ready Education - Education Software - First Lien Term Loan (3M USD TERM SOFR+7.00%), 11.47% Cash, 8/5/2027 2024-03-01 2024-11-30 0001377936 Ready Education - Education Software - First Lien Term Loan (3M USD TERM SOFR+7.00%), 11.47% Cash, 8/5/2027 2024-11-30 0001377936 Education Software 2024-11-30 0001377936 TG Pressure Washing Holdings, LLC - Facilities Maintenance - Preferred Equity 2024-03-01 2024-11-30 0001377936 TG Pressure Washing Holdings, LLC - Facilities Maintenance - Preferred Equity 2024-11-30 0001377936 Facilities Maintenance 2024-11-30 0001377936 Davisware, LLC - Field Service Management - First Lien Term Loan (3M USD TERM SOFR+6.50%), 10.97% Cash, 11/30/2025 2024-03-01 2024-11-30 0001377936 Davisware, LLC - Field Service Management - First Lien Term Loan (3M USD TERM SOFR+6.50%), 10.97% Cash, 11/30/2025 2024-11-30 0001377936 Davisware, LLC - Field Service Management - Delayed Draw Term Loan (3M USD TERM SOFR+6.50%), 10.97% Cash, 11/30/2025 2024-03-01 2024-11-30 0001377936 Davisware, LLC - Field Service Management - Delayed Draw Term Loan (3M USD TERM SOFR+6.50%), 10.97% Cash, 11/30/2025 2024-11-30 0001377936 Field Service Management 2024-11-30 0001377936 GDS Software Holdings, LLC - First Lien Term Loan (3M USD TERM SOFR+7.00%), 11.47% Cash, 12/30/2026 2024-03-01 2024-11-30 0001377936 GDS Software Holdings, LLC - First Lien Term Loan (3M USD TERM SOFR+7.00%), 11.47% Cash, 12/30/2026 2024-11-30 0001377936 GDS Software Holdings, LLC - Financial Services - Delayed Draw Term Loan (3M USD TERM SOFR+7.00%), 11.47% Cash, 12/30/2026 2024-03-01 2024-11-30 0001377936 GDS Software Holdings, LLC - Financial Services - Delayed Draw Term Loan (3M USD TERM SOFR+7.00%), 11.47% Cash, 12/30/2026 2024-11-30 0001377936 GDS Software Holdings, LLC - Financial Services - Common Stock Class A Units 2024-03-01 2024-11-30 0001377936 GDS Software Holdings, LLC - Financial Services - Common Stock Class A Units 2024-11-30 0001377936 Financial Services 2024-11-30 0001377936 Ascend Software, LLC - Financial Services Software - First Lien Term Loan (3M USD TERM SOFR+7.50%), 12.23% Cash, 12/15/2026 2024-03-01 2024-11-30 0001377936 Ascend Software, LLC - Financial Services Software - First Lien Term Loan (3M USD TERM SOFR+7.50%), 12.23% Cash, 12/15/2026 2024-11-30 0001377936 Ascend Software, LLC - Financial Services Software - Delayed Draw Term Loan (3M USD TERM SOFR+7.50%), 12.23% Cash, 12/15/2026 2024-03-01 2024-11-30 0001377936 Ascend Software, LLC - Financial Services Software - Delayed Draw Term Loan (3M USD TERM SOFR+7.50%), 12.23% Cash, 12/15/2026 2024-11-30 0001377936 Financial Services Software 2024-11-30 0001377936 Inspect Point Holdings, LLC - Fire Inspection Business Software - First Lien Term Loan (1M USD TERM SOFR+6.50%), 11.03% Cash, 07/19/2028 2024-03-01 2024-11-30 0001377936 Inspect Point Holdings, LLC - Fire Inspection Business Software - First Lien Term Loan (1M USD TERM SOFR+6.50%), 11.03% Cash, 07/19/2028 2024-11-30 0001377936 Inspect Point Holdings, LLC - Fire Inspection Business Software -First Lien Term Loan (1M USD TERM SOFR+6.50%), 11.03% Cash, 07/19/2028 2024-03-01 2024-11-30 0001377936 Inspect Point Holdings, LLC - Fire Inspection Business Software -First Lien Term Loan (1M USD TERM SOFR+6.50%), 11.03% Cash, 07/19/2028 2024-11-30 0001377936 Fire Inspection Business Software 2024-11-30 0001377936 Stretch Zone Franchising, LLC - Health/Fitness Franchisor - First Lien Term Loan (3M USD TERM SOFR+7.00%), 11.47% Cash, 3/31/2028 2024-03-01 2024-11-30 0001377936 Stretch Zone Franchising, LLC - Health/Fitness Franchisor - First Lien Term Loan (3M USD TERM SOFR+7.00%), 11.47% Cash, 3/31/2028 2024-11-30 0001377936 Stretch Zone Franchising, LLC - Health/Fitness Franchisor - Delayed Draw Term Loan (3M USD TERM SOFR+7.00%), 11.47% Cash, 3/31/2028 2024-03-01 2024-11-30 0001377936 Stretch Zone Franchising, LLC - Health/Fitness Franchisor - Delayed Draw Term Loan (3M USD TERM SOFR+7.00%), 11.47% Cash, 3/31/2028 2024-11-30 0001377936 Stretch Zone Franchising, LLC - Health/Fitness Franchisor - Class A Units 2024-03-01 2024-11-30 0001377936 Stretch Zone Franchising, LLC - Health/Fitness Franchisor - Class A Units 2024-11-30 0001377936 Health/Fitness Franchisor 2024-11-30 0001377936 Alpha Aesthetics Partners OpCo, LLC - Healthcare Services - First Lien Term Loan (1M USD TERM SOFR+9.93%), 14.46% Cash, 3/20/2028 2024-03-01 2024-11-30 0001377936 Alpha Aesthetics Partners OpCo, LLC - Healthcare Services - First Lien Term Loan (1M USD TERM SOFR+9.93%), 14.46% Cash, 3/20/2028 2024-11-30 0001377936 Alpha Aesthetics Partners OpCo, LLC - Healthcare Services - Delayed Draw Term Loan (1M USD TERM SOFR+9.93%), 14.46% Cash, 3/20/2028 2024-03-01 2024-11-30 0001377936 Alpha Aesthetics Partners OpCo, LLC - Healthcare Services - Delayed Draw Term Loan (1M USD TERM SOFR+9.93%), 14.46% Cash, 3/20/2028 2024-11-30 0001377936 Alpha Aesthetics Partners OpCo, LLC - Healthcare Services -Class A Preferred Units 2024-03-01 2024-11-30 0001377936 Alpha Aesthetics Partners OpCo, LLC - Healthcare Services -Class A Preferred Units 2024-11-30 0001377936 Axiom Medical Consulting, LLC - Healthcare Services - First Lien Term Loan (3M USD TERM SOFR+6.00%), 10.47% Cash, 9/11/2028 2024-03-01 2024-11-30 0001377936 Axiom Medical Consulting, LLC - Healthcare Services - First Lien Term Loan (3M USD TERM SOFR+6.00%), 10.47% Cash, 9/11/2028 2024-11-30 0001377936 Axiom Medical Consulting, LLC - Healthcare Services - Delayed Draw Term Loan (3M USD TERM SOFR+6.00%), 10.47% Cash, 9/11/2028 2024-03-01 2024-11-30 0001377936 Axiom Medical Consulting, LLC - Healthcare Services - Delayed Draw Term Loan (3M USD TERM SOFR+6.00%), 10.47% Cash, 9/11/2028 2024-11-30 0001377936 Axiom Parent Holdings, LLC - Healthcare Services - Class A Preferred Units 2024-03-01 2024-11-30 0001377936 Axiom Parent Holdings, LLC - Healthcare Services - Class A Preferred Units 2024-11-30 0001377936 ComForCare Health Care - Healthcare Services - First Lien Term Loan (3M USD TERM SOFR+6.25%), 10.72% Cash, 12/31/2027 2024-03-01 2024-11-30 0001377936 ComForCare Health Care - Healthcare Services - First Lien Term Loan (3M USD TERM SOFR+6.25%), 10.72% Cash, 12/31/2027 2024-11-30 0001377936 Healthcare Services 2024-11-30 0001377936 Procurement Partners, LLC - Healthcare Software - First Lien Term Loan (3M USD TERM SOFR+6.50%), 10.97% Cash, 5/12/2026 2024-03-01 2024-11-30 0001377936 Procurement Partners, LLC - Healthcare Software - First Lien Term Loan (3M USD TERM SOFR+6.50%), 10.97% Cash, 5/12/2026 2024-11-30 0001377936 Procurement Partners, LLC - Healthcare Software - Delayed Draw Term Loan (3M USD TERM SOFR+6.50%), 10.97% Cash, 5/12/2026 2024-03-01 2024-11-30 0001377936 Procurement Partners, LLC - Healthcare Software - Delayed Draw Term Loan (3M USD TERM SOFR+6.50%), 10.97% Cash, 5/12/2026 2024-11-30 0001377936 Procurement Partners Holdings LLC - Healthcare Software - Class A Units 2024-03-01 2024-11-30 0001377936 Procurement Partners Holdings LLC - Healthcare Software - Class A Units 2024-11-30 0001377936 Procurement Partners Holdings LLC - Healthcare Software - Class AA Units 2024-03-01 2024-11-30 0001377936 Procurement Partners Holdings LLC - Healthcare Software - Class AA Units 2024-11-30 0001377936 Healthcare Software 2024-11-30 0001377936 Roscoe Medical, Inc. - Healthcare Supply - Common Stock 2024-03-01 2024-11-30 0001377936 Roscoe Medical, Inc. - Healthcare Supply - Common Stock 2024-11-30 0001377936 Healthcare Supply 2024-11-30 0001377936 Granite Comfort, LP - HVAC Services and Sales - First Lien Term Loan (3M USD TERM SOFR+7.41%), 11.88% Cash, 5/16/2027 2024-03-01 2024-11-30 0001377936 Granite Comfort, LP - HVAC Services and Sales - First Lien Term Loan (3M USD TERM SOFR+7.41%), 11.88% Cash, 5/16/2027 2024-11-30 0001377936 Granite Comfort, LP - HVAC Services and Sales - Delayed Draw Term Loan (3M USD TERM SOFR+7.41%), 11.88% Cash, 5/16/2027 2024-03-01 2024-11-30 0001377936 Granite Comfort, LP - HVAC Services and Sales - Delayed Draw Term Loan (3M USD TERM SOFR+7.41%), 11.88% Cash, 5/16/2027 2024-11-30 0001377936 HVAC Services and Sales 2024-11-30 0001377936 Vector Controls Holding Co., LLC - Industrial Products - Warrants to Purchase Limited Liability Company Interests, Expires 3/6/2025 2024-03-01 2024-11-30 0001377936 Vector Controls Holding Co., LLC - Industrial Products - Warrants to Purchase Limited Liability Company Interests, Expires 3/6/2025 2024-11-30 0001377936 Industrial Products 2024-11-30 0001377936 AgencyBloc, LLC - Insurance Software - First Lien Term Loan (1M USD TERM SOFR+7.76%), 12.29% Cash, 10/1/2026 2024-03-01 2024-11-30 0001377936 AgencyBloc, LLC - Insurance Software - First Lien Term Loan (1M USD TERM SOFR+7.76%), 12.29% Cash, 10/1/2026 2024-11-30 0001377936 Panther ParentCo LLC - Insurance Software - Class A Units 2024-03-01 2024-11-30 0001377936 Panther ParentCo LLC - Insurance Software - Class A Units 2024-11-30 0001377936 Insurance Software 2024-11-30 0001377936 Avantra (Maple Holdings Midco Limited) - IT Services - First Lien Term Loan (3M USD TERM SOFR+7.97%), 12.44% Cash, 9/20/2029 2024-03-01 2024-11-30 0001377936 Avantra (Maple Holdings Midco Limited) - IT Services - First Lien Term Loan (3M USD TERM SOFR+7.97%), 12.44% Cash, 9/20/2029 2024-11-30 0001377936 Maple Holdings Midco Limited (h) - IT Services - Class A Common Units 2024-03-01 2024-11-30 0001377936 Maple Holdings Midco Limited (h) - IT Services - Class A Common Units 2024-11-30 0001377936 IT Services 2024-11-30 0001377936 ActiveProspect, Inc. - Lead Management Software - First Lien Term Loan (3M USD TERM SOFR+6.00%), 10.67% Cash, 8/8/2027 2024-03-01 2024-11-30 0001377936 ActiveProspect, Inc. - Lead Management Software - First Lien Term Loan (3M USD TERM SOFR+6.00%), 10.67% Cash, 8/8/2027 2024-11-30 0001377936 ActiveProspect, Inc. - Lead Management Software - Delayed Draw Term Loan (3M USD TERM SOFR+6.00%), 10.67% Cash, 8/8/2027 2024-03-01 2024-11-30 0001377936 ActiveProspect, Inc. - Lead Management Software - Delayed Draw Term Loan (3M USD TERM SOFR+6.00%), 10.67% Cash, 8/8/2027 2024-11-30 0001377936 Lead Management Software 2024-11-30 0001377936 Madison Logic, Inc. - Marketing Orchestration Software - First Lien Term Loan (1M USD TERM SOFR+7.50%), 12.03% Cash, 12/30/2028 2024-03-01 2024-11-30 0001377936 Madison Logic, Inc. - Marketing Orchestration Software - First Lien Term Loan (1M USD TERM SOFR+7.50%), 12.03% Cash, 12/30/2028 2024-11-30 0001377936 Marketing Orchestration Software 2024-11-30 0001377936 ARC Health OpCo LLC - Mental Healthcare Services - First Lien Term Loan (3M USD TERM SOFR+8.40%), 12.86% Cash, 8/5/2027 2024-03-01 2024-11-30 0001377936 ARC Health OpCo LLC - Mental Healthcare Services - First Lien Term Loan (3M USD TERM SOFR+8.40%), 12.86% Cash, 8/5/2027 2024-11-30 0001377936 ARC Health OpCo LLC - Mental Healthcare Services - Delayed Draw Term Loan (3M USD TERM SOFR+8.40%), 12.86% Cash, 8/5/2027 2024-03-01 2024-11-30 0001377936 ARC Health OpCo LLC - Mental Healthcare Services - Delayed Draw Term Loan (3M USD TERM SOFR+8.40%), 12.86% Cash, 8/5/2027 2024-11-30 0001377936 ARC Health OpCo LLC - Mental Healthcare Services - Class A Preferred Units 2024-03-01 2024-11-30 0001377936 ARC Health OpCo LLC - Mental Healthcare Services - Class A Preferred Units 2024-11-30 0001377936 Mental Healthcare Services 2024-11-30 0001377936 Chronus LLC - Mentoring Software - First Lien Term Loan (3M USD TERM SOFR+5.25%), 9.87% Cash, 8/26/2026 2024-03-01 2024-11-30 0001377936 Chronus LLC - Mentoring Software - First Lien Term Loan (3M USD TERM SOFR+5.25%), 9.87% Cash, 8/26/2026 2024-11-30 0001377936 Chronus LLC - Mentoring Software - First Lien Term Loan (3M USD TERM SOFR+6.00%), 10.62% Cash, 8/26/2026 2024-03-01 2024-11-30 0001377936 Chronus LLC - Mentoring Software - First Lien Term Loan (3M USD TERM SOFR+6.00%), 10.62% Cash, 8/26/2026 2024-11-30 0001377936 Chronus LLC - Mentoring Software - Series A Preferred Stock 2024-03-01 2024-11-30 0001377936 Chronus LLC - Mentoring Software - Series A Preferred Stock 2024-11-30 0001377936 Mentoring Software 2024-11-30 0001377936 Cloudpermit Intermediate Holding Company - Municipal Government Software - First Lien Term Loan (3M USD TERM SOFR+5.75%), 10.22% Cash, 9/5/2029 2024-03-01 2024-11-30 0001377936 Cloudpermit Intermediate Holding Company - Municipal Government Software - First Lien Term Loan (3M USD TERM SOFR+5.75%), 10.22% Cash, 9/5/2029 2024-11-30 0001377936 Cloudpermit Intermediate Holding Company - Municipal Government Software - Delayed Draw Term Loan (3M USD TERM SOFR+5.75%), 10.22% Cash, 9/5/2029 2024-03-01 2024-11-30 0001377936 Cloudpermit Intermediate Holding Company - Municipal Government Software - Delayed Draw Term Loan (3M USD TERM SOFR+5.75%), 10.22% Cash, 9/5/2029 2024-11-30 0001377936 Cloudpermit Intermediate Holding Company - Municipal Government Software - Limited Partner Interests 2024-03-01 2024-11-30 0001377936 Cloudpermit Intermediate Holding Company - Municipal Government Software - Limited Partner Interests 2024-11-30 0001377936 Municipal Government Software 2024-11-30 0001377936 Omatic Software, LLC - Non-profit Services - First Lien Term Loan (3M USD TERM SOFR+8.00%), 12.73% Cash/1.00% PIK, 6/30/2025 2024-03-01 2024-11-30 0001377936 Omatic Software, LLC - Non-profit Services - First Lien Term Loan (3M USD TERM SOFR+8.00%), 12.73% Cash/1.00% PIK, 6/30/2025 2024-11-30 0001377936 Non-profit Services 2024-11-30 0001377936 Emily Street Enterprises, L.L.C. - Office Supplies - Senior Secured Note (3M USD TERM SOFR+6.25%), 11.00% Cash, 12/31/2027 2024-03-01 2024-11-30 0001377936 Emily Street Enterprises, L.L.C. - Office Supplies - Senior Secured Note (3M USD TERM SOFR+6.25%), 11.00% Cash, 12/31/2027 2024-11-30 0001377936 Emily Street Enterprises, L.L.C. - Office Supplies - Warrant Membership Interests, Expires 12/31/2027 2024-03-01 2024-11-30 0001377936 Emily Street Enterprises, L.L.C. - Office Supplies - Warrant Membership Interests, Expires 12/31/2027 2024-11-30 0001377936 Office Supplies 2024-11-30 0001377936 Buildout, Inc. - Real Estate Services - First Lien Term Loan (3M USD TERM SOFR+7.00%), 11.57% Cash, 7/9/2025 2024-03-01 2024-11-30 0001377936 Buildout, Inc. - Real Estate Services - First Lien Term Loan (3M USD TERM SOFR+7.00%), 11.57% Cash, 7/9/2025 2024-11-30 0001377936 Buildout, Inc. - Real Estate Services - Delayed Draw Term Loan (3M USD TERM SOFR+7.00%), 11.57% Cash, 7/9/2025 2024-03-01 2024-11-30 0001377936 Buildout, Inc. - Real Estate Services - Delayed Draw Term Loan (3M USD TERM SOFR+7.00%), 11.57% Cash, 7/9/2025 2024-11-30 0001377936 Buildout, Inc. - Real Estate Services - Limited Partner Interests 2024-03-01 2024-11-30 0001377936 Buildout, Inc. - Real Estate Services - Limited Partner Interests 2024-11-30 0001377936 Real Estate Services 2024-11-30 0001377936 Wellspring Worldwide Inc. - Research Software - First Lien Term Loan (3M USD TERM SOFR+8.42%), 12.89% Cash, 12/22/2028 2024-03-01 2024-11-30 0001377936 Wellspring Worldwide Inc. - Research Software - First Lien Term Loan (3M USD TERM SOFR+8.42%), 12.89% Cash, 12/22/2028 2024-11-30 0001377936 Wellspring Worldwide Inc. - Research Software - Delayed DrawTerm Loan (3M USD TERM SOFR+8.42%), 12.89% Cash, 12/22/2028 2024-03-01 2024-11-30 0001377936 Wellspring Worldwide Inc. - Research Software - Delayed DrawTerm Loan (3M USD TERM SOFR+8.42%), 12.89% Cash, 12/22/2028 2024-11-30 0001377936 Archimedes Parent LLC - Research Software - Class A Common Units 2024-03-01 2024-11-30 0001377936 Archimedes Parent LLC - Research Software - Class A Common Units 2024-11-30 0001377936 Research Software 2024-11-30 0001377936 LFR Chicken LLC - Restaurant - First Lien Term Loan (1M USD TERM SOFR+7.00%), 11.53% Cash, 11/19/2026 2024-03-01 2024-11-30 0001377936 LFR Chicken LLC - Restaurant - First Lien Term Loan (1M USD TERM SOFR+7.00%), 11.53% Cash, 11/19/2026 2024-11-30 0001377936 LFR Chicken LLC - Restaurant -Delayed Draw Term Loan (1M USD TERM SOFR+7.00%), 11.53% Cash, 11/19/2026 2024-03-01 2024-11-30 0001377936 LFR Chicken LLC - Restaurant -Delayed Draw Term Loan (1M USD TERM SOFR+7.00%), 11.53% Cash, 11/19/2026 2024-11-30 0001377936 LFR Chicken LLC - Restaurant - Series B Preferred Units 2024-03-01 2024-11-30 0001377936 LFR Chicken LLC - Restaurant - Series B Preferred Units 2024-11-30 0001377936 Restaurant 2024-11-30 0001377936 Avionte Holdings, LLC - Staffing Services -Class A Units 2024-03-01 2024-11-30 0001377936 Avionte Holdings, LLC - Staffing Services -Class A Units 2024-11-30 0001377936 Staffing Services 2024-11-30 0001377936 JDXpert - Talent Acquisition Software - First Lien Term Loan (3M USD TERM SOFR+8.50%), 13.23% Cash, 5/2/2027 2024-03-01 2024-11-30 0001377936 JDXpert - Talent Acquisition Software - First Lien Term Loan (3M USD TERM SOFR+8.50%), 13.23% Cash, 5/2/2027 2024-11-30 0001377936 JDXpert - Talent Acquisition Software - Delayed Draw Term Loan (3M USD TERM SOFR+8.50%), 13.23% Cash, 5/2/2027 2024-03-01 2024-11-30 0001377936 JDXpert - Talent Acquisition Software - Delayed Draw Term Loan (3M USD TERM SOFR+8.50%), 13.23% Cash, 5/2/2027 2024-11-30 0001377936 JDXpert - Talent Acquisition Software - Delayed Draw Term Loan 3M USD TERM SOFR+8.50%), 13.23% Cash, 5/2/2027 2024-03-01 2024-11-30 0001377936 JDXpert - Talent Acquisition Software - Delayed Draw Term Loan 3M USD TERM SOFR+8.50%), 13.23% Cash, 5/2/2027 2024-11-30 0001377936 Jobvite, Inc. - Talent Acquisition Software - First Lien Term Loan (3M USD TERM SOFR+7.50%), 11.97% Cash, 8/5/2028 2024-03-01 2024-11-30 0001377936 Jobvite, Inc. - Talent Acquisition Software - First Lien Term Loan (3M USD TERM SOFR+7.50%), 11.97% Cash, 8/5/2028 2024-11-30 0001377936 Talent Acquisition Software 2024-11-30 0001377936 VetnCare MSO, LLC - Veterinary Services - Delayed Draw Term Loan (3M USD TERM SOFR+5.75%), 10.22% Cash, 5/12/2028 2024-03-01 2024-11-30 0001377936 VetnCare MSO, LLC - Veterinary Services - Delayed Draw Term Loan (3M USD TERM SOFR+5.75%), 10.22% Cash, 5/12/2028 2024-11-30 0001377936 Veterinary Services 2024-11-30 0001377936 Sub Total Non-control/Non-affiliate investments 2024-11-30 0001377936 ETU Holdings, Inc. - Corporate Education Software - First Lien Term Loan (3M USD TERM SOFR+9.00%), 13.62% Cash, 8/18/2027 2024-03-01 2024-11-30 0001377936 ETU Holdings, Inc. - Corporate Education Software - First Lien Term Loan (3M USD TERM SOFR+9.00%), 13.62% Cash, 8/18/2027 2024-11-30 0001377936 ETU Holdings, Inc. - Corporate Education Software - Second Lien Term Loan 15.00% PIK, 2/18/2028 2024-03-01 2024-11-30 0001377936 ETU Holdings, Inc. - Corporate Education Software - Second Lien Term Loan 15.00% PIK, 2/18/2028 2024-11-30 0001377936 ETU Holdings, Inc. - Corporate Education Software - Series A Preferred Units 2024-03-01 2024-11-30 0001377936 ETU Holdings, Inc. - Corporate Education Software - Series A Preferred Units 2024-11-30 0001377936 Corporate Education Software - Affiliate investments 2024-11-30 0001377936 Axero Holdings, LLC - Employee Collaboration Software - First Lien Term Loan 4.50% Cash, (3M USD TERM SOFR + 2.50%) PIK, 12/31/2027 2024-03-01 2024-11-30 0001377936 Axero Holdings, LLC - Employee Collaboration Software - First Lien Term Loan 4.50% Cash, (3M USD TERM SOFR + 2.50%) PIK, 12/31/2027 2024-11-30 0001377936 Axero Holdings, LLC - Employee Collaboration Software - Delayed Draw Term Loan 4.50% Cash, (3M USD TERM SOFR + 2.50%) PIK, 12/31/2027 2024-03-01 2024-11-30 0001377936 Axero Holdings, LLC - Employee Collaboration Software - Delayed Draw Term Loan 4.50% Cash, (3M USD TERM SOFR + 2.50%) PIK, 12/31/2027 2024-11-30 0001377936 Axero Holdings, LLC - Employee Collaboration Software - Revolving Credit Facility 4.50% Cash, (3M USD TERM SOFR + 2.50%) PIK, 12/31/2027 2024-03-01 2024-11-30 0001377936 Axero Holdings, LLC - Employee Collaboration Software - Revolving Credit Facility 4.50% Cash, (3M USD TERM SOFR + 2.50%) PIK, 12/31/2027 2024-11-30 0001377936 Axero Holdings, LLC - Employee Collaboration Software - Series A Preferred Units 2024-03-01 2024-11-30 0001377936 Axero Holdings, LLC - Employee Collaboration Software - Series A Preferred Units 2024-11-30 0001377936 Axero Holdings, LLC - Employee Collaboration Software - Series B Preferred Units 2024-03-01 2024-11-30 0001377936 Axero Holdings, LLC - Employee Collaboration Software - Series B Preferred Units 2024-11-30 0001377936 Employee Collaboration Software 2024-11-30 0001377936 Sub Total Affiliate investments 2024-11-30 0001377936 Zollege PBC - Education Services - First Lien Term Loan 4.84% PIK, 8/9/2027 2024-03-01 2024-11-30 0001377936 Zollege PBC - Education Services - First Lien Term Loan 4.84% PIK, 8/9/2027 2024-11-30 0001377936 Zollege PBC - Education Services - Common Stock 2024-03-01 2024-11-30 0001377936 Zollege PBC - Education Services - Common Stock 2024-11-30 0001377936 Education Services - Control investments 2024-11-30 0001377936 Pepper Palace, Inc. - Specialty Food Retailer - First Lien Term Loan 4.42% PIK, 12/31/2028 2024-03-01 2024-11-30 0001377936 Pepper Palace, Inc. - Specialty Food Retailer - First Lien Term Loan 4.42% PIK, 12/31/2028 2024-11-30 0001377936 Pepper Palace, Inc. - Specialty Food Retailer - Delayed Draw Term Loan 4.42% PIK, 12/31/2028 2024-03-01 2024-11-30 0001377936 Pepper Palace, Inc. - Specialty Food Retailer - Delayed Draw Term Loan 4.42% PIK, 12/31/2028 2024-11-30 0001377936 Pepper Palace, Inc. - Specialty Food Retailer - Revolving Credit Facility 4.42% PIK, 12/31/2028 2024-03-01 2024-11-30 0001377936 Pepper Palace, Inc. - Specialty Food Retailer - Revolving Credit Facility 4.42% PIK, 12/31/2028 2024-11-30 0001377936 Pepper Palace, Inc. - Specialty Food Retailer - Class A Units 2024-03-01 2024-11-30 0001377936 Pepper Palace, Inc. - Specialty Food Retailer - Class A Units 2024-11-30 0001377936 Specialty Food Retailer 2024-11-30 0001377936 Saratoga Investment Corp. CLO 2013-1, Ltd. - Structured Finance Securities - Other/Structured Finance Securities 0.00%, 4/20/2033 2024-03-01 2024-11-30 0001377936 Saratoga Investment Corp. CLO 2013-1, Ltd. - Structured Finance Securities - Other/Structured Finance Securities 0.00%, 4/20/2033 2024-11-30 0001377936 Saratoga Investment Corp. CLO 2013-1, Ltd. Class F-2-R-3 Note - Structured Finance Securities - Other/Structured Finance Securities (3M USD TERM SOFR+10.00%), 14.73%, 4/20/2033 2024-03-01 2024-11-30 0001377936 Saratoga Investment Corp. CLO 2013-1, Ltd. Class F-2-R-3 Note - Structured Finance Securities - Other/Structured Finance Securities (3M USD TERM SOFR+10.00%), 14.73%, 4/20/2033 2024-11-30 0001377936 Saratoga Investment Corp. Senior Loan Fund 2022-1, Ltd. Class E Note - Structured Finance Securities - Other/Structured Finance Securities (3M USD TERM SOFR+8.55%), 13.02%, 10/20/2033 2024-03-01 2024-11-30 0001377936 Saratoga Investment Corp. Senior Loan Fund 2022-1, Ltd. Class E Note - Structured Finance Securities - Other/Structured Finance Securities (3M USD TERM SOFR+8.55%), 13.02%, 10/20/2033 2024-11-30 0001377936 Structured Finance Securities 2024-11-30 0001377936 Saratoga Senior Loan Fund I JV, LLC - Investment Fund - Unsecured Loan 10.00%, 10/20/2033 2024-03-01 2024-11-30 0001377936 Saratoga Senior Loan Fund I JV, LLC - Investment Fund - Unsecured Loan 10.00%, 10/20/2033 2024-11-30 0001377936 Saratoga Senior Loan Fund I JV, LLC - Investment Fund - Membership Interest 2024-03-01 2024-11-30 0001377936 Saratoga Senior Loan Fund I JV, LLC - Investment Fund - Membership Interest 2024-11-30 0001377936 Investment Fund 2024-11-30 0001377936 Sub Total Control investments 2024-11-30 0001377936 TOTAL INVESTMENTS - 256.5% 2024-11-30 0001377936 Altvia MidCo, LLC. - Alternative Investment Management Software - First Lien Term Loan (3M USD TERM SOFR+8.50%), 13.83% Cash, 7/18/2027 2023-03-01 2024-02-29 0001377936 Altvia MidCo, LLC. - Alternative Investment Management Software - First Lien Term Loan (3M USD TERM SOFR+8.50%), 13.83% Cash, 7/18/2027 2024-02-29 0001377936 Altvia MidCo, LLC. - Alternative Investment Management Software - Series A-1 Preferred Shares 2023-03-01 2024-02-29 0001377936 Altvia MidCo, LLC. - Alternative Investment Management Software - Series A-1 Preferred Shares 2024-02-29 0001377936 Alternative Investment Management Software 2024-02-29 0001377936 BQE Software, Inc. - Architecture & Engineering Software - First Lien Term Loan (3M USD TERM SOFR+6.75%), 12.08% Cash, 4/13/2028 2023-03-01 2024-02-29 0001377936 BQE Software, Inc. - Architecture & Engineering Software - First Lien Term Loan (3M USD TERM SOFR+6.75%), 12.08% Cash, 4/13/2028 2024-02-29 0001377936 BQE Software, Inc. - Architecture & Engineering Software - Delayed Draw Term Loan (3M USD TERM SOFR+6.75%), 12.08% Cash, 4/13/2028 2023-03-01 2024-02-29 0001377936 BQE Software, Inc. - Architecture & Engineering Software - Delayed Draw Term Loan (3M USD TERM SOFR+6.75%), 12.08% Cash, 4/13/2028 2024-02-29 0001377936 Architecture & Engineering Software 2024-02-29 0001377936 GrowthZone, LLC - Association Management Software - First Lien Term Loan (3M USD TERM SOFR+8.25%), 13.58% Cash, 5/10/2028 2023-03-01 2024-02-29 0001377936 GrowthZone, LLC - Association Management Software - First Lien Term Loan (3M USD TERM SOFR+8.25%), 13.58% Cash, 5/10/2028 2024-02-29 0001377936 Golden TopCo LP - Association Management Software - Class A-2 Common Units 2023-03-01 2024-02-29 0001377936 Golden TopCo LP - Association Management Software - Class A-2 Common Units 2024-02-29 0001377936 Association Management Software 2024-02-29 0001377936 Artemis Wax Corp. - Consumer Services - Delayed Draw Term Loan (1M USD TERM SOFR+6.75%), 12.07% Cash, 5/20/2026 2023-03-01 2024-02-29 0001377936 Artemis Wax Corp. - Consumer Services - Delayed Draw Term Loan (1M USD TERM SOFR+6.75%), 12.07% Cash, 5/20/2026 2024-02-29 0001377936 Artemis Wax Corp. - Consumer Services - Series B-1 Preferred Stock 2023-03-01 2024-02-29 0001377936 Artemis Wax Corp. - Consumer Services - Series B-1 Preferred Stock 2024-02-29 0001377936 Artemis Wax Corp. - Consumer Services - Series D Preferred Stock 2023-03-01 2024-02-29 0001377936 Artemis Wax Corp. - Consumer Services - Series D Preferred Stock 2024-02-29 0001377936 Consumer Services 2024-02-29 0001377936 Schoox, Inc. - Corporate Education Software - Series 1 Membership Interest 2023-03-01 2024-02-29 0001377936 Schoox, Inc. - Corporate Education Software - Series 1 Membership Interest 2024-02-29 0001377936 Corporate Education Software 2024-02-29 0001377936 GreyHeller LLC - Cyber Security - Common Stock 2023-03-01 2024-02-29 0001377936 GreyHeller LLC - Cyber Security - Common Stock 2024-02-29 0001377936 Cyber Security 2024-02-29 0001377936 Gen4 Dental Partners Holdings, LLC - Dental Practice Management - Delayed Draw Term Loan (3M USD TERM SOFR+10.22%), 15.55% Cash, 4/29/2026 2023-03-01 2024-02-29 0001377936 Gen4 Dental Partners Holdings, LLC - Dental Practice Management - Delayed Draw Term Loan (3M USD TERM SOFR+10.22%), 15.55% Cash, 4/29/2026 2024-02-29 0001377936 Gen4 Dental Partners Holdings, LLC - Dental Practice Management - Series A Preferred Units 2023-03-01 2024-02-29 0001377936 Gen4 Dental Partners Holdings, LLC - Dental Practice Management - Series A Preferred Units 2024-02-29 0001377936 Modis Dental Partners OpCo, LLC - Dental Practice Management - First Lien Term Loan (1M USD TERM SOFR+9.48%), 14.80% Cash, 4/18/2028 2023-03-01 2024-02-29 0001377936 Modis Dental Partners OpCo, LLC - Dental Practice Management - First Lien Term Loan (1M USD TERM SOFR+9.48%), 14.80% Cash, 4/18/2028 2024-02-29 0001377936 Modis Dental Partners OpCo, LLC - Dental Practice Management - Delayed Draw Term Loan (1M USD TERM SOFR+9.48%), 14.80% Cash, 4/18/2028 2023-03-01 2024-02-29 0001377936 Modis Dental Partners OpCo, LLC - Dental Practice Management - Delayed Draw Term Loan (1M USD TERM SOFR+9.48%), 14.80% Cash, 4/18/2028 2024-02-29 0001377936 Modis Dental Partners OpCo, LLC - Dental Practice Management - Class A Preferred Units 2023-03-01 2024-02-29 0001377936 Modis Dental Partners OpCo, LLC - Dental Practice Management - Class A Preferred Units 2024-02-29 0001377936 New England Dental Partners - Dental Practice Management - First Lien Term Loan (3M USD TERM SOFR+8.00%), 13.48% Cash, 11/25/2025 2023-03-01 2024-02-29 0001377936 New England Dental Partners - Dental Practice Management - First Lien Term Loan (3M USD TERM SOFR+8.00%), 13.48% Cash, 11/25/2025 2024-02-29 0001377936 New England Dental Partners - Dental Practice Management - Delayed Draw Term Loan (3M USD TERM SOFR+8.00%), 13.48% Cash, 11/25/2025 2023-03-01 2024-02-29 0001377936 New England Dental Partners - Dental Practice Management - Delayed Draw Term Loan (3M USD TERM SOFR+8.00%), 13.48% Cash, 11/25/2025 2024-02-29 0001377936 Dental Practice Management 2024-02-29 0001377936 Exigo, LLC - Direct Selling Software - First Lien Term Loan (1M USD TERM SOFR+5.75%), 11.17% Cash, 3/16/2027 2023-03-01 2024-02-29 0001377936 Exigo, LLC - Direct Selling Software - First Lien Term Loan (1M USD TERM SOFR+5.75%), 11.17% Cash, 3/16/2027 2024-02-29 0001377936 Exigo, LLC - Direct Selling Software - Revolving Credit Facility (1M USD TERM SOFR+5.75%), 11.17% Cash, 3/16/2027 2023-03-01 2024-02-29 0001377936 Exigo, LLC - Direct Selling Software - Revolving Credit Facility (1M USD TERM SOFR+5.75%), 11.17% Cash, 3/16/2027 2024-02-29 0001377936 Exigo, LLC - Direct Selling Software - Common Units 2023-03-01 2024-02-29 0001377936 Exigo, LLC - Direct Selling Software - Common Units 2024-02-29 0001377936 Direct Selling Software 2024-02-29 0001377936 C2 Educational Systems, Inc. - Education Services - First Lien Term Loan (3M USD TERM SOFR+8.50%), 13.83% Cash, 5/31/2025 2023-03-01 2024-02-29 0001377936 C2 Educational Systems, Inc. - Education Services - First Lien Term Loan (3M USD TERM SOFR+8.50%), 13.83% Cash, 5/31/2025 2024-02-29 0001377936 C2 Educational Systems, Inc. - Education Services - Delayed Draw Term Loan (3M USD TERM SOFR+8.50%), 13.83% Cash, 5/31/2025 2023-03-01 2024-02-29 0001377936 C2 Educational Systems, Inc. - Education Services - Delayed Draw Term Loan (3M USD TERM SOFR+8.50%), 13.83% Cash, 5/31/2025 2024-02-29 0001377936 C2 Education Systems, Inc. - Education Services - Series A-1 Preferred Stock 2023-03-01 2024-02-29 0001377936 C2 Education Systems, Inc. - Education Services - Series A-1 Preferred Stock 2024-02-29 0001377936 Zollege PBC - Education Services - First Lien Term Loan (3M USD TERM SOFR+7.00%), 12.33% Cash/2.00% PIK, 5/11/2026 2023-03-01 2024-02-29 0001377936 Zollege PBC - Education Services - First Lien Term Loan (3M USD TERM SOFR+7.00%), 12.33% Cash/2.00% PIK, 5/11/2026 2024-02-29 0001377936 Zollege PBC - Education Services -Delayed Draw Term Loan (3M USD TERM SOFR+7.00%), 12.33% Cash/2.00% PIK, 5/11/2026 2023-03-01 2024-02-29 0001377936 Zollege PBC - Education Services -Delayed Draw Term Loan (3M USD TERM SOFR+7.00%), 12.33% Cash/2.00% PIK, 5/11/2026 2024-02-29 0001377936 Zollege PBC - Education Services - Class A Units 2023-03-01 2024-02-29 0001377936 Zollege PBC - Education Services - Class A Units 2024-02-29 0001377936 Education Services 2024-02-29 0001377936 Destiny Solutions Inc. - Education Software - Limited Partner Interests 2023-03-01 2024-02-29 0001377936 Destiny Solutions Inc. - Education Software - Limited Partner Interests 2024-02-29 0001377936 GoReact - Education Software - First Lien Term Loan (3M USD TERM SOFR+7.50%), 13.03% Cash/1.00% PIK, 1/17/2025 2023-03-01 2024-02-29 0001377936 GoReact - Education Software - First Lien Term Loan (3M USD TERM SOFR+7.50%), 13.03% Cash/1.00% PIK, 1/17/2025 2024-02-29 0001377936 GoReact - Education Software - Delayed Draw Term Loan (3M USD TERM SOFR+7.50%), 13.03% Cash/1.00% PIK, 1/17/2025 2023-03-01 2024-02-29 0001377936 GoReact - Education Software - Delayed Draw Term Loan (3M USD TERM SOFR+7.50%), 13.03% Cash/1.00% PIK, 1/17/2025 2024-02-29 0001377936 Identity Automation Systems - Education Software - Common Stock Class A-2 Units 2023-03-01 2024-02-29 0001377936 Identity Automation Systems - Education Software - Common Stock Class A-2 Units 2024-02-29 0001377936 Identity Automation Systems - Education Software - Common Stock Class A-1 Units 2023-03-01 2024-02-29 0001377936 Identity Automation Systems - Education Software - Common Stock Class A-1 Units 2024-02-29 0001377936 Ready Education - Education Software - First Lien Term Loan (3M USD TERM SOFR+7.00%), 12.33% Cash, 8/5/2027 2023-03-01 2024-02-29 0001377936 Ready Education - Education Software - First Lien Term Loan (3M USD TERM SOFR+7.00%), 12.33% Cash, 8/5/2027 2024-02-29 0001377936 Education Software 2024-02-29 0001377936 TG Pressure Washing Holdings, LLC - Facilities Maintenance - Preferred Equity 2023-03-01 2024-02-29 0001377936 TG Pressure Washing Holdings, LLC - Facilities Maintenance - Preferred Equity 2024-02-29 0001377936 Facilities Maintenance 2024-02-29 0001377936 Davisware, LLC - Field Service Management - First Lien Term Loan (3M USD TERM SOFR+7.00%), 12.33% Cash, 7/31/2024 2023-03-01 2024-02-29 0001377936 Davisware, LLC - Field Service Management - First Lien Term Loan (3M USD TERM SOFR+7.00%), 12.33% Cash, 7/31/2024 2024-02-29 0001377936 Davisware, LLC - Field Service Management - Delayed Draw Term Loan (3M USD TERM SOFR+7.00%), 12.33% Cash, 7/31/2024 2023-03-01 2024-02-29 0001377936 Davisware, LLC - Field Service Management - Delayed Draw Term Loan (3M USD TERM SOFR+7.00%), 12.33% Cash, 7/31/2024 2024-02-29 0001377936 Field Service Management 2024-02-29 0001377936 GDS Software Holdings, LLC - Financial Services - First Lien Term Loan (3M USD TERM SOFR+7.00%), 12.33% Cash, 12/30/2026 2023-03-01 2024-02-29 0001377936 GDS Software Holdings, LLC - Financial Services - First Lien Term Loan (3M USD TERM SOFR+7.00%), 12.33% Cash, 12/30/2026 2024-02-29 0001377936 GDS Software Holdings, LLC - Financial Services - Delayed Draw Term Loan (3M USD TERM SOFR+7.00%), 12.33% Cash, 12/30/2026 2023-03-01 2024-02-29 0001377936 GDS Software Holdings, LLC - Financial Services - Delayed Draw Term Loan (3M USD TERM SOFR+7.00%), 12.33% Cash, 12/30/2026 2024-02-29 0001377936 GDS Software Holdings, LLC - Financial Services - Common Stock Class A Units 2023-03-01 2024-02-29 0001377936 GDS Software Holdings, LLC - Financial Services - Common Stock Class A Units 2024-02-29 0001377936 Financial Services 2024-02-29 0001377936 Ascend Software, LLC - Financial Services Software - First Lien Term Loan (3M USD TERM SOFR+7.50%), 13.10% Cash, 12/15/2026 2023-03-01 2024-02-29 0001377936 Ascend Software, LLC - Financial Services Software - First Lien Term Loan (3M USD TERM SOFR+7.50%), 13.10% Cash, 12/15/2026 2024-02-29 0001377936 Ascend Software, LLC - Financial Services Software - Delayed Draw Term Loan (3M USD TERM SOFR+7.50%), 13.10% Cash, 12/15/2026 2023-03-01 2024-02-29 0001377936 Ascend Software, LLC - Financial Services Software - Delayed Draw Term Loan (3M USD TERM SOFR+7.50%), 13.10% Cash, 12/15/2026 2024-02-29 0001377936 Financial Services Software 2024-02-29 0001377936 Inspect Point Holdings, LLC - Fire Inspection Business Software - First Lien Term Loan (1M USD TERM SOFR+6.50%), 11.82% Cash, 07/19/2028 2023-03-01 2024-02-29 0001377936 Inspect Point Holdings, LLC - Fire Inspection Business Software - First Lien Term Loan (1M USD TERM SOFR+6.50%), 11.82% Cash, 07/19/2028 2024-02-29 0001377936 Inspect Point Holdings, LLC - Fire Inspection Business Software - First Lien Term Loan (1M USD TERM SOFR+6.50%), 11.82% Cash, 07/19/2028 2 2023-03-01 2024-02-29 0001377936 Inspect Point Holdings, LLC - Fire Inspection Business Software - First Lien Term Loan (1M USD TERM SOFR+6.50%), 11.82% Cash, 07/19/2028 2 2024-02-29 0001377936 Fire Inspection Business Software 2024-02-29 0001377936 Stretch Zone Franchising, LLC - Health/Fitness Franchisor - First Lien Term Loan (3M USD TERM SOFR+7.00%), 12.33% Cash, 3/31/2028 2023-03-01 2024-02-29 0001377936 Stretch Zone Franchising, LLC - Health/Fitness Franchisor - First Lien Term Loan (3M USD TERM SOFR+7.00%), 12.33% Cash, 3/31/2028 2024-02-29 0001377936 Stretch Zone Franchising, LLC - Health/Fitness Franchisor - Delayed Draw Term Loan (3M USD TERM SOFR+7.00%), 12.33% Cash, 3/31/2028 2023-03-01 2024-02-29 0001377936 Stretch Zone Franchising, LLC - Health/Fitness Franchisor - Delayed Draw Term Loan (3M USD TERM SOFR+7.00%), 12.33% Cash, 3/31/2028 2024-02-29 0001377936 Stretch Zone Franchising, LLC - Health/Fitness Franchisor - Class A Units 2023-03-01 2024-02-29 0001377936 Stretch Zone Franchising, LLC - Health/Fitness Franchisor - Class A Units 2024-02-29 0001377936 Health/Fitness Franchisor 2024-02-29 0001377936 Alpha Aesthetics Partners OpCo, LLC - Healthcare Services - First Lien Term Loan (1M USD TERM SOFR+9.98%), 15.30% Cash, 3/20/2028 2023-03-01 2024-02-29 0001377936 Alpha Aesthetics Partners OpCo, LLC - Healthcare Services - First Lien Term Loan (1M USD TERM SOFR+9.98%), 15.30% Cash, 3/20/2028 2024-02-29 0001377936 Alpha Aesthetics Partners OpCo, LLC - Healthcare Services - Delayed Draw Term Loan (1M USD TERM SOFR+9.98%), 15.30% Cash, 3/20/2028 2023-03-01 2024-02-29 0001377936 Alpha Aesthetics Partners OpCo, LLC - Healthcare Services - Delayed Draw Term Loan (1M USD TERM SOFR+9.98%), 15.30% Cash, 3/20/2028 2024-02-29 0001377936 Alpha Aesthetics Partners OpCo, LLC - Healthcare Services - Class A Preferred Units 2023-03-01 2024-02-29 0001377936 Alpha Aesthetics Partners OpCo, LLC - Healthcare Services - Class A Preferred Units 2024-02-29 0001377936 Axiom Medical Consulting, LLC - Healthcare Services - First Lien Term Loan (3M USD TERM SOFR+6.00%), 11.33% Cash, 9/11/2028 2023-03-01 2024-02-29 0001377936 Axiom Medical Consulting, LLC - Healthcare Services - First Lien Term Loan (3M USD TERM SOFR+6.00%), 11.33% Cash, 9/11/2028 2024-02-29 0001377936 Axiom Medical Consulting, LLC - Healthcare Services - Delayed Draw Term Loan (3M USD TERM SOFR+6.00%), 11.33% Cash, 9/11/2028 2023-03-01 2024-02-29 0001377936 Axiom Medical Consulting, LLC - Healthcare Services - Delayed Draw Term Loan (3M USD TERM SOFR+6.00%), 11.33% Cash, 9/11/2028 2024-02-29 0001377936 Axiom Parent Holdings, LLC - Healthcare Services - Class A Preferred Units 2023-03-01 2024-02-29 0001377936 Axiom Parent Holdings, LLC - Healthcare Services - Class A Preferred Units 2024-02-29 0001377936 ComForCare Health Care - Healthcare Services - First Lien Term Loan (3M USD TERM SOFR+6.25%), 11.58% Cash, 1/31/2025 2023-03-01 2024-02-29 0001377936 ComForCare Health Care - Healthcare Services - First Lien Term Loan (3M USD TERM SOFR+6.25%), 11.58% Cash, 1/31/2025 2024-02-29 0001377936 Healthcare Services 2024-02-29 0001377936 HemaTerra Holding Company, LLC - Healthcare Software - First Lien Term Loan (1M USD TERM SOFR+8.25%), 13.57% Cash, 1/31/2027 2023-03-01 2024-02-29 0001377936 HemaTerra Holding Company, LLC - Healthcare Software - First Lien Term Loan (1M USD TERM SOFR+8.25%), 13.57% Cash, 1/31/2027 2024-02-29 0001377936 HemaTerra Holding Company, LLC - Healthcare Software - Delayed Draw Term Loan (1M USD TERM SOFR+8.25%), 13.57% Cash, 1/31/2027 2023-03-01 2024-02-29 0001377936 HemaTerra Holding Company, LLC - Healthcare Software - Delayed Draw Term Loan (1M USD TERM SOFR+8.25%), 13.57% Cash, 1/31/2027 2024-02-29 0001377936 TRC HemaTerra, LLC - Healthcare Software - Class D Membership Interests 2023-03-01 2024-02-29 0001377936 TRC HemaTerra, LLC - Healthcare Software - Class D Membership Interests 2024-02-29 0001377936 Procurement Partners, LLC - Healthcare Software - First Lien Term Loan (3M USD TERM SOFR+6.50%), 11.83% Cash, 5/12/2026 2023-03-01 2024-02-29 0001377936 Procurement Partners, LLC - Healthcare Software - First Lien Term Loan (3M USD TERM SOFR+6.50%), 11.83% Cash, 5/12/2026 2024-02-29 0001377936 Procurement Partners, LLC - Healthcare Software - Delayed Draw Term Loan (3M USD TERM SOFR+6.50%), 11.83% Cash, 5/12/2026 2023-03-01 2024-02-29 0001377936 Procurement Partners, LLC - Healthcare Software - Delayed Draw Term Loan (3M USD TERM SOFR+6.50%), 11.83% Cash, 5/12/2026 2024-02-29 0001377936 Procurement Partners Holdings LLC - Healthcare Software - Class A Units 2023-03-01 2024-02-29 0001377936 Procurement Partners Holdings LLC - Healthcare Software - Class A Units 2024-02-29 0001377936 Healthcare Software 2024-02-29 0001377936 Roscoe Medical, Inc. - Healthcare Supply - Common Stock 2023-03-01 2024-02-29 0001377936 Roscoe Medical, Inc. - Healthcare Supply - Common Stock 2024-02-29 0001377936 Healthcare Supply 2024-02-29 0001377936 Book4Time, Inc. - Hospitality/Hotel - First Lien Term Loan (3M USD TERM SOFR+7.50%), 12.83%, 12/22/2025 2023-03-01 2024-02-29 0001377936 Book4Time, Inc. - Hospitality/Hotel - First Lien Term Loan (3M USD TERM SOFR+7.50%), 12.83%, 12/22/2025 2024-02-29 0001377936 Book4Time, Inc. - Hospitality/Hotel - Delayed Draw Term Loan (3M USD TERM SOFR+7.50%), 12.83%, 12/22/2025 2023-03-01 2024-02-29 0001377936 Book4Time, Inc. - Hospitality/Hotel - Delayed Draw Term Loan (3M USD TERM SOFR+7.50%), 12.83%, 12/22/2025 2024-02-29 0001377936 Book4Time, Inc. - Hospitality/Hotel - Class A Preferred Shares 2023-03-01 2024-02-29 0001377936 Book4Time, Inc. - Hospitality/Hotel - Class A Preferred Shares 2024-02-29 0001377936 Knowland Group, LLC - Hospitality/Hotel - Second Lien Term Loan (3M USD TERM SOFR+8.00%), 13.48% Cash/3.00% PIK, 12/31/2024 2023-03-01 2024-02-29 0001377936 Knowland Group, LLC - Hospitality/Hotel - Second Lien Term Loan (3M USD TERM SOFR+8.00%), 13.48% Cash/3.00% PIK, 12/31/2024 2024-02-29 0001377936 Sceptre Hospitality Resources, LLC - Hospitality/Hotel - First Lien Term Loan (3M USD TERM SOFR+7.25%), 12.58% Cash, 11/15/2027 2023-03-01 2024-02-29 0001377936 Sceptre Hospitality Resources, LLC - Hospitality/Hotel - First Lien Term Loan (3M USD TERM SOFR+7.25%), 12.58% Cash, 11/15/2027 2024-02-29 0001377936 Sceptre Hospitality Resources, LLC - Hospitality/Hotel - Delayed Draw Term Loan (3M USD TERM SOFR+7.25%), 12.58% Cash, 11/15/2027 2023-03-01 2024-02-29 0001377936 Sceptre Hospitality Resources, LLC - Hospitality/Hotel - Delayed Draw Term Loan (3M USD TERM SOFR+7.25%), 12.58% Cash, 11/15/2027 2024-02-29 0001377936 Hospitality/Hotel 2024-02-29 0001377936 Granite Comfort, LP - HVAC Services and Sales - First Lien Term Loan (3M USD TERM SOFR+7.46%), 12.79% Cash, 5/16/2027 2023-03-01 2024-02-29 0001377936 Granite Comfort, LP - HVAC Services and Sales - First Lien Term Loan (3M USD TERM SOFR+7.46%), 12.79% Cash, 5/16/2027 2024-02-29 0001377936 Granite Comfort, LP - HVAC Services and Sales - Delayed Draw Term Loan (3M USD TERM SOFR+7.46%), 12.79% Cash, 5/16/2027 2023-03-01 2024-02-29 0001377936 Granite Comfort, LP - HVAC Services and Sales - Delayed Draw Term Loan (3M USD TERM SOFR+7.46%), 12.79% Cash, 5/16/2027 2024-02-29 0001377936 HVAC Services and Sales 2024-02-29 0001377936 Vector Controls Holding Co., LLC - Industrial Products - First Lien Term Loan (3M USD TERM SOFR+6.50%), 11.75% Cash, 3/6/2025 2023-03-01 2024-02-29 0001377936 Vector Controls Holding Co., LLC - Industrial Products - First Lien Term Loan (3M USD TERM SOFR+6.50%), 11.75% Cash, 3/6/2025 2024-02-29 0001377936 Vector Controls Holding Co., LLC - Industrial Products - Warrants to Purchase Limited Liability Company Interests, Expires 11/30/2027 2023-03-01 2024-02-29 0001377936 Vector Controls Holding Co., LLC - Industrial Products - Warrants to Purchase Limited Liability Company Interests, Expires 11/30/2027 2024-02-29 0001377936 Industrial Products 2024-02-29 0001377936 AgencyBloc, LLC - Insurance Software - First Lien Term Loan (1M USD TERM SOFR+7.76%), 13.09% Cash, 10/1/2026 2023-03-01 2024-02-29 0001377936 AgencyBloc, LLC - Insurance Software - First Lien Term Loan (1M USD TERM SOFR+7.76%), 13.09% Cash, 10/1/2026 2024-02-29 0001377936 Panther ParentCo LLC - Insurance Software - Class A Units 2023-03-01 2024-02-29 0001377936 Panther ParentCo LLC - Insurance Software - Class A Units 2024-02-29 0001377936 Insurance Software 2024-02-29 0001377936 LogicMonitor, Inc. - IT Services - First Lien Term Loan (3M USD TERM SOFR+6.50%), 11.83% Cash, 5/17/2026 2023-03-01 2024-02-29 0001377936 LogicMonitor, Inc. - IT Services - First Lien Term Loan (3M USD TERM SOFR+6.50%), 11.83% Cash, 5/17/2026 2024-02-29 0001377936 IT Services 2024-02-29 0001377936 ActiveProspect, Inc. - Lead Management Software - First Lien Term Loan (3M USD TERM SOFR+6.00%), 11.53% Cash, 8/8/2027 2023-03-01 2024-02-29 0001377936 ActiveProspect, Inc. - Lead Management Software - First Lien Term Loan (3M USD TERM SOFR+6.00%), 11.53% Cash, 8/8/2027 2024-02-29 0001377936 ActiveProspect, Inc. - Lead Management Software - Delayed Draw Term Loan (3M USD TERM SOFR+6.00%), 11.53% Cash, 8/8/2027 2023-03-01 2024-02-29 0001377936 ActiveProspect, Inc. - Lead Management Software - Delayed Draw Term Loan (3M USD TERM SOFR+6.00%), 11.53% Cash, 8/8/2027 2024-02-29 0001377936 Lead Management Software 2024-02-29 0001377936 Centerbase, LLC - Legal Software - First Lien Term Loan (3M USD TERM SOFR+7.75%), 13.08% Cash, 1/18/2027 2023-03-01 2024-02-29 0001377936 Centerbase, LLC - Legal Software - First Lien Term Loan (3M USD TERM SOFR+7.75%), 13.08% Cash, 1/18/2027 2024-02-29 0001377936 Legal Software 2024-02-29 0001377936 Madison Logic, Inc. - Marketing Orchestration Software - First Lien Term Loan (3M USD TERM SOFR+7.00%), 12.33% Cash, 12/30/2028 2023-03-01 2024-02-29 0001377936 Madison Logic, Inc. - Marketing Orchestration Software - First Lien Term Loan (3M USD TERM SOFR+7.00%), 12.33% Cash, 12/30/2028 2024-02-29 0001377936 Marketing Orchestration Software 2024-02-29 0001377936 ARC Health OpCo LLC - Mental Healthcare Services - First Lien Term Loan (3M USD TERM SOFR+8.47%), 13.81% Cash, 8/5/2027 2023-03-01 2024-02-29 0001377936 ARC Health OpCo LLC - Mental Healthcare Services - First Lien Term Loan (3M USD TERM SOFR+8.47%), 13.81% Cash, 8/5/2027 2024-02-29 0001377936 ARC Health OpCo LLC - Mental Healthcare Services - Delayed Draw Term Loan (3M USD TERM SOFR+8.47%), 13.81% Cash, 8/5/2027 2023-03-01 2024-02-29 0001377936 ARC Health OpCo LLC - Mental Healthcare Services - Delayed Draw Term Loan (3M USD TERM SOFR+8.47%), 13.81% Cash, 8/5/2027 2024-02-29 0001377936 ARC Health OpCo LLC - Mental Healthcare Services - Class A Preferred Units 2023-03-01 2024-02-29 0001377936 ARC Health OpCo LLC - Mental Healthcare Services - Class A Preferred Units 2024-02-29 0001377936 Mental Healthcare Services 2024-02-29 0001377936 Chronus LLC - Mentoring Software - First Lien Term Loan (3M USD TERM SOFR+5.25%), 10.73% Cash, 8/26/2026 2023-03-01 2024-02-29 0001377936 Chronus LLC - Mentoring Software - First Lien Term Loan (3M USD TERM SOFR+5.25%), 10.73% Cash, 8/26/2026 2024-02-29 0001377936 Chronus LLC - Mentoring Software - First Lien Term Loan (3M USD TERM SOFR+6.00%), 11.48% Cash, 8/26/2026 2023-03-01 2024-02-29 0001377936 Chronus LLC - Mentoring Software - First Lien Term Loan (3M USD TERM SOFR+6.00%), 11.48% Cash, 8/26/2026 2024-02-29 0001377936 Chronus LLC - Mentoring Software - Series A Preferred Stock 2023-03-01 2024-02-29 0001377936 Chronus LLC - Mentoring Software - Series A Preferred Stock 2024-02-29 0001377936 Mentoring Software 2024-02-29 0001377936 Omatic Software, LLC - Non-profit Services - First Lien Term Loan (3M USD TERM SOFR+8.00%), 13.59% Cash/1.00% PIK, 6/30/2025 2023-03-01 2024-02-29 0001377936 Omatic Software, LLC - Non-profit Services - First Lien Term Loan (3M USD TERM SOFR+8.00%), 13.59% Cash/1.00% PIK, 6/30/2025 2024-02-29 0001377936 Non-profit Services 2024-02-29 0001377936 Emily Street Enterprises, L.L.C. - Office Supplies - Senior Secured Note (3M USD TERM SOFR+7.50%), 12.83% Cash, 12/31/2025 2023-03-01 2024-02-29 0001377936 Emily Street Enterprises, L.L.C. - Office Supplies - Senior Secured Note (3M USD TERM SOFR+7.50%), 12.83% Cash, 12/31/2025 2024-02-29 0001377936 Emily Street Enterprises, L.L.C. - Office Supplies - Warrant Membership Interests, Expires 12/31/2025 2023-03-01 2024-02-29 0001377936 Emily Street Enterprises, L.L.C. - Office Supplies - Warrant Membership Interests, Expires 12/31/2025 2024-02-29 0001377936 Office Supplies 2024-02-29 0001377936 Buildout, Inc. - Real Estate Services - First Lien Term Loan (3M USD TERM SOFR+7.00%), 12.43% Cash, 7/9/2025 2023-03-01 2024-02-29 0001377936 Buildout, Inc. - Real Estate Services - First Lien Term Loan (3M USD TERM SOFR+7.00%), 12.43% Cash, 7/9/2025 2024-02-29 0001377936 Buildout, Inc. - Real Estate Services - Delayed Draw Term Loan (3M USD TERM SOFR+7.00%), 12.47% Cash, 7/9/2025 2023-03-01 2024-02-29 0001377936 Buildout, Inc. - Real Estate Services - Delayed Draw Term Loan (3M USD TERM SOFR+7.00%), 12.47% Cash, 7/9/2025 2024-02-29 0001377936 Buildout, Inc. - Real Estate Services - Limited Partner Interests 2023-03-01 2024-02-29 0001377936 Buildout, Inc. - Real Estate Services - Limited Partner Interests 2024-02-29 0001377936 Real Estate Services 2024-02-29 0001377936 Wellspring Worldwide Inc.- Research Software - First Lien Term Loan (1M USD TERM SOFR+6.00%), 11.32% Cash, 12/22/2028 2023-03-01 2024-02-29 0001377936 Wellspring Worldwide Inc.- Research Software - First Lien Term Loan (1M USD TERM SOFR+6.00%), 11.32% Cash, 12/22/2028 2024-02-29 0001377936 Wellspring Worldwide Inc. - Research Software - Delayed DrawTerm Loan (1M USD TERM SOFR+6.00%), 11.32% Cash, 12/22/2028 2023-03-01 2024-02-29 0001377936 Wellspring Worldwide Inc. - Research Software - Delayed DrawTerm Loan (1M USD TERM SOFR+6.00%), 11.32% Cash, 12/22/2028 2024-02-29 0001377936 Archimedes Parent LLC - Research Software - Class A Common Units 2023-03-01 2024-02-29 0001377936 Archimedes Parent LLC - Research Software - Class A Common Units 2024-02-29 0001377936 Research Software 2024-02-29 0001377936 LFR Chicken LLC - Restaurant - First Lien Term Loan (1M USD TERM SOFR+7.00%), 12.32% Cash, 11/19/2026 2023-03-01 2024-02-29 0001377936 LFR Chicken LLC - Restaurant - First Lien Term Loan (1M USD TERM SOFR+7.00%), 12.32% Cash, 11/19/2026 2024-02-29 0001377936 LFR Chicken LLC - Restaurant - Delayed Draw Term Loan (1M USD TERM SOFR+7.00%), 12.32% Cash, 11/19/2026 2023-03-01 2024-02-29 0001377936 LFR Chicken LLC - Restaurant - Delayed Draw Term Loan (1M USD TERM SOFR+7.00%), 12.32% Cash, 11/19/2026 2024-02-29 0001377936 LFR Chicken LLC - Restaurant - Series B Preferred Units 2023-03-01 2024-02-29 0001377936 LFR Chicken LLC - Restaurant - Series B Preferred Units 2024-02-29 0001377936 Restaurant 2024-02-29 0001377936 JobNimbus LLC - Roofing Contractor Software - First Lien Term Loan (1M USD TERM SOFR+8.75%), 14.17% Cash, 9/20/2026 2023-03-01 2024-02-29 0001377936 JobNimbus LLC - Roofing Contractor Software - First Lien Term Loan (1M USD TERM SOFR+8.75%), 14.17% Cash, 9/20/2026 2024-02-29 0001377936 Roofing Contractor Software 2024-02-29 0001377936 Pepper Palace, Inc. - Specialty Food Retailer - First Lien Term Loan (3M USD TERM SOFR+6.25%), 11.73% Cash, 6/30/2026 2023-03-01 2024-02-29 0001377936 Pepper Palace, Inc. - Specialty Food Retailer - First Lien Term Loan (3M USD TERM SOFR+6.25%), 11.73% Cash, 6/30/2026 2024-02-29 0001377936 Pepper Palace, Inc. - Specialty Food Retailer - Delayed Draw Term Loan (3M USD TERM SOFR+6.25%), 11.73% Cash, 6/30/2026 2023-03-01 2024-02-29 0001377936 Pepper Palace, Inc. - Specialty Food Retailer - Delayed Draw Term Loan (3M USD TERM SOFR+6.25%), 11.73% Cash, 6/30/2026 2024-02-29 0001377936 Pepper Palace, Inc - Specialty Food Retailer - Revolving Credit Facility (3M USD TERM SOFR+6.25%), 11.73% Cash, 6/30/2026 2023-03-01 2024-02-29 0001377936 Pepper Palace, Inc - Specialty Food Retailer - Revolving Credit Facility (3M USD TERM SOFR+6.25%), 11.73% Cash, 6/30/2026 2024-02-29 0001377936 Pepper Palace, Inc. - Specialty Food Retailer - Membership Interest (Series A) 2023-03-01 2024-02-29 0001377936 Pepper Palace, Inc. - Specialty Food Retailer - Membership Interest (Series A) 2024-02-29 0001377936 Pepper Palace, Inc. - Specialty Food Retailer -Membership Interest (Series B) 2023-03-01 2024-02-29 0001377936 Pepper Palace, Inc. - Specialty Food Retailer -Membership Interest (Series B) 2024-02-29 0001377936 Specialty Food Retailer 2024-02-29 0001377936 ArbiterSports, LLC - Sports Management - First Lien Term Loan (3M USD TERM SOFR+6.00%), 11.33% Cash, 2/21/2025 2023-03-01 2024-02-29 0001377936 ArbiterSports, LLC - Sports Management - First Lien Term Loan (3M USD TERM SOFR+6.00%), 11.33% Cash, 2/21/2025 2024-02-29 0001377936 ArbiterSports, LLC - Sports Management - Delayed Draw Term Loan (3M USD TERM SOFR+6.00%), 11.33% Cash, 2/21/2025 2023-03-01 2024-02-29 0001377936 ArbiterSports, LLC - Sports Management - Delayed Draw Term Loan (3M USD TERM SOFR+6.00%), 11.33% Cash, 2/21/2025 2024-02-29 0001377936 Sports Management 2024-02-29 0001377936 Avionte Holdings, LLC - Staffing Services - Class A Units 2023-03-01 2024-02-29 0001377936 Avionte Holdings, LLC - Staffing Services - Class A Units 2024-02-29 0001377936 Staffing Services 2024-02-29 0001377936 JDXpert - Talent Acquisition Software - First Lien Term Loan (3M USD TERM SOFR+8.50%), 14.10% Cash, 5/2/2027 2023-03-01 2024-02-29 0001377936 JDXpert - Talent Acquisition Software - First Lien Term Loan (3M USD TERM SOFR+8.50%), 14.10% Cash, 5/2/2027 2024-02-29 0001377936 JDXpert - Talent Acquisition Software - Delayed Draw Term Loan (3M USD TERM SOFR+8.50%), 14.10% Cash, 5/2/2027 2023-03-01 2024-02-29 0001377936 JDXpert - Talent Acquisition Software - Delayed Draw Term Loan (3M USD TERM SOFR+8.50%), 14.10% Cash, 5/2/2027 2024-02-29 0001377936 Jobvite, Inc. - Talent Acquisition Software - First Lien Term Loan (6M USD TERM SOFR+8.00%), 13.27% Cash, 8/5/2028 2023-03-01 2024-02-29 0001377936 Jobvite, Inc. - Talent Acquisition Software - First Lien Term Loan (6M USD TERM SOFR+8.00%), 13.27% Cash, 8/5/2028 2024-02-29 0001377936 Talent Acquisition Software 2024-02-29 0001377936 VetnCare MSO, LLC - Veterinary Services - Delayed Draw Term Loan (3M USD TERM SOFR+5.75%), 11.08% Cash, 5/12/2028 2023-03-01 2024-02-29 0001377936 VetnCare MSO, LLC - Veterinary Services - Delayed Draw Term Loan (3M USD TERM SOFR+5.75%), 11.08% Cash, 5/12/2028 2024-02-29 0001377936 Veterinary Services 2024-02-29 0001377936 Sub Total Non-control/Non-affiliate investments 2024-02-29 0001377936 ETU Holdings, Inc. - Corporate Education Software - First Lien Term Loan (3M USD TERM SOFR+9.00%), 14.48% Cash, 8/18/2027 2023-03-01 2024-02-29 0001377936 ETU Holdings, Inc. - Corporate Education Software - First Lien Term Loan (3M USD TERM SOFR+9.00%), 14.48% Cash, 8/18/2027 2024-02-29 0001377936 ETU Holdings, Inc. - Corporate Education Software - Second Lien Term Loan 15.00% PIK, 2/18/2028 2023-03-01 2024-02-29 0001377936 ETU Holdings, Inc. - Corporate Education Software - Second Lien Term Loan 15.00% PIK, 2/18/2028 2024-02-29 0001377936 ETU Holdings, Inc. - Corporate Education Software - Series A Preferred Units 2023-03-01 2024-02-29 0001377936 ETU Holdings, Inc. - Corporate Education Software - Series A Preferred Units 2024-02-29 0001377936 Corporate Education Software - Affiliate investments 2024-02-29 0001377936 Axero Holdings, LLC - Employee Collaboration Software - First Lien Term Loan (3M USD TERM SOFR+8.00%), 13.48% Cash, 6/30/2026 2023-03-01 2024-02-29 0001377936 Axero Holdings, LLC - Employee Collaboration Software - First Lien Term Loan (3M USD TERM SOFR+8.00%), 13.48% Cash, 6/30/2026 2024-02-29 0001377936 Axero Holdings, LLC - Employee Collaboration Software - Delayed Draw Term Loan (3M USD TERM SOFR+8.00%), 13.48% Cash, 6/30/2026 2023-03-01 2024-02-29 0001377936 Axero Holdings, LLC - Employee Collaboration Software - Delayed Draw Term Loan (3M USD TERM SOFR+8.00%), 13.48% Cash, 6/30/2026 2024-02-29 0001377936 Axero Holdings, LLC - Employee Collaboration Software - Revolving Credit Facility (3M USD TERM SOFR+8.00%), 13.48% Cash, 6/30/2026 2023-03-01 2024-02-29 0001377936 Axero Holdings, LLC - Employee Collaboration Software - Revolving Credit Facility (3M USD TERM SOFR+8.00%), 13.48% Cash, 6/30/2026 2024-02-29 0001377936 Axero Holdings, LLC - Employee Collaboration Software - Series A Preferred Units 2023-03-01 2024-02-29 0001377936 Axero Holdings, LLC - Employee Collaboration Software - Series A Preferred Units 2024-02-29 0001377936 Axero Holdings, LLC - Employee Collaboration Software - Series B Preferred Units 2023-03-01 2024-02-29 0001377936 Axero Holdings, LLC - Employee Collaboration Software - Series B Preferred Units 2024-02-29 0001377936 Employee Collaboration Software 2024-02-29 0001377936 Sub Total Affiliate investments 2024-02-29 0001377936 Netreo Holdings, LLC - IT Services - First Lien Term Loan (3M USD TERM SOFR +6.50%), 11.98% Cash/3.50% PIK 12/31/2025 2023-03-01 2024-02-29 0001377936 Netreo Holdings, LLC - IT Services - First Lien Term Loan (3M USD TERM SOFR +6.50%), 11.98% Cash/3.50% PIK 12/31/2025 2024-02-29 0001377936 Netreo Holdings, LLC - IT Services - Delayed Draw Term Loan (3M USD TERM SOFR +6.50%), 11.98% Cash/3.50% PIK, 12/31/2025 2023-03-01 2024-02-29 0001377936 Netreo Holdings, LLC - IT Services - Delayed Draw Term Loan (3M USD TERM SOFR +6.50%), 11.98% Cash/3.50% PIK, 12/31/2025 2024-02-29 0001377936 Netreo Holdings, LLC - IT Services - Common Stock Class A Units 2023-03-01 2024-02-29 0001377936 Netreo Holdings, LLC - IT Services - Common Stock Class A Units 2024-02-29 0001377936 IT Services - Control investments 2024-02-29 0001377936 Saratoga Investment Corp. CLO 2013-1, Ltd. - Structured Finance Securities - Other/Structured Finance Securities 0.00%, 4/20/2033 2023-03-01 2024-02-29 0001377936 Saratoga Investment Corp. CLO 2013-1, Ltd. - Structured Finance Securities - Other/Structured Finance Securities 0.00%, 4/20/2033 2024-02-29 0001377936 Saratoga Investment Corp. CLO 2013-1, Ltd. Class F-2-R-3 Note - Structured Finance Securities - Other/Structured Finance Securities (3M USD TERM SOFR+10.00%), 15.60%, 4/20/2033 2023-03-01 2024-02-29 0001377936 Saratoga Investment Corp. CLO 2013-1, Ltd. Class F-2-R-3 Note - Structured Finance Securities - Other/Structured Finance Securities (3M USD TERM SOFR+10.00%), 15.60%, 4/20/2033 2024-02-29 0001377936 Saratoga Investment Corp. Senior Loan Fund 2022-1, Ltd. Class E Note - Structured Finance Securities - Other/Structured Finance Securities (3M USD TERM SOFR+8.55%), 13.88%, 10/20/2033 2023-03-01 2024-02-29 0001377936 Saratoga Investment Corp. Senior Loan Fund 2022-1, Ltd. Class E Note - Structured Finance Securities - Other/Structured Finance Securities (3M USD TERM SOFR+8.55%), 13.88%, 10/20/2033 2024-02-29 0001377936 Structured Finance Securities 2024-02-29 0001377936 Saratoga Senior Loan Fund I JV, LLC - Investment Fund - Unsecured Loan 10.00%, 10/20/2033 2023-03-01 2024-02-29 0001377936 Saratoga Senior Loan Fund I JV, LLC - Investment Fund - Unsecured Loan 10.00%, 10/20/2033 2024-02-29 0001377936 Saratoga Senior Loan Fund I JV, LLC - Investment Fund - Membership Interest 2023-03-01 2024-02-29 0001377936 Saratoga Senior Loan Fund I JV, LLC - Investment Fund - Membership Interest 2024-02-29 0001377936 Investment Fund 2024-02-29 0001377936 Sub Total Control investments 2024-02-29 0001377936 TOTAL INVESTMENTS 2024-02-29 0001377936 us-gaap:CashAndCashEquivalentsMember 2024-11-30 0001377936 us-gaap:CashAndCashEquivalentsMember 2024-02-29 0001377936 us-gaap:InvestmentAffiliatedIssuerMember sar:AxeroHoldingsLLCMember 2024-09-01 2024-11-30 0001377936 us-gaap:InvestmentAffiliatedIssuerMember sar:ETUHoldingsIncMember 2024-09-01 2024-11-30 0001377936 us-gaap:InvestmentAffiliatedIssuerControlledMember sar:NetreoHoldingsLLCMember 2024-09-01 2024-11-30 0001377936 us-gaap:InvestmentAffiliatedIssuerControlledMember sar:PepperPalaceIncMember 2024-09-01 2024-11-30 0001377936 us-gaap:InvestmentAffiliatedIssuerControlledMember sar:ZollegePBCMember 2024-09-01 2024-11-30 0001377936 us-gaap:InvestmentAffiliatedIssuerControlledMember sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-09-01 2024-11-30 0001377936 us-gaap:InvestmentAffiliatedIssuerControlledMember sar:SaratogaInvestmentCorpSeniorLoanFund20221LtdClassENoteMember 2024-09-01 2024-11-30 0001377936 us-gaap:InvestmentAffiliatedIssuerControlledMember sar:SaratogaInvestmentCorpCLO20131LtdClassF2R3NoteMember 2024-09-01 2024-11-30 0001377936 us-gaap:InvestmentAffiliatedIssuerControlledMember sar:SaratogaSeniorLoanFundIJVLLC1Member 2024-09-01 2024-11-30 0001377936 us-gaap:InvestmentAffiliatedIssuerControlledMember sar:SaratogaSeniorLoanFundIJVLLC2Member 2024-09-01 2024-11-30 0001377936 us-gaap:InvestmentAffiliatedIssuerMember sar:AxeroHoldingsLLCMember 2023-03-01 2024-02-29 0001377936 us-gaap:InvestmentAffiliatedIssuerMember sar:ETUHoldingsIncMember 2023-03-01 2024-02-29 0001377936 us-gaap:InvestmentAffiliatedIssuerMember sar:ModisDentalPartnersOpCoLLCMember 2023-03-01 2024-02-29 0001377936 us-gaap:InvestmentAffiliatedIssuerMember sar:AlphaAestheticsPartnersOpCoLLCMember 2023-03-01 2024-02-29 0001377936 us-gaap:InvestmentAffiliatedIssuerMember 2023-03-01 2024-02-29 0001377936 us-gaap:InvestmentAffiliatedIssuerControlledMember sar:NetreoHoldingsLLCMember 2023-03-01 2024-02-29 0001377936 us-gaap:InvestmentAffiliatedIssuerControlledMember sar:SaratogaInvestmentCorpCLO20131LtdMember 2023-03-01 2024-02-29 0001377936 us-gaap:InvestmentAffiliatedIssuerControlledMember sar:SaratogaInvestmentCorpSeniorLoanFund20221LtdClassENoteMember 2023-03-01 2024-02-29 0001377936 us-gaap:InvestmentAffiliatedIssuerControlledMember sar:SaratogaInvestmentCorpCLO20131LtdClassF2R3NoteMember 2023-03-01 2024-02-29 0001377936 us-gaap:InvestmentAffiliatedIssuerControlledMember sar:SaratogaSeniorLoanFundIJVLLC1Member 2023-03-01 2024-02-29 0001377936 us-gaap:InvestmentAffiliatedIssuerControlledMember sar:SaratogaSeniorLoanFundIJVLLC2Member 2023-03-01 2024-02-29 0001377936 us-gaap:InvestmentAffiliatedIssuerControlledMember 2023-03-01 2024-02-29 0001377936 sar:SBADebenturesMember 2024-03-01 2024-11-30 0001377936 us-gaap:CollateralizedLoanObligationsMember 2022-10-28 2022-10-28 0001377936 sar:SLFJVMember 2024-11-30 0001377936 us-gaap:CashAndCashEquivalentsMember 2024-11-30 0001377936 srt:MinimumMember 2024-11-30 0001377936 srt:MaximumMember 2024-11-30 0001377936 us-gaap:InvestmentAffiliatedIssuerControlledMember 2024-11-30 0001377936 srt:MinimumMember us-gaap:InvestmentAffiliatedIssuerMember 2024-11-30 0001377936 srt:MaximumMember us-gaap:InvestmentAffiliatedIssuerMember 2024-11-30 0001377936 2023-03-01 2024-02-29 0001377936 2022-03-01 2023-02-28 0001377936 2021-03-01 2022-02-28 0001377936 sar:SaratogaInvestmentCorpMember 2024-03-01 2024-11-30 0001377936 sar:PIKMember 2024-03-01 2024-11-30 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel1Member sar:FirstLienTermLoansMember 2024-11-30 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel2Member sar:FirstLienTermLoansMember 2024-11-30 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel3Member sar:FirstLienTermLoansMember 2024-11-30 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember sar:FirstLienTermLoansMember 2024-11-30 0001377936 us-gaap:InvestmentsMember sar:FirstLienTermLoansMember 2024-11-30 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel1Member sar:SecondLienTermLoansMember 2024-11-30 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel2Member sar:SecondLienTermLoansMember 2024-11-30 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel3Member sar:SecondLienTermLoansMember 2024-11-30 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember sar:SecondLienTermLoansMember 2024-11-30 0001377936 us-gaap:InvestmentsMember sar:SecondLienTermLoansMember 2024-11-30 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:UnsecuredDebtMember 2024-11-30 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:UnsecuredDebtMember 2024-11-30 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel3Member us-gaap:UnsecuredDebtMember 2024-11-30 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:UnsecuredDebtMember 2024-11-30 0001377936 us-gaap:InvestmentsMember us-gaap:UnsecuredDebtMember 2024-11-30 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:SecuritiesFinancingTransactionFairValueMember 2024-11-30 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:SecuritiesFinancingTransactionFairValueMember 2024-11-30 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel3Member us-gaap:SecuritiesFinancingTransactionFairValueMember 2024-11-30 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:SecuritiesFinancingTransactionFairValueMember 2024-11-30 0001377936 us-gaap:InvestmentsMember us-gaap:SecuritiesFinancingTransactionFairValueMember 2024-11-30 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:EquitySecuritiesMember 2024-11-30 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:EquitySecuritiesMember 2024-11-30 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel3Member us-gaap:EquitySecuritiesMember 2024-11-30 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:EquitySecuritiesMember 2024-11-30 0001377936 us-gaap:InvestmentsMember us-gaap:EquitySecuritiesMember 2024-11-30 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel1Member 2024-11-30 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel2Member 2024-11-30 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel3Member 2024-11-30 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember 2024-11-30 0001377936 us-gaap:InvestmentsMember 2024-11-30 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel1Member sar:FirstLienTermLoansMember 2024-02-29 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel2Member sar:FirstLienTermLoansMember 2024-02-29 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel3Member sar:FirstLienTermLoansMember 2024-02-29 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember sar:FirstLienTermLoansMember 2024-02-29 0001377936 us-gaap:InvestmentsMember sar:FirstLienTermLoansMember 2024-02-29 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel1Member sar:SecondLienTermLoansMember 2024-02-29 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel2Member sar:SecondLienTermLoansMember 2024-02-29 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel3Member sar:SecondLienTermLoansMember 2024-02-29 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember sar:SecondLienTermLoansMember 2024-02-29 0001377936 us-gaap:InvestmentsMember sar:SecondLienTermLoansMember 2024-02-29 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:UnsecuredDebtMember 2024-02-29 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:UnsecuredDebtMember 2024-02-29 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel3Member us-gaap:UnsecuredDebtMember 2024-02-29 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:UnsecuredDebtMember 2024-02-29 0001377936 us-gaap:InvestmentsMember us-gaap:UnsecuredDebtMember 2024-02-29 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:SecuritiesFinancingTransactionFairValueMember 2024-02-29 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:SecuritiesFinancingTransactionFairValueMember 2024-02-29 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel3Member us-gaap:SecuritiesFinancingTransactionFairValueMember 2024-02-29 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:SecuritiesFinancingTransactionFairValueMember 2024-02-29 0001377936 us-gaap:InvestmentsMember us-gaap:SecuritiesFinancingTransactionFairValueMember 2024-02-29 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:EquitySecuritiesMember 2024-02-29 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:EquitySecuritiesMember 2024-02-29 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel3Member us-gaap:EquitySecuritiesMember 2024-02-29 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:EquitySecuritiesMember 2024-02-29 0001377936 us-gaap:InvestmentsMember us-gaap:EquitySecuritiesMember 2024-02-29 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel1Member 2024-02-29 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel2Member 2024-02-29 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueInputsLevel3Member 2024-02-29 0001377936 us-gaap:InvestmentsMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember 2024-02-29 0001377936 us-gaap:InvestmentsMember 2024-02-29 0001377936 us-gaap:FairValueInputsLevel3Member sar:FirstLienTermLoansMember 2024-02-29 0001377936 us-gaap:FairValueInputsLevel3Member sar:SecondLienTermLoansMember 2024-02-29 0001377936 us-gaap:FairValueInputsLevel3Member us-gaap:UnsecuredDebtMember 2024-02-29 0001377936 us-gaap:FairValueInputsLevel3Member us-gaap:SecuritiesFinancingTransactionFairValueMember 2024-02-29 0001377936 us-gaap:FairValueInputsLevel3Member us-gaap:EquitySecuritiesMember 2024-02-29 0001377936 us-gaap:FairValueInputsLevel3Member 2024-02-29 0001377936 us-gaap:FairValueInputsLevel3Member sar:FirstLienTermLoansMember 2024-03-01 2024-11-30 0001377936 us-gaap:FairValueInputsLevel3Member sar:SecondLienTermLoansMember 2024-03-01 2024-11-30 0001377936 us-gaap:FairValueInputsLevel3Member us-gaap:UnsecuredDebtMember 2024-03-01 2024-11-30 0001377936 us-gaap:FairValueInputsLevel3Member us-gaap:SecuritiesFinancingTransactionFairValueMember 2024-03-01 2024-11-30 0001377936 us-gaap:FairValueInputsLevel3Member us-gaap:EquitySecuritiesMember 2024-03-01 2024-11-30 0001377936 us-gaap:FairValueInputsLevel3Member 2024-03-01 2024-11-30 0001377936 us-gaap:FairValueInputsLevel3Member sar:FirstLienTermLoansMember 2024-11-30 0001377936 us-gaap:FairValueInputsLevel3Member sar:SecondLienTermLoansMember 2024-11-30 0001377936 us-gaap:FairValueInputsLevel3Member us-gaap:UnsecuredDebtMember 2024-11-30 0001377936 us-gaap:FairValueInputsLevel3Member us-gaap:SecuritiesFinancingTransactionFairValueMember 2024-11-30 0001377936 us-gaap:FairValueInputsLevel3Member us-gaap:EquitySecuritiesMember 2024-11-30 0001377936 us-gaap:FairValueInputsLevel3Member 2024-11-30 0001377936 us-gaap:FairValueInputsLevel3Member sar:FirstLienTermLoansMember 2023-02-28 0001377936 us-gaap:FairValueInputsLevel3Member sar:SecondLienTermLoansMember 2023-02-28 0001377936 us-gaap:FairValueInputsLevel3Member us-gaap:UnsecuredDebtMember 2023-02-28 0001377936 us-gaap:FairValueInputsLevel3Member us-gaap:SecuritiesFinancingTransactionFairValueMember 2023-02-28 0001377936 us-gaap:FairValueInputsLevel3Member us-gaap:EquitySecuritiesMember 2023-02-28 0001377936 us-gaap:FairValueInputsLevel3Member 2023-02-28 0001377936 us-gaap:FairValueInputsLevel3Member sar:FirstLienTermLoansMember 2023-03-01 2023-11-30 0001377936 us-gaap:FairValueInputsLevel3Member sar:SecondLienTermLoansMember 2023-03-01 2023-11-30 0001377936 us-gaap:FairValueInputsLevel3Member us-gaap:UnsecuredDebtMember 2023-03-01 2023-11-30 0001377936 us-gaap:FairValueInputsLevel3Member us-gaap:SecuritiesFinancingTransactionFairValueMember 2023-03-01 2023-11-30 0001377936 us-gaap:FairValueInputsLevel3Member us-gaap:EquitySecuritiesMember 2023-03-01 2023-11-30 0001377936 us-gaap:FairValueInputsLevel3Member 2023-03-01 2023-11-30 0001377936 us-gaap:FairValueInputsLevel3Member sar:FirstLienTermLoansMember 2023-11-30 0001377936 us-gaap:FairValueInputsLevel3Member sar:SecondLienTermLoansMember 2023-11-30 0001377936 us-gaap:FairValueInputsLevel3Member us-gaap:UnsecuredDebtMember 2023-11-30 0001377936 us-gaap:FairValueInputsLevel3Member us-gaap:SecuritiesFinancingTransactionFairValueMember 2023-11-30 0001377936 us-gaap:FairValueInputsLevel3Member us-gaap:EquitySecuritiesMember 2023-11-30 0001377936 us-gaap:FairValueInputsLevel3Member 2023-11-30 0001377936 us-gaap:FairValueInputsLevel3Member sar:FirstLienTermLoansMember sar:MeasurementInputMarketYieldMember us-gaap:MarketApproachValuationTechniqueMember 2024-11-30 0001377936 srt:MinimumMember us-gaap:FairValueInputsLevel3Member sar:FirstLienTermLoansMember sar:MeasurementInputMarketYieldMember us-gaap:MarketApproachValuationTechniqueMember 2024-11-30 0001377936 srt:MaximumMember us-gaap:FairValueInputsLevel3Member sar:FirstLienTermLoansMember sar:MeasurementInputMarketYieldMember us-gaap:MarketApproachValuationTechniqueMember 2024-11-30 0001377936 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member sar:FirstLienTermLoansMember sar:MeasurementInputMarketYieldMember us-gaap:MarketApproachValuationTechniqueMember 2024-11-30 0001377936 us-gaap:FairValueInputsLevel3Member sar:FirstLienTermLoansMember us-gaap:MeasurementInputRevenueMultipleMember us-gaap:MarketApproachValuationTechniqueMember 2024-11-30 0001377936 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member sar:FirstLienTermLoansMember us-gaap:MeasurementInputRevenueMultipleMember us-gaap:MarketApproachValuationTechniqueMember 2024-11-30 0001377936 us-gaap:FairValueInputsLevel3Member sar:FirstLienTermLoansMember sar:MeasurementInputThirdpartyBidMember us-gaap:MarketApproachValuationTechniqueMember 2024-11-30 0001377936 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member sar:FirstLienTermLoansMember sar:MeasurementInputThirdpartyBidMember us-gaap:MarketApproachValuationTechniqueMember 2024-11-30 0001377936 us-gaap:FairValueInputsLevel3Member sar:SecondLienTermLoansMember sar:MeasurementInputMarketYieldMember us-gaap:MarketApproachValuationTechniqueMember 2024-11-30 0001377936 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member sar:SecondLienTermLoansMember sar:MeasurementInputMarketYieldMember us-gaap:MarketApproachValuationTechniqueMember 2024-11-30 0001377936 us-gaap:FairValueInputsLevel3Member us-gaap:UnsecuredDebtMember us-gaap:MeasurementInputDiscountRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2024-11-30 0001377936 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:UnsecuredDebtMember us-gaap:MeasurementInputDiscountRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2024-11-30 0001377936 us-gaap:FairValueInputsLevel3Member us-gaap:SecuritiesFinancingTransactionFairValueMember us-gaap:MeasurementInputDiscountRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2024-11-30 0001377936 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:SecuritiesFinancingTransactionFairValueMember us-gaap:MeasurementInputDiscountRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2024-11-30 0001377936 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:SecuritiesFinancingTransactionFairValueMember us-gaap:MeasurementInputDiscountRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2024-11-30 0001377936 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:SecuritiesFinancingTransactionFairValueMember us-gaap:MeasurementInputDiscountRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2024-11-30 0001377936 us-gaap:FairValueInputsLevel3Member us-gaap:SecuritiesFinancingTransactionFairValueMember sar:MeasurementInputRecoveryRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2024-11-30 0001377936 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:SecuritiesFinancingTransactionFairValueMember sar:MeasurementInputRecoveryRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2024-11-30 0001377936 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:SecuritiesFinancingTransactionFairValueMember sar:MeasurementInputRecoveryRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2024-11-30 0001377936 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:SecuritiesFinancingTransactionFairValueMember sar:MeasurementInputRecoveryRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2024-11-30 0001377936 us-gaap:FairValueInputsLevel3Member us-gaap:SecuritiesFinancingTransactionFairValueMember us-gaap:MeasurementInputPrepaymentRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2024-11-30 0001377936 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:SecuritiesFinancingTransactionFairValueMember us-gaap:MeasurementInputPrepaymentRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2024-11-30 0001377936 us-gaap:FairValueInputsLevel3Member us-gaap:EquitySecuritiesMember us-gaap:MeasurementInputRevenueMultipleMember sar:EnterpriseValueWaterfallMember 2024-11-30 0001377936 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:EquitySecuritiesMember us-gaap:MeasurementInputRevenueMultipleMember sar:EnterpriseValueWaterfallMember 2024-11-30 0001377936 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:EquitySecuritiesMember us-gaap:MeasurementInputRevenueMultipleMember sar:EnterpriseValueWaterfallMember 2024-11-30 0001377936 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:EquitySecuritiesMember us-gaap:MeasurementInputRevenueMultipleMember sar:EnterpriseValueWaterfallMember 2024-11-30 0001377936 us-gaap:FairValueInputsLevel3Member us-gaap:EquitySecuritiesMember us-gaap:MeasurementInputEbitdaMultipleMember sar:EnterpriseValueWaterfallMember 2024-11-30 0001377936 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:EquitySecuritiesMember us-gaap:MeasurementInputEbitdaMultipleMember sar:EnterpriseValueWaterfallMember 2024-11-30 0001377936 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:EquitySecuritiesMember us-gaap:MeasurementInputEbitdaMultipleMember sar:EnterpriseValueWaterfallMember 2024-11-30 0001377936 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:EquitySecuritiesMember us-gaap:MeasurementInputEbitdaMultipleMember sar:EnterpriseValueWaterfallMember 2024-11-30 0001377936 us-gaap:FairValueInputsLevel3Member sar:FirstLienTermLoansMember sar:MeasurementInputMarketYieldMember us-gaap:MarketApproachValuationTechniqueMember 2024-02-29 0001377936 srt:MinimumMember us-gaap:FairValueInputsLevel3Member sar:FirstLienTermLoansMember sar:MeasurementInputMarketYieldMember us-gaap:MarketApproachValuationTechniqueMember 2024-02-29 0001377936 srt:MaximumMember us-gaap:FairValueInputsLevel3Member sar:FirstLienTermLoansMember sar:MeasurementInputMarketYieldMember us-gaap:MarketApproachValuationTechniqueMember 2024-02-29 0001377936 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member sar:FirstLienTermLoansMember sar:MeasurementInputMarketYieldMember us-gaap:MarketApproachValuationTechniqueMember 2024-02-29 0001377936 us-gaap:FairValueInputsLevel3Member sar:FirstLienTermLoansMember us-gaap:MeasurementInputRevenueMultipleMember us-gaap:MarketApproachValuationTechniqueMember 2024-02-29 0001377936 srt:MinimumMember us-gaap:FairValueInputsLevel3Member sar:FirstLienTermLoansMember us-gaap:MeasurementInputRevenueMultipleMember us-gaap:MarketApproachValuationTechniqueMember 2024-02-29 0001377936 srt:MaximumMember us-gaap:FairValueInputsLevel3Member sar:FirstLienTermLoansMember us-gaap:MeasurementInputRevenueMultipleMember us-gaap:MarketApproachValuationTechniqueMember 2024-02-29 0001377936 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member sar:FirstLienTermLoansMember us-gaap:MeasurementInputRevenueMultipleMember us-gaap:MarketApproachValuationTechniqueMember 2024-02-29 0001377936 us-gaap:FairValueInputsLevel3Member sar:FirstLienTermLoansMember us-gaap:MeasurementInputEbitdaMultipleMember us-gaap:MarketApproachValuationTechniqueMember 2024-02-29 0001377936 srt:MinimumMember us-gaap:FairValueInputsLevel3Member sar:FirstLienTermLoansMember us-gaap:MeasurementInputEbitdaMultipleMember us-gaap:MarketApproachValuationTechniqueMember 2024-02-29 0001377936 srt:MaximumMember us-gaap:FairValueInputsLevel3Member sar:FirstLienTermLoansMember us-gaap:MeasurementInputEbitdaMultipleMember us-gaap:MarketApproachValuationTechniqueMember 2024-02-29 0001377936 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member sar:FirstLienTermLoansMember us-gaap:MeasurementInputEbitdaMultipleMember us-gaap:MarketApproachValuationTechniqueMember 2024-02-29 0001377936 us-gaap:FairValueInputsLevel3Member sar:FirstLienTermLoansMember sar:MeasurementInputThirdpartyBidMember us-gaap:MarketApproachValuationTechniqueMember 2024-02-29 0001377936 srt:MinimumMember us-gaap:FairValueInputsLevel3Member sar:FirstLienTermLoansMember sar:MeasurementInputThirdpartyBidMember us-gaap:MarketApproachValuationTechniqueMember 2024-02-29 0001377936 srt:MaximumMember us-gaap:FairValueInputsLevel3Member sar:FirstLienTermLoansMember sar:MeasurementInputThirdpartyBidMember us-gaap:MarketApproachValuationTechniqueMember 2024-02-29 0001377936 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member sar:FirstLienTermLoansMember sar:MeasurementInputThirdpartyBidMember us-gaap:MarketApproachValuationTechniqueMember 2024-02-29 0001377936 us-gaap:FairValueInputsLevel3Member sar:SecondLienTermLoansMember sar:MeasurementInputMarketYieldMember us-gaap:MarketApproachValuationTechniqueMember 2024-02-29 0001377936 srt:MinimumMember us-gaap:FairValueInputsLevel3Member sar:SecondLienTermLoansMember sar:MeasurementInputMarketYieldMember us-gaap:MarketApproachValuationTechniqueMember 2024-02-29 0001377936 srt:MaximumMember us-gaap:FairValueInputsLevel3Member sar:SecondLienTermLoansMember sar:MeasurementInputMarketYieldMember us-gaap:MarketApproachValuationTechniqueMember 2024-02-29 0001377936 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member sar:SecondLienTermLoansMember sar:MeasurementInputMarketYieldMember us-gaap:MarketApproachValuationTechniqueMember 2024-02-29 0001377936 us-gaap:FairValueInputsLevel3Member sar:SecondLienTermLoansMember us-gaap:MeasurementInputRevenueMultipleMember us-gaap:MarketApproachValuationTechniqueMember 2024-02-29 0001377936 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member sar:SecondLienTermLoansMember us-gaap:MeasurementInputRevenueMultipleMember us-gaap:MarketApproachValuationTechniqueMember 2024-02-29 0001377936 us-gaap:FairValueInputsLevel3Member sar:SecondLienTermLoansMember sar:MeasurementInputThirdpartyBidMember us-gaap:MarketApproachValuationTechniqueMember 2024-02-29 0001377936 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member sar:SecondLienTermLoansMember sar:MeasurementInputThirdpartyBidMember us-gaap:MarketApproachValuationTechniqueMember 2024-02-29 0001377936 us-gaap:FairValueInputsLevel3Member us-gaap:UnsecuredDebtMember us-gaap:MeasurementInputDiscountRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2024-02-29 0001377936 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:UnsecuredDebtMember us-gaap:MeasurementInputDiscountRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2024-02-29 0001377936 us-gaap:FairValueInputsLevel3Member us-gaap:SecuritiesFinancingTransactionFairValueMember us-gaap:MeasurementInputDiscountRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2024-02-29 0001377936 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:SecuritiesFinancingTransactionFairValueMember us-gaap:MeasurementInputDiscountRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2024-02-29 0001377936 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:SecuritiesFinancingTransactionFairValueMember us-gaap:MeasurementInputDiscountRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2024-02-29 0001377936 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:SecuritiesFinancingTransactionFairValueMember us-gaap:MeasurementInputDiscountRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2024-02-29 0001377936 us-gaap:FairValueInputsLevel3Member us-gaap:SecuritiesFinancingTransactionFairValueMember sar:MeasurementInputRecoveryRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2024-02-29 0001377936 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:SecuritiesFinancingTransactionFairValueMember sar:MeasurementInputRecoveryRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2024-02-29 0001377936 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:SecuritiesFinancingTransactionFairValueMember sar:MeasurementInputRecoveryRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2024-02-29 0001377936 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:SecuritiesFinancingTransactionFairValueMember sar:MeasurementInputRecoveryRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2024-02-29 0001377936 us-gaap:FairValueInputsLevel3Member us-gaap:SecuritiesFinancingTransactionFairValueMember us-gaap:MeasurementInputPrepaymentRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2024-02-29 0001377936 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:SecuritiesFinancingTransactionFairValueMember us-gaap:MeasurementInputPrepaymentRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2024-02-29 0001377936 us-gaap:FairValueInputsLevel3Member us-gaap:EquitySecuritiesMember us-gaap:MeasurementInputEbitdaMultipleMember sar:EnterpriseValueWaterfallMember 2024-02-29 0001377936 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:EquitySecuritiesMember us-gaap:MeasurementInputEbitdaMultipleMember sar:EnterpriseValueWaterfallMember 2024-02-29 0001377936 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:EquitySecuritiesMember us-gaap:MeasurementInputEbitdaMultipleMember sar:EnterpriseValueWaterfallMember 2024-02-29 0001377936 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:EquitySecuritiesMember us-gaap:MeasurementInputEbitdaMultipleMember sar:EnterpriseValueWaterfallMember 2024-02-29 0001377936 us-gaap:FairValueInputsLevel3Member us-gaap:EquitySecuritiesMember us-gaap:MeasurementInputRevenueMultipleMember sar:EnterpriseValueWaterfallMember 2024-02-29 0001377936 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:EquitySecuritiesMember us-gaap:MeasurementInputRevenueMultipleMember sar:EnterpriseValueWaterfallMember 2024-02-29 0001377936 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:EquitySecuritiesMember us-gaap:MeasurementInputRevenueMultipleMember sar:EnterpriseValueWaterfallMember 2024-02-29 0001377936 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:EquitySecuritiesMember us-gaap:MeasurementInputRevenueMultipleMember sar:EnterpriseValueWaterfallMember 2024-02-29 0001377936 us-gaap:FairValueInputsLevel3Member us-gaap:EquitySecuritiesMember sar:MeasurementInputThirdpartyBidMember sar:EnterpriseValueWaterfallMember 2024-02-29 0001377936 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:EquitySecuritiesMember sar:MeasurementInputThirdpartyBidMember sar:EnterpriseValueWaterfallMember 2024-02-29 0001377936 sar:FirstLienTermLoansMember 2024-11-30 0001377936 sar:SecondLienTermLoansMember 2024-11-30 0001377936 us-gaap:UnsecuredDebtMember 2024-11-30 0001377936 us-gaap:SecuritiesFinancingTransactionFairValueMember 2024-11-30 0001377936 us-gaap:EquitySecuritiesMember 2024-11-30 0001377936 sar:FirstLienTermLoansMember 2024-02-29 0001377936 sar:SecondLienTermLoansMember 2024-02-29 0001377936 us-gaap:UnsecuredDebtMember 2024-02-29 0001377936 us-gaap:SecuritiesFinancingTransactionFairValueMember 2024-02-29 0001377936 us-gaap:EquitySecuritiesMember 2024-02-29 0001377936 sar:SaratogaCLOMember 2024-03-01 2024-11-30 0001377936 2018-12-14 2018-12-14 0001377936 srt:MinimumMember 2018-12-14 2018-12-14 0001377936 srt:MaximumMember 2018-12-14 2018-12-14 0001377936 srt:MinimumMember sar:SaratogaCLOMember 2021-02-26 0001377936 srt:MaximumMember sar:SaratogaCLOMember 2021-02-26 0001377936 2021-02-26 2021-02-26 0001377936 sar:ClassFR3NotesMember 2021-02-26 2021-02-26 0001377936 sar:TheClassFR2Member 2021-02-26 2021-02-26 0001377936 sar:TheClassGR2Member 2021-02-26 2021-02-26 0001377936 sar:SaratogaInvestmentCorpCLO20131LtdMember 2021-02-26 2021-02-26 0001377936 2021-02-26 0001377936 2021-08-31 2021-08-31 0001377936 sar:ClassFR3NotesMember 2021-08-09 0001377936 sar:ClassF1R3Member 2021-08-09 0001377936 sar:ClassF2R3Member 2021-08-09 0001377936 sar:ClassF1R3Member 2021-08-11 2021-08-11 0001377936 2024-06-10 0001377936 sar:SaratogaCLOMember 2024-06-01 2024-08-31 0001377936 sar:SaratogaCLOMember 2023-06-01 2023-08-31 0001377936 2024-06-01 2024-08-31 0001377936 2023-06-01 2023-08-31 0001377936 us-gaap:SubordinatedDebtMember 2024-03-01 2024-11-30 0001377936 us-gaap:SubordinatedDebtMember 2023-03-01 2023-11-30 0001377936 us-gaap:SubordinatedDebtMember 2024-11-30 0001377936 sar:ClassF2R3Member 2024-11-30 0001377936 sar:ClassF2R3Member 2024-03-01 2024-11-30 0001377936 sar:LIBORMember 2024-11-30 0001377936 sar:SaratogaCLOMember 2024-11-30 0001377936 sar:SaratogaCLOMember 2008-01-01 2008-01-31 0001377936 sar:SaratogaCLOMember 2018-12-31 0001377936 sar:SaratogaCLOMember 2021-02-28 0001377936 sar:SaratogaCLOMember 2024-03-01 2024-11-30 0001377936 us-gaap:SubordinatedDebtMember 2023-03-01 2024-02-29 0001377936 sar:SaratogaCLOMember 2024-02-29 0001377936 sar:SaratogaCLOMember 2018-12-01 2018-12-31 0001377936 sar:SaratogaCLOMember 2021-02-28 2021-02-28 0001377936 sar:SaratogaCLOMember 2024-03-01 2024-11-30 0001377936 sar:SecuredOvernightFinancingRateMember 2024-03-01 2024-11-30 0001377936 us-gaap:PrimeRateMember 2024-03-01 2024-11-30 0001377936 sar:LIBORMember 2023-03-01 2024-02-29 0001377936 sar:SecuredOvernightFinancingRateMember 2023-03-01 2024-02-29 0001377936 us-gaap:PrimeRateMember 2023-03-01 2024-02-29 0001377936 sar:SaratogaCLOMember 2024-03-01 2024-11-30 0001377936 sar:SaratogaCLOMember us-gaap:DebtMember 2024-11-30 0001377936 sar:SaratogaCLOMember us-gaap:DebtMember 2024-02-29 0001377936 sar:SaratogaCLOMember us-gaap:EquitySecuritiesMember 2024-11-30 0001377936 sar:SaratogaCLOMember us-gaap:EquitySecuritiesMember 2024-02-29 0001377936 sar:SaratogaCLOMember 2024-11-30 0001377936 sar:SaratogaCLOMember 2024-02-29 0001377936 sar:ClassA1R3Member sar:SaratogaCLOMember 2024-11-30 0001377936 sar:ClassA1R3Member sar:SaratogaCLOMember 2024-02-29 0001377936 sar:ClassA2R3Member sar:SaratogaCLOMember 2024-11-30 0001377936 sar:ClassA2R3Member sar:SaratogaCLOMember 2024-02-29 0001377936 sar:ClassA1R4Member sar:SaratogaCLOMember 2024-11-30 0001377936 sar:ClassA1R4Member sar:SaratogaCLOMember 2024-02-29 0001377936 sar:ClassA2R4Member sar:SaratogaCLOMember 2024-11-30 0001377936 sar:ClassA2R4Member sar:SaratogaCLOMember 2024-02-29 0001377936 sar:ClassBFLR3Member sar:SaratogaCLOMember 2024-11-30 0001377936 sar:ClassBFLR3Member sar:SaratogaCLOMember 2024-02-29 0001377936 sar:ClassBFXDR3Member sar:SaratogaCLOMember 2024-11-30 0001377936 sar:ClassBFXDR3Member sar:SaratogaCLOMember 2024-02-29 0001377936 sar:ClassCFLR3Member sar:SaratogaCLOMember 2024-11-30 0001377936 sar:ClassCFLR3Member sar:SaratogaCLOMember 2024-02-29 0001377936 sar:ClassCFXDR3Member sar:SaratogaCLOMember 2024-11-30 0001377936 sar:ClassCFXDR3Member sar:SaratogaCLOMember 2024-02-29 0001377936 sar:ClassDR3Member sar:SaratogaCLOMember 2024-11-30 0001377936 sar:ClassDR3Member sar:SaratogaCLOMember 2024-02-29 0001377936 sar:ClassER3Member sar:SaratogaCLOMember 2024-11-30 0001377936 sar:ClassER3Member sar:SaratogaCLOMember 2024-02-29 0001377936 sar:ClassF1R3Member sar:SaratogaCLOMember 2024-11-30 0001377936 sar:ClassF1R3Member sar:SaratogaCLOMember 2024-02-29 0001377936 sar:ClassF2R3Member sar:SaratogaCLOMember 2024-11-30 0001377936 sar:ClassF2R3Member sar:SaratogaCLOMember 2024-02-29 0001377936 sar:SaratogaCLOMember 2024-09-01 2024-11-30 0001377936 sar:SaratogaCLOMember 2023-09-01 2023-11-30 0001377936 sar:SaratogaCLOMember 2024-03-01 2024-11-30 0001377936 sar:SaratogaCLOMember 2023-03-01 2023-11-30 0001377936 Altisource Solutions S.a r.l. - Banking, Finance, Insurance & Real Estate - Common Stock - Equity sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Endo Finance Holdings, Inc. - Healthcare & Pharmaceuticals - Common Stock - Equity sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Endo Finance Holdings, Inc. - Healthcare & Pharmaceuticals - Warrants - Equity sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Envision Parent Inc - Healthcare & Pharmaceuticals - Common Stock - Equity sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Envision Parent Inc - Healthcare & Pharmaceuticals - Warrants - Equity sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Instant Brands Litigation Trust - Consumer goods: Durable -Equity Interest- Equity sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Isagenix International, LLC - Beverage, Food & Tobacco - Common Stock - Equity sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Research Now Group, Inc - Media: Advertising, Printing & Publishing - Common Stock - Equity sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Resolute Investment Managers (American Beacon), Inc. - Banking, Finance, Insurance & Real Estate - Common Stock - Equity sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 URS TOPCO, LLC - Transportation: Cargo - Common Stock - Equity sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 1011778 B.C Unltd Liability Co - Beverage, Food & Tobacco - Term Loan B6 - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 19TH HOLDINGS GOLF, LLC - Consumer goods: Durable - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 888 Acquisitions Limited - Hotel, Gaming & Leisure - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Adtalem Global Education Inc. - Services: Business - Term Loan B (08/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Aegis Sciences Corporation - Healthcare & Pharmaceuticals - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Agiliti Health Inc. - Healthcare & Pharmaceuticals - Term Loan B (03/23) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 AHEAD DB Holdings, LLC - Services: Business - Term Loan B3 (07/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Air Canada - Transportation: Consumer - Term Loan B (03/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 AIT Worldwide Logistics Holdings, Inc. - Transportation: Cargo - Term Loan B (10/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 AlixPartners, LLP - Banking, Finance, Insurance & Real Estate - Term Loan B (01/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Alkermes, Inc. - Healthcare & Pharmaceuticals - Term Loan B (3/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Allen Media, LLC - Media: Diversified & Production - Term Loan (7/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Alliant Holdings Intermediate, LLC - Banking, Finance, Insurance & Real Estate - Term Loan B6 (09/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Allied Universal Holdco LLC - Services: Business - Term Loan 4/21 - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Alterra Mountain Company (Intrawest Resort Holdings) - Hotel, Gaming & Leisure - First Lien Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Altisource Solutions S.a r.l. (c) - Banking, Finance, Insurance & Real Estate - Term Loan B (03/18) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Altium Packaging LLC - Containers, Packaging & Glass - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Amer Sports Oyj (MASCOT BIDCO OY) - Consumer goods: Durable - USD Term Loan B (01/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 American Axle & Manufacturing Inc. - Automotive - Term Loan (12/22) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 American Greetings Corporation - Media: Advertising, Printing & Publishing - Term Loan B (04/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 American Trailer World Corp - Automotive - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 AmWINS Group, LLC - Banking, Finance, Insurance & Real Estate - Term Loan 2/21 - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Anastasia Parent LLC - Consumer goods: Non-durable - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Anchor Packaging, LLC - Containers, Packaging & Glass - Term Loan (4/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 AP Core Holdings II LLC - High Tech Industries - Term Loan B2 - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 AP Core Holdings II LLC - High Tech Industries - Term Loan B2 - Loan One sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 APEX GROUP TREASURY LLC - Banking, Finance, Insurance & Real Estate - Term Loan B (07/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Apollo Commercial Real Estate Finance, Inc. - Banking, Finance, Insurance & Real Estate - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Apollo Commercial Real Estate Finance, Inc. - Banking, Finance, Insurance & Real Estate - Term Loan B1 (2/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 AppLovin Corporation - High Tech Industries - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 AppLovin Corporation - High Tech Industries - Term Loan B (3/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 AqGen Ascensus, Inc. - Banking, Finance, Insurance & Real Estate - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Aramark Services, Inc. - Services: Consumer - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Aramark Services, Inc. - Services: Consumer - Term Loan B7 (03/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 ARC FALCON I INC. - Chemicals, Plastics, & Rubber - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 ARCIS GOLF LLC - Services: Consumer - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Aretec Group, Inc. - Banking, Finance, Insurance & Real Estate - Term Loan B 2 - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Aspire Bakeries Holdings, LLC sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Assuredpartners Inc. - Banking, Finance, Insurance & Real Estate - Term Loan B5 (02/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Asurion, LLC - Banking, Finance, Insurance & Real Estate - Term Loan B10 - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Asurion, LLC - Banking, Finance, Insurance & Real Estate - Term Loan B12 - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 ATHENAHEALTH GROUP INC. - Healthcare & Pharmaceuticals - Term Loan B (2/22) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Avolon TLB Borrower 1 (US) LLC - Capital Equipment - Term Loan B6 - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Axalta Coating Systems US Holdings - Chemicals, Plastics, & Rubber - Term Loan B (11/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 AZURITY PHARMACEUTICALS, INC. - Healthcare & Pharmaceuticals - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 B&G Foods, Inc. - Beverage, Food & Tobacco - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 BAKELITE UK INTERMEDIATE LTD. - Chemicals, Plastics, & Rubber - Term Loan (5/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Baldwin Insurance Group Holdings, LLC - Banking, Finance, Insurance & Real Estate - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Belfor Holdings Inc. - Services: Consumer - Term Loan B-1 (11/23) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Bengal Debt Merger Sub LLC - Beverage, Food & Tobacco - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Blackstone Mortgage Trust, Inc. - Banking, Finance, Insurance & Real Estate - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Blackstone Mortgage Trust, Inc. - Banking, Finance, Insurance & Real Estate - Term Loan (6/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Bombardier Recreational Products, Inc. - Consumer goods: Durable - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Bombardier Recreational Products, Inc. - Consumer goods: Durable - Term Loan B3 - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Boost Newco Borrower, LLC (Worldpay) - Banking, Finance, Insurance & Real Estate - Term Loan (06/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Boxer Parent Company, Inc. - High Tech Industries - Term Loan B (06/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 BrightSpring Health Services (Phoenix Guarantor) - Healthcare & Pharmaceuticals - Term Loan (02/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 BroadStreet Partners, Inc. -Banking, Finance, Insurance & Real Estate - Term Loan B-4 - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Brookfield WEC Holdings Inc. - Energy: Electricity - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 BROWN GROUP HOLDING, LLC - Aerospace & Defense - Term Loan B-2 - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Buckeye Partners, L.P. - Utilities: Oil & Gas - Term Loan B4 (05/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Buckeye Partners, L.P. - Utilities: Oil & Gas - Term Loan B5 (09/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 BW Gas & Convenience Holdings LLC - Beverage, Food & Tobacco - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Callaway Golf Company - Retail - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Calpine Corporation - Utilities: Electric - Term Loan B10 (01/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Camping World, Inc. - Retail - Term Loan B (5/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 CAPSTONE BORROWER INC - Services: Business - Term Loan B (05/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 CareerBuilder, LLC (c) - Services: Business - Term Loan B3 - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Castle US Holding Corporation - Media: Advertising, Printing & Publishing - Term Loan B (USD) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 CASTLELAKE AVIATION LLC - Aerospace & Defense - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 CBL & Associates Limited Partnership - Retail - Term Loan 11/21 - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 CCC Intelligent Solutions Inc. - Services: Business - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 CCI Buyer, Inc - Telecommunications - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 CCRR Parent, Inc. - Healthcare & Pharmaceuticals - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 CCRR Parent, Inc. - Healthcare & Pharmaceuticals - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 CCS-CMGC Holdings, Inc. - Healthcare & Pharmaceuticals - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 CDK GLOBAL, INC. - High Tech Industries - Term Loan B (05/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 CENTURI GROUP, INC. - Construction & Building - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Charlotte Buyer, Inc. - Services: Business - Term Loan B (07/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Chemours Company, (The) - Chemicals, Plastics, & Rubber - Term Loan B2 - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Churchill Downs Incorporated - Hotel, Gaming & Leisure - Term Loan B1 (3/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 CIMPRESS PUBLIC LIMITED COMPANY - Media: Advertising, Printing & Publishing - Term Loan B1 (05/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 CITADEL SECURITIES LP sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Citco Funding LLC - Banking, Finance, Insurance & Real Estate - Term Loan B (06/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Clarios Global LP - Automotive - Term Loan B (07/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Claros Mortgage Trust, Inc sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 CLYDESDALE ACQUISITION HOLDINGS, INC. - Containers, Packaging & Glass - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Columbus McKinnon Corporation - Capital Equipment - Term Loan (03/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Connect Finco SARL - Telecommunications - Term Loan B (03/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Consolidated Communications, Inc. - Telecommunications - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 CORAL-US CO-BORROWER LLC - Telecommunications - Term Loan B-5 - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Corelogic, Inc. - Services: Business - Term Loan (4/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Cortes NP Acquisition Corp (Vertiv) - Capital Equipment - Term Loan B (05/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Creative Artists Agency, LLC - Media: Diversified & Production - Term Loan B (09/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 CROCS INC - Consumer goods: Durable - Term Loan B (01/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Cross Financial Corp - Banking, Finance, Insurance & Real Estate - Term Loan B2 (10/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Crown Subsea Communications Holding, Inc. - Construction & Building - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 CTC Holdings, LP - Banking, Finance, Insurance & Real Estate - Term Loan (2/22) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 CTS Midco, LLC - High Tech Industries - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Dave & Buster's Inc. - Hotel, Gaming & Leisure - Term Loan B (1/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 DCert Buyer, Inc. - High Tech Industries - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Delek US Holdings, Inc. - Utilities: Oil & Gas - Term Loan B (11/22) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Derby Buyer LLC - Chemicals, Plastics, & Rubber - Term Loan (5/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 DexKo Global, Inc. (Dragon Merger) - Automotive - Term Loan (9/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Diamond Sports Group, LLC - Media: Broadcasting & Subscription - 1st Priority Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 DIRECTV FINANCING, LLC - Media: Broadcasting & Subscription - Term Loan (1/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 DISCOVERY PURCHASER CORPORATION - Chemicals, Plastics, & Rubber - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Dispatch Acquisition Holdings, LLC - Environmental Industries - Term Loan B (3/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 DOMTAR CORPORATION - Forest Products & Paper - Term Loan 9/21 - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 DOTDASH MEREDITH, INC. - Media: Advertising, Printing & Publishing - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 DRI HOLDING INC. - Media: Advertising, Printing & Publishing - Term Loan (12/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 DRW Holdings, LLC - Banking, Finance, Insurance & Real Estate - Term Loan B (06/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 DTZ U.S. Borrower, LLC - Construction & Building - 2024-3 Term Loan (09/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 DTZ U.S. Borrower, LLC - Construction & Building - Term Loan B1 (06/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Dye & Durham Corporation - Services: Business - Term Loan B (04/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 EAB Global, Inc. - Services: Business - Term Loan (08/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Echo Global Logistics, Inc. - Services: Business - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Edelman Financial Group Inc., The - Banking, Finance, Insurance & Real Estate - Term Loan B (05/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 ELECTRON BIDCO INC. - Healthcare & Pharmaceuticals - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 ELO Touch Solutions, Inc. - Media: Diversified & Production - Term Loan (12/18) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Embecta Corp - Healthcare & Pharmaceuticals - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Emrld Borrower LP - Capital Equipment - Term Loan B (04/23) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Endo Finance Holdings, Inc. - Healthcare & Pharmaceuticals - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Endure Digital, Inc. - High Tech Industries - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Entain Holdings (Gibraltar) Limited - Hotel, Gaming & Leisure - Term Loan B3 (5/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 EOS U.S. FINCO LLC - Transportation: Cargo - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Equiniti Group PLC - Services: Business - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Evertec Group LLC - Banking, Finance, Insurance & Real Estate - Term Loan B (09/23) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Fiesta Purchaser, Inc. - Beverage, Food & Tobacco - First Lien TLB - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Finco I LLC - Banking, Finance, Insurance & Real Estate - Term Loan B (9/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 First Brands Group, LLC - Automotive - 1st Lien Term Loan (3/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 First Eagle Investment Management - Banking, Finance, Insurance & Real Estate - Term Loan B (02/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 First Student Bidco Inc. - Transportation: Consumer - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 First Student Bidco Inc. - Transportation: Consumer - Term Loan C - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Fitness International, LLC (LA Fitness) - Services: Consumer - Term Loan B (1/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Flutter Financing B.V. - Hotel, Gaming & Leisure - Term Loan B3 (11/23) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Franchise Group, Inc. - Services: Consumer - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Franchise Group, Inc. (c) - Services: Consumer - First Out Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Franchise Group, Inc. (c) - Services: Consumer - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Franchise Group, Inc. (d) - Services: Consumer - Term Loan DIP New Money - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Franklin Square Holdings, L.P. - Banking, Finance, Insurance & Real Estate - Term Loan B (04/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Froneri International (R&R Ice Cream) - Beverage, Food & Tobacco - Term Loan B4 (10/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Garrett LX III S.a r.l. - Automotive - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Gemini HDPE LLC - Chemicals, Plastics, & Rubber - Term Loan B (12/20) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Genesee & Wyoming, Inc. - Transportation: Cargo - Term Loan B (03/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 GGP Inc. - Banking, Finance, Insurance & Real Estate - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 GIP Pilot Acquisition Partners, L.P. - Energy: Oil & Gas - Term Loan (05/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Global Tel*Link Corporation - Telecommunications - Term Loan (6/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Go Daddy Operating Company, LLC - High Tech Industries - Term Loan B7 - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 GOLDEN WEST PACKAGING GROUP LLC - Forest Products & Paper - Term Loan (11/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 GOTO GROUP, INC. - High Tech Industries - First Lien Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 GOTO GROUP, INC. - High Tech Industries - Second-Out Term Loan (02/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Graham Packaging Co Inc - Containers, Packaging & Glass - Term Loan B (07/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Great Outdoors Group, LLC - Retail - Term Loan B2 - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Griffon Corporation - Consumer goods: Durable - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Grosvenor Capital Management Holdings, LLLP - Banking, Finance, Insurance & Real Estate - Term Loan B (5/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Groupe Solmax Inc. - Environmental Industries - Term Loan (6/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 GYP HOLDINGS III CORP. - Construction & Building - Term Loan (1/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Hertz Corporation (The) - Transportation: Consumer - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Hillman Group Inc. (The) (New) - Consumer goods: Durable - Term Loan B-1 (2/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Hilton Domestic Operating Company Inc. - Hotel, Gaming & Leisure - Term Loan B 4 - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Hilton Grand Vacations Borrower LLC - Hotel, Gaming & Leisure - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 HLF Financing SARL (Herbalife) - Consumer goods: Non-durable - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Holley Purchaser, Inc - Automotive - Term Loan (11/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Hudson River Trading LLC - Banking, Finance, Insurance & Real Estate - Term Loan (10/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Hunter Douglas Inc - Consumer goods: Durable - Term Loan B-1 - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Hyperion Refinance S.a.r.l. - Banking, Finance, Insurance & Real Estate - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Idera, Inc. - High Tech Industries - Term Loan (06/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 IMA Financial Group, Inc. - Banking, Finance, Insurance & Real Estate - Term Loan (10/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 INDY US BIDCO, LLC - Services: Business - Term Loan (11/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 INEOS 226 Ltd. - Chemicals, Plastics, & Rubber - Term Loan 3/23 - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Ineos US Finance LLC - Chemicals, Plastics, & Rubber - Term Loan C - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 INEOS US PETROCHEM LLC - Chemicals, Plastics, & Rubber - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Informatica Inc. - High Tech Industries - Term Loan B (06/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Ingram Micro Inc. - Wholesale - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Inmar, Inc. - Services: Business - Term Loan (06/23) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Innophos, Inc. - Chemicals, Plastics, & Rubber - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 IRB Holding Corporation - Beverage, Food & Tobacco - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Isagenix International, LLC (c) - Beverage, Food & Tobacco - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Isolved Inc. - Services: Business - Term Loan B (11/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Jane Street Group - Banking, Finance, Insurance & Real Estate - Term Loan B (10/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Journey Personal Care Corp. - Consumer goods: Non-durable - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 JP Intermediate B, LLC - Consumer goods: Non-durable - Term Loan 7/23 - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Kleopatra Finco S.a r.l. - Containers, Packaging & Glass - Term Loan (1/21) (USD) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Kodiak BP, LLC - Construction & Building - Term Loan B2 - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Kodiak BP, LLC - Construction & Building - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Koppers Inc - Chemicals, Plastics, & Rubber - Term Loan B (04/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 KREF Holdings X LLC - Banking, Finance, Insurance & Real Estate - Term Loan (11/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Lakeland Tours, LLC (c) - Hotel, Gaming & Leisure - Holdco Fixed Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Latham Pool Products, Inc. - Consumer goods: Durable - Term Loan 2/22 - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Lealand Finance Company B.V. (c) - Energy: Oil & Gas - Exit Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 LHS BORROWER, LLC - Construction & Building - Term Loan (02/22) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Lifetime Brands, Inc - Consumer goods: Non-durable - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Liquid Tech Solutions Holdings, LLC - Services: Business - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 LOYALTY VENTURES INC. (b) - Services: Business - Loyalty Ventures Claims - Term Loan B sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 LPL Holdings, Inc. - Banking, Finance, Insurance & Real Estate - Term Loan B1 - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 LSF11 A5 HOLDCO LLC - Chemicals, Plastics, & Rubber - Term Loan B (06/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 LSF11 TRINITY BIDCO INC - Aerospace & Defense - Term Loan B (06/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 LSF9 Atlantis Holdings, LLC (A Wireless) - Retail - Term Loan Extended - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Lumen Technologies Inc - Telecommunications - Term Loan B1 (3/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Lumen Technologies Inc - Telecommunications - Term Loan B2 (3/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 MAGNITE, INC. - Services: Business - Term Loan B (09/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Marriott Ownership Resorts, Inc. - Hotel, Gaming & Leisure -Term Loan B (3/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Match Group, Inc, The - Services: Consumer - Term Loan (1/20) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Max US Bidco Inc. - Beverage, Food & Tobacco - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Mayfield Agency Borrower Inc. (FeeCo) - Banking, Finance, Insurance & Real Estate - Term Loan B (06/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 McGraw-Hill Education, Inc. - Media: Advertising, Printing & Publishing - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 MedAssets Software Inter Hldg, Inc. - High Tech Industries - FINThrive Software Intermediate Holdings Inc. - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Michaels Companies Inc - Retail - Term Loan B (Magic Mergeco) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 MIWD Holdco II LLC - Construction & Building - Term Loan B2 (03/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 MKS Instruments, Inc. - High Tech Industries - Term Loan B (07/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Momentive Performance Materials Inc. - Chemicals, Plastics, & Rubber - Term Loan (03/23) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Moneygram International, Inc. - Services: Business - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Mosel Bidco SE - High Tech Industries - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 MPH Acquisition Holdings LLC (Multiplan) - Services: Business - Term Loan B (08/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 NAB Holdings, LLC (North American Bancard) - Banking, Finance, Insurance & Real Estate - Term Loan B (06/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Napa Management Services Corp - Healthcare & Pharmaceuticals - Term Loan B (02/22) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Natgasoline LLC - Chemicals, Plastics, & Rubber - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 National Mentor Holdings, Inc. - Healthcare & Pharmaceuticals - Term Loan C 2/21 - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 National Mentor Holdings, Inc. - Healthcare & Pharmaceuticals - Term Loan 2/21 - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Nexstar Broadcasting, Inc. (Mission Broadcasting) - Media: Broadcasting & Subscription - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Next Level Apparel, Inc. - Retail - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 NortonLifeLock Inc. - High Tech Industries - Term Loan B (05/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Nouryon Finance B.V. - Chemicals, Plastics, & Rubber - Term Loan B (10/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Novae LLC - Automotive - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Olaplex, Inc. - Consumer goods: Non-durable - Term Loan (2/22) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Open Text Corporation - High Tech Industries - Term Loan B (08/23) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Oxbow Carbon, LLC - Metals & Mining - Term Loan B (04/23) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 PACIFIC DENTAL SERVICES, LLC - Healthcare & Pharmaceuticals - Term Loan B (02//24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 PACTIV EVERGREEN GROUP HOLDINGS INC. - Containers, Packaging & Glass - Term Loan B4 (05/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Padagis LLC - Healthcare & Pharmaceuticals - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 PAR PETROLEUM LLC - Energy: Oil & Gas - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 PATAGONIA HOLDCO LLC - Telecommunications - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Pathway Partners Vet Management Company LLC - Services: Business - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 PCI Gaming Authority - Hotel, Gaming & Leisure - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 PEARLS (Netherlands) Bidco B.V. - Chemicals, Plastics, & Rubber - USD Term Loan (02/22) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 PEDIATRIC ASSOCIATES HOLDING COMPANY, LLC - Healthcare & Pharmaceuticals - Term Loan (12/22) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Penn National Gaming, Inc - Hotel, Gaming & Leisure - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Peraton Corp. - Aerospace & Defense - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 PHYSICIAN PARTNERS, LLC - Healthcare & Pharmaceuticals - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Pitney Bowes Inc - Services: Business - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Plastipak Holdings Inc. - Containers, Packaging & Glass - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Playtika Holding Corp. - High Tech Industries - Term Loan B (3/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 PMHC II, INC. - Chemicals, Plastics, & Rubber - Term Loan (02/22) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 PointClickCare Technologies, Inc. - High Tech Industries - Term Loan B (10/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Polymer Process Holdings, Inc. - Containers, Packaging & Glass - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Pre-Paid Legal Services, Inc. - Services: Consumer - Term Loan (12/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Prime Security Services Borrower, LLC (ADT) - Services: Consumer - Term Loan B (04/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 PRIORITY HOLDINGS, LLC - Services: Consumer - Term Loan B (5/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 PriSo Acquisition Corporation - Construction & Building - Term Loan (01/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Project Leopard Holdings, Inc. (NEW) - High Tech Industries - Term Loan B (06/22) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Propulsion (BC) Finco - Aerospace & Defense - Term Loan B (10/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 PUG LLC - Services: Consumer - Term Loan B (03/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Quartz AcquireCo, LLC - High Tech Industries - Term Loan B (05/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Quikrete Holdings, Inc. - Construction & Building - Quikrete 3/24 (2031) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 R1 RCM INC. - Healthcare & Pharmaceuticals - Term Loan (12/23) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Rackspace Technology Global, Inc. - High Tech Industries - Super-Priority Term Loan (03/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Rackspace Technology Global, Inc. - High Tech Industries - Term Loan (3/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 RAND PARENT LLC - Transportation: Cargo - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 RealPage, Inc. - High Tech Industries - Term Loan (04/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Rent-A-Center, Inc. - Retail - Term Loan B2 (9/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Research Now Group, Inc - Media: Advertising, Printing & Publishing - Second-Out Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Research Now Group, Inc - Media: Advertising, Printing & Publishing - Term Loan (07/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Resideo Funding Inc. - Services: Consumer - Term Loan B (05/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Resolute Investment Managers (American Beacon), Inc. - Banking, Finance, Insurance & Real Estate - Term Loan (12/23) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Restoration Hardware, Inc. - Retail - Term Loan (9/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Reynolds Consumer Products LLC - Containers, Packaging & Glass - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Russell Investments US Inst'l Holdco, Inc. (c) - Banking, Finance, Insurance & Real Estate - Term Loan B PIK (3/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 RV Retailer LLC - Automotive - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Ryan Specialty Group LLC sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 S&S HOLDINGS LLC - Services: Business - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Sally Holdings LLC - Retail - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Schweitzer-Mauduit International, Inc. - High Tech Industries - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Scientific Games Holdings LP - Hotel, Gaming & Leisure - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Sedgwick Claims Management Services, Inc. sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 SETANTA AIRCRAFT LEASING DAC - Aerospace & Defense - Term Loan B (05/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Sitel Worldwide Corporation - Services: Business - USD Term Loan (7/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 SiteOne Landscape Supply, LLC - Services: Business - Term Loan B (06/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Smyrna Ready Mix Concrete, LLC - Construction & Building - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Sparta U.S. HoldCo LLC - Chemicals, Plastics, & Rubber - Term Loan (04/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Specialty Pharma III Inc. - Services: Business - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Spin Holdco, Inc. - Services: Consumer - Term Loan 3/21 - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 SRAM, LLC - Consumer goods: Durable - Term Loan (05/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 STANDARD INDUSTRIES INC. - Construction & Building - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Staples, Inc. - Wholesale - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Star Parent, Inc. - Services: Business - Term Loan B (09/23) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Storable, Inc - High Tech Industries - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Superannuation & Investments US LLC - Banking, Finance, Insurance & Real Estate - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 SupplyOne, Inc - Wholesale - Term Loan B (03/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Sweetwater Borrower, LLC - Retail - Term Loan (8/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Syncsort Incorporated - High Tech Industries - Term Loan B (10/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Ta TT Buyer LLC - Media: Broadcasting & Subscription - Term Loan B (6/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Tenable Holdings, Inc. - Services: Business - Term Loan B (6/21) -Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Teneo Holdings LLC - Banking, Finance, Insurance & Real Estate - Term Loan B (03/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Ten-X, LLC - Banking, Finance, Insurance & Real Estate - Term Loan 5/23 - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Thor Industries, Inc. - Automotive - Term Loan B (06/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 TIBCO Software Inc - High Tech Industries - Term Loan (Cov-Lite) (10/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Torrid LLC - Wholesale - Term Loan 5/21 - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 TORY BURCH LLC - Retail - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Tosca Services, LLC - Containers, Packaging & Glass - Term Loan A (08/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Tosca Services, LLC (c) - Containers, Packaging & Glass - Superpriority Second-Out Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Trans Union LLC - Banking, Finance, Insurance & Real Estate - Term Loan B7 (02/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 TRITON WATER HOLDINGS, INC. - Beverage, Food & Tobacco - Term Loan (03/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Tronox Finance LLC - Chemicals, Plastics, & Rubber - Term Loan B (09/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Tronox Finance LLC - Chemicals, Plastics, & Rubber - Term Loan B (04/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 TruGreen Limited Partnership - Services: Consumer - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Ultra Clean Holdings, Inc. - High Tech Industries - Term Loan B (09/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Unimin Corporation - Metals & Mining - Term Loan (12/20) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Univision Communications Inc. - Media: Broadcasting & Subscription - Term Loan B (05/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Univision Communications Inc. - Media: Broadcasting & Subscription - Term Loan B (6/22) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Vaco Holdings, LLC - Services: Business - Term Loan (01/22) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Vericast Corp. (c) - Media: Advertising, Printing & Publishing - Extended Term Loan (07/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Verifone Systems, Inc. - Banking, Finance, Insurance & Real Estate - Term Loan (7/18) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Vertex Aerospace Services Corp - Aerospace & Defense - Term Loan (10/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Viasat Inc - Telecommunications - Term Loan (2/22) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Virtus Investment Partners, Inc. - Banking, Finance, Insurance & Real Estate - Term Loan B (9/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Vistra Operations Company LLC - Energy: Electricity - 2018 Incremental Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 VM Consolidated, Inc. - Construction & Building - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Walker & Dunlop, Inc. - Banking, Finance, Insurance & Real Estate - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Warner Music Group Corp. (WMG Acquisition Corp.) - Hotel, Gaming & Leisure - Term Loan J - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Watlow Electric Manufacturing Company - High Tech Industries - Term Loan B (03/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 WeddingWire, Inc. - Services: Consumer - Term Loan (09/23) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 WEX Inc. - Services: Business - Term Loan B (11/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Windsor Holdings III, LLC - Chemicals, Plastics, & Rubber - Term Loan B (09/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Wyndham Hotels & Resorts, Inc. - Hotel, Gaming & Leisure - Term Loan (05/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Xperi Corporation - High Tech Industries - Term Loan B (05/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Zayo Group, LLC - Telecommunications - Term Loan 4/22 - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 ZEBRA BUYER (Allspring) LLC - Banking, Finance, Insurance & Real Estate - Term Loan 4/21 - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Zekelman Industries, Inc. - Metals & Mining - Term Loan B (03/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Zest Acquisition Corp. - Healthcare & Pharmaceuticals - Term Loan (1/23) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Zodiac Pool Solutions - Consumer goods: Durable - Term Loan (1/22) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 TOTAL INVESTMENTS sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 U.S. Bank Money Market sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Total cash and cash equivalents sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-11-30 0001377936 Altisource Solutions S.a r.l. - Banking, Finance, Insurance & Real Estate - Common Stock - Equity sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Envision Parent Inc - Healthcare & Pharmaceuticals - Common Stock - Equity sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Envision Parent Inc - Healthcare & Pharmaceuticals - Warrants - Equity sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Isagenix International, LLC - Beverage, Food & Tobacco - Common Stock - Equity sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Resolute Investment Managers (American Beacon), Inc. - Banking, Finance, Insurance & Real Estate - Common Stock - Equity sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 URS TOPCO LLC - Transportation: Cargo - Common Stock - Equity sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 1011778 B.C Unltd Liability Co - Beverage, Food & Tobacco - Term Loan B (09/23) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 19TH HOLDINGS GOLF, LLC - Consumer goods: Durable - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 888 Acquisitions Limited - Hotel, Gaming & Leisure - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Adtalem Global Education Inc. - Services: Business - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Aegis Sciences Corporation - Healthcare & Pharmaceuticals - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Agiliti Health Inc. - Healthcare & Pharmaceuticals - Term Loan B (03/23) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 AHEAD DB Holdings, LLC - Services: Business - Term Loan (04/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Air Canada - Transportation: Consumer - Term Loan B (07/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 AIS HoldCo, LLC - Services: Business - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 AIT Worldwide Logistics Holdings, Inc. - Transportation: Cargo - Term Loan (04/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Alchemy US Holdco 1, LLC - Metals & Mining - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 AlixPartners, LLP - Banking, Finance, Insurance & Real Estate - Term Loan B (01/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Alkermes, Inc. - Healthcare & Pharmaceuticals - Term Loan B (3/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Allen Media, LLC - Media: Diversified & Production - Term Loan (7/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Alliant Holdings Intermediate, LLC - Banking, Finance, Insurance & Real Estate - Term Loan (12/23) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Allied Universal Holdco LLC - Services: Business - Term Loan 4/21 - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Alterra Mountain Company (Intrawest Resort Holdings) - Hotel, Gaming & Leisure - Term Loan B Add-on - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Altisource Solutions S.a r.l. (c) - Banking, Finance, Insurance & Real Estate - Term Loan B (03/18) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Altium Packaging LLC - Containers, Packaging & Glass - Term Loan (01/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Amer Sports Oyj (MASCOT BIDCO OY) - Consumer goods: Durable - USD Term Loan B (01/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 American Axle & Manufacturing Inc. - Automotive - Term Loan (12/22) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 American Greetings Corporation - Media: Advertising, Printing & Publishing - Term Loan (01/23) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 American Trailer World Corp - Automotive - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 AmWINS Group, LLC - Banking, Finance, Insurance & Real Estate - Term Loan 2/21 - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Anastasia Parent LLC - Consumer goods: Non-durable - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Anchor Packaging, LLC - Containers, Packaging & Glass - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 ANI Pharmaceuticals, Inc. - Healthcare & Pharmaceuticals - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 AP Core Holdings II LLC - High Tech Industries - Term Loan B1 - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 AP Core Holdings II LLC - High Tech Industries - Term Loan B2 - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 APEX GROUP TREASURY LLC - Banking, Finance, Insurance & Real Estate - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Apollo Commercial Real Estate Finance, Inc. - Banking, Finance, Insurance & Real Estate - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Apollo Commercial Real Estate Finance, Inc. - Banking, Finance, Insurance & Real Estate - Term Loan B1 (2/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 AppLovin Corporation - High Tech Industries - Term Loan (10/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 AppLovin Corporation - High Tech Industries - Term Loan (08/23) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 AqGen Ascensus, Inc. - Banking, Finance, Insurance & Real Estate - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Aramark Services, Inc. - Services: Consumer - Term Loan B (4/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Aramark Services, Inc. - Services: Consumer - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 ARC FALCON I INC. - Chemicals, Plastics, & Rubber - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Arches Buyer Inc. - Services: Consumer - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 ARCIS GOLF LLC - Services: Consumer - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Aretec Group, Inc. - Banking, Finance, Insurance & Real Estate - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Aspire Bakeries Holdings, LLC - Beverage, Food & Tobacco - Term loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Asplundh Tree Expert, LLC - Services: Business - Term Loan 2/21 - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 AssuredPartners Capital, Inc. - Banking, Finance, Insurance & Real Estate - Term Loan B (2/20) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Assuredpartners Inc. - Banking, Finance, Insurance & Real Estate - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Assuredpartners Inc. - Banking, Finance, Insurance & Real Estate - Incremental Term Loan (7/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Asurion, LLC - Banking, Finance, Insurance & Real Estate - Term Loan B10 - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Asurion, LLC - Banking, Finance, Insurance & Real Estate - Term Loan B8 - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 ATHENAHEALTH GROUP INC. - Healthcare & Pharmaceuticals - Term Loan B (2/22) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Avolon TLB Borrower 1 (US) LLC - Capital Equipment - Term Loan B6 - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Axalta Coating Systems US Holdings - Chemicals, Plastics, & Rubber - Term Loan B (08/23) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 AZURITY PHARMACEUTICALS, INC. - Healthcare & Pharmaceuticals - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 B&G Foods, Inc. - Beverage, Food & Tobacco - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 BAKELITE UK INTERMEDIATE LTD. - Chemicals, Plastics, & Rubber - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Baldwin Risk Partners, LLC - Banking, Finance, Insurance & Real Estate - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Barnes Group Inc. - Aerospace & Defense - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Bausch Health Companies Inc. - Healthcare & Pharmaceuticals - Term Loan B (1/22) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Belfor Holdings Inc. - Services: Consumer - Term Loan B-1 (11/23) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Belron Finance US LLC - Automotive - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Belron Finance US LLC - Automotive - Term Loan B - Loan - One sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Bengal Debt Merger Sub LLC - Beverage, Food & Tobacco - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Blackstone Mortgage Trust, Inc. - Banking, Finance, Insurance & Real Estate - Term Loan (6/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Blackstone Mortgage Trust, Inc. - Banking, Finance, Insurance & Real Estate - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Blue Tree Holdings, Inc. - Chemicals, Plastics, & Rubber - Term Loan (2/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Bombardier Recreational Products, Inc. - Consumer goods: Durable - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Bombardier Recreational Products, Inc. - Consumer goods: Durable - Term Loan B3 - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Boost Newco Borrower, LLC (Worldpay) - Banking, Finance, Insurance & Real Estate - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Boxer Parent Company, Inc. - High Tech Industries - Term Loan USD (11/23) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 BrightSpring Health Services (Phoenix Guarantor) - Healthcare & Pharmaceuticals - Term Loan (02/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 BroadStreet Partners, Inc. - Banking, Finance, Insurance & Real Estate - Term Loan B3 - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Brookfield WEC Holdings Inc. - Energy: Electricity - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 BROWN GROUP HOLDING, LLC - Aerospace & Defense - Term Loan B-2 - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Buckeye Partners, L.P. - Utilities: Oil & Gas - Term Loan B2 - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Buckeye Partners, L.P. - Utilities: Oil & Gas - Term Loan B 3 - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 BW Gas & Convenience Holdings LLC - Beverage, Food & Tobacco - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Callaway Golf Company - Retail - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Calpine Corporation - Utilities: Electric - Term Loan B-10 (01/20) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Camping World, Inc. - Retail - Term Loan B (5/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 CAPSTONE BORROWER INC - Services: Business - Term Loan (06/23) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 CareerBuilder, LLC - Services: Business - Term Loan B3 - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Castle US Holding Corporation - Media: Advertising, Printing & Publishing - Term Loan B (USD) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 CASTLELAKE AVIATION LLC - Aerospace & Defense - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Catalent Pharma Solutions, Inc. - Healthcare & Pharmaceuticals - Term Loan B4 - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Catalent Pharma Solutions, Inc. - Healthcare & Pharmaceuticals - Term Loan B3 (2/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 CBL & Associates Limited Partnership - Retail - Term Loan 11/21 - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 CCC Intelligent Solutions Inc. - Services: Business - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 CCI Buyer, Inc - Telecommunications - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 CCRR Parent, Inc. - Healthcare & Pharmaceuticals - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 CCRR Parent, Inc. - Healthcare & Pharmaceuticals - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 CCS-CMGC Holdings, Inc. - Healthcare & Pharmaceuticals - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 CDK GLOBAL, INC. - High Tech Industries - Term Loan B (10/23) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Cengage Learning, Inc. - Media: Advertising, Printing & Publishing - Term Loan B (6/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 CENTURI GROUP, INC. - Construction & Building - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 CenturyLink, Inc. - Telecommunications - Term Loan B (1/20) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Charlotte Buyer, Inc. - Services: Business - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Chemours Company, (The) - Chemicals, Plastics, & Rubber - Term Loan B2 - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Churchill Downs Incorporated - Hotel, Gaming & Leisure - Term Loan B1 (3/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 CIMPRESS PUBLIC LIMITED COMPANY - Media: Advertising, Printing & Publishing - USD Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 CITADEL SECURITIES LP - Banking, Finance, Insurance & Real Estate - Term Loan B (01/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Citco Funding LLC - Banking, Finance, Insurance & Real Estate - Term Loa 1st Lien Incremental - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Clarios Global LP - Automotive - Term Loan (12/23) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Claros Mortgage Trust, Inc - Banking, Finance, Insurance & Real Estate - Term Loan B-1 (11/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 CLYDESDALE ACQUISITION HOLDINGS, INC. - Containers, Packaging & Glass - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Columbus McKinnon Corporation - Capital Equipment - Term Loan (4/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Conduent, Inc. - Services: Business - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Connect Finco SARL - Telecommunications - Term Loan (1/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Consolidated Communications, Inc. - Telecommunications - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 CORAL-US CO-BORROWER LLC - Telecommunications - Term Loan B-5 - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Corelogic, Inc. - Services: Business - Term Loan (4/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Cortes NP Acquisition Corp (Vertiv) - Capital Equipment - Term Loan B (12/23) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Creative Artists Agency, LLC - Media: Diversified & Production - Term Loan B (02/23) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 CROCS INC - Consumer goods: Durable - Term Loan B (01/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Cross Financial Corp - Banking, Finance, Insurance & Real Estate - Term Loan B2 - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Crown Subsea Communications Holding, Inc. - Construction & Building - Term Loan B (01/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 CSC Holdings LLC (Neptune Finco Corp.) - Media: Broadcasting & Subscription - Term Loan B-5 - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 CSC Holdings LLC (Neptune Finco Corp.) - Media: Broadcasting & Subscription - Term Loan 12/22 - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 CTC Holdings, LP - Banking, Finance, Insurance & Real Estate - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 CTS Midco, LLC - High Tech Industries - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Daseke Inc - Transportation: Cargo - Term Loan 2/21 - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Dave & Buster's Inc. - Hotel, Gaming & Leisure - Term Loan B (1/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 DCert Buyer, Inc. - High Tech Industries - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Delek US Holdings, Inc. - Utilities: Oil & Gas - Term Loan B (11/22) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Delos Aircraft DAC - Transportation: Consumer - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Delta 2 Lux Sarl - Hotel, Gaming & Leisure - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Derby Buyer LLC - Chemicals, Plastics, & Rubber - Term Loan (09/23) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 DexKo Global, Inc. (Dragon Merger) - Automotive - Term Loan (9/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 DG Investment Intermediate Holdings 2, Inc. - Aerospace & Defense - Incremental Term Loan (3/22) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Diamond Sports Group, LLC - Media: Broadcasting & Subscription - 1st Priority Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 DIRECTV FINANCING, LLC - Media: Broadcasting & Subscription - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 DISCOVERY PURCHASER CORPORATION - Chemicals, Plastics, & Rubber - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Dispatch Acquisition Holdings, LLC - Environmental Industries - Term Loan B (3/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 DOMTAR CORPORATION - Forest Products & Paper - Term Loan 9/21 - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 DOTDASH MEREDITH, INC. - Media: Advertising, Printing & Publishing - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 DRI HOLDING INC. - Media: Advertising, Printing & Publishing - Term Loan (12/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 DRW Holdings, LLC - Banking, Finance, Insurance & Real Estate - Term Loan (2/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 DTZ U.S. Borrower, LLC - Construction & Building - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 DTZ U.S. Borrower, LLC - Construction & Building - Term Loan (01/23) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 DTZ U.S. Borrower, LLC - Construction & Building - Term Loan (08/23) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 EAB Global, Inc. - Services: Business - Term Loan (08/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Echo Global Logistics, Inc. - Services: Business - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Edelman Financial Group Inc., The - Banking, Finance, Insurance & Real Estate - Term Loan B (3/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Electrical Components Inter., Inc. - Capital Equipment - Term Loan (6/18) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 ELECTRON BIDCO INC. - Healthcare & Pharmaceuticals - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 ELO Touch Solutions, Inc. - Media: Diversified & Production - Term Loan (12/18) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Embecta Corp - Healthcare & Pharmaceuticals - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Emerson Climate Technologies Inc - Services: Business - Term Loan B (04/23) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Endo Luxembourg Finance Company I S.a.r.l. - Healthcare & Pharmaceuticals - Term Loan (3/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Endure Digital, Inc. - High Tech Industries - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Entain Holdings (Gibraltar) Limited - Hotel, Gaming & Leisure - Term Loan B (10/22) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 EOS U.S. FINCO LLC - Transportation: Cargo - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Equiniti Group PLC - Services: Business - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Evertec Group LLC - Banking, Finance, Insurance & Real Estate - Term Loan B (09/23) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 EyeCare Partners, LLC - Healthcare & Pharmaceuticals - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Fiesta Purchaser, Inc. - Beverage, Food & Tobacco - First Lien TLB - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Finco I LLC - Banking, Finance, Insurance & Real Estate - Term Loan B (08/23) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 First Brands Group, LLC - Automotive - 1st Lien Term Loan (3/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 First Eagle Investment Management - Banking, Finance, Insurance & Real Estate - Refinancing Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 First Student Bidco Inc. - Transportation: Consumer - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 First Student Bidco Inc. - Transportation: Consumer - Term Loan C - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Fitness International, LLC (LA Fitness) - Services: Consumer - Term Loan B (1/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Flutter Financing B.V. - Hotel, Gaming & Leisure - Third Amendment 2028-B Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Flutter Financing B.V. - Hotel, Gaming & Leisure - Term Loan B3 (11/23) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 FOCUS FINANCIAL PARTNERS, LLC - Banking, Finance, Insurance & Real Estate - Term Loan B7 - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Franchise Group, Inc. - Services: Consumer - First Out Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Franchise Group, Inc. - Services: Consumer - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Franklin Square Holdings, LP sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Froneri International (R&R Ice Cream) - Beverage, Food & Tobacco - Term Loan B-2 - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Garrett LX III S.a r.l. - Automotive - Dollar Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Gemini HDPE LLC - Chemicals, Plastics, & Rubber - Term Loan B (12/20) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Genesee & Wyoming, Inc. - Transportation: Cargo - Term Loan (11/19) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 GGP Inc. - Banking, Finance, Insurance & Real Estate - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 GIP Pilot Acquisition Partners, L.P. - Energy: Oil & Gas - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Global Tel*Link Corporation - Telecommunications - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Go Daddy Operating Company, LLC - High Tech Industries - Term Loan 2/21 - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 GOLDEN WEST PACKAGING GROUP LLC - Forest Products & Paper - Term Loan (11/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 GOTO GROUP, INC. - High Tech Industries - First Lien Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 GOTO GROUP, INC. - High Tech Industries - Second-Out Term Loan (02/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Graham Packaging Co Inc - Containers, Packaging & Glass - Term Loan (2/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Great Outdoors Group, LLC - Retail - Term Loan B2 - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Griffon Corporation - Consumer goods: Durable - Term Loan B -Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Grosvenor Capital Management Holdings, LLLP - Banking, Finance, Insurance & Real Estate - Amendment 5 Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Groupe Solmax Inc. - Environmental Industries - Term Loan (6/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 GYP HOLDINGS III CORP. - Construction & Building - Term Loan (1/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Harbor Freight Tools USA, Inc. - Retail - Term Loan B (06/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Helix Gen Funding, LLc - Energy: Electricity - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Hertz Corporation (The) - Transportation: Consumer - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Hillman Group Inc. (The) (New) - Consumer goods: Durable - Term Loan B-1 (2/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Hilton Domestic Operating Company Inc. - Hotel, Gaming & Leisure - Term Loan B 4 - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Hilton Grand Vacations Borrower LLC - Hotel, Gaming & Leisure - Term Loan (3/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Hilton Grand Vacations Borrower LLC - Hotel, Gaming & Leisure - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 HLF Financing SARL (Herbalife) - Consumer goods: Non-durable - Term Loan B (08/18) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Holley Purchaser, Inc - Automotive - Term Loan (11/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Hudson River Trading LLC - Banking, Finance, Insurance & Real Estate - Term Loan (3/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Hunter Douglas Inc - Consumer goods: Durable - Term Loan B-1 - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Hyperion Refinance S.a.r.l. - Banking, Finance, Insurance & Real Estate - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Idera, Inc. - High Tech Industries - Term Loan (02/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 IMA Financial Group, Inc. - Banking, Finance, Insurance & Real Estate - Term Loan (10/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 INDY US BIDCO, LLC - Services: Business - Term Loan (11/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 INEOS 226 Ltd. - Chemicals, Plastics, & Rubber - Term Loan 3/23 - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Ineos US Finance LLC - Chemicals, Plastics, & Rubber - Term Loan C - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 INEOS US PETROCHEM LLC - Chemicals, Plastics, & Rubber - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Informatica Inc. - High Tech Industries - Term Loan B (10/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Ingram Micro Inc. - Wholesale - Term Loan (09/23) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Inmar, Inc. - Services: Business - Term Loan (06/23) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Innophos, Inc. - Chemicals, Plastics, & Rubber - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 INSTANT BRANDS HOLDINGS INC. - Consumer goods: Durable - Instant Brands TL - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 INSTANT BRANDS HOLDINGS INC. (b) - Consumer goods: Durable - Term Loan 4/21 - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 INSTANT BRANDS HOLDINGS INC. (c) - Consumer goods: Durable - PIK DIP Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 IRB Holding Corporation - Beverage, Food & Tobacco - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Isagenix International, LLC (c) - Beverage, Food & Tobacco - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Isolved Inc. - Services: Business - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Jane Street Group - Banking, Finance, Insurance & Real Estate - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Journey Personal Care Corp. - Consumer goods: Non-durable - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 JP Intermediate B, LLC - Consumer goods: Non-durable - Term Loan 7/23 - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Kleopatra Finco S.a r.l. - Containers, Packaging & Glass - Term Loan (1/21) (USD) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Kodiak BP, LLC - Construction & Building - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Koppers Inc - Chemicals, Plastics, & Rubber - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 KREF Holdings X LLC - Banking, Finance, Insurance & Real Estate - Term Loan (11/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Lakeland Tours, LLC (c) - Hotel, Gaming & Leisure - Holdco Fixed Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Lealand Finance Company B.V. (c) - Energy: Oil & Gas - Exit Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 LHS BORROWER, LLC - Construction & Building - Term Loan (02/22) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Lifetime Brands, Inc - Consumer goods: Non-durable - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Liquid Tech Solutions Holdings, LLC - Services: Business - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 LOYALTY VENTURES INC. (b) - Services: Business - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 LPL Holdings, Inc. - Banking, Finance, Insurance & Real Estate - Term Loan B1 - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 LSF11 A5 HOLDCO LLC - Chemicals, Plastics, & Rubber - Term Loan (01/23) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 LSF11 A5 HOLDCO LLC - Chemicals, Plastics, & Rubber - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 LSF11 TRINITY BIDCO INC - Aerospace & Defense - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 LSF9 Atlantis Holdings, LLC(A Wireless) - Retail - Term Loan (2/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 MAGNITE, INC. - Services: Business - Term Loan B (01/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Marriott Ownership Resorts, Inc. - Hotel, Gaming & Leisure - Term Loan (11/19) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Match Group, Inc, The - Services: Consumer - Term Loan (1/20) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Max US Bidco Inc. - Beverage, Food & Tobacco - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Mayfield Agency Borrower Inc. (FeeCo) - Banking, Finance, Insurance & Real Estate - First Lien Term Loan B (12/23) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 McGraw-Hill Education, Inc. - Media: Advertising, Printing & Publishing - Term Loan (07/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 MedAssets Software Inter Hldg, Inc. - High Tech Industries - Term Loan (11/21) (USD) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Mermaid Bidco Inc. - High Tech Industries - Term Loan B2 - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Michaels Companies Inc - Retail - Term Loan B (Magic Mergeco) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 MKS Instruments, Inc. - High Tech Industries - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Momentive Performance Materials Inc. - Chemicals, Plastics, & Rubber - Term Loan (03/23) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Moneygram International, Inc. - Services: Business - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Mosel Bidco SE - High Tech Industries - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 MPH Acquisition Holdings LLC (Multiplan) - Services: Business - Term Loan B (08/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 NAB Holdings, LLC (North American Bancard) - Banking, Finance, Insurance & Real Estate - Term Loan (11/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Napa Management Services Corp - Healthcare & Pharmaceuticals - Term Loan B (02/22) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Natgasoline LLC - Chemicals, Plastics, & Rubber - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 National Mentor Holdings, Inc. - Healthcare & Pharmaceuticals - Term Loan 2/21 - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 National Mentor Holdings, Inc. - Healthcare & Pharmaceuticals - Term Loan C 2/21 - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 New Trojan Parent, Inc. (c) - Consumer goods: Durable - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Nexstar Broadcasting, Inc. (Mission Broadcasting) - Media: Broadcasting & Subscription - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Next Level Apparel, Inc. - Retail - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 NortonLifeLock Inc. - High Tech Industries - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Nouryon Finance B.V. - Chemicals, Plastics, & Rubber - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Nouryon Finance B.V. - Chemicals, Plastics, & Rubber - Term Loan (05/23) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Novae LLC - Automotive - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Nuvei Technologies Corp. - High Tech Industries - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Olaplex, Inc. - Consumer goods: Non-durable - Term Loan (2/22) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Open Text Corporation - High Tech Industries - Term Loan B (08/23) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Organon & Co. - Healthcare & Pharmaceuticals - Term Loan USD - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Oxbow Carbon, LLC - Metals & Mining - Term Loan B (04/23) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 PACIFIC DENTAL SERVICES, LLC - Healthcare & Pharmaceuticals - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Pacific Gas & Electric - Utilities: Electric - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 PACTIV EVERGREEN GROUP HOLDINGS INC. - Containers, Packaging & Glass - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Padagis LLC - Healthcare & Pharmaceuticals - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 PAR PETROLEUM LLC - Energy: Oil & Gas - Term Loan 2/23 - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 PATAGONIA HOLDCO LLC - Telecommunications - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Pathway Partners Vet Management Company LLC - Services: Business - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 PCI Gaming Authority - Hotel, Gaming & Leisure - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 PEARLS (Netherlands) Bidco B.V. - Chemicals, Plastics, & Rubber - USD Term Loan (02/22) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 PEDIATRIC ASSOCIATES HOLDING COMPANY, LLC - Healthcare & Pharmaceuticals - Term Loan (12/22) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Penn National Gaming, Inc - Hotel, Gaming & Leisure - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Peraton Corp. - Aerospace & Defense - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 PHYSICIAN PARTNERS, LLC - Healthcare & Pharmaceuticals - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Pitney Bowes Inc - Services: Business - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Plastipak Holdings Inc. - Containers, Packaging & Glass - Term Loan B (11/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Playtika Holding Corp. - High Tech Industries - Term Loan B (3/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 PMHC II, INC. - Chemicals, Plastics, & Rubber - Term Loan (02/22) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 PointClickCare Technologies, Inc. - High Tech Industries - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Polymer Process Holdings, Inc. - Containers, Packaging & Glass - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Pre-Paid Legal Services, Inc. - Services: Consumer - Term Loan (12/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Presidio, Inc. - Services: Business - Term Loan B (1/20) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Prime Security Services Borrower, LLC (ADT) - Services: Consumer - Term Loan B (10/23) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 PRIORITY HOLDINGS, LLC - Services: Consumer - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 PriSo Acquisition Corporation - Construction & Building - Term Loan (01/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Project Leopard Holdings, Inc. (NEW) - High Tech Industries - Term Loan B (06/22) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Propulsion (BC) Finco - Aerospace & Defense - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 PUG LLC - Services: Consumer - Term Loan B (02/20) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Quartz AcquireCo, LLC - High Tech Industries - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 QUEST BORROWER LIMITED - High Tech Industries - Term Loan (1/22) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 R1 RCM INC. - Healthcare & Pharmaceuticals - Term Loan (12/23) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 R1 RCM INC. - Healthcare & Pharmaceuticals - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Rackspace Technology Global, Inc. - High Tech Industries - Term Loan (1/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 RAND PARENT LLC - Transportation: Cargo - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 RealPage, Inc. - High Tech Industries - Term Loan (04/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Rent-A-Center, Inc. - Retail - Term Loan B2 (9/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Research Now Group, Inc - Media: Advertising, Printing & Publishing - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Resideo Funding Inc. - Services: Consumer - Term Loan (1/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Resolute Investment Managers (American Beacon), Inc. - Banking, Finance, Insurance & Real Estate - Term Loan (12/23) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Restoration Hardware, Inc. - Retail - Term Loan (9/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Reynolds Consumer Products LLC - Containers, Packaging & Glass - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Reynolds Group Holdings Inc. - Containers, Packaging & Glass - Term Loan B2 - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Russell Investments US Inst'l Holdco, Inc. - Banking, Finance, Insurance & Real Estate - Term Loan (10/20) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 RV Retailer LLC - Automotive- Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Ryan Specialty Group LLC - Banking, Finance, Insurance & Real Estate - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 S&S HOLDINGS LLC - Services: Business - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Sally Holdings LLC - Retail - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Schweitzer-Mauduit International, Inc. - High Tech Industries - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Scientific Games Holdings LP - Hotel, Gaming & Leisure - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Sedgwick Claims Management Services, Inc. - Services: Business - Term Loan B 2/23 - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 SETANTA AIRCRAFT LEASING DAC - Aerospace & Defense - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Sitel Worldwide Corporation - Services: Business - USD Term Loan (7/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 SiteOne Landscape Supply, LLC - Services: Business - Term Loan (3/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 SMG US Midco 2, Inc. - Services: Business - Term Loan (01/20) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Smyrna Ready Mix Concrete, LLC - Construction & Building - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Sotheby's - Services: Business - Term Loan (7/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Sparta U.S. HoldCo LLC - Chemicals, Plastics, & Rubber - Term Loan (04/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Specialty Pharma III Inc. - Services: Business - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Spin Holdco, Inc. - Services: Consumer - Term Loan 3/21 - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 SRAM, LLC - Consumer goods: Durable - Term Loan (05/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 STANDARD INDUSTRIES INC. - Construction & Building - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Staples, Inc. - Wholesale - Term Loan (03/19) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Star Parent, Inc. - Services: Business - Term Loan B (09/23) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Storable, Inc - High Tech Industries - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Superannuation & Investments US LLC - Banking, Finance, Insurance & Real Estate - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Sweetwater Borrower, LLC - Retail - Term Loan (8/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Syncsort Incorporated - High Tech Industries - Term Loan B (10/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Ta TT Buyer LLC - Media: Broadcasting & Subscription - Term Loan 3/22 - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Tenable Holdings, Inc. - Services: Business - Term Loan B (6/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Teneo Holdings LLC - Banking, Finance, Insurance & Real Estate - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Ten-X, LLC - Banking, Finance, Insurance & Real Estate - Term Loan 5/23 - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 The Dun & Bradstreet Corporation - Services: Business - Term Loan (01/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Thor Industries, Inc. - Automotive - Term Loan B2 - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Torrid LLC - Wholesale - Term Loan 5/21 - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 TORY BURCH LLC - Retail - Term Loan -Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Tosca Services, LLC - Containers, Packaging & Glass - Term Loan (2/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Trans Union LLC - Banking, Finance, Insurance & Real Estate - Term Loan B7 (02/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Transdigm, Inc. - Aerospace & Defense - Term Loan H - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 TRITON WATER HOLDINGS, INC. - Beverage, Food & Tobacco - Term Loan (03/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Tronox Finance LLC - Chemicals, Plastics, & Rubber - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Tronox Finance LLC - Chemicals, Plastics, & Rubber - Incremental Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 TruGreen Limited Partnership - Services: Consumer - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Uber Technologies, Inc. - Transportation: Consumer - Term Loan 2/23 - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Ultra Clean Holdings, Inc. - High Tech Industries - Incremental Term Loan 3/21 - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Unimin Corporation - Metals & Mining - Term Loan (12/20) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 United Natural Foods, Inc - Beverage, Food & Tobacco - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Univision Communications Inc. - Media: Broadcasting & Subscription - Term Loan B (6/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Univision Communications Inc. - Media: Broadcasting & Subscription - Term Loan B (6/22) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Utz Quality Foods, LLC - Beverage, Food & Tobacco - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Vaco Holdings, LLC - Services: Business - Term Loan (01/22) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Vericast Corp. (c) - Media: Advertising, Printing & Publishing - Term Loan (12/23) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Verifone Systems, Inc. - Banking, Finance, Insurance & Real Estate - Term Loan (7/18) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Vertex Aerospace Services Corp - Aerospace & Defense - Term Loan (10/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 VFH Parent LLC - Banking, Finance, Insurance & Real Estate - Term Loan (01/22) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Viasat Inc - Telecommunications - Term Loan (2/22) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Virtus Investment Partners, Inc. - Banking, Finance, Insurance & Real Estate - Term Loan B (9/21) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Vistra Operations Company LLC - Energy: Electricity - 2018 Incremental Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Vizient, Inc - Healthcare & Pharmaceuticals - Term Loan 4/22 - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 VM Consolidated, Inc. - Construction & Building - Term Loan B (01/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Vouvray US Finance LLC - High Tech Industries - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Walker & Dunlop, Inc. - Banking, Finance, Insurance & Real Estate - Term Loan B (12/22) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Warner Music Group Corp. (WMG Acquisition Corp.) - Hotel, Gaming & Leisure - First Lien TL I (01/24) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Watlow Electric Manufacturing Company - High Tech Industries - Term Loan B - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 WeddingWire, Inc. - Services: Consumer - Term Loan (09/23) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 WEX Inc. - Services: Business - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 WildBrain Ltd. - Media: Diversified & Production - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Windsor Holdings III, LLC - Chemicals, Plastics, & Rubber - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Wyndham Hotels & Resorts, Inc. - Hotel, Gaming & Leisure - Term Loan 5/23 - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Xperi Corporation - High Tech Industries - Term Loan - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Zayo Group, LLC - Telecommunications - Term Loan 4/22 - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 ZEBRA BUYER (Allspring) LLC - Banking, Finance, Insurance & Real Estate - Term Loan 4/21 - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Zekelman Industries, Inc. - Metals & Mining - Term Loan (01/20) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Zest Acquisition Corp. - Healthcare & Pharmaceuticals - Term Loan (1/23) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Zodiac Pool Solutions - Consumer goods: Durable - Term Loan (1/22) - Loan sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 TOTAL INVESTMENTS sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 U.S. Bank Money Market sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 Total cash and cash equivalents sar:SaratogaInvestmentCorpCLO20131LtdMember 2024-02-29 0001377936 sar:SLFJVMember 2024-03-01 2024-11-30 0001377936 sar:TJHAMember sar:SeniorLoanFundJointVentureMember 2024-11-30 0001377936 sar:SeniorLoanFundJointVentureMember 2024-11-30 0001377936 sar:TJHAMember 2024-11-30 0001377936 srt:MaximumMember sar:TJHAAndSLFJVMember 2024-11-30 0001377936 srt:MinimumMember sar:TJHAAndSLFJVMember 2024-11-30 0001377936 sar:SeniorLoanFundJointVentureMember 2024-02-29 0001377936 sar:TJHAMember sar:SeniorLoanFundJointVentureMember 2024-02-29 0001377936 sar:VotingInterestInSLFJVMember 2024-11-30 0001377936 sar:SeniorLoanFundJointVentureMember 2024-09-01 2024-11-30 0001377936 sar:SeniorLoanFundJointVentureMember 2023-09-01 2023-11-30 0001377936 sar:SeniorLoanFundJointVentureMember 2024-03-01 2024-11-30 0001377936 sar:SeniorLoanFundJointVentureMember 2023-03-01 2023-11-30 0001377936 sar:SeniorLoanFundJointVentureMember 2024-11-30 2024-11-30 0001377936 sar:SeniorLoanFundJointVentureMember 2024-02-29 2024-02-29 0001377936 sar:SeniorLoanFundJointVentureMember 2023-06-09 2023-06-09 0001377936 sar:SeniorLoanFundJointVentureMember 2022-10-28 0001377936 sar:ClassEMember 2022-10-28 2022-10-28 0001377936 sar:ClassEMember 2024-11-30 0001377936 sar:ClassEMember 2024-02-29 0001377936 2010-07-30 2010-07-30 0001377936 sar:ManagementAgreementMember 2024-03-01 2024-11-30 0001377936 sar:PreIncentiveFeeMember 2024-09-01 2024-11-30 0001377936 sar:PreIncentiveFeeMember 2023-09-01 2023-11-30 0001377936 us-gaap:GainLossOnInvestmentsMember1 2024-09-01 2024-11-30 0001377936 us-gaap:GainLossOnInvestmentsMember1 2023-09-01 2023-11-30 0001377936 us-gaap:GainLossOnInvestmentsMember1 2024-03-01 2024-11-30 0001377936 us-gaap:GainLossOnInvestmentsMember1 2023-03-01 2023-11-30 0001377936 2024-11-30 2024-11-30 0001377936 srt:MaximumMember 2024-02-29 2024-02-29 0001377936 srt:MinimumMember 2024-02-29 2024-02-29 0001377936 sar:AdministrationAgreementsMember srt:MinimumMember 2024-08-01 2024-08-01 0001377936 sar:AdministrationAgreementsMember srt:MaximumMember 2024-08-01 2024-08-01 0001377936 sar:AdministrationAgreementsMember 2024-11-30 2024-11-30 0001377936 sar:AdministrationAgreementsMember 2024-02-29 2024-02-29 0001377936 sar:SaratogaCLOMember 2018-12-14 0001377936 2018-12-14 0001377936 sar:SaratogaCLOMember 2021-02-26 0001377936 sar:ClassFRThreeNotesTrancheMember 2021-02-26 0001377936 sar:ClassFRTwoNotesTrancheMember 2021-02-26 0001377936 sar:ClassGRTwoNotesTrancheMember 2021-02-26 0001377936 srt:WarehouseMember 2021-02-01 2021-02-26 0001377936 sar:SaratogaCLOMember 2021-02-01 2021-02-26 0001377936 sar:SaratogaCLOMember 2021-11-30 0001377936 sar:ClassFR3NotesMember 2021-08-09 0001377936 sar:ClassF1R3Member 2021-08-09 0001377936 sar:ClassF2R3Member 2021-08-09 0001377936 sar:ClassF1R3Member 2021-08-01 2021-08-11 0001377936 2024-06-10 2024-06-10 0001377936 sar:SaratogaCLOMember 2024-09-01 2024-11-30 0001377936 sar:SaratogaCLOMember 2023-09-01 2023-11-30 0001377936 2021-10-26 0001377936 2022-10-28 0001377936 us-gaap:FairValueInputsLevel1Member us-gaap:CorporateJointVentureMember 2024-11-30 0001377936 srt:MinimumMember us-gaap:UnsecuredDebtMember 2024-11-30 0001377936 sar:SLFJVMember 2024-11-30 0001377936 us-gaap:FairValueInputsLevel1Member us-gaap:CorporateJointVentureMember 2023-11-30 0001377936 srt:MinimumMember us-gaap:UnsecuredDebtMember 2023-11-30 0001377936 sar:SLFJVMember 2023-11-30 0001377936 sar:SLFJVMember 2024-09-01 2024-11-30 0001377936 sar:SLFJVMember 2023-09-01 2023-11-30 0001377936 sar:SLFJVMember 2024-03-01 2024-11-30 0001377936 sar:SLFJVMember 2023-03-01 2023-11-30 0001377936 sar:SLFJVMember sar:AgreementsAndRelatedPartyTransactionsMember 2024-11-30 0001377936 sar:OneNineFourZeroMember 2024-03-01 2024-11-30 0001377936 srt:MinimumMember 2018-03-23 0001377936 us-gaap:RevolvingCreditFacilityMember 2019-04-16 0001377936 us-gaap:RevolvingCreditFacilityMember 2007-04-11 0001377936 us-gaap:RevolvingCreditFacilityMember 2007-05-01 0001377936 us-gaap:RevolvingCreditFacilityMember sar:LIBORMember 2024-03-01 2024-11-30 0001377936 sar:MadisonCreditFacilityMember 2010-07-30 0001377936 sar:MadisonCreditFacilityMember 2024-03-01 2024-11-30 0001377936 sar:MadisonCreditFacilityMember 2021-10-04 2021-10-04 0001377936 sar:EncinaCreditFacilityMember 2021-10-04 0001377936 srt:MinimumMember 2021-10-04 2021-10-04 0001377936 srt:MaximumMember 2021-10-04 2021-10-04 0001377936 sar:EncinaCreditFacilityMember 2021-10-04 2021-10-04 0001377936 sar:EncinaCreditFacilityMember 2023-01-27 2023-01-27 0001377936 sar:EncinaCreditFacilityMember 2024-03-01 2024-11-30 0001377936 sar:EncinaCreditFacilityMember sar:EncinaCreditFacilityMember 2024-11-30 2024-11-30 0001377936 sar:EncinaCreditFacilityMember sar:EncinaCreditFacilityMember 2024-02-29 2024-02-29 0001377936 sar:EncinaCreditFacilityMember 2024-09-01 2024-11-30 0001377936 sar:EncinaCreditFacilityMember 2023-09-01 2023-11-30 0001377936 sar:EncinaCreditFacilityMember 2024-11-30 0001377936 sar:EncinaCreditFacilityMember 2023-03-01 2023-11-30 0001377936 sar:EncinaCreditFacilityMember 2023-11-30 0001377936 sar:OakCreditFacilityMember 2024-11-30 0001377936 srt:ScenarioForecastMember sar:LiveOakCreditFacilityMember 2025-03-27 0001377936 us-gaap:BorrowingsMember 2024-03-01 2024-11-30 0001377936 sar:LiveOakCreditFacilityMember 2024-09-01 2024-11-30 0001377936 sar:LiveOakCreditFacilityMember 2024-11-30 0001377936 sar:OakCreditFacilityMember 2024-03-01 2024-11-30 0001377936 sar:SBICMember 2024-11-30 0001377936 sar:SBICLPMember 2024-11-30 0001377936 sar:SBICMember 2024-11-30 0001377936 sar:SBICMember 2024-03-01 2024-11-30 0001377936 sar:SmallerEnterpriseMember 2024-11-30 0001377936 sar:SmallerEnterpriseMember 2024-03-01 2024-11-30 0001377936 sar:SBICIILPMember 2024-11-30 0001377936 sar:SBICIIILPMember 2024-11-30 0001377936 srt:MaximumMember sar:SBADebenturesMember 2024-11-30 0001377936 sar:SBICIILPMember 2024-03-01 2024-11-30 0001377936 sar:SBICIIILPMember 2024-03-01 2024-11-30 0001377936 sar:SBADebenturesMember 2024-09-01 2024-11-30 0001377936 sar:SBADebenturesMember 2023-09-01 2023-11-30 0001377936 sar:SBADebenturesMember 2023-03-01 2023-11-30 0001377936 sar:SevenPointSeventyFivePercentageTwoThousandTwentyFiveNotesMember 2020-07-09 0001377936 sar:SevenPointSeventyFivePercentageTwoThousandTwentyFiveNotesMember 2020-07-09 2020-07-09 0001377936 sar:SevenPointSeventyFivePercentageTwoThousandTwentyFiveNotesMember us-gaap:BorrowingsMember 2024-11-30 0001377936 sar:SevenPointSeventyFivePercentageTwoThousandTwentyFiveNotesMember 2024-09-01 2024-11-30 0001377936 sar:SevenPointSeventyFivePercentageTwoThousandTwentyFiveNotesMember 2023-09-01 2023-11-30 0001377936 sar:SevenPointSeventyFivePercentageTwoThousandTwentyFiveNotesMember 2024-03-01 2024-11-30 0001377936 sar:SevenPointSeventyFivePercentageTwoThousandTwentyFiveNotesMember 2023-03-01 2023-11-30 0001377936 sar:SixPointTwentyFiveTwoThousandTwentySevenNotesMember 2020-12-29 0001377936 sar:SixPointTwentyFiveTwoThousandTwentySevenNotesMember 2020-12-29 2020-12-29 0001377936 sar:SixPointTwentyFiveTwoThousandTwentySevenNotesMember 2021-01-28 0001377936 sar:SixPointTwentyFiveTwoThousandTwentySevenNotesMember 2021-01-28 2021-01-28 0001377936 sar:SixPointTwentyFiveTwoThousandTwentySevenNotesMember 2024-03-01 2024-11-30 0001377936 srt:MaximumMember sar:SixPointTwentyFiveTwoThousandTwentySevenNotesMember 2024-02-29 0001377936 srt:MinimumMember sar:SixPointTwentyFiveTwoThousandTwentySevenNotesMember 2024-02-29 0001377936 sar:SixPointTwentyFiveTwoThousandTwentySevenNotesMember 2024-09-01 2024-11-30 0001377936 sar:SixPointTwentyFiveTwoThousandTwentySevenNotesMember 2023-09-01 2023-11-30 0001377936 sar:SixPointTwentyFiveTwoThousandTwentySevenNotesMember 2023-03-01 2023-11-30 0001377936 sar:FourPointThreeHunderendSeventyFiveTwoThousandTwintySixNotesMember 2021-03-10 0001377936 sar:FourPointThreeHunderendSeventyFiveTwoThousandTwintySixNotesMember us-gaap:BorrowingsMember 2021-03-10 0001377936 sar:FourPointThreeHunderendSeventyFiveTwoThousandTwintySixNotesMember 2021-03-10 2021-03-10 0001377936 sar:FourPointThreeHunderendSeventyFiveTwoThousandTwintySixNotesMember 2021-07-15 0001377936 sar:FourPointThreeHunderendSeventyFiveTwoThousandTwintySixNotesMember 2021-07-15 2021-07-15 0001377936 sar:FourPointThreeHunderendSeventyFiveTwoThousandTwintySixNotesMember us-gaap:FairValueInputsLevel3Member 2024-11-30 0001377936 srt:MinimumMember sar:FourPointThreeHunderendSeventyFiveTwoThousandTwintySixNotesMember 2024-09-01 2024-11-30 0001377936 srt:MinimumMember sar:FourPointThreeHunderendSeventyFiveTwoThousandTwintySixNotesMember 2023-09-01 2023-11-30 0001377936 srt:MaximumMember sar:FourPointThreeHunderendSeventyFiveTwoThousandTwintySixNotesMember 2024-09-01 2024-11-30 0001377936 sar:FourPointThreeHunderendSeventyFiveTwoThousandTwintySixNotesMember 2024-09-01 2024-11-30 0001377936 srt:MaximumMember sar:FourPointThreeHunderendSeventyFiveTwoThousandTwintySixNotesMember 2023-09-01 2023-11-30 0001377936 sar:FourPointThreeHunderendSeventyFiveTwoThousandTwintySixNotesMember 2023-09-01 2023-11-30 0001377936 sar:FourPointThreeHunderendSeventyFiveTwoThousandTwintySixNotesMember 2024-03-01 2024-11-30 0001377936 sar:FourPointThreeHunderendSeventyFiveTwoThousandTwintySixNotesMember 2023-03-01 2023-11-30 0001377936 sar:FourPointThreeHunderendSeventyFiveTwoThousandTwintySixNotesMember us-gaap:SecuritiesFinancingTransactionCostMember 2024-03-01 2024-11-30 0001377936 sar:FourPointThirtyFiveTwoThousandTwentySevenNotesMember 2022-01-19 0001377936 sar:FourPointThirtyFiveTwoThousandTwentySevenNotesMember 2022-01-19 2022-01-19 0001377936 sar:FourPointThirtyFiveTwoThousandTwentySevenNotesMember us-gaap:FairValueInputsLevel1Member 2024-11-30 0001377936 srt:MinimumMember sar:FourPointThirtyFiveTwoThousandTwentySevenNotesMember 2024-02-29 0001377936 srt:MaximumMember sar:FourPointThirtyFiveTwoThousandTwentySevenNotesMember 2024-02-29 0001377936 sar:FourPointThirtyFiveTwoThousandTwentySevenNotesMember 2024-09-01 2024-11-30 0001377936 sar:FourPointThirtyFiveTwoThousandTwentySevenNotesMember 2023-09-01 2023-11-30 0001377936 srt:MinimumMember sar:FourPointThirtyFiveTwoThousandTwentySevenNotesMember 2023-09-01 2023-11-30 0001377936 srt:MinimumMember sar:FourPointThirtyFiveTwoThousandTwentySevenNotesMember 2024-09-01 2024-11-30 0001377936 sar:FourPointThirtyFiveTwoThousandTwentySevenNotesMember 2024-03-01 2024-11-30 0001377936 sar:FourPointThirtyFiveTwoThousandTwentySevenNotesMember 2023-03-01 2023-11-30 0001377936 sar:SixPointZeroTwoTHousandTwentySevenNotesMember 2022-04-27 0001377936 sar:SixPointZeroTwoTHousandTwentySevenNotesMember 2022-04-27 2022-04-27 0001377936 sar:SixPointZeroTwoTHousandTwentySevenNotesMember 2022-05-10 0001377936 sar:SixPointZeroTwoTHousandTwentySevenNotesMember 2022-05-10 2022-05-10 0001377936 sar:SixPointZeroTwoTHousandTwentySevenNotesMember 2022-08-15 0001377936 sar:SixPointZeroTwoTHousandTwentySevenNotesMember 2022-08-15 2022-08-15 0001377936 srt:MinimumMember sar:SixPointZeroTwoTHousandTwentySevenNotesMember 2024-11-30 0001377936 srt:MaximumMember sar:SixPointZeroTwoTHousandTwentySevenNotesMember 2024-11-30 0001377936 srt:MaximumMember sar:SixPointZeroTwoTHousandTwentySevenNotesMember 2024-02-29 0001377936 srt:MinimumMember sar:SixPointZeroTwoTHousandTwentySevenNotesMember 2024-02-29 0001377936 sar:SixPointZeroTwoTHousandTwentySevenNotesMember 2024-09-01 2024-11-30 0001377936 sar:SixPointZeroTwoTHousandTwentySevenNotesMember 2023-09-01 2023-11-30 0001377936 sar:SixPointZeroTwoTHousandTwentySevenNotesMember 2024-03-01 2024-11-30 0001377936 sar:SixPointZeroTwoTHousandTwentySevenNotesMember 2023-03-01 2023-11-30 0001377936 sar:SevenPointZeroPercentageTwoThousandTwentyFiveNotesMember 2022-09-08 0001377936 sar:SevenPointZeroPercentageTwoThousandTwentyFiveNotesMember 2022-09-08 2022-09-08 0001377936 srt:MinimumMember sar:SevenPointZeroPercentageTwoThousandTwentyFiveNotesMember 2024-02-29 0001377936 srt:MaximumMember sar:SevenPointZeroPercentageTwoThousandTwentyFiveNotesMember 2024-02-29 0001377936 sar:SevenPointZeroPercentageTwoThousandTwentyFiveNotesMember 2024-09-01 2024-11-30 0001377936 sar:SevenPointZeroPercentageTwoThousandTwentyFiveNotesMember 2023-09-01 2023-11-30 0001377936 sar:SevenPointZeroPercentageTwoThousandTwentyFiveNotesMember 2024-03-01 2024-11-30 0001377936 sar:SevenPointZeroPercentageTwoThousandTwentyFiveNotesMember 2023-03-01 2023-11-30 0001377936 sar:EightPointZeroZeroTwoThousandTwentySevenNotesMember 2022-10-27 0001377936 sar:EightPointZeroZeroTwoThousandTwentySevenNotesMember 2022-10-27 2022-10-27 0001377936 sar:EightPointZeroZeroTwoThousandTwentySevenNotesMember 2022-11-10 0001377936 srt:MinimumMember sar:EightPointZeroZeroTwoThousandTwentySevenNotesMember 2022-11-10 2022-11-10 0001377936 sar:EightPointZeroZeroTwoThousandTwentySevenNotesMember 2022-11-10 2022-11-10 0001377936 sar:EightPointZeroZeroTwoThousandTwentySevenNotesMember 2024-03-01 2024-11-30 0001377936 srt:MinimumMember sar:EightPointZeroZeroTwoThousandTwentySevenNotesMember 2024-11-30 0001377936 srt:MaximumMember sar:EightPointZeroZeroTwoThousandTwentySevenNotesMember 2024-11-30 0001377936 sar:EightPointZeroZeroTwoThousandTwentySevenNotesMember 2024-09-01 2024-11-30 0001377936 sar:EightPointZeroZeroTwoThousandTwentySevenNotesMember 2023-09-01 2023-11-30 0001377936 sar:EightPointZeroZeroTwoThousandTwentySevenNotesMember 2023-03-01 2023-11-30 0001377936 sar:EightPointOneTwentyFiveTwoThousandTwentySevenNotesMember 2022-12-13 0001377936 sar:EightPointOneTwentyFiveTwoThousandTwentySevenNotesMember 2022-12-13 2022-12-13 0001377936 sar:EightPointOneTwentyFiveTwoThousandTwentySevenNotesMember 2022-12-21 2022-12-21 0001377936 srt:MinimumMember sar:EightPointOneTwentyFiveTwoThousandTwentySevenNotesMember 2024-11-30 0001377936 srt:MaximumMember sar:EightPointOneTwentyFiveTwoThousandTwentySevenNotesMember 2024-11-30 0001377936 srt:MinimumMember sar:EightPointOneTwentyFiveTwoThousandTwentySevenNotesMember 2024-02-29 0001377936 srt:MaximumMember sar:EightPointOneTwentyFiveTwoThousandTwentySevenNotesMember 2024-02-29 0001377936 sar:EightPointOneTwentyFiveTwoThousandTwentySevenNotesMember 2024-09-01 2024-11-30 0001377936 sar:EightPointOneTwentyFiveTwoThousandTwentySevenNotesMember 2023-09-01 2023-11-30 0001377936 sar:EightPointOneTwentyFiveTwoThousandTwentySevenNotesMember 2024-03-01 2024-11-30 0001377936 sar:EightPointOneTwentyFiveTwoThousandTwentySevenNotesMember 2023-03-01 2023-11-30 0001377936 sar:EightPointOneTwentyFiveTwoThousandTwentySevenNotesMember us-gaap:SecuritiesFinancingTransactionCostMember 2024-03-01 2024-11-30 0001377936 sar:TwoThousandAndTwentyFiveNotes1Member 2023-03-31 0001377936 sar:TwoThousandAndTwentyFiveNotes1Member 2023-03-31 2023-03-31 0001377936 sar:TwoThousandAndTwentyFiveNotes1Member 2023-05-01 2023-05-01 0001377936 sar:TwoThousandAndTwentyFiveNotes1Member 2024-03-01 2024-11-30 0001377936 srt:MinimumMember sar:TwoThousandAndTwentyFiveNotes1Member 2024-02-29 0001377936 srt:MaximumMember sar:TwoThousandAndTwentyFiveNotes1Member 2024-02-29 0001377936 sar:TwoThousandAndTwentyFiveNotes1Member 2024-09-01 2024-11-30 0001377936 sar:TwoThousandAndTwentyFiveNotes1Member 2023-09-01 2023-11-30 0001377936 sar:TwoThousandAndTwentyFiveNotes1Member us-gaap:InterestExpenseMember 2024-03-01 2024-11-30 0001377936 sar:TwoThousandAndTwentyFiveNotes1Member 2023-03-01 2023-11-30 0001377936 sar:EightPointFiftyPercentageTwoThosandTwentyEightNotesMember 2023-04-14 0001377936 sar:EightPointFiftyPercentageTwoThosandTwentyEightNotesMember 2023-04-14 2023-04-14 0001377936 sar:EightPointFiftyPercentageTwoThosandTwentyEightNotesMember 2023-05-01 0001377936 sar:EightPointFiftyPercentageTwoThosandTwentyEightNotesMember 2023-04-26 0001377936 sar:EightPointFiftyPercentageTwoThosandTwentyEightNotesMember 2023-04-26 2023-04-26 0001377936 sar:EightPointFiftyPercentageTwoThosandTwentyEightNotesMember 2024-03-01 2024-11-30 0001377936 srt:MinimumMember sar:EightPointFiftyPercentageTwoThosandTwentyEightNotesMember 2024-02-29 0001377936 srt:MaximumMember sar:EightPointFiftyPercentageTwoThosandTwentyEightNotesMember 2024-02-29 0001377936 sar:EightPointFiftyPercentageTwoThosandTwentyEightNotesMember 2024-09-01 2024-11-30 0001377936 sar:EightPointFiftyPercentageTwoThosandTwentyEightNotesMember 2023-09-01 2023-11-30 0001377936 sar:EightPointFiftyPercentageTwoThosandTwentyEightNotesMember 2023-11-30 0001377936 sar:EightPointFiftyPercentageTwoThosandTwentyEightNotesMember 2023-03-01 2023-11-30 0001377936 2019-12-21 2019-12-21 0001377936 2020-02-07 2020-02-07 0001377936 sar:SixPointSevenFiveNotesDueTwoZeroTwoThreeMember 2024-11-30 0001377936 sar:TwoThousandAndTwentyFiveNotes3Member 2022-07-14 0001377936 sar:EncinaCreditFacilityMember 2024-02-29 0001377936 sar:EncinaCreditFacilityMember 2023-03-01 2024-02-29 0001377936 sar:EncinaCreditFacilityMember 2023-02-28 0001377936 sar:EncinaCreditFacilityMember 2022-03-01 2023-02-28 0001377936 sar:EncinaCreditFacilityMember 2022-02-28 0001377936 sar:EncinaCreditFacilityMember 2021-03-01 2022-02-28 0001377936 sar:LiveOakCreditFacilityMember 2024-03-01 2024-11-30 0001377936 sar:MadisonCreditFacilityMember 2021-02-28 0001377936 sar:MadisonCreditFacilityMember 2020-03-01 2021-02-28 0001377936 sar:MadisonCreditFacilityMember 2020-02-29 0001377936 sar:MadisonCreditFacilityMember 2019-03-01 2020-02-29 0001377936 sar:MadisonCreditFacilityMember 2019-02-28 0001377936 sar:MadisonCreditFacilityMember 2018-03-01 2019-02-28 0001377936 sar:MadisonCreditFacilityMember 2018-02-28 0001377936 sar:MadisonCreditFacilityMember 2017-03-01 2018-02-28 0001377936 sar:MadisonCreditFacilityMember 2017-02-28 0001377936 sar:MadisonCreditFacilityMember 2016-03-01 2017-02-28 0001377936 sar:MadisonCreditFacilityMember 2016-02-29 0001377936 sar:MadisonCreditFacilityMember 2015-03-01 2016-02-29 0001377936 sar:MadisonCreditFacilityMember 2015-02-28 0001377936 sar:MadisonCreditFacilityMember 2014-03-01 2015-02-28 0001377936 sar:MadisonCreditFacilityMember 2014-02-28 0001377936 sar:MadisonCreditFacilityMember 2013-03-01 2014-02-28 0001377936 sar:MadisonCreditFacilityMember 2013-02-28 0001377936 sar:MadisonCreditFacilityMember 2012-03-01 2013-02-28 0001377936 sar:MadisonCreditFacilityMember 2012-02-28 0001377936 sar:MadisonCreditFacilityMember 2011-03-01 2012-02-28 0001377936 sar:MadisonCreditFacilityMember 2011-02-28 0001377936 sar:MadisonCreditFacilityMember 2010-03-01 2011-02-28 0001377936 sar:MadisonCreditFacilityMember 2010-02-28 0001377936 sar:MadisonCreditFacilityMember 2009-03-01 2010-02-28 0001377936 sar:MadisonCreditFacilityMember 2009-02-28 0001377936 sar:MadisonCreditFacilityMember 2008-03-01 2009-02-28 0001377936 sar:MadisonCreditFacilityMember 2008-02-28 0001377936 sar:MadisonCreditFacilityMember 2007-03-01 2008-02-28 0001377936 sar:MadisonCreditFacilityMember 2007-02-28 0001377936 sar:MadisonCreditFacilityMember 2006-03-01 2007-02-28 0001377936 sar:SevenPointFiveZeroNotesDueTwoZeroTwoZeroMember 2017-02-28 0001377936 sar:SevenPointFiveZeroNotesDueTwoZeroTwoZeroMember 2016-03-01 2017-02-28 0001377936 sar:SevenPointFiveZeroNotesDueTwoZeroTwoZeroMember 2016-02-28 0001377936 sar:SevenPointFiveZeroNotesDueTwoZeroTwoZeroMember 2015-03-01 2016-02-28 0001377936 sar:SevenPointFiveZeroNotesDueTwoZeroTwoZeroMember 2015-02-28 0001377936 sar:SevenPointFiveZeroNotesDueTwoZeroTwoZeroMember 2014-03-01 2015-02-28 0001377936 sar:SevenPointFiveZeroNotesDueTwoZeroTwoZeroMember 2014-02-28 0001377936 sar:SevenPointFiveZeroNotesDueTwoZeroTwoZeroMember 2013-03-01 2014-02-28 0001377936 sar:SevenPointFiveZeroNotesDueTwoZeroTwoZeroMember 2013-02-28 0001377936 sar:SevenPointFiveZeroNotesDueTwoZeroTwoZeroMember 2012-03-01 2013-02-28 0001377936 sar:SevenPointFiveZeroNotesDueTwoZeroTwoZeroMember 2012-02-28 0001377936 sar:SevenPointFiveZeroNotesDueTwoZeroTwoZeroMember 2011-03-01 2012-02-28 0001377936 sar:SevenPointFiveZeroNotesDueTwoZeroTwoZeroMember 2011-02-28 0001377936 sar:SevenPointFiveZeroNotesDueTwoZeroTwoZeroMember 2010-03-01 2011-02-28 0001377936 sar:SevenPointFiveZeroNotesDueTwoZeroTwoZeroMember 2010-02-28 0001377936 sar:SevenPointFiveZeroNotesDueTwoZeroTwoZeroMember 2009-03-01 2010-02-28 0001377936 sar:SevenPointFiveZeroNotesDueTwoZeroTwoZeroMember 2009-02-28 0001377936 sar:SevenPointFiveZeroNotesDueTwoZeroTwoZeroMember 2008-03-01 2009-02-28 0001377936 sar:SevenPointFiveZeroNotesDueTwoZeroTwoZeroMember 2008-02-28 0001377936 sar:SevenPointFiveZeroNotesDueTwoZeroTwoZeroMember 2007-03-01 2008-02-28 0001377936 sar:SevenPointFiveZeroNotesDueTwoZeroTwoZeroMember 2007-02-28 0001377936 sar:SevenPointFiveZeroNotesDueTwoZeroTwoZeroMember 2006-03-01 2007-02-28 0001377936 sar:SixPointSevenFiveNotesDueTwoZeroTwoThreeMember 2020-02-29 0001377936 sar:SixPointSevenFiveNotesDueTwoZeroTwoThreeMember 2019-03-01 2020-02-29 0001377936 sar:SixPointSevenFiveNotesDueTwoZeroTwoThreeMember 2019-02-28 0001377936 sar:SixPointSevenFiveNotesDueTwoZeroTwoThreeMember 2018-03-01 2019-02-28 0001377936 sar:SixPointSevenFiveNotesDueTwoZeroTwoThreeMember 2018-02-28 0001377936 sar:SixPointSevenFiveNotesDueTwoZeroTwoThreeMember 2017-03-01 2018-02-28 0001377936 sar:SixPointSevenFiveNotesDueTwoZeroTwoThreeMember 2017-02-28 0001377936 sar:SixPointSevenFiveNotesDueTwoZeroTwoThreeMember 2016-03-01 2017-02-28 0001377936 sar:TwoThousandAndTwentyFiveNotes1Member 2024-11-30 0001377936 sar:TwoThousandAndTwentyFiveNotes1Member 2024-03-01 2024-11-30 0001377936 sar:TwoThousandAndTwentyFiveNotes1Member 2024-02-29 0001377936 sar:TwoThousandAndTwentyFiveNotes1Member 2023-03-01 2024-02-29 0001377936 sar:SixPointTwoFiveNotesDueTwoZeroTwoFiveMember 2022-02-28 0001377936 sar:SixPointTwoFiveNotesDueTwoZeroTwoFiveMember 2021-03-01 2022-02-28 0001377936 sar:SixPointTwoFiveNotesDueTwoZeroTwoFiveMember 2021-02-28 0001377936 sar:SixPointTwoFiveNotesDueTwoZeroTwoFiveMember 2020-03-01 2021-02-28 0001377936 sar:SixPointTwoFiveNotesDueTwoZeroTwoFiveMember 2020-02-29 0001377936 sar:SixPointTwoFiveNotesDueTwoZeroTwoFiveMember 2019-03-01 2020-02-29 0001377936 sar:SixPointTwoFiveNotesDueTwoZeroTwoFiveMember 2019-02-28 0001377936 sar:SixPointTwoFiveNotesDueTwoZeroTwoFiveMember 2018-03-01 2019-02-28 0001377936 sar:SevenPointZeroPercentageTwoThousandTwentyFiveNotesMember 2024-11-30 0001377936 sar:SevenPointZeroPercentageTwoThousandTwentyFiveNotesMember 2024-03-01 2024-11-30 0001377936 sar:SevenPointZeroPercentageTwoThousandTwentyFiveNotesMember 2024-02-29 0001377936 sar:SevenPointZeroPercentageTwoThousandTwentyFiveNotesMember 2023-03-01 2024-02-29 0001377936 sar:SevenPointZeroPercentageTwoThousandTwentyFiveNotesMember 2023-02-28 0001377936 sar:SevenPointZeroPercentageTwoThousandTwentyFiveNotesMember 2022-03-01 2023-02-28 0001377936 sar:TwoThousandAndTwentyFiveNotes3Member 2023-02-28 0001377936 sar:TwoThousandAndTwentyFiveNotes3Member 2022-03-01 2023-02-28 0001377936 sar:TwoThousandAndTwentyFiveNotes3Member 2022-02-28 0001377936 sar:TwoThousandAndTwentyFiveNotes3Member 2021-03-01 2022-02-28 0001377936 sar:TwoThousandAndTwentyFiveNotes3Member 2021-02-28 0001377936 sar:TwoThousandAndTwentyFiveNotes3Member 2020-03-01 2021-02-28 0001377936 sar:SevenPointSeventyFivePercentageTwoThousandTwentyFiveNotesMember 2024-11-30 0001377936 sar:SevenPointSeventyFivePercentageTwoThousandTwentyFiveNotesMember 2024-03-01 2024-11-30 0001377936 sar:SevenPointSeventyFivePercentageTwoThousandTwentyFiveNotesMember 2024-02-29 0001377936 sar:SevenPointSeventyFivePercentageTwoThousandTwentyFiveNotesMember 2023-03-01 2024-02-29 0001377936 sar:SevenPointSeventyFivePercentageTwoThousandTwentyFiveNotesMember 2023-02-28 0001377936 sar:SevenPointSeventyFivePercentageTwoThousandTwentyFiveNotesMember 2022-03-01 2023-02-28 0001377936 sar:SevenPointSeventyFivePercentageTwoThousandTwentyFiveNotesMember 2022-02-28 0001377936 sar:SevenPointSeventyFivePercentageTwoThousandTwentyFiveNotesMember 2021-03-01 2022-02-28 0001377936 sar:SevenPointSeventyFivePercentageTwoThousandTwentyFiveNotesMember 2021-02-28 0001377936 sar:SevenPointSeventyFivePercentageTwoThousandTwentyFiveNotesMember 2020-03-01 2021-02-28 0001377936 sar:FourPointThreeHunderendSeventyFiveTwoThousandTwintySixNotesMember 2024-11-30 0001377936 sar:FourPointThreeHunderendSeventyFiveTwoThousandTwintySixNotesMember 2024-03-01 2024-11-30 0001377936 sar:FourPointThreeHunderendSeventyFiveTwoThousandTwintySixNotesMember 2024-02-29 0001377936 sar:FourPointThreeHunderendSeventyFiveTwoThousandTwintySixNotesMember 2023-03-01 2024-02-29 0001377936 sar:FourPointThreeHunderendSeventyFiveTwoThousandTwintySixNotesMember 2023-02-28 0001377936 sar:FourPointThreeHunderendSeventyFiveTwoThousandTwintySixNotesMember 2022-03-01 2023-02-28 0001377936 sar:FourPointThreeHunderendSeventyFiveTwoThousandTwintySixNotesMember 2022-02-28 0001377936 sar:FourPointThreeHunderendSeventyFiveTwoThousandTwintySixNotesMember 2021-03-01 2022-02-28 0001377936 sar:FourPointThirtyFiveTwoThousandTwentySevenNotesMember 2024-11-30 0001377936 sar:FourPointThirtyFiveTwoThousandTwentySevenNotesMember 2024-03-01 2024-11-30 0001377936 sar:FourPointThirtyFiveTwoThousandTwentySevenNotesMember 2024-02-29 0001377936 sar:FourPointThirtyFiveTwoThousandTwentySevenNotesMember 2023-03-01 2024-02-29 0001377936 sar:FourPointThirtyFiveTwoThousandTwentySevenNotesMember 2023-02-28 0001377936 sar:FourPointThirtyFiveTwoThousandTwentySevenNotesMember 2022-03-01 2023-02-28 0001377936 sar:FourPointThirtyFiveTwoThousandTwentySevenNotesMember 2022-02-28 0001377936 sar:FourPointThirtyFiveTwoThousandTwentySevenNotesMember 2021-03-01 2022-02-28 0001377936 sar:SixPointZeroTwoTHousandTwentySevenNotesMember 2024-11-30 0001377936 sar:SixPointZeroTwoTHousandTwentySevenNotesMember 2024-03-01 2024-11-30 0001377936 sar:SixPointZeroTwoTHousandTwentySevenNotesMember 2024-02-29 0001377936 sar:SixPointZeroTwoTHousandTwentySevenNotesMember 2023-03-01 2024-02-29 0001377936 sar:SixPointZeroTwoTHousandTwentySevenNotesMember 2023-02-28 0001377936 sar:SixPointZeroTwoTHousandTwentySevenNotesMember 2022-03-01 2023-02-28 0001377936 sar:SixPointTwentyFiveTwoThousandTwentySevenNotesMember 2024-11-30 0001377936 sar:SixPointTwentyFiveTwoThousandTwentySevenNotesMember 2024-03-01 2024-11-30 0001377936 sar:SixPointTwentyFiveTwoThousandTwentySevenNotesMember 2024-02-29 0001377936 sar:SixPointTwentyFiveTwoThousandTwentySevenNotesMember 2023-03-01 2024-02-29 0001377936 sar:SixPointTwentyFiveTwoThousandTwentySevenNotesMember 2023-02-28 0001377936 sar:SixPointTwentyFiveTwoThousandTwentySevenNotesMember 2022-03-01 2023-02-28 0001377936 sar:SixPointTwentyFiveTwoThousandTwentySevenNotesMember 2022-02-28 0001377936 sar:SixPointTwentyFiveTwoThousandTwentySevenNotesMember 2021-03-01 2022-02-28 0001377936 sar:SixPointTwentyFiveTwoThousandTwentySevenNotesMember 2021-02-28 0001377936 sar:SixPointTwentyFiveTwoThousandTwentySevenNotesMember 2020-03-01 2021-02-28 0001377936 sar:EightPointZeroZeroTwoThousandTwentySevenNotesMember 2024-11-30 0001377936 sar:EightPointZeroZeroTwoThousandTwentySevenNotesMember 2024-03-01 2024-11-30 0001377936 sar:EightPointZeroZeroTwoThousandTwentySevenNotesMember 2024-02-29 0001377936 sar:EightPointZeroZeroTwoThousandTwentySevenNotesMember 2023-03-01 2024-02-29 0001377936 sar:EightPointOneTwentyFiveTwoThousandTwentySevenNotesMember 2024-11-30 0001377936 sar:EightPointOneTwentyFiveTwoThousandTwentySevenNotesMember 2024-03-01 2024-11-30 0001377936 sar:EightPointOneTwentyFiveTwoThousandTwentySevenNotesMember 2024-02-29 0001377936 sar:EightPointOneTwentyFiveTwoThousandTwentySevenNotesMember 2023-03-01 2024-02-29 0001377936 sar:EightPointOneTwentyFiveTwoThousandTwentySevenNotesMember 2023-02-28 0001377936 sar:EightPointOneTwentyFiveTwoThousandTwentySevenNotesMember 2022-03-01 2023-02-28 0001377936 sar:EightPointFiftyPercentageTwoThosandTwentyEightNotesMember 2024-11-30 0001377936 sar:EightPointFiftyPercentageTwoThosandTwentyEightNotesMember 2024-03-01 2024-11-30 0001377936 sar:EightPointFiftyPercentageTwoThosandTwentyEightNotesMember 2024-02-29 0001377936 sar:EightPointFiftyPercentageTwoThosandTwentyEightNotesMember 2023-03-01 2024-02-29 0001377936 sar:EncinaCreditFacilityMember 2024-11-30 0001377936 sar:EncinaCreditFacilityMember 2024-11-30 0001377936 sar:LiveOakCreditFacilityMember 2024-11-30 0001377936 sar:EightPointSevenFivePercentageNotesMember 2024-11-30 0001377936 sar:ActiveProspectIncMember sar:CompanysDiscretionMember 2024-11-30 0001377936 sar:ActiveProspectIncMember sar:CompanysDiscretionMember 2024-02-29 0001377936 sar:ArtemisWaxCorpMember sar:CompanysDiscretionMember 2024-11-30 0001377936 sar:ArtemisWaxCorpMember sar:CompanysDiscretionMember 2024-02-29 0001377936 sar:AscendSoftwareLLCMember sar:CompanysDiscretionMember 2024-11-30 0001377936 sar:AscendSoftwareLLCMember sar:CompanysDiscretionMember 2024-02-29 0001377936 sar:C2EducationalSystemsIncMember sar:CompanysDiscretionMember 2024-11-30 0001377936 sar:C2EducationalSystemsIncMember sar:CompanysDiscretionMember 2024-02-29 0001377936 sar:DaviswareLLCMember sar:CompanysDiscretionMember 2024-11-30 0001377936 sar:DaviswareLLCMember sar:CompanysDiscretionMember 2024-02-29 0001377936 sar:GraniteComfortLPMember sar:CompanysDiscretionMember 2024-11-30 0001377936 sar:GraniteComfortLPMember sar:CompanysDiscretionMember 2024-02-29 0001377936 sar:JDXpertMember sar:CompanysDiscretionMember 2024-11-30 0001377936 sar:JDXpertMember sar:CompanysDiscretionMember 2024-02-29 0001377936 sar:LFRChickenLLCMember sar:CompanysDiscretionMember 2024-11-30 0001377936 sar:LFRChickenLLCMember sar:CompanysDiscretionMember 2024-02-29 0001377936 sar:PepperPalaceIncMember sar:CompanysDiscretionMember 2024-11-30 0001377936 sar:PepperPalaceIncMember sar:CompanysDiscretionMember 2024-02-29 0001377936 sar:ProcurementPartnersLLCMember sar:CompanysDiscretionMember 2024-11-30 0001377936 sar:ProcurementPartnersLLCMember sar:CompanysDiscretionMember 2024-02-29 0001377936 sar:SaratogaSeniorLoanFundIJVLLC1Member sar:CompanysDiscretionMember 2024-11-30 0001377936 sar:SaratogaSeniorLoanFundIJVLLC1Member sar:CompanysDiscretionMember 2024-02-29 0001377936 sar:SceptreHospitalityResourcesLLCMember sar:CompanysDiscretionMember 2024-11-30 0001377936 sar:SceptreHospitalityResourcesLLCMember sar:CompanysDiscretionMember 2024-02-29 0001377936 sar:StretchZoneFranchisingLLCMember sar:CompanysDiscretionMember 2024-11-30 0001377936 sar:StretchZoneFranchisingLLCMember sar:CompanysDiscretionMember 2024-02-29 0001377936 sar:VetnCareMSOLLCMember sar:CompanysDiscretionMember 2024-11-30 0001377936 sar:VetnCareMSOLLCMember sar:CompanysDiscretionMember 2024-02-29 0001377936 sar:CompanysDiscretionMember 2024-11-30 0001377936 sar:CompanysDiscretionMember 2024-02-29 0001377936 sar:AlphaAestheticsPartnersOpCoLLCMember sar:PortfolioCompanysDiscretionSatisfactionOfCertainFinancialAndNonfinancialCovenantsRequiredMember 2024-11-30 0001377936 sar:AlphaAestheticsPartnersOpCoLLCMember sar:PortfolioCompanysDiscretionSatisfactionOfCertainFinancialAndNonfinancialCovenantsRequiredMember 2024-02-29 0001377936 sar:ARCHealthOpCoLLCMember sar:PortfolioCompanysDiscretionSatisfactionOfCertainFinancialAndNonfinancialCovenantsRequiredMember 2024-11-30 0001377936 sar:ARCHealthOpCoLLCMember sar:PortfolioCompanysDiscretionSatisfactionOfCertainFinancialAndNonfinancialCovenantsRequiredMember 2024-02-29 0001377936 sar:AxeroHoldingsRevolverMember sar:PortfolioCompanysDiscretionSatisfactionOfCertainFinancialAndNonfinancialCovenantsRequiredMember 2024-11-30 0001377936 sar:AxeroHoldingsRevolverMember sar:PortfolioCompanysDiscretionSatisfactionOfCertainFinancialAndNonfinancialCovenantsRequiredMember 2024-02-29 0001377936 sar:AxiomMedicalConsultingLLCMember sar:PortfolioCompanysDiscretionSatisfactionOfCertainFinancialAndNonfinancialCovenantsRequiredMember 2024-11-30 0001377936 sar:AxiomMedicalConsultingLLCMember sar:PortfolioCompanysDiscretionSatisfactionOfCertainFinancialAndNonfinancialCovenantsRequiredMember 2024-02-29 0001377936 sar:BQESoftwareIncMember sar:PortfolioCompanysDiscretionSatisfactionOfCertainFinancialAndNonfinancialCovenantsRequiredMember 2024-11-30 0001377936 sar:BQESoftwareIncMember sar:PortfolioCompanysDiscretionSatisfactionOfCertainFinancialAndNonfinancialCovenantsRequiredMember 2024-02-29 0001377936 sar:C2EducationalSystemsIncMember sar:PortfolioCompanysDiscretionSatisfactionOfCertainFinancialAndNonfinancialCovenantsRequiredMember 2024-11-30 0001377936 sar:C2EducationalSystemsIncMember sar:PortfolioCompanysDiscretionSatisfactionOfCertainFinancialAndNonfinancialCovenantsRequiredMember 2024-02-29 0001377936 sar:CloudpermitIntermediateHoldingCompanyMember sar:PortfolioCompanysDiscretionSatisfactionOfCertainFinancialAndNonfinancialCovenantsRequiredMember 2024-11-30 0001377936 sar:CloudpermitIntermediateHoldingCompanyMember sar:PortfolioCompanysDiscretionSatisfactionOfCertainFinancialAndNonfinancialCovenantsRequiredMember 2024-02-29 0001377936 sar:DaviswareLLCMember sar:PortfolioCompanysDiscretionSatisfactionOfCertainFinancialAndNonfinancialCovenantsRequiredMember 2024-11-30 0001377936 sar:DaviswareLLCMember sar:PortfolioCompanysDiscretionSatisfactionOfCertainFinancialAndNonfinancialCovenantsRequiredMember 2024-02-29 0001377936 sar:ExigoLLCMember sar:PortfolioCompanysDiscretionSatisfactionOfCertainFinancialAndNonfinancialCovenantsRequiredMember 2024-11-30 0001377936 sar:ExigoLLCMember sar:PortfolioCompanysDiscretionSatisfactionOfCertainFinancialAndNonfinancialCovenantsRequiredMember 2024-02-29 0001377936 sar:Gen4DentalPartnersHoldingsLLCMember sar:PortfolioCompanysDiscretionSatisfactionOfCertainFinancialAndNonfinancialCovenantsRequiredMember 2024-11-30 0001377936 sar:Gen4DentalPartnersHoldingsLLCMember sar:PortfolioCompanysDiscretionSatisfactionOfCertainFinancialAndNonfinancialCovenantsRequiredMember 2024-02-29 0001377936 sar:GoReactMember sar:PortfolioCompanysDiscretionSatisfactionOfCertainFinancialAndNonfinancialCovenantsRequiredMember 2024-11-30 0001377936 sar:GoReactMember sar:PortfolioCompanysDiscretionSatisfactionOfCertainFinancialAndNonfinancialCovenantsRequiredMember 2024-02-29 0001377936 sar:GraniteComfortLPMember sar:PortfolioCompanysDiscretionSatisfactionOfCertainFinancialAndNonfinancialCovenantsRequiredMember 2024-11-30 0001377936 sar:GraniteComfortLPMember sar:PortfolioCompanysDiscretionSatisfactionOfCertainFinancialAndNonfinancialCovenantsRequiredMember 2024-02-29 0001377936 sar:InspectPointHoldingsLLCMember sar:PortfolioCompanysDiscretionSatisfactionOfCertainFinancialAndNonfinancialCovenantsRequiredMember 2024-11-30 0001377936 sar:InspectPointHoldingsLLCMember sar:PortfolioCompanysDiscretionSatisfactionOfCertainFinancialAndNonfinancialCovenantsRequiredMember 2024-02-29 0001377936 sar:ModisDentalPartnersOpCoLLCMember sar:PortfolioCompanysDiscretionSatisfactionOfCertainFinancialAndNonfinancialCovenantsRequiredMember 2024-11-30 0001377936 sar:ModisDentalPartnersOpCoLLCMember sar:PortfolioCompanysDiscretionSatisfactionOfCertainFinancialAndNonfinancialCovenantsRequiredMember 2024-02-29 0001377936 sar:PepperPalaceRevolverMember sar:PortfolioCompanysDiscretionSatisfactionOfCertainFinancialAndNonfinancialCovenantsRequiredMember 2024-11-30 0001377936 sar:PepperPalaceRevolverMember sar:PortfolioCompanysDiscretionSatisfactionOfCertainFinancialAndNonfinancialCovenantsRequiredMember 2024-02-29 0001377936 sar:StretchZoneFranchisingLLCMember sar:PortfolioCompanysDiscretionSatisfactionOfCertainFinancialAndNonfinancialCovenantsRequiredMember 2024-11-30 0001377936 sar:StretchZoneFranchisingLLCMember sar:PortfolioCompanysDiscretionSatisfactionOfCertainFinancialAndNonfinancialCovenantsRequiredMember 2024-02-29 0001377936 sar:VetnCareMSOLLCMember sar:PortfolioCompanysDiscretionSatisfactionOfCertainFinancialAndNonfinancialCovenantsRequiredMember 2024-11-30 0001377936 sar:VetnCareMSOLLCMember sar:PortfolioCompanysDiscretionSatisfactionOfCertainFinancialAndNonfinancialCovenantsRequiredMember 2024-02-29 0001377936 sar:ZollegePBCMember sar:PortfolioCompanysDiscretionSatisfactionOfCertainFinancialAndNonfinancialCovenantsRequiredMember 2024-11-30 0001377936 sar:ZollegePBCMember sar:PortfolioCompanysDiscretionSatisfactionOfCertainFinancialAndNonfinancialCovenantsRequiredMember 2024-02-29 0001377936 sar:DefinedBenefitPlanPortfolioMember sar:PortfolioCompanysDiscretionSatisfactionOfCertainFinancialAndNonfinancialCovenantsRequiredMember 2024-11-30 0001377936 sar:DefinedBenefitPlanPortfolioMember sar:PortfolioCompanysDiscretionSatisfactionOfCertainFinancialAndNonfinancialCovenantsRequiredMember 2024-02-29 0001377936 sar:PortfolioCompanysDiscretionSatisfactionOfCertainFinancialAndNonfinancialCovenantsRequiredMember 2024-11-30 0001377936 sar:PortfolioCompanysDiscretionSatisfactionOfCertainFinancialAndNonfinancialCovenantsRequiredMember 2024-02-29 0001377936 sar:ShareRepurchasePlanMember us-gaap:CommonStockMember 2014-09-24 0001377936 sar:ShareRepurchasePlanMember 2014-09-24 0001377936 sar:SaleOfStockUnderTheShareRepurchaseProgramTrancheOneMember sar:ShareRepurchasePlanMember 2024-11-30 0001377936 sar:SaleOfStockUnderTheShareRepurchaseProgramTrancheOneMember sar:ShareRepurchasePlanMember us-gaap:CommonStockMember 2024-11-30 0001377936 sar:PublicEquityOfferingMember 2018-07-13 2018-07-13 0001377936 2018-07-13 0001377936 us-gaap:CommonStockMember 2018-07-13 0001377936 2018-07-13 2018-07-13 0001377936 2017-03-16 2017-03-16 0001377936 2019-07-11 2019-07-11 0001377936 2019-10-08 2019-10-08 0001377936 2021-07-29 2021-07-29 0001377936 2021-07-29 0001377936 2021-07-30 2021-07-30 0001377936 srt:MaximumMember 2023-07-06 2023-07-06 0001377936 srt:MinimumMember 2023-07-06 2023-07-06 0001377936 sar:SaleOfStockUnderTheATMProgramTrancheOneMember 2024-03-01 2024-11-30 0001377936 sar:SaleOfStockUnderTheATMProgramTrancheOneMember 2024-11-30 0001377936 sar:SaleOfStockUnderTheATMProgramTrancheOneMember 2024-09-01 2024-11-30 0001377936 us-gaap:CommonStockMember 2023-02-28 0001377936 us-gaap:AdditionalPaidInCapitalMember 2023-02-28 0001377936 us-gaap:RetainedEarningsMember 2023-02-28 0001377936 us-gaap:RetainedEarningsMember 2023-03-01 2023-05-31 0001377936 2023-03-01 2023-05-31 0001377936 us-gaap:CommonStockMember 2023-03-01 2023-05-31 0001377936 us-gaap:AdditionalPaidInCapitalMember 2023-03-01 2023-05-31 0001377936 us-gaap:CommonStockMember 2023-05-31 0001377936 us-gaap:AdditionalPaidInCapitalMember 2023-05-31 0001377936 us-gaap:RetainedEarningsMember 2023-05-31 0001377936 2023-05-31 0001377936 us-gaap:RetainedEarningsMember 2023-06-01 2023-08-31 0001377936 us-gaap:CommonStockMember 2023-06-01 2023-08-31 0001377936 us-gaap:AdditionalPaidInCapitalMember 2023-06-01 2023-08-31 0001377936 us-gaap:CommonStockMember 2023-08-31 0001377936 us-gaap:AdditionalPaidInCapitalMember 2023-08-31 0001377936 us-gaap:RetainedEarningsMember 2023-08-31 0001377936 2023-08-31 0001377936 us-gaap:RetainedEarningsMember 2023-09-01 2023-11-30 0001377936 us-gaap:CommonStockMember 2023-09-01 2023-11-30 0001377936 us-gaap:AdditionalPaidInCapitalMember 2023-09-01 2023-11-30 0001377936 us-gaap:CommonStockMember 2023-11-30 0001377936 us-gaap:AdditionalPaidInCapitalMember 2023-11-30 0001377936 us-gaap:RetainedEarningsMember 2023-11-30 0001377936 us-gaap:RetainedEarningsMember 2023-12-01 2024-02-29 0001377936 2023-12-01 2024-02-29 0001377936 us-gaap:CommonStockMember 2023-12-01 2024-02-29 0001377936 us-gaap:AdditionalPaidInCapitalMember 2023-12-01 2024-02-29 0001377936 us-gaap:CommonStockMember 2024-02-29 0001377936 us-gaap:AdditionalPaidInCapitalMember 2024-02-29 0001377936 us-gaap:RetainedEarningsMember 2024-02-29 0001377936 us-gaap:RetainedEarningsMember 2024-03-01 2024-05-31 0001377936 2024-03-01 2024-05-31 0001377936 us-gaap:CommonStockMember 2024-03-01 2024-05-31 0001377936 us-gaap:AdditionalPaidInCapitalMember 2024-03-01 2024-05-31 0001377936 us-gaap:CommonStockMember 2024-05-31 0001377936 us-gaap:AdditionalPaidInCapitalMember 2024-05-31 0001377936 us-gaap:RetainedEarningsMember 2024-05-31 0001377936 2024-05-31 0001377936 us-gaap:RetainedEarningsMember 2024-06-01 2024-08-31 0001377936 us-gaap:CommonStockMember 2024-06-01 2024-08-31 0001377936 us-gaap:AdditionalPaidInCapitalMember 2024-06-01 2024-08-31 0001377936 us-gaap:CommonStockMember 2024-08-31 0001377936 us-gaap:AdditionalPaidInCapitalMember 2024-08-31 0001377936 us-gaap:RetainedEarningsMember 2024-08-31 0001377936 2024-08-31 0001377936 us-gaap:RetainedEarningsMember 2024-09-01 2024-11-30 0001377936 us-gaap:CommonStockMember 2024-09-01 2024-11-30 0001377936 us-gaap:AdditionalPaidInCapitalMember 2024-09-01 2024-11-30 0001377936 us-gaap:CommonStockMember 2024-11-30 0001377936 us-gaap:AdditionalPaidInCapitalMember 2024-11-30 0001377936 us-gaap:RetainedEarningsMember 2024-11-30 0001377936 sar:O2024H2DividendsMember 2024-11-07 0001377936 2024-11-07 0001377936 sar:O2024H2DividendsMember 2024-11-07 2024-11-07 0001377936 sar:O2024Q1DividendsMember 2024-03-01 2024-11-30 0001377936 sar:O2024Q1DividendsMember 2024-11-30 0001377936 sar:O2024Q2DividendsMember 2024-03-01 2024-11-30 0001377936 sar:O2024Q2DividendsMember 2024-11-30 0001377936 sar:O2024Q3DividendsMember 2024-03-01 2024-11-30 0001377936 sar:O2024Q3DividendsMember 2024-11-30 0001377936 sar:O2024H2DividendsMember 2024-03-01 2024-11-30 0001377936 sar:O2024H2DividendsMember 2024-11-30 0001377936 sar:O2023Q1DividendsMember 2023-03-01 2023-11-30 0001377936 sar:O2023Q1DividendsMember 2023-11-30 0001377936 sar:O2023Q2DividendsMember 2023-03-01 2023-11-30 0001377936 sar:O2023Q2DividendsMember 2023-11-30 0001377936 sar:O2023Q3DividendsMember 2023-03-01 2023-11-30 0001377936 sar:O2023Q3DividendsMember 2023-11-30 0001377936 sar:O2023H2DividendsMember 2023-03-01 2023-11-30 0001377936 sar:O2023H2DividendsMember 2023-11-30 0001377936 sar:TwoThousandAndTwentyFiveNotes3Member 2024-03-01 2024-11-30 0001377936 sar:TwoThousandAndTwentyFiveNotes3Member 2023-03-01 2023-11-30 0001377936 sar:RISKSRELATEDTOOURNOTESMember 2024-03-01 2024-11-30 xbrli:shares iso4217:USD xbrli:pure iso4217:USD xbrli:shares
TABLE OF CONTENTS
Part I. Financial InformationItem 1. Consolidated Financial StatementsNote 1. OrganizationNote 2. Summary Of Significant Accounting PoliciesNote 3. InvestmentsNote 4. Investment in Saratoga CloNote 5. Investment in Slf JvNote 6. Income TaxesNote 7. Agreements and Related Party TransactionsNote 8. BorrowingsNote 9. Commitments and ContingenciesNote 10. Directors FeesNote 11. Stockholders EquityNote 12. Earnings Per ShareNote 13. DividendNote 14. Financial HighlightsNote 15. Subsequent EventsItem 2. Management S Discussion and Analysis Of Financial Condition and Results Of OperationsItem 3. Quantitative and Qualitative Disclosures About Market RiskItem 4. Controls and ProceduresPart II. Other InformationItem 1. Legal ProceedingsItem 1A. Risk FactorsItem 2. Unregistered Sales Of Equity Securities and Use Of ProceedsItem 3. Defaults Upon Senior SecuritiesItem 4. Mine Safety DisclosuresItem 5. Other InformationItem 6. Exhibits

Exhibits

3.1(a) Articles of Incorporation of Saratoga Investment Corp. (incorporated by reference to Saratoga Investment Corp.s Quarterly Report on Form 10-Q filed on July 13, 2007). 3.1(b) Articles of Amendment of Saratoga Investment Corp. (incorporated by reference to Saratoga Investment Corp.s Current Report on Form 8-K filed on August 3, 2010). 3.1(c) Articles of Amendment of Saratoga Investment Corp. (incorporated by reference to Saratoga Investment Corp.s Current Report on Form 8-K filed on August 13, 2010). 3.2 Third Amended and Restated Bylaws of Saratoga Investment Corp. (incorporated by reference to Saratoga Investment Corp.s Quarterly Report on Form 10-Q filed January 6, 2021). 4.1 Specimen certificate of Saratoga Investment Corp.s common stock, par value $0.001 per share (incorporated by reference to Saratoga Investment Corp.s Registration Statement on Form N-2, File No. 333-169135, filed on September 1, 2010). 4.2 Registration Rights Agreement dated July 30, 2010 between GSC Investment Corp., GSC CDO III L.L.C., and the investors party thereto (incorporated by reference to Saratoga Investment Corp.s Current Report on Form 8-K filed on August 3, 2010). 4.3 Dividend Reinvestment Plan (incorporated by reference to Saratoga Investment Corp.s Current Report on Form 8-K filed on September 24, 2014). 4.4 Form of Indenture by and between the Company and U.S. Bank National Association, as trustee (incorporated by reference to Saratoga Investment Corp.s Pre-Effective Amendment No. 2 to the Registration Statement on Form N-2, File No. 333-186323 filed on April 30, 2013). 4.5 Form of Articles Supplementary Establishing and Fixing the Rights and Preferences of Preferred Stock (incorporated by reference to Saratoga Investment Corp.s Pre-Effective Amendment No. 1 to the Registration Statement on Form N-2, File No. 333-196526, filed on December 5, 2014). 4.6 Fifth Supplemental Indenture between Saratoga Investment Corp. and U.S. Bank National Association, as trustee, relating to 7.75% Notes due 2025 (incorporated by reference to Saratoga Investment Corp.s Quarterly Report on Form 10-Q, filed on January 10, 2023). 4.7 Seventh Supplemental Indenture between Saratoga Investment Corp. and U.S. Bank National Association, as trustee, relating to 6.25% Notes due 2027 (incorporated by reference to Saratoga Investment Corp.s Quarterly Report on Form 10-Q, filed on January 10, 2023). 4.8 Eighth Supplemental Indenture between the Saratoga Investment Corp. and U.S. Bank National Association, as trustee, relating to the 4.375% Note due 2026 (incorporated by reference to Exhibit 4.2 to Saratoga Investment Corp.s Current Report on Form 8-K (File No. 814-00732) filed on March 10, 2021). 4.9 Ninth Supplemental Indenture between Saratoga Investment Corp. and U.S. Bank National Association, as trustee, relating to the 4.35% Note due 2027 (incorporated by reference to Saratoga Investment Corp.s Current Report on Form 8-K (File No. 814-00732) filed on January 19, 2022). 4.10 Tenth Supplemental Indenture between Saratoga Investment Corp. and U.S. Bank National Association, as trustee, relating to the 6.00% Note due 2027 (incorporated by reference to Saratoga Investment Corp.s Current Report on Form 8-K (File No. 814-00732) filed on April 27, 2022). 4.11 Eleventh Supplemental Indenture between Saratoga Investment Corp. and U.S. Bank Trust Company, National Association (as successor in interest to U.S. Bank National Association), as trustee, relating to the 7.00% Notes due 2025 (incorporated by reference to Saratoga Investment Corp.s Quarterly Report on Form 10-Q, filed on January 10, 2023). 4.12 Twelfth Supplemental Indenture between Saratoga Investment Corp. and U.S. Bank Trust Company, National Association, as trustee, relating to the 8.00% Notes due 2027 (incorporated by reference to the Saratoga Investment Corp.s Current Report on Form 8-K (File No. 813-00732) filed on October 27, 2022). 4.13 Thirteenth Supplemental Indenture between Saratoga Investment Corp. and U.S. Bank Trust Company, National Association (as successor in interest to U.S. Bank National Association), as trustee, relating to the 8.125% Notes due 2027 (incorporated by reference to the Registrants Current Report on Form 8-K, filed on December 13, 2022). 4.15 Fifteenth Supplemental Indenture between Saratoga Investment Corp. and U.S. Bank Trust Company, National Association (as successor in interest to U.S. Bank National Association), as trustee, relating to the 8.50% Notes due 2028 (incorporated by reference to Saratoga Investment Corp.s Current Report on Form 8-K filed on April 14, 2023). 4.16 Form of 7.75% Notes due 2025 (incorporated by reference to Exhibit 4.6 hereto). 4.17 Form of 6.25% Notes due 2027 (incorporated by reference to Exhibit 4.7 hereto). 4.18 Form of 4.375% Notes due 2026 (incorporated by reference to Exhibit 4.8 hereto). 4.19 Form of 4.35% Notes due 2027 (incorporated by reference to Exhibit 4.9 hereto). 4.20 Form of 6.00% Notes due 2027 (incorporated by reference to Exhibit 4.10 hereto). 4.21 Form of 7.00% Notes due 2025 (incorporated by reference to Exhibit 4.11 hereto). 4.22 Form of 8.00% Notes due 2027 (incorporated by reference to Exhibit 4.12 hereto). 4.23 Form of 8.125% Notes due 2027 (incorporated by reference to Exhibit 4.13 hereto). 4.25 Form of 8.50% Notes due 2028 (incorporated by reference to Exhibit 4.15 hereto). 31.1* Certification of Chief Executive Officer Pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934 31.2* Certification of Chief Financial Officer Pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934 32.1* Certification of Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C.1350) 32.2* Certification of Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350)